UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number: 811-07874
JPMorgan Insurance Trust
(Exact name of registrant as specified in charter)
277 Park Avenue
New York, NY 10172
(Address of principal executive offices) (Zip code)
Gregory S. Samuels
277 Park Avenue
New York, NY 10172
(Name and Address of Agent for Service)
Registrant’s telephone number, including area code: (800) 480-4111
Date of fiscal year end: December 31
Date of reporting period: January 1, 2022 through December 31, 2022
Form N-CSR is to be used by management investment companies to file reports with the Commission not later than 10 days after the transmission to stockholders of any report that is required to be transmitted to stockholders under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1). The Commission may use the information provided on Form N-CSR in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-CSR, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-CSR unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. Section 3507.
ITEM 1. REPORTS TO STOCKHOLDERS.
a.) The following is a copy of the report transmitted to shareholders pursuant to Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1).
b.) A copy of the notice transmitted to shareholders in reliance on Rule 30e-3 under the 1940 Act that contains disclosures specified by paragraph (c)(3) of that rule is included in the Annual Reports. Not Applicable. Notices do not incorporate disclosures from the
shareholder report.
Annual Report
JPMorgan Insurance Trust
December 31, 2022
JPMorgan Insurance Trust Core Bond Portfolio |
CONTENTS
Investments in the Portfolio are not deposits or obligations of, or guaranteed or endorsed by, any bank and are not insured or guaranteed by the FDIC, the Federal Reserve Board or any other government agency. You could lose money if you sell when the Portfolio’s share price is lower than when you invested.
Past performance is no guarantee of future performance. The general market views expressed in this report are opinions based on market and other conditions through the end of the reporting period and are subject to change without notice. These views are not intended to predict the future performance of the Portfolio or the securities markets.
This Portfolio is intended to be a funding vehicle for variable annuity contracts and variable life insurance policies (collectively “Policies”) offered by the separate accounts of various insurance companies. Portfolio shares may also be offered to qualified pension and retirement plans and accounts permitting accumulation of assets on a tax-deferred basis (“Eligible Plans”). Individuals may not purchase shares directly from the Portfolio.
Prospective investors should refer to the Portfolio’s prospectuses for a discussion of the Portfolio’s investment objective, strategies and risks. Call J.P. Morgan Funds Service Center at 1-800-480-4111 for a prospectus containing more complete information about the Portfolio, including management fees and other expenses. Please read it carefully before investing.
Letter to Shareholders
February 13, 2023 (Unaudited)
Dear Shareholder,
Financial markets have rebounded somewhat as the U.S. and other developed market economies have shown notable resilience in the face of higher inflation, rising interest rates and the ongoing war in Ukraine. While the factors that weighed on equity and bond markets in 2022 largely remain, there are signals that inflationary pressures may have peaked and the long-term economic outlook appears positive.
|
“Investors may face continued economic and geopolitical challenges in the year ahead. However, some of the acute risks encountered in 2022 appear to have receded and last year’s reset in asset prices may provide attractive investment opportunities.” — Brian S. Shlissel
|
While U.S. economic growth was surprisingly strong in the closing months of 2022, with broad gains in employment and consumer spending in the final months of the year, the U.S. Federal Reserve’s efforts to counter inflationary pressure through sharply higher interest rates could slow economic momentum in the months ahead.
Corporate earnings have been squeezed by higher costs for materials and labor, while the strong U.S. dollar has hindered export revenues. However, the impact of higher prices and interest rates has not landed on all sectors of the economy evenly. Energy sector profits have soared over the past year, while earnings in housing and construction sectors have declined.
Across Europe, the war in Ukraine has driven up prices for energy, food and a range of other goods and has fueled negative consumer sentiment. The prolonged nature of the conflict and its potential to spread remain key concerns among policymakers, diplomats, military planners, economists and investors. It is worth noting that Europe’s largest industrialized nations in concert with the European Union have moved swiftly to secure alternatives to Russian sources of natural gas and petroleum, which has eased an energy crisis that began last year.
Investors may face continued economic and geopolitical challenges in the year ahead. However, some of the acute risks encountered in 2022 appear to have receded and last year’s reset in asset prices may provide attractive investment opportunities. A long-term view and a properly diversified portfolio, in our opinion, remain key elements to a successful investment approach.
Our broad array of investment solutions seeks to provide investors with ability to build durable portfolios that can help them meet their financial goals.
Sincerely,
Brian S. Shlissel
President - J.P. Morgan Funds
J.P. Morgan Asset Management
1-800-480-4111 or www.jpmorganfunds.com for more information
JPMorgan Insurance Trust Core Bond Portfolio
PORTFOLIO COMMENTARY
TWELVE MONTHS ENDED December 31, 2022 (Unaudited)
| |
Portfolio (Class 1 Shares)* | |
Bloomberg U.S. Aggregate Index | |
Net Assets as of 12/31/2022 (In Thousands) | |
Duration as of 12/31/2022 | |
INVESTMENT OBJECTIVE**
The JPMorgan Insurance Trust Core Bond Portfolio (the “Portfolio”) seeks to maximize total return by investing primarily in a diversified portfolio of intermediate- and long-term debt securities.
HOW DID THE MARKET PERFORM?
Overall, financial markets tumbled in the first three quarters of 2022, but rebounded moderately in the final months of the year. Bond markets fell amid accelerating inflation, pandemic lockdowns across China and Russia’s invasion of Ukraine. However, investor demand for U.S. Treasury bonds and core U.S. corporate debt provided some support for the Bloomberg U.S. Aggregate Index, which broadly tr acks the performance of the U.S. investment-grade bond market.
Early in 2022, investor sentiment began to sour as accelerating inflation started to erode consumer confidence and raise expectations for an increase in benchmark interest rates by the U.S. Federal Reserve (the “Fed”). Russia’s invasion of Ukraine at the end of February 2022 initiated a sell-off in global financial markets that was further fueled by the highest U.S. inflation rate in more than 40 years.
In response to accelerating inflationary pressure, the Fed raised its benchmark interest rate mid-March, the first increase since December 2018. The central bank followed with six more rate increases over the course of 2022. The Bank of England, which began raising interest rates in late 2021, also continued to raise interest rates throughout the year, while the European Central Bank waited until June before sharply raising interest rates for the first time in 11 years.
In the U.S., corporate earnings for both the second and third quarters of 2022 generally were better than expected given a cooling economy and slower consumer spending. Meanwhile, the U.S. unemployment rate remained historically low - hovering between 3.5% and 3.7% for the six-month period - and by the end of 2022 data indicated some inflationary pressures had eased.
Across Europe, the energy crisis that followed Russia’s invasion of Ukraine in late February 2022 eased somewhat in the second half of the year as both the U.K. and the EU obtained alternatives to Russian energy imports and global energy prices receded. A political crisis in the U.K. roiled financial markets in London but the ascension of Rishi Sunak to prime minister appeared to remove some investor uncertainty.
Emerging markets broadly declined during the period but there was wide variance among individual nations. Chinese equities continued to underperform amid investor concerns about the
economic impact of the country’s strict anti-pandemic policies, as well as weakness within China’s real estate sector and changes in the global trade for information. While energy prices retreated from historically high levels in the second half of 2022, overall commodities prices remained elevated, which benefitted markets in exporting nations but hurt markets in net importing nations.
For the twelve-month period, bonds in both developed and emerging markets generally declined for the year.
WHAT WERE THE MAIN DRIVERS OF THE PORTFOLIO’S PERFORMANCE?
The Portfolio’s Class 1 shares outperformed the Bloomberg U.S. Aggregate Index (the “Benchmark”) for the twelve months ended December 31, 2022.
Relative to the Benchmark, the Portfolio’s underweight allocation to agency mortgage-backed securities and its overweight position in asset-backed securities were leading contributors to performance. The Portfolio’s security selection in agency mortgage-backed securities and asset-backed securities, and its shorter duration relative to the Benchmark also contributed to relative performance. Generally, bonds of shorter duration will experience a smaller decrease in price as interest rates rise versus bonds of longer duration.
The Portfolio’s underweight allocation to U.S. Treasury securities, and its overweight allocation to corporate credit, non-agency mortgage-backed securities, and commercial mortgage-backed securities detracted from relative performance. The Portfolio’s security selection within corporate credit also detracted from relative performance.
HOW WAS THE PORTFOLIO POSITIONED?
The portfolio managers’ primary strategy was to focus on security selection and relative value, which seeks to identify undervalued bonds among individual securities and across market sectors. The portfolio managers used bottom-up fundamental research to construct what they believed to be a portfolio of undervalued fixed income securities.
Relative to the Benchmark, the Portfolio ended the reporting period with underweight positions in U.S. Treasury securities and agency mortgage-backed securities, and overweight positions in corporate credit and securitized debt sectors, including asset-backed securities, commercial mortgage-backed securities and non-agency mortgage-backed securities. The Portfolio was overweight in the intermediate part of the yield curve, underweight in the long end of the yield curve and maintained a shorter duration profile than the
*
The return shown is based on net asset values calculated for shareholder transactions and may differ from the return shown in the financial highlights, which reflects adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
**
The adviser seeks to achieve the Portfolio’s objective. There can be no guarantee it will be achieved.
Benchmark at the end of the period. The yield curve shows the relationship between yields and maturity dates for a set of similar bonds at a given point in time.
PORTFOLIO COMPOSITION BY ASSET CLASS
AS OF December 31, 2022 | PERCENT OF
TOTAL
INVESTMENTS |
U.S. Treasury Obligations | |
| |
Mortgage-Backed Securities | |
| |
Commercial Mortgage-Backed Securities | |
Collateralized Mortgage Obligations | |
Others (each less than 1.0%) | |
| |
JPMorgan Insurance Trust Core Bond Portfolio
PORTFOLIO COMMENTARY
TWELVE MONTHS ENDED December 31, 2022 (Unaudited) (continued)
AVERAGE ANNUAL TOTAL RETURNS AS OF December 31, 2022
TEN YEAR PORTFOLIO PERFORMANCE (12/31/12 TO 12/31/22)
The performance quoted is past performance and is not a guarantee of future results. Mutual funds are subject to certain market risks. Investment returns and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance data shown. For up-to-date month-end performance information please call 1-800-480-4111.
The graph illustrates comparative performance for $10,000 invested in Class 1 Shares of the JPMorgan Insurance Trust Core Bond Portfolio and the Bloomberg U.S. Aggregate Index from December 31, 2012 to December 31, 2022. The performance of the Portfolio assumes reinvestment of all dividends and capital gain distributions, if any. The performance of the Bloomberg U.S. Aggregate Index does not reflect the deduction of expenses associated with a mutual fund and has been adjusted to reflect reinvestment of all dividends and capital gain distributions of the securities included in the benchmark, if applicable. The
Bloomberg U.S. Aggregate Index is an unmanaged index that represents securities that are SEC-registered, taxable, and dollar denominated. The index covers the U.S. investment grade fixed rate bond market, with index components for government and corporate securities, mortgage pass-through securities, and asset-backed securities. Investors cannot invest directly in an index.
Portfolio performance does not reflect any charges imposed by the Policies or Eligible Plans. If these charges were included, the returns would be lower than shown. Portfolio performance may reflect the waiver of the Portfolio’s fees and reimbursement of expenses for certain periods. Without these waivers and reimbursements, performance would have been lower. The returns shown are based on net asset values calculated for shareholder transactions and may differ from the returns shown in the financial highlights, which reflect adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
JPMorgan Insurance Trust Core Bond Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022
| | |
U.S. Treasury Obligations — 25.1% |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
U.S. Treasury Inflation Indexed Bonds | | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Core Bond Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
U.S. Treasury Obligations — continued |
| | |
| | |
| | |
| | |
U.S. Treasury STRIPS Bonds | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Total U.S. Treasury Obligations
(Cost $138,877) | | |
| | |
|
Aerospace & Defense — 0.6% |
Airbus SE (France) 3.15%, 4/10/2027 (b) | | |
BAE Systems Holdings, Inc. (United Kingdom) 3.80%, 10/7/2024 (b) | | |
BAE Systems plc (United Kingdom) | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
L3Harris Technologies, Inc. 1.80%, 1/15/2031 | | |
Leidos, Inc. 2.30%, 2/15/2031 | | |
Northrop Grumman Corp. 5.15%, 5/1/2040 | | |
Raytheon Technologies Corp. | | |
| | |
| | |
| | |
| | |
| | |
| | |
|
Continental Airlines Pass-Through Trust Series 2012-2, Class A Shares, 4.00%, 10/29/2024 | | |
|
Lear Corp. 2.60%, 1/15/2032 | | |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Nissan Motor Co. Ltd. (Japan) 4.35%, 9/17/2027 (b) | | |
Stellantis Finance US, Inc. 2.69%, 9/15/2031 (b) | | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Corporate Bonds — continued |
|
ABN AMRO Bank NV (Netherlands) (US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 1.10%), 2.47%, 12/13/2029 (b) (c) | | |
AIB Group plc (Ireland) (ICE LIBOR USD 3 Month + 1.87%), 4.26%, 4/10/2025 (b) (c) | | |
ANZ New Zealand Int'l Ltd. (New Zealand) | | |
| | |
| | |
Banco Nacional de Panama (Panama) 2.50%, 8/11/2030 (b) | | |
Banco Santander SA (Spain) | | |
| | |
| | |
| | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 0.90%), 1.72%, 9/14/2027(c) | | |
| | |
Series L, 3.95%, 4/21/2025 | | |
(ICE LIBOR USD 3 Month + 0.81%), 3.37%, 1/23/2026(c) | | |
Series N, (SOFR + 0.91%), 1.66%, 3/11/2027(c) | | |
(SOFR + 0.96%), 1.73%, 7/22/2027(c) | | |
(ICE LIBOR USD 3 Month + 1.51%), 3.71%, 4/24/2028(c) | | |
(SOFR + 1.58%), 4.38%, 4/27/2028(c) | | |
(ICE LIBOR USD 3 Month + 1.07%), 3.97%, 3/5/2029(c) | | |
(SOFR + 1.06%), 2.09%, 6/14/2029(c) | | |
(SOFR + 2.15%), 2.59%, 4/29/2031(c) | | |
(SOFR + 1.53%), 1.90%, 7/23/2031(c) | | |
(SOFR + 1.21%), 2.57%, 10/20/2032(c) | | |
(SOFR + 1.33%), 2.97%, 2/4/2033(c) | | |
(SOFR + 1.93%), 2.68%, 6/19/2041(c) | | |
Bank of Ireland Group plc (Ireland) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 2.65%), 6.25%, 9/16/2026(b) (c) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 1.10%), 2.03%, 9/30/2027(b) (c) | | |
Bank of Montreal (Canada) | | |
| | |
(USD Swap Semi 5 Year + 1.43%), 3.80%, 12/15/2032(c) | | |
| | |
|
|
Banque Federative du Credit Mutuel SA (France) | | |
| | |
| | |
Barclays plc (United Kingdom) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 0.80%), 1.01%, 12/10/2024(c) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 2.30%), 5.30%, 8/9/2026(c) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 1.30%), 2.89%, 11/24/2032(c) | | |
| | |
(SOFR + 2.07%), 2.22%, 6/9/2026(b) (c) | | |
(SOFR + 1.00%), 1.32%, 1/13/2027(b) (c) | | |
(SOFR + 1.22%), 2.16%, 9/15/2029(b) (c) | | |
(SOFR + 1.51%), 3.05%, 1/13/2031(b) (c) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.05%), 2.59%, 8/12/2035(b) (c) | | |
| | |
| | |
| | |
(ICE LIBOR USD 3 Month + 1.56%), 3.89%, 1/10/2028(c) | | |
(ICE LIBOR USD 3 Month + 1.39%), 3.67%, 7/24/2028(c) | | |
(ICE LIBOR USD 3 Month + 1.15%), 3.52%, 10/27/2028(c) | | |
(ICE LIBOR USD 3 Month + 1.19%), 4.07%, 4/23/2029(c) | | |
(SOFR + 1.17%), 2.56%, 5/1/2032(c) | | |
(SOFR + 1.18%), 2.52%, 11/3/2032(c) | | |
(SOFR + 1.35%), 3.06%, 1/25/2033(c) | | |
(ICE LIBOR USD 3 Month + 1.17%), 3.88%, 1/24/2039(c) | | |
(SOFR + 1.38%), 2.90%, 11/3/2042(c) | | |
Comerica, Inc. 4.00%, 2/1/2029 | | |
Cooperatieve Rabobank UA (Netherlands) 3.75%, 7/21/2026 | | |
Credit Agricole SA (France) | | |
(SOFR + 1.68%), 1.91%, 6/16/2026(b) (c) | | |
(SOFR + 0.89%), 1.25%, 1/26/2027(b) (c) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Core Bond Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Corporate Bonds — continued |
|
DNB Bank ASA (Norway) (US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 0.68%), 1.60%, 3/30/2028 (b) (c) | | |
HSBC Holdings plc (United Kingdom) | | |
(ICE LIBOR USD 3 Month + 0.99%), 3.95%, 5/18/2024(c) | | |
(SOFR + 3.03%), 7.34%, 11/3/2026(c) | | |
(SOFR + 1.29%), 1.59%, 5/24/2027(c) | | |
(SOFR + 1.29%), 2.21%, 8/17/2029(c) | | |
(SOFR + 1.95%), 2.36%, 8/18/2031(c) | | |
| | |
| | |
ING Groep NV (Netherlands) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 1.10%), 1.40%, 7/1/2026(b) (c) | | |
| | |
KeyCorp (SOFRINDX + 2.06%), 4.79%, 6/1/2033 (c) | | |
Lloyds Banking Group plc (United Kingdom) | | |
| | |
| | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 1.60%), 3.51%, 3/18/2026(c) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 0.85%), 1.63%, 5/11/2027(c) | | |
Mitsubishi UFJ Financial Group, Inc. (Japan) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 0.75%), 1.54%, 7/20/2027(c) | | |
| | |
| | |
Mizuho Financial Group, Inc. (Japan) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 0.67%), 1.23%, 5/22/2027(c) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 2.05%), 5.41%, 9/13/2028(c) | | |
(SOFR + 1.57%), 2.87%, 9/13/2030(c) | | |
National Australia Bank Ltd. (Australia) | | |
| | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 1.88%), 3.93%, 8/2/2034(b) (c) | | |
| | |
|
|
NatWest Group plc (United Kingdom) | | |
| | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 2.55%), 3.07%, 5/22/2028(c) | | |
(ICE LIBOR USD 3 Month + 1.75%), 4.89%, 5/18/2029(c) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.10%), 3.75%, 11/1/2029(c) | | |
Nordea Bank Abp (Finland) 5.38%, 9/22/2027 (b) | | |
PNC Bank NA 2.50%, 8/27/2024 | | |
Santander UK Group Holdings plc (United Kingdom) | | |
(SOFR + 2.75%), 6.83%, 11/21/2026(c) | | |
(SOFR + 0.99%), 1.67%, 6/14/2027(c) | | |
Societe Generale SA (France) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 1.10%), 1.49%, 12/14/2026(b) (c) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 1.00%), 1.79%, 6/9/2027(b) (c) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 1.30%), 2.89%, 6/9/2032(b) (c) | | |
Standard Chartered plc (United Kingdom) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 3.10%), 7.78%, 11/16/2025(b) (c) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 1.00%), 1.46%, 1/14/2027(b) (c) | | |
Sumitomo Mitsui Financial Group, Inc. (Japan) | | |
| | |
| | |
Sumitomo Mitsui Trust Bank Ltd. (Japan) 1.55%, 3/25/2026 (b) | | |
| | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 1.20%), 1.98%, 6/3/2027(b) (c) | | |
(USD ICE Swap Rate 5 Year + 3.70%), 5.86%, 6/19/2032(b) (c) | | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Corporate Bonds — continued |
|
| | |
Westpac Banking Corp. (Australia) | | |
(USD ICE Swap Rate 5 Year + 2.24%), 4.32%, 11/23/2031(c) | | |
| | |
| | |
|
Anheuser-Busch Cos. LLC (Belgium) | | |
| | |
| | |
Anheuser-Busch InBev Finance, Inc. (Belgium) 4.70%, 2/1/2036 | | |
Anheuser-Busch InBev Worldwide, Inc. (Belgium) | | |
| | |
| | |
Coca-Cola Femsa SAB de CV (Mexico) 1.85%, 9/1/2032 | | |
Constellation Brands, Inc. | | |
| | |
| | |
Diageo Capital plc (United Kingdom) 1.38%, 9/29/2025 | | |
Fomento Economico Mexicano SAB de CV (Mexico) 3.50%, 1/16/2050 | | |
Keurig Dr Pepper, Inc. 4.42%, 12/15/2046 | | |
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
Amgen, Inc. 1.65%, 8/15/2028 | | |
Baxalta, Inc. 5.25%, 6/23/2045 | | |
Biogen, Inc. 2.25%, 5/1/2030 | | |
Gilead Sciences, Inc. 2.60%, 10/1/2040 | | |
Regeneron Pharmaceuticals, Inc. 1.75%, 9/15/2030 | | |
| | |
|
Lennox International, Inc. 1.35%, 8/1/2025 | | |
| | |
|
Building Products — continued |
| | |
| | |
| | |
| | |
|
Blackstone Holdings Finance Co. LLC 4.45%, 7/15/2045 (b) | | |
Blackstone Secured Lending Fund 3.65%, 7/14/2023 | | |
Brookfield Finance, Inc. (Canada) | | |
| | |
| | |
| | |
Charles Schwab Corp. (The) 3.20%, 3/2/2027 | | |
Credit Suisse Group AG (Switzerland) | | |
(SOFR + 1.56%), 2.59%, 9/11/2025(b) (c) | | |
(SOFR + 2.04%), 2.19%, 6/5/2026(b) (c) | | |
Deutsche Bank AG (Germany) | | |
(SOFR + 2.16%), 2.22%, 9/18/2024(c) | | |
(SOFR + 1.87%), 2.13%, 11/24/2026(c) | | |
(SOFR + 1.32%), 2.55%, 1/7/2028(c) | | |
Goldman Sachs Group, Inc. (The) | | |
(ICE LIBOR USD 3 Month + 1.20%), 3.27%, 9/29/2025(c) | | |
| | |
| | |
(SOFR + 0.91%), 1.95%, 10/21/2027(c) | | |
(SOFR + 1.11%), 2.64%, 2/24/2028(c) | | |
(ICE LIBOR USD 3 Month + 1.51%), 3.69%, 6/5/2028(c) | | |
| | |
(SOFR + 1.25%), 2.38%, 7/21/2032(c) | | |
| | |
(ICE LIBOR USD 3 Month + 1.37%), 4.02%, 10/31/2038(c) | | |
(ICE LIBOR USD 3 Month + 1.43%), 4.41%, 4/23/2039(c) | | |
Jefferies Financial Group, Inc. 6.45%, 6/8/2027 | | |
Macquarie Bank Ltd. (Australia) (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 1.70%), 3.05%, 3/3/2036 (b) (c) | | |
Macquarie Group Ltd. (Australia) | | |
| | |
(SOFR + 1.07%), 1.34%, 1/12/2027(b) (c) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Core Bond Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Corporate Bonds — continued |
Capital Markets — continued |
(ICE LIBOR USD 3 Month + 1.75%), 5.03%, 1/15/2030(b) (c) | | |
| | |
(SOFR + 1.99%), 2.19%, 4/28/2026(c) | | |
| | |
| | |
(SOFR + 1.00%), 2.48%, 1/21/2028(c) | | |
(ICE LIBOR USD 3 Month + 1.34%), 3.59%, 7/22/2028(c) | | |
(ICE LIBOR USD 3 Month + 1.14%), 3.77%, 1/24/2029(c) | | |
(ICE LIBOR USD 3 Month + 1.63%), 4.43%, 1/23/2030(c) | | |
(SOFR + 1.03%), 1.79%, 2/13/2032(c) | | |
(SOFR + 1.49%), 3.22%, 4/22/2042(c) | | |
| | |
Nomura Holdings, Inc. (Japan) | | |
| | |
| | |
Northern Trust Corp. (ICE LIBOR USD 3 Month + 1.13%), 3.38%, 5/8/2032 (c) | | |
Nuveen LLC 4.00%, 11/1/2028 (b) | | |
| | |
| | |
| | |
UBS Group AG (Switzerland) | | |
| | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 1.55%), 4.49%, 5/12/2026(b) (c) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 1.08%), 1.36%, 1/30/2027(b) (c) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 2.05%), 4.70%, 8/5/2027(b) (c) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 1.00%), 2.09%, 2/11/2032(b) (c) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 1 Year + 1.10%), 2.75%, 2/11/2033(b) (c) | | |
| | |
|
Air Products and Chemicals, Inc. 1.85%, 5/15/2027 | | |
| | |
|
|
Albemarle Corp. 5.45%, 12/1/2044 | | |
Celanese US Holdings LLC 6.05%, 3/15/2025 | | |
Chevron Phillips Chemical Co. LLC 5.13%, 4/1/2025 (b) | | |
Dow Chemical Co. (The) 4.55%, 11/30/2025 | | |
DuPont de Nemours, Inc. 5.32%, 11/15/2038 | | |
Eastman Chemical Co. 4.50%, 12/1/2028 | | |
International Flavors & Fragrances, Inc. | | |
| | |
| | |
| | |
| | |
LYB International Finance III LLC | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
RPM International, Inc. 2.95%, 1/15/2032 | | |
Union Carbide Corp. 7.75%, 10/1/2096 | | |
| | |
Commercial Services & Supplies — 0.0% ^ |
Ford Foundation (The) Series 2020, 2.82%, 6/1/2070 | | |
Construction & Engineering — 0.1% |
| | |
| | |
| | |
| | |
Construction Materials — 0.0% ^ |
Martin Marietta Materials, Inc. | | |
| | |
| | |
| | |
|
AerCap Ireland Capital DAC (Ireland) | | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Corporate Bonds — continued |
Consumer Finance — continued |
| | |
| | |
American Express Co. 4.20%, 11/6/2025 | | |
American Honda Finance Corp. 2.30%, 9/9/2026 | | |
Avolon Holdings Funding Ltd. (Ireland) | | |
| | |
| | |
| | |
| | |
| | |
| | |
Capital One Financial Corp. | | |
| | |
(SOFR + 2.16%), 4.98%, 7/24/2026(c) | | |
(SOFR + 0.86%), 1.88%, 11/2/2027(c) | | |
(SOFR + 1.27%), 2.62%, 11/2/2032(c) | | |
General Motors Financial Co., Inc. | | |
| | |
| | |
| | |
| | |
| | |
| | |
Park Aerospace Holdings Ltd. (Ireland) | | |
| | |
| | |
| | |
Containers & Packaging — 0.1% |
Graphic Packaging International LLC 1.51%, 4/15/2026 (b) | | |
Packaging Corp. of America 4.05%, 12/15/2049 | | |
| | |
| | |
| | |
| | |
Diversified Consumer Services — 0.1% |
Pepperdine University Series 2020, 3.30%, 12/1/2059 | | |
| | |
|
Diversified Consumer Services — continued |
University of Miami Series 2022, 4.06%, 4/1/2052 | | |
University of Southern California Series A, 3.23%, 10/1/2120 | | |
| | |
Diversified Financial Services — 0.2% |
Corebridge Financial, Inc. | | |
| | |
| | |
GTP Acquisition Partners I LLC 3.48%, 6/16/2025 (b) | | |
LSEGA Financing plc (United Kingdom) 2.00%, 4/6/2028 (b) | | |
ORIX Corp. (Japan) 3.25%, 12/4/2024 | | |
| | |
Diversified Telecommunication Services — 0.4% |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Deutsche Telekom International Finance BV (Germany) 4.88%, 3/6/2042 (b) | | |
Verizon Communications, Inc. | | |
| | |
| | |
| | |
| | |
| | |
| | |
Electric Utilities — 1.6% |
AEP Transmission Co. LLC 3.15%, 9/15/2049 | | |
Alabama Power Co. 6.13%, 5/15/2038 | | |
Avangrid, Inc. 3.15%, 12/1/2024 | | |
Baltimore Gas and Electric Co. | | |
| | |
| | |
CenterPoint Energy Houston Electric LLC | | |
| | |
Series AD, 2.90%, 7/1/2050 | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Core Bond Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Corporate Bonds — continued |
Electric Utilities — continued |
China Southern Power Grid International Finance BVI Co. Ltd. (China) 3.50%, 5/8/2027 (b) | | |
Cleveland Electric Illuminating Co. (The) | | |
| | |
| | |
Commonwealth Edison Co. 3.65%, 6/15/2046 | | |
Duke Energy Corp. 2.65%, 9/1/2026 | | |
Duke Energy Indiana LLC 3.75%, 5/15/2046 | | |
Duke Energy Ohio, Inc. 3.70%, 6/15/2046 | | |
Duke Energy Progress LLC 3.70%, 10/15/2046 | | |
Duquesne Light Holdings, Inc. | | |
| | |
| | |
Edison International 3.55%, 11/15/2024 | | |
Emera US Finance LP (Canada) 4.75%, 6/15/2046 | | |
Entergy Arkansas LLC 3.50%, 4/1/2026 | | |
Entergy Corp. 2.95%, 9/1/2026 | | |
| | |
| | |
| | |
| | |
| | |
Entergy Mississippi LLC 3.85%, 6/1/2049 | | |
| | |
| | |
| | |
| | |
Evergy, Inc. 2.90%, 9/15/2029 | | |
Fells Point Funding Trust 3.05%, 1/31/2027 (b) | | |
Florida Power & Light Co. 5.40%, 9/1/2035 | | |
Fortis, Inc. (Canada) 3.06%, 10/4/2026 | | |
Hydro-Quebec (Canada) Series IO, 8.05%, 7/7/2024 | | |
ITC Holdings Corp. 2.95%, 5/14/2030 (b) | | |
Jersey Central Power & Light Co. | | |
| | |
| | |
Massachusetts Electric Co. 4.00%, 8/15/2046 (b) | | |
MidAmerican Energy Co. 3.50%, 10/15/2024 | | |
Mid-Atlantic Interstate Transmission LLC 4.10%, 5/15/2028 (b) | | |
Nevada Power Co. Series CC, 3.70%, 5/1/2029 | | |
| | |
|
Electric Utilities — continued |
New England Power Co. (United Kingdom) 3.80%, 12/5/2047 (b) | | |
NextEra Energy Capital Holdings, Inc. 3.55%, 5/1/2027 | | |
Niagara Mohawk Power Corp. | | |
| | |
| | |
| | |
| | |
| | |
| | |
OGE Energy Corp. 0.70%, 5/26/2023 | | |
Oklahoma Gas and Electric Co. 0.55%, 5/26/2023 | | |
Oncor Electric Delivery Co. LLC | | |
| | |
| | |
Pacific Gas and Electric Co. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
PECO Energy Co. 2.80%, 6/15/2050 | | |
Pennsylvania Electric Co. 3.25%, 3/15/2028 (b) | | |
PG&E Recovery Funding LLC Series A-3, 5.54%, 7/15/2047 | | |
PG&E Wildfire Recovery Funding LLC | | |
Series A-2, 4.26%, 6/1/2036 | | |
Series A-4, 5.21%, 12/1/2047 | | |
Series A-5, 5.10%, 6/1/2052 | | |
Potomac Electric Power Co. 6.50%, 11/15/2037 | | |
Public Service Co. of Oklahoma Series G, 6.63%, 11/15/2037 | | |
Public Service Electric and Gas Co. 5.38%, 11/1/2039 | | |
Southern California Edison Co. | | |
Series C, 3.50%, 10/1/2023 | | |
Series B, 3.65%, 3/1/2028 | | |
Series 05-B, 5.55%, 1/15/2036 | | |
| | |
Tampa Electric Co. 4.45%, 6/15/2049 | | |
Toledo Edison Co. (The) 6.15%, 5/15/2037 | | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Corporate Bonds — continued |
Electric Utilities — continued |
Union Electric Co. 2.95%, 6/15/2027 | | |
Virginia Electric and Power Co. 6.35%, 11/30/2037 | | |
| | |
Electronic Equipment, Instruments & Components — 0.1% |
| | |
| | |
| | |
| | |
Corning, Inc. 3.90%, 11/15/2049 | | |
| | |
Energy Equipment & Services — 0.2% |
Baker Hughes Holdings LLC | | |
| | |
| | |
| | |
| | |
| | |
| | |
NOV, Inc. 3.60%, 12/1/2029 | | |
Schlumberger Finance Canada Ltd. 1.40%, 9/17/2025 | | |
Schlumberger Holdings Corp. 3.90%, 5/17/2028 (b) | | |
| | |
|
Activision Blizzard, Inc. 1.35%, 9/15/2030 | | |
Equity Real Estate Investment Trusts (REITs) — 1.8% |
Alexandria Real Estate Equities, Inc. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
Equity Real Estate Investment Trusts (REITs) — continued |
| | |
| | |
| | |
| | |
Brixmor Operating Partnership LP | | |
| | |
| | |
| | |
| | |
Corporate Office Properties LP | | |
| | |
| | |
Crown Castle, Inc. 4.00%, 3/1/2027 | | |
Digital Realty Trust LP 3.70%, 8/15/2027 | | |
| | |
| | |
| | |
| | |
| | |
| | |
GAIF Bond Issuer Pty. Ltd. (Australia) 3.40%, 9/30/2026 (b) | | |
Goodman US Finance Three LLC (Australia) 3.70%, 3/15/2028 (b) | | |
Healthcare Realty Holdings LP | | |
| | |
| | |
Healthpeak Properties, Inc. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Mid-America Apartments LP | | |
| | |
| | |
National Retail Properties, Inc. | | |
| | |
| | |
Office Properties Income Trust | | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Core Bond Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Corporate Bonds — continued |
Equity Real Estate Investment Trusts (REITs) — continued |
Physicians Realty LP 2.63%, 11/1/2031 | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Regency Centers LP 2.95%, 9/15/2029 | | |
Sabra Health Care LP 3.20%, 12/1/2031 | | |
Safehold Operating Partnership LP 2.85%, 1/15/2032 | | |
Scentre Group Trust 1 (Australia) 3.50%, 2/12/2025 (b) | | |
SITE Centers Corp. 3.63%, 2/1/2025 | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Vornado Realty LP 3.50%, 1/15/2025 | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Food & Staples Retailing — 0.3% |
| | |
| | |
| | |
| | |
Alimentation Couche-Tard, Inc. (Canada) | | |
| | |
| | |
| | |
| | |
|
Food & Staples Retailing — continued |
| | |
| | |
| | |
Series 2013, 4.70%, 1/10/2036(b) | | |
| | |
| | |
| | |
| | |
|
Bimbo Bakeries USA, Inc. (Mexico) 4.00%, 5/17/2051 (b) | | |
Bunge Ltd. Finance Corp. 2.75%, 5/14/2031 | | |
Campbell Soup Co. 3.13%, 4/24/2050 | | |
Conagra Brands, Inc. 5.30%, 11/1/2038 | | |
General Mills, Inc. 3.00%, 2/1/2051 | | |
| | |
| | |
| | |
McCormick & Co., Inc. 2.50%, 4/15/2030 | | |
Mead Johnson Nutrition Co. (United Kingdom) 4.13%, 11/15/2025 | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
| | |
| | |
| | |
Boston Gas Co. 4.49%, 2/15/2042 (b) | | |
Brooklyn Union Gas Co. (The) 4.27%, 3/15/2048 (b) | | |
ONE Gas, Inc. 2.00%, 5/15/2030 | | |
Piedmont Natural Gas Co., Inc. 3.50%, 6/1/2029 | | |
Southern California Gas Co. | | |
Series XX, 2.55%, 2/1/2030 | | |
| | |
Southern Natural Gas Co. LLC | | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Corporate Bonds — continued |
Gas Utilities — continued |
| | |
Southwest Gas Corp. 3.80%, 9/29/2046 | | |
| | |
Health Care Equipment & Supplies — 0.1% |
Abbott Laboratories 4.75%, 11/30/2036 | | |
Becton Dickinson and Co. 4.67%, 6/6/2047 | | |
Boston Scientific Corp. 4.55%, 3/1/2039 | | |
DH Europe Finance II SARL 3.25%, 11/15/2039 | | |
| | |
Health Care Providers & Services — 0.8% |
Advocate Health & Hospitals Corp. Series 2020, 2.21%, 6/15/2030 | | |
Ascension Health Series B, 2.53%, 11/15/2029 | | |
Children's Hospital Series 2020, 2.93%, 7/15/2050 | | |
Cigna Corp. 4.50%, 2/25/2026 | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Hackensack Meridian Health, Inc. | | |
Series 2020, 2.68%, 9/1/2041 | | |
Series 2020, 2.88%, 9/1/2050 | | |
| | |
| | |
| | |
| | |
Memorial Health Services 3.45%, 11/1/2049 | | |
Mount Sinai Hospitals Group, Inc. Series 2017, 3.98%, 7/1/2048 | | |
MultiCare Health System 2.80%, 8/15/2050 | | |
MyMichigan Health Series 2020, 3.41%, 6/1/2050 | | |
Providence St. Joseph Health Obligated Group Series H, 2.75%, 10/1/2026 | | |
| | |
|
Health Care Providers & Services — continued |
Quest Diagnostics, Inc. 3.45%, 6/1/2026 | | |
Texas Health Resources 2.33%, 11/15/2050 | | |
| | |
| | |
| | |
| | |
| | |
Universal Health Services, Inc. 2.65%, 10/15/2030 | | |
Yale-New Haven Health Services Corp. Series 2020, 2.50%, 7/1/2050 | | |
| | |
Hotels, Restaurants & Leisure — 0.0% ^ |
McDonald's Corp. 4.70%, 12/9/2035 | | |
Household Durables — 0.0% ^ |
Lennar Corp. 4.50%, 4/30/2024 | | |
Independent Power and Renewable Electricity Producers — 0.2% |
Alexander Funding Trust 1.84%, 11/15/2023 (b) | | |
Constellation Energy Generation LLC | | |
| | |
| | |
| | |
Southern Power Co. 5.15%, 9/15/2041 | | |
Tri-State Generation and Transmission Association, Inc. 4.25%, 6/1/2046 | | |
| | |
Industrial Conglomerates — 0.0% ^ |
Honeywell International, Inc. 2.50%, 11/1/2026 | | |
|
AIA Group Ltd. (Hong Kong) | | |
| | |
| | |
| | |
Assurant, Inc. 4.20%, 9/27/2023 | | |
| | |
| | |
| | |
| | |
| | |
Berkshire Hathaway Finance Corp. | | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Core Bond Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Corporate Bonds — continued |
|
| | |
Brown & Brown, Inc. 2.38%, 3/15/2031 | | |
Chubb INA Holdings, Inc. 2.70%, 3/13/2023 | | |
CNA Financial Corp. 3.95%, 5/15/2024 | | |
F&G Global Funding 1.75%, 6/30/2026 (b) | | |
Guardian Life Insurance Co. of America (The) 4.85%, 1/24/2077 (b) | | |
Hanover Insurance Group, Inc. (The) 2.50%, 9/1/2030 | | |
Hartford Financial Services Group, Inc. (The) 4.30%, 4/15/2043 | | |
Jackson National Life Global Funding 3.88%, 6/11/2025 (b) | | |
Liberty Mutual Group, Inc. | | |
| | |
| | |
Markel Corp. 3.63%, 3/30/2023 | | |
MetLife, Inc. 4.13%, 8/13/2042 | | |
New York Life Global Funding 2.35%, 7/14/2026 (b) | | |
New York Life Insurance Co. 4.45%, 5/15/2069 (b) | | |
Northwestern Mutual Global Funding 1.70%, 6/1/2028 (b) | | |
Pacific Life Insurance Co. (ICE LIBOR USD 3 Month + 2.80%), 4.30%, 10/24/2067 (b) (c) | | |
Principal Financial Group, Inc. 3.70%, 5/15/2029 | | |
Prudential Financial, Inc. 3.91%, 12/7/2047 | | |
Prudential Insurance Co. of America (The) 8.30%, 7/1/2025 (b) | | |
Teachers Insurance & Annuity Association of America 4.27%, 5/15/2047 (b) | | |
| | |
Internet & Direct Marketing Retail — 0.2% |
| | |
| | |
| | |
eBay, Inc. 2.60%, 5/10/2031 | | |
| | |
|
CGI, Inc. (Canada) 2.30%, 9/14/2031 | | |
| | |
| | |
| | |
|
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
Hasbro, Inc. 3.90%, 11/19/2029 | | |
Life Sciences Tools & Services — 0.1% |
Thermo Fisher Scientific, Inc. 2.00%, 10/15/2031 | | |
|
nVent Finance SARL (United Kingdom) 4.55%, 4/15/2028 | | |
Otis Worldwide Corp. 2.57%, 2/15/2030 | | |
Parker-Hannifin Corp. 4.45%, 11/21/2044 | | |
Xylem, Inc. 2.25%, 1/30/2031 | | |
| | |
|
Charter Communications Operating LLC | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Discovery Communications LLC | | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Corporate Bonds — continued |
|
Paramount Global 4.00%, 1/15/2026 | | |
Time Warner Cable Enterprises LLC 8.38%, 7/15/2033 | | |
| | |
| | |
| | |
| | |
| | |
|
Glencore Funding LLC (Australia) | | |
| | |
| | |
Nucor Corp. 2.98%, 12/15/2055 | | |
Reliance Steel & Aluminum Co. 1.30%, 8/15/2025 | | |
Steel Dynamics, Inc. 1.65%, 10/15/2027 | | |
| | |
Multiline Retail — 0.0% ^ |
Nordstrom, Inc. 4.25%, 8/1/2031 | | |
|
Ameren Illinois Co. 3.25%, 3/15/2050 | | |
CenterPoint Energy, Inc. 1.45%, 6/1/2026 | | |
| | |
| | |
| | |
Consolidated Edison Co. of New York, Inc. | | |
| | |
| | |
Consumers Energy Co. 3.25%, 8/15/2046 | | |
Delmarva Power & Light Co. 4.15%, 5/15/2045 | | |
New York State Electric & Gas Corp. 3.25%, 12/1/2026 (b) | | |
| | |
| | |
| | |
San Diego Gas & Electric Co. 5.35%, 5/15/2035 | | |
Southern Co. Gas Capital Corp. | | |
| | |
| | |
| | |
| | |
| | |
|
Multi-Utilities — continued |
| | |
WEC Energy Group, Inc. 3.55%, 6/15/2025 | | |
| | |
Oil, Gas & Consumable Fuels — 1.8% |
Aker BP ASA (Norway) 2.00%, 7/15/2026 (b) | | |
APA Infrastructure Ltd. (Australia) | | |
| | |
| | |
Boardwalk Pipelines LP 3.40%, 2/15/2031 | | |
BP Capital Markets America, Inc. | | |
| | |
| | |
| | |
| | |
BP Capital Markets plc (United Kingdom) 3.28%, 9/19/2027 | | |
Buckeye Partners LP 5.85%, 11/15/2043 | | |
Cameron LNG LLC 3.70%, 1/15/2039 (b) | | |
Chevron USA, Inc. 3.25%, 10/15/2029 | | |
Coterra Energy, Inc. 3.90%, 5/15/2027 | | |
Eastern Gas Transmission & Storage, Inc. 3.90%, 11/15/2049 | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Eni USA, Inc. (Italy) 7.30%, 11/15/2027 | | |
Enterprise Products Operating LLC | | |
| | |
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Core Bond Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Corporate Bonds — continued |
Oil, Gas & Consumable Fuels — continued |
EQM Midstream Partners LP 5.50%, 7/15/2028 | | |
EQT Corp. 3.90%, 10/1/2027 | | |
Equinor ASA (Norway) 3.25%, 11/10/2024 | | |
Exxon Mobil Corp. 3.00%, 8/16/2039 | | |
Flex Intermediate Holdco LLC | | |
| | |
| | |
Galaxy Pipeline Assets Bidco Ltd. (United Arab Emirates) 2.94%, 9/30/2040 (b) | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Magellan Midstream Partners LP 3.20%, 3/15/2025 | | |
Marathon Petroleum Corp. 4.70%, 5/1/2025 | | |
| | |
| | |
| | |
NGPL PipeCo LLC 3.25%, 7/15/2031 (b) | | |
| | |
| | |
| | |
ONEOK, Inc. 2.20%, 9/15/2025 | | |
| | |
| | |
| | |
Pioneer Natural Resources Co. 1.90%, 8/15/2030 | | |
Plains All American Pipeline LP | | |
| | |
| | |
| | |
Sabine Pass Liquefaction LLC | | |
| | |
| | |
| | |
Spectra Energy Partners LP 4.50%, 3/15/2045 | | |
Suncor Energy, Inc. (Canada) | | |
| | |
| | |
| | |
|
Oil, Gas & Consumable Fuels — continued |
Targa Resources Corp. 4.20%, 2/1/2033 | | |
Texas Eastern Transmission LP 3.50%, 1/15/2028 (b) | | |
TotalEnergies Capital International SA (France) | | |
| | |
| | |
| | |
TransCanada PipeLines Ltd. (Canada) | | |
| | |
| | |
| | |
| | |
| | |
| | |
|
Estee Lauder Cos., Inc. (The) | | |
| | |
| | |
GSK Consumer Healthcare Capital US LLC 3.38%, 3/24/2029 | | |
| | |
|
AstraZeneca plc (United Kingdom) | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Mylan, Inc. 5.40%, 11/29/2043 | | |
Royalty Pharma plc 1.20%, 9/2/2025 | | |
Shire Acquisitions Investments Ireland DAC 3.20%, 9/23/2026 | | |
Takeda Pharmaceutical Co. Ltd. (Japan) | | |
| | |
| | |
Utah Acquisition Sub, Inc. 3.95%, 6/15/2026 | | |
Viatris, Inc. 2.30%, 6/22/2027 | | |
Zoetis, Inc. 2.00%, 5/15/2030 | | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Corporate Bonds — continued |
|
Burlington Northern Santa Fe LLC | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
JB Hunt Transport Services, Inc. 3.85%, 3/15/2024 | | |
Kansas City Southern 4.70%, 5/1/2048 | | |
| | |
| | |
| | |
Penske Truck Leasing Co. LP | | |
| | |
| | |
| | |
Triton Container International Ltd. (Bermuda) 1.15%, 6/7/2024 (b) | | |
Union Pacific Corp. 4.10%, 9/15/2067 | | |
| | |
Semiconductors & Semiconductor Equipment — 0.6% |
Analog Devices, Inc. 2.80%, 10/1/2041 | | |
| | |
| | |
| | |
| | |
Intel Corp. 3.10%, 2/15/2060 | | |
KLA Corp. 3.30%, 3/1/2050 | | |
Microchip Technology, Inc. | | |
| | |
| | |
| | |
| | |
| | |
| | |
TSMC Arizona Corp. (Taiwan) 4.50%, 4/22/2052 | | |
| | |
|
Semiconductors & Semiconductor Equipment — continued |
TSMC Global Ltd. (Taiwan) 4.63%, 7/22/2032 (b) | | |
Xilinx, Inc. 2.38%, 6/1/2030 | | |
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Workday, Inc. 3.50%, 4/1/2027 | | |
| | |
|
AutoZone, Inc. 1.65%, 1/15/2031 | | |
| | |
| | |
| | |
| | |
| | |
| | |
O'Reilly Automotive, Inc. | | |
| | |
| | |
| | |
Technology Hardware, Storage & Peripherals — 0.2% |
| | |
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Core Bond Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Corporate Bonds — continued |
Technology Hardware, Storage & Peripherals — continued |
| | |
HP, Inc. 3.00%, 6/17/2027 | | |
| | |
Thrifts & Mortgage Finance — 0.2% |
| | |
| | |
| | |
(SOFR + 1.52%), 1.65%, 10/6/2026(b) (c) | | |
(SOFR + 1.31%), 2.28%, 1/20/2032(b) (c) | | |
| | |
|
Altria Group, Inc. 2.45%, 2/4/2032 | | |
BAT Capital Corp. (United Kingdom) | | |
| | |
| | |
| | |
| | |
BAT International Finance plc (United Kingdom) 1.67%, 3/25/2026 | | |
| | |
Trading Companies & Distributors — 0.3% |
| | |
| | |
| | |
| | |
| | |
| | |
Aviation Capital Group LLC | | |
| | |
| | |
WW Grainger, Inc. 4.60%, 6/15/2045 | | |
| | |
Transportation Infrastructure — 0.1% |
Sydney Airport Finance Co. Pty. Ltd. (Australia) 3.38%, 4/30/2025 (b) | | |
|
American Water Capital Corp. | | |
| | |
| | |
| | |
| | |
| | |
|
Wireless Telecommunication Services — 0.3% |
America Movil SAB de CV (Mexico) 4.38%, 4/22/2049 | | |
Rogers Communications, Inc. (Canada) 4.55%, 3/15/2052 (b) | | |
T-Mobile USA, Inc. 3.88%, 4/15/2030 | | |
Vodafone Group plc (United Kingdom) | | |
| | |
| | |
| | |
Total Corporate Bonds
(Cost $136,241) | | |
Mortgage-Backed Securities — 20.6% |
| | |
Pool # 611141, ARM, 3.72%, 1/1/2027(e) | | |
Pool # 846812, ARM, 3.80%, 4/1/2030(e) | | |
Pool # 1B1665, ARM, 2.83%, 4/1/2034(e) | | |
Pool # 1B2844, ARM, 2.23%, 3/1/2035(e) | | |
Pool # 1B3209, ARM, 3.46%, 1/1/2037(e) | | |
FHLMC Gold Pools, 30 Year | | |
Pool # G00981, 8.50%, 7/1/2028 | | |
Pool # C00785, 6.50%, 6/1/2029 | | |
Pool # C01292, 6.00%, 2/1/2032 | | |
Pool # A13625, 5.50%, 10/1/2033 | | |
Pool # A28796, 6.50%, 11/1/2034 | | |
Pool # A46417, 7.00%, 4/1/2035 | | |
Pool # V83115, 4.50%, 3/1/2047 | | |
Pool # Q48338, 4.50%, 5/1/2047 | | |
Pool # G61060, 4.50%, 6/1/2047 | | |
| | |
Pool # P20570, 7.00%, 7/1/2029 | | |
Pool # WN2203, 3.75%, 8/1/2032 | | |
Pool # U80265, 3.50%, 4/1/2033 | | |
Pool # U90690, 3.50%, 6/1/2042 | | |
Pool # U90975, 4.00%, 6/1/2042 | | |
Pool # U99134, 4.00%, 1/1/2046 | | |
| | |
Pool # RA2008, 4.00%, 1/1/2050 | | |
Pool # QB1397, 2.50%, 7/1/2050 | | |
Pool # QB1284, 3.50%, 7/1/2050 | | |
Pool # QB1248, 4.00%, 7/1/2050 | | |
Pool # RA6702, 3.00%, 2/1/2052 | | |
| | |
Pool # 303532, ARM, 4.03%, 3/1/2029(e) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Mortgage-Backed Securities — continued |
Pool # 745446, ARM, 3.56%, 4/1/2033(e) | | |
Pool # 722985, ARM, 3.90%, 7/1/2033(e) | | |
Pool # 766610, ARM, 3.36%, 1/1/2034(e) | | |
Pool # 735332, ARM, 3.84%, 8/1/2034(e) | | |
Pool # 735740, ARM, 3.19%, 10/1/2034(e) | | |
Pool # 810896, ARM, 4.74%, 1/1/2035(e) | | |
Pool # 823660, ARM, 3.15%, 5/1/2035(e) | | |
| | |
Pool # 949415, 4.50%, 3/1/2023 | | |
Pool # 962871, 4.50%, 5/1/2023 | | |
| | |
Pool # 762498, 5.00%, 11/1/2023 | | |
Pool # 255609, 4.50%, 1/1/2025 | | |
Pool # FM1345, 4.50%, 11/1/2038 | | |
| | |
Pool # 250375, 6.50%, 9/1/2025 | | |
Pool # 689977, 8.00%, 3/1/2027 | | |
Pool # 755973, 8.00%, 11/1/2028 | | |
Pool # 252211, 6.00%, 1/1/2029 | | |
Pool # 524949, 7.50%, 3/1/2030 | | |
Pool # 622534, 3.00%, 9/1/2031 | | |
Pool # 788150, 6.00%, 3/1/2032 | | |
Pool # 545639, 6.50%, 4/1/2032 | | |
Pool # 674349, 6.00%, 3/1/2033 | | |
Pool # AD0755, 7.00%, 6/1/2035 | | |
Pool # 833039, 5.00%, 9/1/2035 | | |
Pool # 745932, 6.50%, 11/1/2036 | | |
Pool # 944831, 5.50%, 2/1/2038 | | |
Pool # 961799, 5.50%, 3/1/2038 | | |
Pool # 985558, 5.50%, 6/1/2038 | | |
Pool # AL3438, 6.50%, 10/1/2038 | | |
Pool # AA4236, 4.50%, 4/1/2039 | | |
Pool # 935241, 4.50%, 5/1/2039 | | |
Pool # MA2535, 4.50%, 2/1/2046 | | |
Pool # BH4683, 4.00%, 6/1/2047 | | |
Pool # BH4684, 4.00%, 6/1/2047 | | |
Pool # BH4685, 4.00%, 6/1/2047 | | |
Pool # BK9030, 5.00%, 10/1/2048 | | |
Pool # BM5430, 5.00%, 1/1/2049 | | |
Pool # BN5899, 5.00%, 2/1/2049 | | |
Pool # BK8745, 4.50%, 4/1/2049 | | |
Pool # BN4707, 5.00%, 4/1/2049 | | |
Pool # FM1939, 4.50%, 5/1/2049 | | |
Pool # CA3713, 5.00%, 6/1/2049 | | |
Pool # BN6475, 4.00%, 7/1/2049 | | |
| | |
|
Pool # BO2170, 4.00%, 7/1/2049 | | |
Pool # BO2305, 4.00%, 7/1/2049 | | |
Pool # BK8758, 4.50%, 7/1/2049 | | |
Pool # BO5625, 3.50%, 8/1/2049 | | |
Pool # BP4357, 3.00%, 2/1/2050 | | |
Pool # CA5702, 2.50%, 5/1/2050 | | |
Pool # BP6439, 2.50%, 7/1/2050 | | |
Pool # BU0070, 2.50%, 10/1/2051 | | |
Pool # BU1805, 2.50%, 12/1/2051 | | |
Pool # CB2637, 2.50%, 1/1/2052 | | |
Pool # CB2670, 3.00%, 1/1/2052 | | |
Pool # FS0882, 2.50%, 3/1/2052(f) | | |
| | |
Pool # 506427, 9.00%, 4/1/2025 | | |
Pool # 535442, 8.50%, 6/1/2030 | | |
| | |
Pool # AM4660, 3.77%, 12/1/2025 | | |
Pool # AN0890, 2.63%, 3/1/2026 | | |
Pool # AM7321, 3.12%, 11/1/2026 | | |
Pool # AM7515, 3.34%, 2/1/2027 | | |
Pool # AN1600, 2.59%, 6/1/2028 | | |
Pool # AN9686, 3.52%, 6/1/2028 | | |
Pool # 109452, 3.64%, 8/1/2028 | | |
Pool # 405220, 6.00%, 9/1/2028 | | |
Pool # BL1040, 3.81%, 12/1/2028 | | |
Pool # BL4435, 2.42%, 10/1/2029 | | |
Pool # AN6846, 2.93%, 10/1/2029 | | |
Pool # BL4333, 2.52%, 11/1/2029 | | |
Pool # BS0448, 1.27%, 12/1/2029 | | |
Pool # AN9976, 3.96%, 2/1/2030 | | |
Pool # BL6267, 2.01%, 4/1/2030 | | |
Pool # AM8692, 3.03%, 4/1/2030 | | |
Pool # AM8544, 3.08%, 4/1/2030 | | |
Pool # BS7168, 4.57%, 6/1/2030 | | |
Pool # BL6386, 2.02%, 8/1/2030 | | |
Pool # BL9251, 1.45%, 10/1/2030 | | |
Pool # AM4789, 4.18%, 11/1/2030 | | |
Pool # BL9645, 1.50%, 1/1/2031 | | |
Pool # BL9627, 1.56%, 1/1/2031 | | |
Pool # BS4313, 1.98%, 1/1/2032 | | |
Pool # BM7037, 1.75%, 3/1/2032(e) | | |
Pool # BS5907, 3.54%, 6/1/2032 | | |
Pool # BS6258, 3.70%, 8/1/2032 | | |
Pool # BS6611, 3.72%, 8/1/2032 | | |
Pool # BS6305, 3.68%, 9/1/2032 | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Core Bond Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Mortgage-Backed Securities — continued |
Pool # BS6339, 3.80%, 9/1/2032 | | |
Pool # BS6822, 3.81%, 10/1/2032 | | |
Pool # BS6845, 4.22%, 10/1/2032 | | |
Pool # BS6601, 3.54%, 11/1/2032 | | |
Pool # BS7115, 3.81%, 11/1/2032 | | |
Pool # BS6819, 4.12%, 11/1/2032 | | |
Pool # BS7090, 4.45%, 12/1/2032 | | |
Pool # BS7298, 4.86%, 12/1/2032 | | |
Pool # 754922, 5.50%, 9/1/2033 | | |
Pool # BS7097, 4.67%, 11/1/2034 | | |
Pool # BL7110, 1.76%, 7/1/2035 | | |
Pool # 847108, 6.50%, 10/1/2035 | | |
Pool # AL9678, 4.00%, 2/1/2036 | | |
Pool # AN1330, 3.19%, 3/1/2036 | | |
Pool # 257172, 5.50%, 4/1/2038 | | |
Pool # AO9352, 4.00%, 7/1/2042 | | |
Pool # MA1125, 4.00%, 7/1/2042 | | |
Pool # MA1178, 4.00%, 9/1/2042 | | |
Pool # MA1437, 3.50%, 5/1/2043 | | |
Pool # AL6167, 3.50%, 1/1/2044 | | |
Pool # MA2545, 3.50%, 2/1/2046 | | |
Pool # MA2793, 3.50%, 10/1/2046 | | |
Pool # BF0558, 5.00%, 12/1/2049 | | |
Pool # BF0230, 5.50%, 1/1/2058 | | |
Pool # BF0464, 3.50%, 3/1/2060 | | |
Pool # BF0497, 3.00%, 7/1/2060 | | |
Pool # BF0546, 2.50%, 7/1/2061 | | |
Pool # BF0560, 2.50%, 9/1/2061 | | |
Pool # BF0583, 4.00%, 12/1/2061 | | |
Pool # BF0586, 5.00%, 12/1/2061 | | |
FREMF Mortgage Trust , 6.64%, 1/25/2029(b) (e) | | |
| | |
Pool # 326977, 7.50%, 5/15/2023 | | |
Pool # 405535, 7.00%, 12/15/2025 | | |
Pool # 412336, 8.00%, 10/15/2027 | | |
Pool # 451507, 8.00%, 10/15/2027 | | |
Pool # 412369, 7.00%, 11/15/2027 | | |
Pool # 467705, 6.50%, 3/15/2028 | | |
Pool # 472679, 7.00%, 6/15/2028 | | |
Pool # 486537, 7.50%, 9/15/2028 | | |
Pool # 781614, 7.00%, 6/15/2033 | | |
Pool # 617653, 6.00%, 5/15/2037 | | |
Pool # 678574, 5.50%, 6/15/2038 | | |
Pool # 681554, 5.50%, 7/15/2038 | | |
| | |
|
Pool # 678169, 5.50%, 9/15/2038 | | |
Pool # 681568, 5.50%, 9/15/2038 | | |
Pool # 694458, 6.00%, 10/15/2038 | | |
Pool # 782510, 6.50%, 12/15/2038 | | |
| | |
Pool # CE5524, ARM, 6.39%, 8/20/2071(e) | | |
Pool # CK2783, ARM, 6.26%, 2/20/2072(e) | | |
Pool # CK2799, ARM, 6.26%, 3/20/2072(e) | | |
Pool # CK2805, ARM, 6.22%, 4/20/2072(e) | | |
Pool # CK2810, ARM, 6.22%, 4/20/2072(e) | | |
Pool # CP1819, ARM, 6.36%, 7/20/2072(e) | | |
| | |
Pool # 2006, 8.50%, 5/20/2025 | | |
Pool # 2324, 8.00%, 11/20/2026 | | |
Pool # 2341, 7.50%, 12/20/2026 | | |
Pool # 2362, 8.00%, 1/20/2027 | | |
Pool # BJ9823, 3.75%, 4/20/2048 | | |
Pool # BP4337, 4.50%, 9/20/2049 | | |
Pool # BP5551, 4.50%, 9/20/2049 | | |
Pool # BR0553, 4.50%, 2/20/2050 | | |
Pool # BS7393, 4.00%, 3/20/2050 | | |
Pool # BT8093, 3.50%, 4/20/2050 | | |
Pool # BS7411, 4.00%, 4/20/2050 | | |
Pool # BT4341, 3.00%, 7/20/2050 | | |
Pool # MA7534, 2.50%, 8/20/2051 | | |
Pool # MA7649, 2.50%, 10/20/2051 | | |
Pool # CK2698, 3.00%, 2/20/2052 | | |
Pool # CL1821, 3.50%, 2/20/2052 | | |
Pool # CK1634, 4.00%, 2/20/2052 | | |
Pool # CM2161, 3.00%, 3/20/2052 | | |
Pool # CM2213, 3.00%, 3/20/2052 | | |
Pool # CN3556, 4.50%, 5/20/2052 | | |
Pool # MA8200, 4.00%, 8/20/2052 | | |
GNMA II, Other Pool # AD0018, 3.75%, 12/20/2032 | | |
Total Mortgage-Backed Securities
(Cost $106,015) | | |
Asset-Backed Securities — 15.0% |
ACC Trust Series 2022-1, Class B, 2.55%, 2/20/2025(b) | | |
Air Canada Pass-Through Trust (Canada) | | |
Series 2013-1, Class A, 4.13%, 5/15/2025(b) | | |
Series 2015-1, Class A, 3.60%, 3/15/2027(b) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Asset-Backed Securities — continued |
Series 2017-1, Class AA, 3.30%, 1/15/2030(b) | | |
Series 2017-1, Class A, 3.55%, 1/15/2030(b) | | |
American Airlines Pass-Through Trust | | |
Series 2014-1, Class A, 3.70%, 10/1/2026 | | |
Series 2016-3, Class AA, 3.00%, 10/15/2028 | | |
American Homes 4 Rent Trust | | |
Series 2014-SFR2, Class A, 3.79%, 10/17/2036(b) | | |
Series 2014-SFR2, Class C, 4.71%, 10/17/2036(b) | | |
Series 2014-SFR3, Class A, 3.68%, 12/17/2036(b) | | |
Series 2014-SFR3, Class E, 6.42%, 12/17/2036(b) | | |
Series 2015-SFR1, Class D, 4.41%, 4/17/2052(b) | | |
Series 2015-SFR1, Class E, 5.64%, 4/17/2052(b) | | |
Series 2015-SFR2, Class C, 4.69%, 10/17/2052(b) | | |
| | |
| | |
| | |
| | |
Series 2020-SFR1, Class E, 3.22%, 4/17/2037(b) | | |
Series 2020-SFR2, Class C, 2.53%, 7/17/2037(b) | | |
Series 2020-SFR3, Class E2, 2.76%, 9/17/2037(b) | | |
Series 2020-SFR4, Class C, 1.86%, 11/17/2037(b) | | |
Series 2021-SFR1, Class D, 2.60%, 6/17/2038(b) (e) | | |
Series 2022-SFR3, Class E2, 4.00%, 10/17/2039(b) | | |
Avid Automobile Receivables Trust Series 2021-1, Class C, 1.55%, 5/15/2026(b) | | |
Bridge Trust Series 2022-SFR1, Class C, 4.45%, 11/17/2037(b) | | |
British Airways Pass-Through Trust (United Kingdom) | | |
Series 2018-1, Class AA, 3.80%, 9/20/2031(b) | | |
| | |
|
Series 2018-1, Class A, 4.13%, 9/20/2031(b) | | |
Series 2019-1, Class AA, 3.30%, 12/15/2032(b) | | |
Business Jet Securities LLC | | |
Series 2020-1A, Class A, 2.98%, 11/15/2035‡ (b) | | |
Series 2021-1A, Class A, 2.16%, 4/15/2036‡ (b) | | |
BXG Receivables Note Trust Series 2022-A, Class C, 5.35%, 9/28/2037(b) | | |
Camillo Issuer LLC Series 2016-SFR, Class 1-A-1, 5.00%, 12/5/2023‡ | | |
Cars Net Lease Mortgage Notes Series 2020-1A, Class A3, 3.10%, 12/15/2050(b) | | |
Carvana Auto Receivables Trust | | |
Series 2019-4A, Class D, 3.07%, 7/15/2025(b) | | |
Series 2020-N1A, Class D, 3.43%, 1/15/2026(b) | | |
CFIN Issuer LLC Series 2022-RTL1, Class AA, 3.25%, 2/16/2026‡ (b) | | |
CIG Auto Receivables Trust Series 2020-1A, Class C, 1.75%, 1/12/2026(b) | | |
Consumer Receivables Asset Investment Trust Series 2021-1, Class A1X, 8.21%, 3/24/2023(b) (e) | | |
Continental Finance Credit Card ABS Master Trust Series 2022-A, Class A, 6.19%, 10/15/2030(b) | | |
CoreVest American Finance Trust | | |
Series 2019-2, Class D, 4.22%, 6/15/2052(b) | | |
Series 2019-3, Class B, 3.16%, 10/15/2052(b) | | |
Series 2020-3, Class B, 2.20%, 8/15/2053(b) | | |
CPS Auto Receivables Trust Series 2022-D, Class C, 7.69%, 1/16/2029(b) | | |
Credit Acceptance Auto Loan Trust | | |
Series 2020-1A, Class B, 2.39%, 4/16/2029(b) | | |
Series 2022-3A, Class C, 8.45%, 2/15/2033(b) | | |
Credit Suisse ABS Trust Series 2020-AT1, Class A, 2.61%, 10/15/2026(b) | | |
Crown Castle Towers LLC, 3.66%, 5/15/2025(b) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Core Bond Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Asset-Backed Securities — continued |
CWABS, Inc. Asset-Backed Certificates | | |
Series 2004-1, Class M1, 5.14%, 3/25/2034(e) | | |
Series 2004-1, Class M2, 5.21%, 3/25/2034(e) | | |
Series 2004-1, Class 3A, 4.95%, 4/25/2034(e) | | |
DataBank Issuer Series 2021-1A, Class A2, 2.06%, 2/27/2051(b) | | |
Delta Air Lines Pass-Through Trust Series 2015-1, Class AA, 3.63%, 7/30/2027 | | |
Diversified Abs Phase III LLC Series 2022-1, 4.88%, 4/28/2039‡ (b) | | |
Drive Auto Receivables Trust Series 2020-2, Class D, 3.05%, 5/15/2028 | | |
| | |
Series 2019-4A, Class C, 2.73%, 7/15/2025(b) | | |
Series 2022-3A, Class C, 7.69%, 7/17/2028(b) | | |
Series 2022-3A, Class D, 8.14%, 7/17/2028(b) | | |
Exeter Automobile Receivables Trust | | |
Series 2019-3A, Class D, 3.11%, 8/15/2025(b) | | |
Series 2019-4A, Class D, 2.58%, 9/15/2025(b) | | |
Series 2022-6A, Class D, 8.03%, 4/6/2029 | | |
| | |
Series 2022-SFR3, Class C, 4.50%, 7/17/2026(b) | | |
Series 2020-SFR1, Class D, 2.24%, 8/17/2037(b) | | |
Series 2020-SFR1, Class E, 2.79%, 8/17/2037(b) | | |
Series 2020-SFR2, Class E, 2.67%, 10/19/2037(b) | | |
Series 2021-SFR1, Class E1, 2.39%, 8/17/2038(b) | | |
Series 2022-SFR2, Class E1, 4.50%, 7/17/2039(b) | | |
| | |
Series 2021-SAT13.65%, 2/25/2024‡ (b) (e) | | |
Series 2020-GT1, Class A, 4.45%, 1/25/2026(b) (e) | | |
Series 2021-GT1, Class A, 3.62%, 7/25/2026(b) (e) | | |
| | |
|
Series 2021-GT2, Class A, 3.85%, 10/25/2026(b) (e) | | |
FNMA, Grantor Trust Series 2017-T1, Class A, 2.90%, 6/25/2027 | | |
Foundation Finance Trust Series 2020-1A, Class A, 3.54%, 7/16/2040(b) | | |
FREED ABS Trust Series 2022-3FP, Class B, 5.79%, 8/20/2029(b) | | |
Freedom Frn Series 2021-SAVF1, 4.90%, 3/25/2023‡ (e) | | |
Gold Key Resorts LLC Series 2014-A, Class A, 3.22%, 3/17/2031(b) | | |
Goodgreen Series 2019-2A, Class A, 2.76%, 4/15/2055‡ (b) | | |
| | |
Series 2017-1A, Class A, 3.74%, 10/15/2052‡ (b) | | |
Series 2017-2A, Class A, 3.26%, 10/15/2053‡ (b) | | |
HERO Funding (Cayman Islands) Series 2017-3A, Class A2, 3.95%, 9/20/2048‡ (b) | | |
| | |
Series 2016-3A, Class A1, 3.08%, 9/20/2042‡ (b) | | |
Series 2017-1A, Class A2, 4.46%, 9/20/2047‡ (b) | | |
Hilton Grand Vacations Trust Series 2017-AA, Class A, 2.66%, 12/26/2028(b) | | |
Jonah Energy Abs LLC Series 2022-1, Class A1, 7.20%, 12/10/2037‡ (b) | | |
Lending Funding Trust Series 2020-2A, Class C, 4.30%, 4/21/2031(b) | | |
Lendmark Funding Trust Series 2022-1A, Class C, 6.60%, 7/20/2032(b) | | |
Long Beach Mortgage Loan Trust | | |
Series 2003-4, Class M1, 5.41%, 8/25/2033(e) | | |
Series 2004-1, Class M1, 5.14%, 2/25/2034(e) | | |
Mariner Finance Issuance Trust Series 2019-AA, Class A, 2.96%, 7/20/2032(b) | | |
Marlette Funding Trust Series 2021-3A, Class C, 1.81%, 12/15/2031(b) | | |
Mercury Financial Credit Card Master Trust Series 2021-1A, Class A, 1.54%, 3/20/2026(b) | | |
MVW LLC Series 2019-2A, Class B, 2.44%, 10/20/2038(b) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Asset-Backed Securities — continued |
MVW Owner Trust Series 2019-1A, Class A, 2.89%, 11/20/2036(b) | | |
New Century Home Equity Loan Trust Series 2005-1, Class M1, 5.06%, 3/25/2035(e) | | |
NRZ Excess Spread-Collateralized Notes | | |
Series 2020-PLS1, Class A, 3.84%, 12/25/2025(b) | | |
Series 2021-FHT1, Class A, 3.10%, 7/25/2026(b) | | |
Series 2021-GNT1, Class A, 3.47%, 11/25/2026(b) | | |
OneMain Direct Auto Receivables Trust | | |
Series 2021-1A, Class A, 0.87%, 7/14/2028(b) | | |
Series 2019-1A, Class B, 3.95%, 11/14/2028(b) | | |
Oportun Funding XIII LLC Series 2019-A, Class A, 3.08%, 8/8/2025(b) | | |
Pagaya AI Debt Selection Trust Series 2021-1, Class A, 1.18%, 11/15/2027(b) | | |
Pagaya AI Technology in Housing Trust Series 2022-1, Class A, 4.25%, 8/25/2025(b) | | |
Pendoor Proper, Zero Coupon, 2/15/2026‡ (b) | | |
PNMAC GMSR ISSUER TRUST Series 2022-GT1, Class A, 8.18%, 5/25/2027(b) (e) | | |
| | |
Series 2021-NPL6, Class A1, 2.49%, 7/25/2051(b) (d) | | |
Series 2021-RN4, Class A1, 2.49%, 10/25/2051(b) (e) | | |
Pretium Mortgage Credit Partners I LLC Series 2021-NPL1, Class A1, 2.24%, 9/27/2060(b) (d) | | |
Progress Residential Trust | | |
Series 2022-SFR2, Class A, 2.95%, 4/17/2027 | | |
Series 2022-SFR2, Class E1, 4.55%, 4/17/2027 | | |
Series 2019-SFR4, Class D, 3.14%, 10/17/2036(b) | | |
Series 2020-SFR1, Class E, 3.03%, 4/17/2037(b) | | |
Renew (Cayman Islands) Series 2017-1A, Class A, 3.67%, 9/20/2052‡ (b) | | |
RMIP Series 2019-1B, Zero Coupon, 8/25/2023‡ | | |
Santander Drive Auto Receivables Trust Series 2022-4, Class A3, 4.14%, 2/16/2027 | | |
| | |
|
SART Series 2018-1, 4.76%, 6/15/2025‡ | | |
SCF Equipment Leasing LLC Series 2022-2A, Class C, 6.50%, 8/20/2032(b) | | |
Sierra Timeshare Receivables Funding LLC | | |
Series 2019-3A, Class C, 3.00%, 8/20/2036(b) | | |
Series 2020-2A, Class A, 1.33%, 7/20/2037(b) | | |
Spirit Airlines Pass-Through Trust Series 2017-1, Class AA, 3.38%, 2/15/2030 | | |
Tricon Residential Trust Series 2022-SFR1, Class D, 4.75%, 4/17/2039(b) | | |
United Airlines Pass-Through Trust | | |
Series 2012-1, Class A, 4.15%, 4/11/2024 | | |
Series 2013-1, Class A, 4.30%, 8/15/2025 | | |
Series 2016-1, Class B, 3.65%, 1/7/2026 | | |
Series 2018-1, Class B, 4.60%, 3/1/2026 | | |
Series 2014-1, Class A, 4.00%, 4/11/2026 | | |
Series 2016-2, Class AA, 2.88%, 10/7/2028 | | |
Series 2016-2, Class A, 3.10%, 10/7/2028 | | |
Series 2018-1, Class A, 3.70%, 3/1/2030 | | |
Series 2019-1, Class AA, 4.15%, 8/25/2031 | | |
Series 2019-2, Class AA, 2.70%, 5/1/2032 | | |
vMobo, Inc., 7.46%, 7/18/2027‡ | | |
VOLT CI LLC Series 2021-NP10, Class A1, 1.99%, 5/25/2051(b) (d) | | |
VOLT XCII LLC Series 2021-NPL1, Class A1, 1.89%, 2/27/2051(b) (d) | | |
VOLT XCIII LLC Series 2021-NPL2, Class A1, 1.89%, 2/27/2051(b) (d) | | |
VOLT XCIV LLC Series 2021-NPL3, Class A1, 2.24%, 2/27/2051(b) (d) | | |
VOLT XCIX LLC Series 2021-NPL8, Class A1, 2.12%, 4/25/2051(b) (d) | | |
VOLT XCV LLC Series 2021-NPL4, Class A1, 2.24%, 3/27/2051(b) (d) | | |
VOLT XCVI LLC Series 2021-NPL5, Class A1, 2.12%, 3/27/2051(b) (d) | | |
VOLT XCVII LLC Series 2021-NPL6, Class A1, 2.24%, 4/25/2051(b) (d) | | |
Westgate Resorts LLC Series 2020-1A, Class B, 3.96%, 3/20/2034(b) | | |
| | |
Total Asset-Backed Securities
(Cost $75,486) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Core Bond Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Commercial Mortgage-Backed Securities — 5.7% |
BB-UBS Trust Series 2012-SHOW, Class A, 3.43%, 11/5/2036(b) | | |
Citigroup Commercial Mortgage Trust Series 2020-GC46, Class A5, 2.72%, 2/15/2053 | | |
Commercial Mortgage Trust | | |
Series 2013-SFS, Class A2, 2.99%, 4/12/2035(b) (e) | | |
Series 2020-CBM, Class A2, 2.90%, 2/10/2037(b) | | |
Series 2020-CBM, Class C, 3.40%, 2/10/2037(b) | | |
Series 2014-CR19, Class A5, 3.80%, 8/10/2047 | | |
Series 2015-CR25, Class A4, 3.76%, 8/10/2048 | | |
| | |
Series 2014-USA, Class A2, 3.95%, 9/15/2037(b) | | |
Series 2014-USA, Class D, 4.37%, 9/15/2037(b) | | |
FHLMC, Multi-Family Structured Credit Risk Series 2021-MN2, Class M1, 5.73%, 7/25/2041(b) (e) | | |
FHLMC, Multi-Family Structured Pass-Through Certificates | | |
Series KJ11, Class A2, 2.93%, 1/25/2023 | | |
Series KJ14, Class A2, 2.81%, 9/25/2024 | | |
Series K065, Class A2, 3.24%, 4/25/2027 | | |
Series K065, Class AM, 3.33%, 5/25/2027 | | |
Series K066, Class A2, 3.12%, 6/25/2027 | | |
Series K070, Class A2, 3.30%, 11/25/2027(e) | | |
Series K072, Class AM, 3.50%, 12/25/2027(e) | | |
Series K079, Class AM, 3.93%, 6/25/2028 | | |
Series K081, Class A2, 3.90%, 8/25/2028(e) | | |
Series KL06, Class XFX, IO, 1.36%, 12/25/2029(e) | | |
Series K146, Class A2, 2.92%, 6/25/2032 | | |
Series K-150, Class A2, 3.71%, 9/25/2032(e) | | |
Series K-151, Class A2, 3.80%, 10/25/2032(e) | | |
Series Q013, Class APT2, 1.17%, 5/25/2050(e) | | |
FHLMC, Multi-Family WI Certificates Series K153, Class A2, 3.82%, 1/25/2033 | | |
| | |
|
| | |
Series 2014-M3, Class A2, 3.50%, 1/25/2024(e) | | |
Series 2017-M7, Class A2, 2.96%, 2/25/2027(e) | | |
Series 2015-M10, Class A2, 3.09%, 4/25/2027(e) | | |
Series 2017-M8, Class A2, 3.06%, 5/25/2027(e) | | |
Series 2017-M12, Class A2, 3.06%, 6/25/2027(e) | | |
Series 2018-M10, Class A2, 3.36%, 7/25/2028(e) | | |
Series 2017-M5, Class A2, 3.10%, 4/25/2029(e) | | |
Series 2018-M3, Class A2, 3.07%, 2/25/2030(e) | | |
Series 2020-M50, Class A1, 0.67%, 10/25/2030 | | |
Series 2020-M50, Class A2, 1.20%, 10/25/2030 | | |
Series 2020-M50, Class X1, IO, 1.89%, 10/25/2030(e) | | |
Series 2022-M1G, Class A2, 1.53%, 9/25/2031(e) | | |
Series 2022-M3, Class A2, 1.71%, 11/25/2031(e) | | |
Series 2022-M1S, Class A2, 2.08%, 4/25/2032(e) | | |
Series 2022-M2S, Class A2, 3.75%, 8/25/2032(e) | | |
Series 2021-M3, Class 1A1, 1.00%, 11/25/2033 | | |
Series 2021-M3, Class X1, IO, 1.94%, 11/25/2033(e) | | |
| | |
Series 2014-K40, Class C, 4.07%, 11/25/2047(b) (e) | | |
Series 2015-K44, Class B, 3.72%, 1/25/2048(b) (e) | | |
Series 2015-K45, Class B, 3.61%, 4/25/2048(b) (e) | | |
Series 2016-K722, Class B, 3.95%, 7/25/2049(b) (e) | | |
Series 2016-K59, Class B, 3.58%, 11/25/2049(b) (e) | | |
Series 2018-K730, Class B, 3.80%, 2/25/2050(b) (e) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Commercial Mortgage-Backed Securities — continued |
Series 2019-K102, Class B, 3.53%, 12/25/2051(b) (e) | | |
| | |
Series 2019-PARK, Class A, 2.72%, 12/15/2036(b) | | |
Series 2019-PARK, Class D, 2.72%, 12/15/2036(b) | | |
SBALR Commercial Mortgage Trust Series 2020-RR1, Class A3, 2.83%, 2/13/2053(b) | | |
SLG Office Trust Series 2021-OVA, Class A, 2.59%, 7/15/2041(b) | | |
UBS-BAMLL Trust Series 2012-WRM, Class A, 3.66%, 6/10/2030(b) | | |
Total Commercial Mortgage-Backed Securities
(Cost $29,451) | | |
Collateralized Mortgage Obligations — 5.6% |
| | |
Series 2004-2CB, Class 1A9, 5.75%, 3/25/2034 | | |
Series 2005-22T1, Class A2, IF, IO, 0.68%, 6/25/2035(e) | | |
Series 2005-20CB, Class 3A8, IF, IO, 0.36%, 7/25/2035(e) | | |
Series 2005-28CB, Class 1A4, 5.50%, 8/25/2035 | | |
Series 2005-54CB, Class 1A11, 5.50%, 11/25/2035 | | |
Banc of America Alternative Loan Trust Series 2004-6, Class 15, PO, 7/25/2019 | | |
Banc of America Funding Trust | | |
Series 2004-1, PO, 3/25/2034 | | |
Series 2005-6, Class 2A7, 5.50%, 10/25/2035 | | |
Series 2005-7, Class 30, PO, 11/25/2035 | | |
| | |
Series 2003-7, Class 3A, 3.59%, 10/25/2033(e) | | |
Series 2006-1, Class A1, 6.80%, 2/25/2036(e) | | |
Cascade MH Asset Trust Series 2021-MH1, Class A1, 1.75%, 2/25/2046(b) | | |
CHL Mortgage Pass-Through Trust | | |
Series 2004-HYB1, Class 2A, 3.76%, 5/20/2034(e) | | |
Series 2004-HYB3, Class 2A, 2.71%, 6/20/2034(e) | | |
| | |
|
Series 2004-7, Class 2A1, 3.16%, 6/25/2034(e) | | |
Series 2005-16, Class A23, 5.50%, 9/25/2035 | | |
Series 2005-22, Class 2A1, 3.45%, 11/25/2035(e) | | |
Citigroup Global Markets Mortgage Securities VII, Inc. | | |
Series 2003-UP2, Class 1, PO, 6/25/2033 | | |
Series 2003-HYB1, Class A, 4.24%, 9/25/2033(e) | | |
Citigroup Mortgage Loan Trust, Inc. | | |
Series 2003-UP3, Class A3, 7.00%, 9/25/2033 | | |
Series 2005-1, Class 2A1A, 2.72%, 2/25/2035(e) | | |
| | |
Series 2021-RPL1, Class A1, 1.67%, 9/27/2060(b) (e) | | |
Series 2022-JR1, Class A1, 4.27%, 10/25/2066‡ (b) (d) | | |
CVS Pass-Through Trust Series 2009, 8.35%, 7/10/2031(b) | | |
FHLMC - GNMA Series 8, Class ZA, 7.00%, 3/25/2023 | | |
| | |
Series 1518, Class G, IF, 4.52%, 5/15/2023(e) | | |
Series 1798, Class F, 5.00%, 5/15/2023 | | |
Series 1505, Class Q, 7.00%, 5/15/2023 | | |
Series 1541, Class O, 3.42%, 7/15/2023(e) | | |
Series 2638, Class DS, IF, 4.28%, 7/15/2023(e) | | |
Series 1577, Class PV, 6.50%, 9/15/2023 | | |
Series 1584, Class L, 6.50%, 9/15/2023 | | |
Series 1633, Class Z, 6.50%, 12/15/2023 | | |
Series 1638, Class H, 6.50%, 12/15/2023 | | |
Series 2283, Class K, 6.50%, 12/15/2023 | | |
Series 1865, Class D, PO, 2/15/2024 | | |
Series 1671, Class QC, IF, 10.00%, 2/15/2024(e) | | |
Series 1694, Class PK, 6.50%, 3/15/2024 | | |
Series 2033, Class SN, HB, IF, 24.47%, 3/15/2024(e) | | |
Series 2306, Class K, PO, 5/15/2024 | | |
Series 2306, Class SE, IF, IO, 6.81%, 5/15/2024(e) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Core Bond Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Collateralized Mortgage Obligations — continued |
Series 1863, Class Z, 6.50%, 7/15/2026 | | |
Series 1981, Class Z, 6.00%, 5/15/2027 | | |
Series 1987, Class PE, 7.50%, 9/15/2027 | | |
Series 1999, Class PU, 7.00%, 10/15/2027 | | |
Series 2031, Class PG, 7.00%, 2/15/2028 | | |
Series 2035, Class PC, 6.95%, 3/15/2028 | | |
Series 2038, Class PN, IO, 7.00%, 3/15/2028 | | |
Series 2057, Class PE, 6.75%, 5/15/2028 | | |
Series 2054, Class PV, 7.50%, 5/15/2028 | | |
Series 2064, Class TE, 7.00%, 6/15/2028 | | |
Series 2075, Class PH, 6.50%, 8/15/2028 | | |
Series 2095, Class PE, 6.00%, 11/15/2028 | | |
Series 2132, Class SB, IF, 12.70%, 3/15/2029(e) | | |
Series 2178, Class PB, 7.00%, 8/15/2029 | | |
Series 2182, Class ZB, 8.00%, 9/15/2029 | | |
Series 2204, Class GB, 8.00%, 12/20/2029(e) | | |
Series 2247, Class Z, 7.50%, 8/15/2030 | | |
Series 2259, Class ZC, 7.35%, 10/15/2030 | | |
Series 2325, Class PM, 7.00%, 6/15/2031 | | |
Series 2359, Class ZB, 8.50%, 6/15/2031 | | |
Series 2344, Class ZD, 6.50%, 8/15/2031 | | |
Series 2344, Class ZJ, 6.50%, 8/15/2031 | | |
Series 2345, Class NE, 6.50%, 8/15/2031 | | |
Series 2367, Class ME, 6.50%, 10/15/2031 | | |
Series 2390, Class DO, PO, 12/15/2031 | | |
Series 2410, Class QX, IF, IO, 4.33%, 2/15/2032(e) | | |
Series 2410, Class OE, 6.38%, 2/15/2032 | | |
Series 2412, Class SP, IF, 7.46%, 2/15/2032(e) | | |
Series 2410, Class QS, IF, 8.27%, 2/15/2032(e) | | |
Series 2444, Class ES, IF, IO, 3.63%, 3/15/2032(e) | | |
Series 2450, Class SW, IF, IO, 3.68%, 3/15/2032(e) | | |
Series 2423, Class MC, 7.00%, 3/15/2032 | | |
Series 2423, Class MT, 7.00%, 3/15/2032 | | |
Series 2647, Class A, 3.25%, 4/15/2032 | | |
Series 2435, Class CJ, 6.50%, 4/15/2032 | | |
Series 2455, Class GK, 6.50%, 5/15/2032 | | |
Series 2484, Class LZ, 6.50%, 7/15/2032 | | |
Series 2500, Class MC, 6.00%, 9/15/2032 | | |
Series 2543, Class YX, 6.00%, 12/15/2032 | | |
| | |
|
Series 2544, Class HC, 6.00%, 12/15/2032 | | |
Series 2574, Class PE, 5.50%, 2/15/2033 | | |
Series 2575, Class ME, 6.00%, 2/15/2033 | | |
Series 2586, Class WI, IO, 6.50%, 3/15/2033 | | |
Series 2764, Class UG, 5.00%, 3/15/2034 | | |
Series 2949, Class GE, 5.50%, 3/15/2035 | | |
Series 3047, Class OD, 5.50%, 10/15/2035 | | |
Series 3085, Class VS, IF, 11.45%, 12/15/2035(e) | | |
Series 3098, Class KG, 5.50%, 1/15/2036 | | |
Series 3117, Class EO, PO, 2/15/2036 | | |
Series 3260, Class CS, IF, IO, 1.82%, 1/15/2037(e) | | |
Series 3380, Class SI, IF, IO, 2.05%, 10/15/2037(e) | | |
Series 3385, Class SN, IF, IO, 1.68%, 11/15/2037(e) | | |
Series 3387, Class SA, IF, IO, 2.10%, 11/15/2037(e) | | |
Series 3423, Class PB, 5.50%, 3/15/2038 | | |
Series 3451, Class SA, IF, IO, 1.73%, 5/15/2038(e) | | |
Series 3455, Class SE, IF, IO, 1.88%, 6/15/2038(e) | | |
Series 3786, Class PD, 4.50%, 1/15/2041 | | |
Series 4664, Class UZ, 4.00%, 3/15/2047 | | |
| | |
Series 233, Class 11, IO, 5.00%, 9/15/2035 | | |
Series 239, Class S30, IF, IO, 3.38%, 8/15/2036(e) | | |
Series 262, Class 35, 3.50%, 7/15/2042 | | |
Series 299, Class 300, 3.00%, 1/15/2043 | | |
FHLMC, Structured Pass-Through Certificates, Whole Loan | | |
Series T-41, Class 3A, 4.40%, 7/25/2032(e) | | |
Series T-54, Class 2A, 6.50%, 2/25/2043 | | |
Series T-54, Class 3A, 7.00%, 2/25/2043 | | |
Series T-56, Class A, PO, 5/25/2043 | | |
Series T-58, Class A, PO, 9/25/2043 | | |
First Horizon Alternative Mortgage Securities Trust Series 2005-FA8, Class 1A19, 5.50%, 11/25/2035 | | |
Fn 3.895, 0.00%, 9/1/2031(f) | | |
Fn 4.748, 0.00%, 2/1/2033‡ (f) | | |
FNMA Trust, Whole Loan Series 2004-W2, Class 2A2, 7.00%, 2/25/2044 | | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Collateralized Mortgage Obligations — continued |
| | |
Series 1997-61, Class ZC, 7.00%, 2/25/2023 | | |
Series G93-17, Class SI, IF, 6.00%, 4/25/2023(e) | | |
Series 1998-43, Class SA, IF, IO, 13.32%, 4/25/2023(e) | | |
Series 1993-146, Class E, PO, 5/25/2023 | | |
Series 1993-84, Class M, 7.50%, 6/25/2023 | | |
Series 1993-205, Class H, PO, 9/25/2023 | | |
Series 1993-165, Class SD, IF, 3.46%, 9/25/2023(e) | | |
Series 1993-155, Class PJ, 7.00%, 9/25/2023 | | |
Series 1993-165, Class SK, IF, 12.50%, 9/25/2023(e) | | |
Series 1993-203, Class PL, 6.50%, 10/25/2023 | | |
Series 1995-19, Class Z, 6.50%, 11/25/2023 | | |
Series 1993-230, Class FA, 4.62%, 12/25/2023(e) | | |
Series 1993-223, Class PZ, 6.50%, 12/25/2023 | | |
Series 1993-225, Class UB, 6.50%, 12/25/2023 | | |
Series 2003-128, Class DY, 4.50%, 1/25/2024 | | |
Series 1994-37, Class L, 6.50%, 3/25/2024 | | |
Series 1994-72, Class K, 6.00%, 4/25/2024 | | |
Series 1995-2, Class Z, 8.50%, 1/25/2025 | | |
Series 1997-20, Class IB, IO, 1.84%, 3/25/2027(e) | | |
Series 1997-39, Class PD, 7.50%, 5/20/2027 | | |
Series 1997-46, Class PL, 6.00%, 7/18/2027 | | |
Series 1998-36, Class ZB, 6.00%, 7/18/2028 | | |
Series 1998-46, Class GZ, 6.50%, 8/18/2028 | | |
Series 1998-58, Class PC, 6.50%, 10/25/2028 | | |
Series 2014-15, Class JI, IO, 3.50%, 4/25/2029 | | |
Series 1999-39, Class JH, IO, 6.50%, 8/25/2029 | | |
Series 2000-52, IO, 8.50%, 1/25/2031 | | |
Series 2001-33, Class ID, IO, 6.00%, 7/25/2031 | | |
Series 2001-30, Class PM, 7.00%, 7/25/2031 | | |
Series 2001-36, Class DE, 7.00%, 8/25/2031 | | |
| | |
|
Series 2001-44, Class PD, 7.00%, 9/25/2031 | | |
Series 2001-61, Class Z, 7.00%, 11/25/2031 | | |
Series 2002-1, Class SA, IF, 10.92%, 2/25/2032(e) | | |
Series 2002-13, Class SJ, IF, IO, 1.60%, 3/25/2032(e) | | |
Series 2002-15, PO, 4/25/2032 | | |
Series 2002-28, Class PK, 6.50%, 5/25/2032 | | |
Series 2002-68, Class SH, IF, IO, 3.66%, 10/18/2032(e) | | |
Series 2004-61, Class SK, IF, 8.50%, 11/25/2032(e) | | |
Series 2002-77, Class S, IF, 6.44%, 12/25/2032(e) | | |
Series 2003-22, Class UD, 4.00%, 4/25/2033 | | |
Series 2003-47, Class PE, 5.75%, 6/25/2033 | | |
Series 2003-44, Class IU, IO, 7.00%, 6/25/2033 | | |
Series 2003-64, Class SX, IF, 3.45%, 7/25/2033(e) | | |
Series 2003-132, Class OA, PO, 8/25/2033 | | |
Series 2003-71, Class DS, IF, 1.97%, 8/25/2033(e) | | |
Series 2003-91, Class SD, IF, 5.19%, 9/25/2033(e) | | |
Series 2003-116, Class SB, IF, IO, 3.21%, 11/25/2033(e) | | |
Series 2003-130, Class SX, IF, 4.94%, 1/25/2034(e) | | |
Series 2003-131, Class CH, 5.50%, 1/25/2034 | | |
Series 2004-46, Class SK, IF, 4.43%, 5/25/2034(e) | | |
Series 2004-35, Class AZ, 4.50%, 5/25/2034 | | |
Series 2004-36, Class SA, IF, 7.46%, 5/25/2034(e) | | |
Series 2004-51, Class SY, IF, 5.46%, 7/25/2034(e) | | |
Series 2004-79, Class ZE, 5.50%, 11/25/2034 | | |
Series 2004-91, Class HC, 6.00%, 12/25/2034 | | |
Series 2005-45, Class DC, IF, 8.22%, 6/25/2035(e) | | |
Series 2005-84, Class XM, 5.75%, 10/25/2035 | | |
Series 2006-22, Class AO, PO, 4/25/2036 | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Core Bond Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Collateralized Mortgage Obligations — continued |
Series 2006-46, Class SW, IF, 8.11%, 6/25/2036(e) | | |
Series 2007-7, Class SG, IF, IO, 2.11%, 8/25/2036(e) | | |
Series 2006-110, PO, 11/25/2036 | | |
Series 2006-117, Class GS, IF, IO, 2.26%, 12/25/2036(e) | | |
Series 2007-53, Class SH, IF, IO, 1.71%, 6/25/2037(e) | | |
Series 2007-88, Class VI, IF, IO, 2.15%, 9/25/2037(e) | | |
Series 2007-100, Class SM, IF, IO, 2.06%, 10/25/2037(e) | | |
Series 2008-1, Class BI, IF, IO, 1.52%, 2/25/2038(e) | | |
Series 2008-16, Class IS, IF, IO, 1.81%, 3/25/2038(e) | | |
Series 2008-46, Class HI, IO, 0.00%, 6/25/2038(e) | | |
Series 2008-53, Class CI, IF, IO, 2.81%, 7/25/2038(e) | | |
Series 2009-112, Class ST, IF, IO, 1.86%, 1/25/2040(e) | | |
Series 2010-35, Class SB, IF, IO, 2.03%, 4/25/2040(e) | | |
Series 2010-80, Class PZ, 5.00%, 7/25/2040 | | |
Series 2010-102, Class PN, 5.00%, 9/25/2040 | | |
Series 2010-134, Class KZ, 4.50%, 12/25/2040 | | |
Series 2012-30, Class DZ, 4.00%, 4/25/2042 | | |
Series 2013-67, Class KZ, 2.50%, 4/25/2043 | | |
Series 2013-128, PO, 12/25/2043 | | |
Series 2014-38, Class QI, IO, 5.50%, 12/25/2043 | | |
Series 2014-19, Class Z, 4.50%, 4/25/2044 | | |
Series 2016-38, Class NA, 3.00%, 1/25/2046 | | |
FNMA, REMIC Trust, Whole Loan | | |
Series 1999-W1, PO, 2/25/2029 | | |
Series 1999-W4, Class A9, 6.25%, 2/25/2029 | | |
Series 2002-W7, Class A4, 6.00%, 6/25/2029 | | |
Series 2003-W1, Class 1A1, 4.84%, 12/25/2042(e) | | |
Series 2003-W1, Class 2A, 5.29%, 12/25/2042(e) | | |
| | |
|
FNMA, REMIC, Whole Loan Series 2003-7, Class A1, 6.50%, 12/25/2042 | | |
| | |
Series 329, Class 1, PO, 1/25/2033 | | |
Series 365, Class 8, IO, 5.50%, 5/25/2036 | | |
GMACM Mortgage Loan Trust Series 2005-AR3, Class 3A4, 3.18%, 6/19/2035(e) | | |
| | |
Series 2001-10, Class PE, 6.50%, 3/16/2031 | | |
Series 2004-28, Class S, IF, 7.77%, 4/16/2034(e) | | |
Series 2006-38, Class OH, 6.50%, 8/20/2036 | | |
Series 2007-45, Class QA, IF, IO, 2.29%, 7/20/2037(e) | | |
Series 2009-79, Class OK, PO, 11/16/2037 | | |
Series 2007-76, Class SA, IF, IO, 2.18%, 11/20/2037(e) | | |
Series 2008-2, Class MS, IF, IO, 2.83%, 1/16/2038(e) | | |
Series 2015-137, Class WA, 5.55%, 1/20/2038(e) | | |
Series 2009-106, Class ST, IF, IO, 1.65%, 2/20/2038(e) | | |
Series 2008-55, Class SA, IF, IO, 1.85%, 6/20/2038(e) | | |
Series 2009-6, Class SA, IF, IO, 1.77%, 2/16/2039(e) | | |
Series 2009-6, Class SH, IF, IO, 1.69%, 2/20/2039(e) | | |
Series 2009-31, Class TS, IF, IO, 1.95%, 3/20/2039(e) | | |
Series 2009-14, Class KI, IO, 6.50%, 3/20/2039 | | |
Series 2009-14, Class NI, IO, 6.50%, 3/20/2039 | | |
Series 2009-22, Class SA, IF, IO, 1.92%, 4/20/2039(e) | | |
Series 2009-64, Class SN, IF, IO, 1.77%, 7/16/2039(e) | | |
Series 2009-104, Class KB, 5.50%, 11/16/2039 | | |
Series 2010-130, Class CP, 7.00%, 10/16/2040 | | |
Series 2011-75, Class SM, IF, IO, 2.25%, 5/20/2041(e) | | |
Series 2013-69, Class MA, 1.50%, 8/20/2042 | | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Collateralized Mortgage Obligations — continued |
Series 2016-135, Class Z, 3.00%, 10/20/2046 | | |
Series 2020-30, Class PT, 4.77%, 3/20/2048(e) | | |
Series 2011-H19, Class FA, 4.31%, 8/20/2061(e) | | |
Series 2012-H23, Class SA, 4.37%, 10/20/2062(e) | | |
Series 2013-H08, Class FC, 4.29%, 2/20/2063(e) | | |
Series 2013-H09, Class HA, 1.65%, 4/20/2063 | | |
Series 2014-H17, Class FC, 4.34%, 7/20/2064(e) | | |
Series 2015-H16, Class FG, 4.28%, 7/20/2065(e) | | |
Series 2015-H30, Class FE, 4.44%, 11/20/2065(e) | | |
Series 2016-H11, Class FD, 2.57%, 5/20/2066(e) | | |
Series 2016-H26, Class FC, 4.84%, 12/20/2066(e) | | |
Series 2017-H14, Class FV, 4.34%, 6/20/2067(e) | | |
Goodgreen Trust Series 2017-R1, 5.00%, 10/20/2051‡ | | |
| | |
Series 2004-6F, Class 1A2, 5.00%, 5/25/2034 | | |
Series 2004-6F, Class 3A4, 6.50%, 5/25/2034 | | |
Series 2004-13F, Class 3A3, 6.00%, 11/25/2034 | | |
Home RE Ltd. (Bermuda) Series 2022-1, Class M1A, 6.78%, 10/25/2034(b) (e) | | |
Impac Secured Assets Trust Series 2006-1, Class 2A1, 5.09%, 5/25/2036(e) | | |
JPMorgan Mortgage Trust Series 2006-A2, Class 5A3, 4.19%, 11/25/2033(e) | | |
LHOME Mortgage Trust Series 2021-RTL1, Class A1, 2.09%, 2/25/2026(b) (e) | | |
MASTR Adjustable Rate Mortgages Trust Series 2004-13, Class 2A1, 4.02%, 4/21/2034(e) | | |
MASTR Alternative Loan Trust | | |
Series 2004-10, Class 1A1, 4.50%, 9/25/2019 | | |
Series 2004-8, Class 6A1, 5.50%, 9/25/2019 | | |
| | |
|
Series 2004-4, Class 10A1, 5.00%, 5/25/2024 | | |
Series 2003-9, Class 8A1, 6.00%, 1/25/2034 | | |
Series 2004-6, Class 7A1, 6.00%, 7/25/2034 | | |
Series 2004-7, Class 30, PO, 8/25/2034 | | |
MASTR Asset Securitization Trust | | |
Series 2003-12, Class 15, PO, 12/25/2018 | | |
Series 2004-6, Class 15, PO, 7/25/2019‡ | | |
Series 2003-11, Class 9A6, 5.25%, 12/25/2033 | | |
Mastr Resecuritization Trust Series 2005-PO, Class 3, PO, 5/28/2035(b) | | |
NACC Reperforming Loan REMIC Trust Series 2004-R2, Class A1, 6.50%, 10/25/2034(b) (e) | | |
PHH Alternative Mortgage Trust Series 2007-2, Class 2X, IO, 6.00%, 5/25/2037 | | |
SACO I, Inc. Series 1997-2, Class 1A5, 7.00%, 8/25/2036‡ (b) | | |
SART Series 2017-1, 4.75%, 7/15/2024‡ | | |
Seasoned Credit Risk Transfer Trust | | |
Series 2019-1, Class MT, 3.50%, 7/25/2058 | | |
Series 2019-3, Class MB, 3.50%, 10/25/2058 | | |
Series 2022-1, Class MTU, 3.25%, 11/25/2061 | | |
Towd Point Mortgage Trust Series 2021-R1, Class A1, 2.92%, 11/30/2060(b) (e) | | |
TVC Mortgage Trust Series 2020-RTL1, Class A1, 3.47%, 9/25/2024(b) | | |
Two Harbors Series 2019-VF1, Class A, IO, 4.00%, 2/8/2023‡ (e) | | |
| | |
Series 1994-1, Class 1, 4.60%, 2/15/2024(e) | | |
Series 1994-1, Class 2ZB, 6.50%, 2/15/2024 | | |
Series 1996-1, Class 1Z, 6.75%, 2/15/2026 | | |
Series 1996-2, Class 1Z, 6.75%, 6/15/2026 | | |
Series 1997-1, Class 2Z, 7.50%, 2/15/2027 | | |
Series 1998-1, Class 2E, 7.00%, 3/15/2028 | | |
VM Master Issuer LLC Series 2022-1, Class A1, 5.16%, 5/24/2025‡ (b) (e) | | |
WaMu Mortgage Pass-Through Certificates Trust | | |
Series 2003-AR8, Class A, 4.16%, 8/25/2033(e) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Core Bond Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Collateralized Mortgage Obligations — continued |
Series 2003-AR9, Class 1A6, 4.12%, 9/25/2033(e) | | |
Series 2004-AR3, Class A2, 3.10%, 6/25/2034(e) | | |
Washington Mutual Mortgage Pass-Through Certificates WMALT Trust | | |
Series 2005-2, Class 2A3, IF, IO, 0.61%, 4/25/2035(e) | | |
Series 2005-2, Class 1A4, IF, IO, 0.66%, 4/25/2035(e) | | |
Series 2005-3, Class CX, IO, 5.50%, 5/25/2035 | | |
Series 2005-4, Class CB7, 5.50%, 6/25/2035 | | |
Series 2005-6, Class 2A4, 5.50%, 8/25/2035 | | |
Total Collateralized Mortgage Obligations
(Cost $27,945) | | |
Foreign Government Securities — 0.3% |
Kingdom of Saudi Arabia 2.25%, 2/2/2033(b) | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Total Foreign Government Securities
(Cost $1,874) | | |
U.S. Government Agency Securities — 0.2% |
FNMA, STRIPS
20.02%, 3/23/2028(a) | | |
Tennessee Valley Authority | | |
| | |
| | |
| | |
Total U.S. Government Agency Securities
(Cost $835) | | |
| | |
Loan Assignments — 0.1%(c) (g) |
Diversified Financial Services — 0.1% |
OneSky Loan Trust, 1st Lien Term Loan (6-MONTH FIXED + 3.88%), 3.88%, 1/15/2031(Cost $834) | | |
Total Loan Assignments
(Cost $834) | | |
Municipal Bonds — 0.1%(h) |
|
New York State Dormitory Authority, State Personal Income Tax, General Purpose Series 2010-D, 5.60%, 3/15/2040 | | |
Port Authority of New York and New Jersey, Consolidated Series 164, 5.65%, 11/1/2040 | | |
| | |
|
Ohio State University (The), General Receipts Series 2011-A, 4.80%, 6/1/2111 | | |
Total Municipal Bonds
(Cost $256) | | |
| | |
Short-Term Investments — 3.0% |
Investment Companies — 3.0% |
JPMorgan Prime Money Market Fund Class Institutional Shares, 4.42%(i) (j)
(Cost $14,131) | | |
Total Investments — 100.3%
(Cost $531,945) | | |
Liabilities in Excess of Other Assets — (0.3)% | | |
| | |
Percentages indicated are based on net assets. |
Amounts presented as a dash ("-") represent amounts that round to less than a thousand. |
| |
| |
| Alternative Credit Enhancement Securities |
| Adjustable Rate Mortgage. The interest rate shown is the rate in effect as of December 31, 2022. |
| Credit Suisse Mortgage Trust |
| Federal Home Loan Mortgage Corp. |
| Federal National Mortgage Association |
| |
SEE NOTES TO FINANCIAL STATEMENTS.
| Government National Mortgage Association |
| High Coupon Bonds (a.k.a. "IOettes") represent the right to receive interest payments on an underlying pool of mortgages with similar features as those associated with IO securities. Unlike IO's the owner also has a right to receive a very small portion of principal. The high interest rates result from taking interest payments from other classes in the Real Estate Mortgage Investment Conduit trust and allocating them to the small principal of the HB class. |
| Intercontinental Exchange |
| Inverse Floaters represent securities that pay interest at a rate that increases (decreases) with a decline (incline) in a specified index or have an interest rate that adjusts periodically based on changes in current interest rates and prepayments on the underlying pool of assets. The interest rate shown is the rate in effect as of December 31, 2022. The rate may be subject to a cap and floor. |
| Interest Only represents the right to receive the monthly interest payments on an underlying pool of mortgage loans. The principal amount shown represents the par value on the underlying pool. The yields on these securities are subject to accelerated principal paydowns as a result of prepayment or refinancing of the underlying pool of mortgage instruments. As a result, interest income may be reduced considerably. |
| London Interbank Offered Rate |
| Principal Only represents the right to receive the principal portion only on an underlying pool of mortgage loans. The market value of these securities is extremely volatile in response to changes in market interest rates. As prepayments on the underlying mortgages of these securities increase, the yield on these securities increases. |
| Real Estate Mortgage Investment Conduit |
| Secured Overnight Financing Rate |
| Compounding index of the Secured Overnight Financing Rate |
| Separate Trading of Registered Interest and Principal of Securities. The STRIPS Program lets investors hold and trade individual interest and principal components of eligible notes and bonds as separate securities. |
| Uniform Mortgage-Backed Securities |
| |
| Amount rounds to less than 0.1% of net assets. |
| Value determined using significant unobservable inputs. | |
| The rate shown is the effective yield as of December 31, 2022. | |
| Securities exempt from registration under Rule 144A or section 4(a)(2), of the Securities Act of 1933, as amended. | |
| Variable or floating rate security, linked to the referenced benchmark. The interest rate shown is the current rate as of December 31, 2022. | |
| Step bond. Interest rate is a fixed rate for an initial period that either resets at a specific date or may reset in the future contingent upon a predetermined trigger. The interest rate shown is the current rate as of December 31, 2022. | |
| Variable or floating rate security, the interest rate of which adjusts periodically based on changes in current interest rates and prepayments on the underlying pool of assets. The interest rate shown is the current rate as of December 31, 2022. | |
| All or a portion of the security is a when-issued security, delayed delivery security, or forward commitment. | |
| Loan assignments are presented by obligor. Each series or loan tranche underlying each obligor may have varying terms. | |
| The date shown represents the earliest of the prerefunded date, next put date or final maturity date. | |
| Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. | |
| The rate shown is the current yield as of December 31, 2022. | |
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF ASSETS AND LIABILITIES
AS OF December 31, 2022
(Amounts in thousands, except per share amounts)
| JPMorgan Insurance
Trust Core Bond
|
| |
Investments in non-affiliates, at value | |
Investments in affiliates, at value | |
| |
| |
Investment securities sold | |
| |
Interest from non-affiliates | |
Dividends from affiliates | |
| |
| |
| |
Investment securities purchased — delayed delivery securities | |
Portfolio shares redeemed | |
| |
| |
| |
| |
Custodian and accounting fees | |
| |
| |
| |
| |
| |
Total distributable earnings (loss) | |
| |
| |
| |
| |
| |
Outstanding units of beneficial interest (shares)
(unlimited number of shares authorized, no par value): | |
| |
| |
| |
Class 1 — Offering and redemption price per share | |
Class 2 — Offering and redemption price per share | |
Cost of investments in non-affiliates | |
Cost of investments in affiliates | |
(a)
Per share amounts may not recalculate due to rounding of net assets and/or shares outstanding.
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF OPERATIONS
FOR THE YEAR ENDED December 31, 2022
(Amounts in thousands)
| JPMorgan Insurance
Trust Core Bond
|
| |
Interest income from non-affiliates | |
Dividend income from affiliates | |
| |
| |
| |
| |
| |
| |
Custodian and accounting fees | |
Interest expense to affiliates | |
| |
Trustees’ and Chief Compliance Officer’s fees | |
Printing and mailing costs | |
Transfer agency fees (See Note 2.H.) | |
| |
| |
| |
Less expense reimbursements | |
| |
Net investment income (loss) | |
REALIZED/UNREALIZED GAINS (LOSSES): | |
Net realized gain (loss) on transactions from: | |
Investments in non-affiliates | |
Investments in affiliates | |
| |
Change in net unrealized appreciation/depreciation on: | |
Investments in non-affiliates | |
Investments in affiliates | |
Change in net unrealized appreciation/depreciation | |
Net realized/unrealized gains (losses) | |
Change in net assets resulting from operations | |
(a)
Amount rounds to less than one thousand.
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENTS OF CHANGES IN NET ASSETS
FOR THE PERIODS INDICATED
(Amounts in thousands)
| JPMorgan Insurance Trust
Core Bond Portfolio |
| Year Ended
December 31, 2022 | Year Ended
December 31, 2021 |
CHANGE IN NET ASSETS RESULTING FROM OPERATIONS: | | |
Net investment income (loss) | | |
| | |
Change in net unrealized appreciation/depreciation | | |
Change in net assets resulting from operations | | |
DISTRIBUTIONS TO SHAREHOLDERS: | | |
| | |
| | |
Total distributions to shareholders | | |
| | |
Change in net assets resulting from capital transactions | | |
| | |
| | |
| | |
| | |
| | |
| | |
Proceeds from shares issued | | |
| | |
| | |
Change in net assets resulting from Class 1 capital transactions | | |
| | |
Proceeds from shares issued | | |
| | |
| | |
Change in net assets resulting from Class 2 capital transactions | | |
Total change in net assets resulting from capital transactions | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
THIS PAGE IS INTENTIONALLY LEFT BLANK
FINANCIAL HIGHLIGHTS
FOR THE PERIODS INDICATED
| Per share operating performance |
| | | |
| Net asset
value,
beginning
of period | Net
investment
income
(loss)(a) | Net realized
and unrealized
gains
(losses) on
investments | Total from
investment
operations | | | |
JPMorgan Insurance Trust Core Bond Portfolio | | | | | | | |
| | | | | | | |
Year Ended December 31, 2022 | | | | | | | |
Year Ended December 31, 2021 | | | | | | | |
Year Ended December 31, 2020 | | | | | | | |
Year Ended December 31, 2019 | | | | | | | |
Year Ended December 31, 2018 | | | | | | | |
| | | | | | | |
Year Ended December 31, 2022 | | | | | | | |
Year Ended December 31, 2021 | | | | | | | |
Year Ended December 31, 2020 | | | | | | | |
Year Ended December 31, 2019 | | | | | | | |
Year Ended December 31, 2018 | | | | | | | |
|
| Calculated based upon average shares outstanding. |
| Includes adjustments in accordance with accounting principles generally accepted in the United States of America and as such, the net asset values for financial reporting purposes and the returns based upon those net asset values may differ from the net asset values and returns for shareholder transactions. |
| Total returns do not include charges that will be imposed by variable insurance contracts or by Eligible Plans. If these charges were reflected, returns would be lower than those shown. |
| Includes earnings credits and interest expense, if applicable, each of which is less than 0.005% unless otherwise noted. |
| Amount rounds to less than $0.005. |
SEE NOTES TO FINANCIAL STATEMENTS.
| |
| | | Ratios to average net assets |
Net asset
value,
end of
period | | Net assets,
end of
period
(000's) | | Net
investment
income
(loss) | Expenses without
waivers and reimbursements | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
SEE NOTES TO FINANCIAL STATEMENTS.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022
(Dollar values in thousands)
1. Organization
JPMorgan Insurance Trust (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company and is a Massachusetts business trust.
The following is a separate portfolio of the Trust (the “Portfolio”) covered by this report:
| | Diversification Classification |
JPMorgan Insurance Trust Core Bond Portfolio | | |
The investment objective of the Portfolio is to seek to maximize total return by investing primarily in a diversified portfolio of intermediate- and long-term debt securities.
Portfolio shares are offered only to separate accounts of participating insurance companies and Eligible Plans. Individuals may not purchase shares directly from the Portfolio.
All classes of shares have equal rights as to earnings, assets and voting privileges, except that each class may bear different transfer agency fees and distribution fees and each class has exclusive voting rights with respect to its distribution plan and administrative services plan.
J.P. Morgan Investment Management Inc. (“JPMIM”), an indirect, wholly-owned subsidiary of JPMorgan Chase & Co. (“JPMorgan”), acts as Adviser (the “Adviser”) and Administrator (the “Administrator”) to the Portfolio.
2. Significant Accounting Policies
The following is a summary of significant accounting policies followed by the Portfolio in the preparation of its financial statements. The Portfolio is an investment company and, accordingly, follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 946 — Investment Companies, which is part of U.S. generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) disclosure of contingent assets and liabilities at the date of the financial statements, and (iii) the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.
A. Valuation of Investments — Investments are valued in accordance with GAAP and the Portfolio's valuation policies set forth by, and under the supervision and responsibility of, the Board of Trustees of the Trust (the "Board"), which established the following approach to valuation, as described more fully below: (i) investments for which market quotations are readily available shall be valued at their market value and (ii) all other investments for which market quotations are not readily available shall be valued at their fair value as determined in good faith by the Board.
Under Section 2(a)(41) of the 1940 Act, the Board is required to determine fair value for securities that do not have readily available market quotations. Under SEC Rule 2a-5 (Good Faith Determinations of Fair Value), the Board may designate the performance of these fair valuation determinations to a valuation designee. The Board has designated the Adviser as the “Valuation Designee” to perform fair valuation determinations for the Portfolio on behalf of the Board subject to appropriate oversight by the Board. The Adviser, as Valuation Designee, leverages the J.P. Morgan Asset Management Americas Valuation Committee (“AVC”) to help oversee and carry out the policies for the valuation of Investments held in the Portfolio. The Adviser, as Valuation Designee, remains responsible for the valuation determinations.
This oversight by the AVC includes monitoring the appropriateness of fair values based on results of ongoing valuation oversight including, but not limited to, consideration of macro or security specific events, market events, and pricing vendor and broker due diligence. The Administrator is responsible for discussing and assessing the potential impacts to the fair values on an ongoing basis, and, at least on a quarterly basis, with the AVC and the Board.
A market-based approach is primarily used to value the Portfolio's investments. Investments for which market quotations are not readily available are fair valued using prices supplied by approved affiliated and/or unaffiliated pricing vendors or third party broker-dealers (collectively referred to as “Pricing Services”) or may be internally fair valued using methods set forth by the valuation policies approved by the Board. This may include the use of related or comparable assets or liabilities, recent transactions, market multiples, book values and other relevant information for the investment. An income-based valuation approach may be used in which the anticipated future cash flows of the investment are discounted to calculate the fair value. Discounts may also be applied due to the nature or duration of any restrictions on the disposition of the investments. Valuations may be based upon current market prices of securities that are comparable in coupon, rating, maturity and industry. It is possible that the estimated values may differ significantly from the values that would have been used had a ready market for the investments existed, and such differences could be material.
Fixed income instruments are valued based on prices received from Pricing Services. The Pricing Services use multiple valuation techniques to determine the valuation of fixed income instruments. In instances where sufficient market activity exists, the Pricing Services may utilize a market-based approach through which trades or quotes from market makers are used to determine the valuation of these instruments. In instances where sufficient market activity may not exist, the Pricing Services also utilize proprietary valuation models which may consider market transactions in
comparable securities and the various relationships between securities in determining fair value and/or market characteristics in order to estimate the relevant cash flows, which are then discounted to calculate the fair values.
Investments in open-end investment companies (“Underlying Funds”) are valued at each Underlying Fund’s net asset values ('NAV") per share as of the report date.
See the table on “Quantitative Information about Level 3 Fair Value Measurements” for information on the valuation techniques and inputs used to value level 3 securities held by at December 31, 2022.
Valuations reflected in this report are as of the report date. As a result, changes in valuation due to market events and/or issuer-related events after the report date and prior to issuance of the report are not reflected herein.
The various inputs that are used in determining the valuation of the Portfolio's investments are summarized into the three broad levels listed below.
•
Level 1 — Unadjusted inputs using quoted prices in active markets for identical investments.
•
Level 2 — Other significant observable inputs including, but not limited to, quoted prices for similar investments, inputs other than quoted prices that are observable for investments (such as interest rates, prepayment speeds, credit risk, etc.) or other market corroborated inputs.
•
Level 3 — Significant inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Portfolio's assumptions in determining the fair value of investments).
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input, both individually and in the aggregate, that is significant to the fair value measurement. The inputs or methodology used for valuing instruments are not necessarily an indication of the risk associated with investing in those instruments.
The following table represents each valuation input as presented on the Schedule of Portfolio Investments ("SOI"):
| | | | |
| | Level 2
Other significant
observable inputs | Level 3
Significant
unobservable inputs | |
Investments in Securities | | | | |
| | | | |
Collateralized Mortgage Obligations | | | | |
Commercial Mortgage-Backed Securities | | | | |
| | | | |
Foreign Government Securities | | | | |
| | | | |
Mortgage-Backed Securities | | | | |
| | | | |
U.S. Government Agency Securities | | | | |
U.S. Treasury Obligations | | | | |
| | | | |
| | | | |
Total Investments in Securities | | | | |
The following is a summary of investments for which significant unobservable inputs (level 3) were used in determining fair value:
| Balance as of
December 31,
2021 | | Change in net
unrealized
appreciation
(depreciation) | Net
accretion
(amortization) | | | | | | Balance as of
December 31,
2022 |
Investments in Securities: | | | | | | | | | | |
| | | | | | | | | | |
Collateralized Mortgage Obligations | | | | | | | | | | |
Commercial Mortgage-Backed Securities | | | | | | | | | | |
| | | | | | | | | | |
|
| Purchases include all purchases of securities and securities received in corporate actions. |
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
| Sales include all sales of securities, maturities, paydowns and securities tendered in corporate actions. |
| Certain Level 3 investments were re-classified between Asset-Backed Securities and Collateralized Mortgage Obligations. |
| Amount rounds to less than one thousand. |
The changes in net unrealized appreciation (depreciation) attributable to securities owned at December 31, 2022, which were valued using significant unobservable inputs (level 3) amounted to $(629). This amount is included in Change in net unrealized appreciation/depreciation on investments in non-affiliates on the Statement of Operations.
For the year ended December 31, 2022, transfers in and out of level 3 were the result of decreased or increased transparency of market activity and observability of certain inputs used in determining fair value. This change in observability and resulting changes in levels does not impact liquidity or fair value of the Portfolio's investments or reflect any change in the investment strategy of the Portfolio.
The significant unobservable inputs used in the fair value measurement of the Portfolio's investments are listed below. Generally, a change in the assumptions used in any input in isolation may be accompanied by a change in another input. Significant changes in any of the unobservable inputs may significantly impact the fair value measurement. The impact is based on the relationship between each unobservable input and the fair value measurement. Significant increases (decreases) in enterprise multiples may increase (decrease) the fair value measurement. Significant increases (decreases) in the discount for lack of marketability, liquidity discount, probability of default, yield and default rate may decrease (increase) the fair value measurement. A significant change in the discount rate or prepayment rate (Constant Prepayment Rate or PSA Prepayment Model) may decrease or increase the fair value measurement.
Quantitative Information about Level 3 Fair Value Measurements #
| Fair Value at
December 31, 2022 | | | Range (Weighted
Average) (a) |
| | | | |
| | | Yield (Discount Rate of Cash Flows) | |
| | | | |
| | | | |
| | | Yield (Discount Rate of Cash Flows) | |
Collateralized Mortgage Obligations | | | | |
| | | | |
| The table above does not include certain level 3 investments that are valued by brokers and Pricing Services. At December 31, 2022, the value of these investments was $11,072. The inputs for these investments are not readily available or cannot be reasonably estimated and are generally those inputs described in Note 2.A. |
| Unobservable inputs were weighted by the relative fair value of the instruments. |
B. Restricted Securities — Certain securities held by the Portfolio may be subject to legal or contractual restrictions on resale. Restricted securities generally are resold in transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). Disposal of these securities may involve time-consuming negotiations and expense. Prompt sale at the current valuation may be difficult and could adversely affect the NAVs of the Portfolio.
As of December 31, 2022, the Portfolio had no investments in restricted securities other than securities sold to the Portfolio under Rule 144A and/or Regulation S under the Securities Act.
C. Loan Assignments — The Portfolio invested in debt instruments that are interests in amounts owed to lenders or lending syndicates (a “Lender”) by corporate, governmental or other borrowers (a “Borrower”). A loan is often administered by a bank or other financial institution (the “Agent”) that acts as Agent for all holders. The Agent administers the terms of the loan, as specified in the loan agreement. The Portfolio invests in loan assignments of all or a portion of the loans. When the Portfolio purchases a loan assignment, the Portfolio has direct rights against the Borrower on a loan, provided, however, the Portfolio's rights may be more limited than the Lender from which it acquired the assignment and the Portfolio may be able to enforce its rights only through the Agent. As a result, the Portfolio assumes the credit risk of the Borrower as well as any other persons interpositioned between the Portfolio and the Borrower (“Intermediate Participants”). The Portfolio may incur certain costs and delays in realizing payment on a loan assignment or suffer a loss of principal and/or interest if assets or interests held by the Agent or other Intermediate Participants are determined to be subject to the claims by their creditors. In addition, it is unclear whether loan assignments and other forms of direct indebtedness offer securities law protections against fraud and misrepresentation. Also, because JPMIM may wish to invest in publicly traded securities of a Borrower, it may not have access to material non-public information regarding the Borrower to which other investors have access. Although certain loan assignments are secured by collateral, the Portfolio could experience delays or limitations in realizing the value on such collateral or have its interest subordinated to other indebtedness of the Borrower.
Loan assignments are vulnerable to market conditions such that economic conditions or other events may reduce the demand for assignments and certain assignments which were liquid when purchased, may become illiquid and difficult to value. In addition, the settlement period for loans is uncertain as there is no standardized settlement schedule applicable to such investments. Therefore, the Portfolio may not receive the proceeds from a sale of such investments for a period after the sale.
D. When-Issued Securities, Delayed Delivery Securities and Forward Commitments — The Portfolio purchased when-issued securities, including To Be Announced ("TBA") securities, and entered into contracts to purchase or sell securities for a fixed price that may be settled a month or more after the trade date, or purchased delayed delivery securities which generally settle seven days after the trade date. When-issued securities are securities that have been authorized, but not issued in the market. A forward commitment involves entering into a contract to purchase or sell securities for a fixed price at a future date that may be settled a month or more after the trade date. A delayed delivery security is agreed upon in advance between the buyer and the seller of the security and is generally delivered beyond seven days of the agreed upon date. The purchase of securities on a when-issued, delayed delivery or forward commitment basis involves the risk that the value of the security to be purchased declines before the settlement date. The sale of securities on a forward commitment basis involves the risk that the value of the securities sold may increase before the settlement date. The Portfolio may be exposed to credit risk if the counterparty fails to perform under the terms of the transaction. Interest income for securities purchased on a when-issued, delayed delivery or forward commitment basis is not accrued until the settlement date.
The Portfolio may be required to post or receive collateral for delayed delivery securities in the form of cash or securities under a Master Securities Forward Transaction Agreement with the counterparties (each, an “MSFTA”). The collateral requirements are generally calculated by netting the mark-to-market amount for a Portfolio's transactions under the MSFTA and comparing that amount to the value of the collateral pledged by a portfolio and the counterparty. Daily movement of cash collateral is subject to minimum threshold amounts. Collateral posted by a portfolio is held in a segregated account at the Portfolio's custodian bank and is included on the Statement of Assets and Liabilities as Restricted cash. Collateral received by the Portfolio is held in a separate segregated account maintained by JPMorgan Chase Bank, N.A. ("JPMCB"), a wholly-owned subsidiary of JPMorgan. These amounts are not reflected on the Portfolio's Statement of Assets and Liabilities.
The Portfolio had when-issued securities, delayed delivery securities or forward commitments outstanding as of December 31, 2022, which are shown as a Receivable for Investment securities sold — delayed delivery securities and a Payable for Investment securities purchased — delayed delivery securities, respectively, on the Statement of Assets and Liabilities. The values of these securities held at December 31, 2022 are detailed on the SOI.
E. Securities Lending — The Portfolio is authorized to engage in securities lending in order to generate additional income. The Portfolio is able to lend to approved borrowers. Citibank N.A. (“Citibank”) serves as lending agent for the Portfolio, pursuant to a Securities Lending Agency Agreement (the “Securities Lending Agency Agreement”). Securities loaned are collateralized by cash equal to at least 100% of the market value plus accrued interest on the securities lent, which is invested in the Class IM Shares of the JPMorgan U.S. Government Money Market Fund and the Agency SL Class Shares of the JPMorgan Securities Lending Money Market Fund. The Portfolio retains the interest earned on cash collateral investments but is required to pay the borrower a rebate for the use of the cash collateral. In cases where the lent security is of high value to borrowers, there may be a negative rebate (i.e., a net payment from the borrower to the Portfolio). Upon termination of a loan, the Portfolio is required to return to the borrower an amount equal to the cash collateral, plus any rebate owed to the borrowers. The remaining maturities of the securities lending transactions are considered overnight and continuous. Loans are subject to termination by the Portfolio or the borrower at any time.
The net income earned on the securities lending (after payment of rebates and Citibank’s fee) is included on the Statement of Operations as Income from securities lending (net). The Portfolio also receives payments from the borrower during the period of the loan, equivalent to dividends and interest earned on the securities loaned, which are recorded as Dividend or Interest income, respectively, on the Statement of Operations.
Under the Securities Lending Agency Agreement, Citibank marks to market the loaned securities on a daily basis. In the event the cash received from the borrower is less than 102% of the value of the loaned securities (105% for loans of non-U.S. securities), Citibank requests additional cash from the borrower so as to maintain a collateralization level of at least 102% of the value of the loaned securities plus accrued interest (105% for loans of non-U.S. securities), subject to certain de minimis amounts.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
The value of securities out on loan is recorded as an asset on the Statement of Assets and Liabilities. The value of the cash collateral received is recorded as a liability on the Statement of Assets and Liabilities and details of collateral investments are disclosed on the SOI.
The Portfolio bears the risk of loss associated with the collateral investments and is not entitled to additional collateral from the borrower to cover any such losses. To the extent that the value of the collateral investments declines below the amount owed to a borrower, the Portfolio may incur losses that exceed the amount it earned on lending the security. Upon termination of a loan, the Portfolio may use leverage (borrow money) to repay the borrower for cash collateral posted if the Adviser does not believe that it is prudent to sell the collateral investments to fund the payment of this liability. Securities lending activity is subject to master netting arrangements.
Securities lending also involves counterparty risks, including the risk that the loaned securities may not be returned in a timely manner or at all. Subject to certain conditions, Citibank has agreed to indemnify the Portfolio from losses resulting from a borrower’s failure to return a loaned security.
The Portfolio did not have any securities out on loan at December 31, 2022.
F. Investment Transactions with Affiliates — The Portfolio invested in Underlying Funds which are advised by the Adviser. An issuer which is under common control with the Portfolio may be considered an affiliate. For the purposes of the financial statements, the Portfolio assumes the issuers listed in the table below to be affiliated issuers. The Underlying Funds’ distributions may be reinvested into such Underlying Funds. Reinvestment amounts are included in the purchases at cost amounts in the table below.
|
For the year ended December 31, 2022 |
| | | | | Change in
Unrealized
Appreciation/
(Depreciation) | | Shares at
December 31,
2022 | | Capital Gain
Distributions |
JPMorgan Prime Money Market Fund Class Institutional Shares, 4.42% (a) (b) | | | | | | | | | |
|
| Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. |
| The rate shown is the current yield as of December 31, 2022. |
G. Security Transactions and Investment Income — Investment transactions are accounted for on the trade date (the date the order to buy or sell is executed). Securities gains and losses are calculated on a specifically identified cost basis. These adjustments are recorded as increases or decreases to interest income on the Statement of Operations. Coupon payments are based on the adjusted principal at the time the interest is paid.
The Portfolio invests in treasury inflation protected securities (TIPS). The principal amount of TIPS is adjusted periodically and is increased for inflation or decreased for deflation based on a monthly published index. These adjustments are recorded as increases or decreases to interest income on the Statement of Operations. Coupon payments are based on the adjusted principal at the time the interest is paid.
To the extent such information is publicly available, the Portfolio records distributions received in excess of income earned from underlying investments as a reduction of cost of investments and/or realized gain. Such amounts are based on estimates if actual amounts are not available and actual amounts of income, realized gain and return of capital may differ from the estimated amounts. The Portfolio adjusts the estimated amounts of the components of distributions (and consequently its net investment income) as necessary, once the issuers provide information about the actual composition of the distributions.
H. Allocation of Income and Expenses— Expenses directly attributable to the Portfolio are charged directly to the Portfolio, while the expenses attributable to more than one portfolio of the Trust are allocated among the applicable portfolios. Investment income, realized and unrealized gains and losses and expenses, other than class-specific expenses, are allocated daily to each class of shares based upon the proportion of net assets of each class at the beginning of each day.
Transfer agency fees are class-specific expenses. The amount of the transfer agency fees charged to each share class of the Portfolio for the year ended December 31, 2022 are as follows:
I. Federal Income Taxes — The Portfolio is treated as a separate taxable entity for Federal income tax purposes. The Portfolio's policy is to comply with the provisions of the Internal Revenue Code (the “Code”) applicable to regulated investment companies and to distribute to shareholders all of its distributable net investment income and net realized capital gains on investments. Accordingly, no provision for Federal income tax is necessary. The Portfolio is also a segregated portfolio of assets for insurance purposes and intends to comply with the diversification requirements of Sub-chapter L of the Code. Management has reviewed the Portfolio's tax positions for all open tax years and has determined that as of December 31, 2022, no liability for Federal income tax is required in the Portfolio's financial statements for net unrecognized tax benefits. However, management’s conclusions may be subject to future review based on changes in, or the interpretation of, the accounting standards or tax laws and regulations. The Portfolio's Federal tax returns for the prior three fiscal years remain subject to examination by the Internal Revenue Service.
J. Distributions to Shareholders — Distributions from net investment income, if any, are generally declared and paid at least annually and are declared separately for each class. No class has preferential dividend rights; differences in per share rates are due to differences in separate class expenses. Net realized capital gains, if any, are distributed at least annually. The amount of distributions from net investment income and net realized capital gains is determined in accordance with Federal income tax regulations, which may differ from GAAP. To the extent these “book/tax” differences are permanent in nature (i.e., that they result from other than timing of recognition — “temporary differences”), such amounts are reclassified within the capital accounts based on their Federal tax basis treatment.
The following amounts were reclassified within the capital accounts:
| | Accumulated
undistributed
(distributions in
excess of)
net investment
income | Accumulated
net realized
gains (losses) |
| | | |
The reclassifications for the Portfolio relate primarily to tax adjustments on certain investments.
3. Fees and Other Transactions with Affiliates
A. Investment Advisory Fee — Pursuant to an Investment Advisory Agreement, the Adviser manages the investments of the Portfolio and for such services is paid a fee. The investment advisory fee is accrued daily and paid monthly at an annual rate of 0.40% of the Portfolio's average daily net assets.
The Adviser waived investment advisory fees and/or reimbursed expenses as outlined in Note 3.E.
B. Administration Fee — Pursuant to an Administration Agreement, the Administrator provides certain administration services to the Portfolio. In consideration of these services, the Administrator receives a fee accrued daily and paid monthly at an annual rate of 0.075% of the first $10 billion of the Portfolio's average daily net assets, plus 0.050% of the Portfolio's average daily net assets between $10 billion and $20 billion, plus 0.025% of the Portfolio's average daily net assets between $20 billion and $25 billion, plus 0.010% of the Portfolio's average daily net assets in excess of $25 billion. For the year ended December 31, 2022, the effective rate was 0.075% of the Portfolio's average daily net assets, notwithstanding any fee waivers and/or expense reimbursements.
The Administrator waived administration fees as outlined in Note 3.E.
JPMCB serves as the Portfolio's sub-administrator (the “Sub-administrator”). For its services as Sub-administrator, JPMCB receives a portion of the fees payable to the Administrator.
C. Distribution Fees — Pursuant to a Distribution Agreement, JPMorgan Distribution Services, Inc. (“JPMDS”), an indirect, wholly-owned subsidiary of JPMorgan, serves as the Portfolio's principal underwriter and promotes and arranges for the sale of the Portfolio's shares.
The Board has adopted a Distribution Plan (the “Distribution Plan”) for Class 2 Shares of the Portfolio pursuant to Rule 12b-1 under the 1940 Act. Class 1 Shares of the Portfolio do not charge a distribution fee. The Distribution Plan provides that the Portfolio shall pay, with respect to the applicable share classes, distribution fees, including payments to JPMDS, at an annual rate of 0.25% of the average daily net assets of Class 2 Shares.
D. Custodian and Accounting Fees — JPMCB provides portfolio custody and accounting services to the Portfolio. For performing these services, the Portfolio pays JPMCB transaction and asset-based fees that vary according to the number of transactions and positions, plus out-of-pocket expenses. The amounts paid directly to JPMCB by the Portfolio for custody and accounting services are included in Custodian and accounting fees on the Statement of Operations.
Interest income earned on cash balances at the custodian, if any, is included in Interest income from affiliates on the Statement of Operations.
Interest expense paid to the custodian related to cash overdrafts, if any, is included in Interest expense to affiliates on the Statement of Operations.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
E. Waivers and Reimbursements —The Adviser (for all share classes), Administrator (for all share classes) and/or JPMDS (for Class 2 Shares) have contractually agreed to waive fees and/or reimburse the Portfolio to the extent that total annual operating expenses (excluding acquired fund fees and expenses other than certain money market fund fees as described below, dividend and interest expenses related to short sales, interest, taxes, expenses related to litigation and potential litigation, expenses related to trustee elections and extraordinary expenses) exceed the percentages of the Portfolio's respective average daily net assets as shown in the table below:
The expense limitation agreement was in effect for the year ended December 31, 2022 and the contractual expense limitation percentages in the table above are in place until at least April 30, 2023.
For the year ended December 31, 2022, the Portfolio's service providers did not waive fees and/or reimburse expenses for the Portfolio.
Additionally, the Portfolio may invest in one or more money market funds advised by the Adviser (affiliated money market funds). The Adviser, Administrator and/or JPMDS, have contractually agreed to waive fees and/or reimburse expenses in an amount sufficient to offset the respective net fees each collects from the affiliated money market fund on the Portfolio's investment in such affiliated money market fund, except for investments of securities lending cash collateral. None of these parties expect the Portfolio to repay any such waived fees and/or reimbursed expenses in future years.
The amount of these waivers resulting from investments in these money market funds for the year ended December 31, 2022 was $55.
JPMIM voluntarily agreed to reimburse the Portfolio for the Trustee Fees paid to one of the interested Trustees. For the year ended December 31, 2022 the amount of this reimbursement was $2.
F. Other — Certain officers of the Trust are affiliated with the Adviser, the Administrator and JPMDS. Such officers, with the exception of the Chief Compliance Officer, receive no compensation from the Portfolio for serving in their respective roles.
The Board designated and appointed a Chief Compliance Officer to the Portfolio pursuant to Rule 38a-1 under the 1940 Act. The Portfolio, along with affiliated funds, makes reimbursement payments, on a pro-rata basis, to the Administrator for a portion of the fees associated with the office of the Chief Compliance Officer. Such fees are included in Trustees’ and Chief Compliance Officer’s fees on the Statement of Operations.
The Trust adopted a Trustee Deferred Compensation Plan (the “Plan”) which allows the independent Trustees to defer the receipt of all or a portion of compensation related to performance of their duties as Trustees. The deferred fees are invested in various J.P. Morgan Funds until distribution in accordance with the Plan.
During the year ended December 31, 2022, the Portfolio purchased securities from an underwriting syndicate in which the principal underwriter or members of the syndicate were affiliated with the Adviser.
The Securities and Exchange Commission ("SEC") has granted an exemptive order permitting the Portfolio to engage in principal transactions with J.P. Morgan Securities LLC, an affiliated broker, involving taxable money market instruments, subject to certain conditions.
4. Investment Transactions
During the year ended December 31, 2022, purchases and sales of investments (excluding short-term investments) were as follows:
| Purchases
(excluding
U.S. Government) | Sales
(excluding
U.S. Government) | Purchases
of U.S.
Government | |
| | | | |
5. Federal Income Tax Matters
For Federal income tax purposes, the estimated cost and unrealized appreciation (depreciation) in value of investments held at December 31, 2022 were as follows:
| | Gross
Unrealized
Appreciation | Gross
Unrealized
Depreciation | Net Unrealized
Appreciation
(Depreciation) |
| | | | |
The difference between book and tax basis appreciation (depreciation) on investments is primarily attributed to tax adjustments on certain investments.
The tax character of distributions paid during the year ended December 31, 2022 was as follows:
| | Net
Long-Term
Capital Gains | |
| | | |
|
| Short-term gain distributions are treated as ordinary income for income tax purposes. |
The tax character of distributions paid during the year ended December 31, 2021 was as follows:
| | Net
Long-Term
Capital Gains | |
| | | |
|
| Short-term gain distributions are treated as ordinary income for income tax purposes. |
As of December 31, 2022, the estimated components of net assets (excluding paid-in-capital) on a tax basis were as follows:
| Current
Distributable
Ordinary
Income | Current
Distributable
Long-Term
Capital Gain
(Tax Basis Capital
Loss Carryover) | Unrealized
Appreciation
(Depreciation) |
| | | |
The cumulative timing differences primarily consist of tax adjustments on certain investments.
At December 31, 2022, the Portfolio had net capital loss carryforwards which are available to offset future realized gains.
| Capital Loss Carryforward Character |
| | |
| | |
6. Borrowings
The Portfolio relies upon an exemptive order granted by the SEC (the “Order”) permitting the establishment and operation of an Interfund Lending Facility (the “Facility”). The Facility allows the Portfolio to directly lend and borrow money to or from any other fund relying upon the Order at rates beneficial to both the borrowing and lending funds. Advances under the Facility are taken primarily for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities, and are subject to the Portfolio's borrowing restrictions. The interfund loan rate is determined, as specified in the Order, by averaging the current repurchase agreement rate and the current bank loan rate. The Order was granted to the Trust and may be relied upon by the Portfolio because the Portfolio and the series of the Trust are all investment companies in the same “group of investment companies” (as defined in Section 12(d)(1)(G) of the 1940 Act).
The Portfolio had no borrowings outstanding from another fund, or loans outstanding to another fund, during the year ended December 31, 2022.
The Trust and JPMCB have entered into a financing arrangement. Under this arrangement, JPMCB provides an unsecured, uncommitted credit facility in the aggregate amount of $100 million to certain of the J.P. Morgan Funds, including the Portfolio. Advances under the arrangement are taken primarily for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities, and are subject to the Portfolio's borrowing restrictions. Interest on borrowings is payable at a rate determined by JPMCB at the time of borrowing. This agreement has been extended until October 30, 2023.
The Portfolio had no borrowings outstanding from the unsecured, uncommitted credit facility during the year ended December 31, 2022.
The Trust, along with certain other trusts for J.P. Morgan Funds (“Borrowers”), has entered into a joint syndicated senior unsecured revolving credit facility totaling $1.5 billion (“Credit Facility”) with various lenders and The Bank of New York Mellon, as administrative agent for the lenders. This Credit Facility provides a source of funds to the Borrowers for temporary and emergency purposes, including the meeting of redemption requests
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
that otherwise might require the untimely disposition of securities. Under the terms of the Credit Facility, a borrowing portfolio must have a minimum of $25 million in adjusted net asset value and not exceed certain adjusted net asset coverage ratios prior to and during the time in which any borrowings are outstanding. If a portfolio does not comply with the aforementioned requirements, the portfolio must remediate within three business days with respect to the $25 million minimum adjusted net asset value or within one business day with respect to certain asset coverage ratios or the administrative agent at the request of, or with the consent of, the lenders may terminate the Credit Facility and declare any outstanding borrowings to be due and payable immediately.
Interest associated with any borrowing under the Credit Facility is charged to the borrowing portfolio at a rate of interest equal to 1.00% (the “Applicable Margin”), plus the greater of the federal funds effective rate or one month London Interbank Offered Rate ("LIBOR"). The annual commitment fee to maintain the Credit Facility is 0.15% and is incurred on the unused portion of the Credit Facility and is allocated to all participating portfolios pro rata based on their respective net assets. Effective August 9, 2022, the Credit Facility has been amended and restated for a term of 364 days, unless extended, and to include a change in the interest associated with any borrowing to the higher, on the day of the borrowing, of (a) the federal funds effective rate, or (b) the one-month Adjusted SOFR Rate plus the Applicable Margin.
The Portfolio did not utilize the Credit Facility during the year ended December 31, 2022.
7. Risks, Concentrations and Indemnifications
In the normal course of business, the Portfolio enters into contracts that contain a variety of representations which provide general indemnifications. The Portfolio's maximum exposure under these arrangements is unknown. The amount of exposure would depend on future claims that may be brought against the Portfolio. However, based on experience, the Portfolio expects the risk of loss to be remote.
As of December 31, 2022, the Portfolio had three individual shareholder and/or non-affiliated omnibus accounts each owning more than 10% of the Portfolio's outstanding shares, and, collectively owning 73.1% of the Portfolio's outstanding shares.
Significant shareholder transactions by these shareholders may impact the Portfolio's performance and liquidity.
The Portfolio is subject to risks associated with securities with contractual cash flows including asset-backed and mortgage-related securities such as collateralized mortgage obligations, mortgage pass-through securities and commercial mortgage-backed securities, including securities backed by sub-prime mortgage loans. The value, liquidity and related income of these securities are sensitive to changes in economic conditions, including real estate value, pre-payments, delinquencies and/or defaults, and may be adversely affected by shifts in the market’s perception of the issuers and changes in interest rates.
The Portfolio is subject to the risk that, should the Portfolio decide to sell an illiquid investment when a ready buyer is not available at a price the Portfolio deems to be representative of its value, the value of the Portfolio’s net assets could be adversely affected.
The Portfolio is subject to interest rate risk. Investments in bonds and other debt securities will change in value based on changes in interest rates. If rates increase, the value of these investments generally declines. Securities with greater interest rate sensitivity and longer maturities generally are subject to greater fluctuations in value. The Portfolio may face a heightened level of interest rate risk due to certain changes in monetary policy. It is difficult to predict the pace at which central banks or monetary authorities may increase interest rates or the timing, frequency, or magnitude of such increases. Any such changes could be sudden and could expose debt markets to significant volatility and reduced liquidity for Portfolio investments.
The Portfolio is subject to credit risk. The Portfolio's investments are subject to the risk that an issuer and/or a counterparty will fail to make payments when due or default completely. Prices of the Portfolio's investments may be adversely affected if any of the issuers or counterparties it is invested in are subject to an actual or perceived deterioration in their credit quality. Credit spreads may increase, which may reduce the market values of the Portfolio's securities. Credit spread risk is the risk that economic and market conditions or any actual or perceived credit deterioration may lead to an increase in the credit spreads (i.e. the difference in yield between two securities of similar maturity but different credit quality) and a decline in price of the issuer’s securities.
LIBOR is intended to represent the rate at which contributing banks may obtain short-term borrowings from each other in the London interbank market. On March 5, 2021, the U.K. Financial Conduct Authority ("FCA") publicly announced that (i) immediately after December 31, 2021, publication of the 1-week and 2-month U.S. Dollar LIBOR settings will permanently cease; (ii) immediately after June 30, 2023, publication of the overnight and 12-month U.S. Dollar LIBOR settings will permanently cease; and (iii) immediately after June 30, 2023, the 1-month, 3-month and 6-month U.S. Dollar LIBOR settings will cease to be provided or, subject to the FCA's consideration of the case, be provided on a synthetic basis and no longer be representative of the underlying market and economic reality they are intended to measure and that representativeness will not be restored. There is no assurance that the dates announced by the FCA will not change or that the administrator of LIBOR and/or regulators will not take further action that could impact the availability, composition or characteristics of LIBOR or the currencies and/or tenors for which LIBOR is published. In addition, certain regulated entities ceased entering into most new LIBOR contracts in connection with regulatory guidance or prohibitions. Public and private sector industry initiatives are currently underway to implement new or alternative reference rates to be used in place of LIBOR. There is no assurance that any such alternative reference rate will be similar to or produce the same value or economic equivalence as LIBOR or that it will have the same volume or liquidity as did LIBOR prior to its discontinuance, unavailability or replacement, all of which may affect the value, volatility, liquidity or return on certain of the Portfolio's loans, notes, derivatives and other instruments or investments comprising some or all of the Portfolio's
investments and result in costs incurred in connection with changing reference rates used for positions closing out positions and entering into new trades. Certain of the Portfolio's investments may transition from LIBOR prior to the dates announced by the FCA. The transition from LIBOR to alternative reference rates may result in operational issues for the Portfolio or its investments. No assurances can be given as to the impact of the LIBOR transition (and the timing of any such impact) on the Portfolio and its investments.
The Portfolio is subject to infectious disease epidemics/pandemics risk. The worldwide outbreak of COVID-19 has negatively affected economies, markets and individual companies throughout the world. The effects of this COVID-19 pandemic to public health, and business and market conditions, including among other things, reduced consumer demand and economic output, supply chain disruptions and increased government spending may continue to have a significant negative impact on the performance of the Portfolio's investments, increase the Portfolio's volatility, exacerbate other pre-existing political, social and economic risks to the Portfolio and negatively impact broad segments of businesses and populations. In addition, governments, their regulatory agencies, or self-regulatory organizations have taken or may take actions in response to the pandemic that affect the instruments in which the Portfolio invests, or the issuers of such instruments, in ways that could also have a significant negative impact on the Portfolio's investment performance. The duration and extent of COVID-19 and associated economic and market conditions and uncertainty over the long-term cannot be reasonably estimated at this time. The ultimate impact of COVID-19 and the extent to which the associated conditions impact the Portfolio will also depend on future developments, which are highly uncertain, difficult to accurately predict and subject to frequent changes.
8. Other Matters
On December 12, 2022, the Board approved a proposal to reorganize the Portfolio into a newly organized series (the “Acquiring Fund") of Lincoln Variable Insurance Products Trust (the “Reorganization”).
The Acquiring Fund has the same investment objective and substantially identical principal investment strategies and principal risks as the Portfolio. The Acquiring Fund’s investment adviser will be Lincoln Investment Advisors Corporation, and it is anticipated that JPMIM will be retained as the sub-adviser to the Acquiring Fund upon consummation of the Reorganization. Upon the closing of the Reorganization, the Class 1 Shares and Class 2 Shares of the Portfolio will be exchanged for the same value of Standard Class Shares and Service Class Shares, respectively, of the Acquiring Fund.
The Reorganization is subject to the approval of the Portfolio’s shareholders at a special shareholder meeting to be held on or about March 15, 2023. If shareholder approval of the Reorganization is obtained, the Reorganization is expected to be effective on or about May 1, 2023. All costs related to the Reorganization will be borne by Lincoln Investment Advisors Corporation and JPMIM and not by the Portfolio or Acquiring Fund.
More detailed information about the reorganization was included in a proxy statement provided to shareholders.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Trustees of JPMorgan Insurance Trust and Shareholders of JPMorgan Insurance Trust Core Bond Portfolio
Opinion on the Financial Statements
We have audited the accompanying statement of assets and liabilities, including the schedule of portfolio investments, of JPMorgan Insurance Trust Core Bond Portfolio (one of the portfolios constituting JPMorgan Insurance Trust, referred to hereafter as the “Portfolio”) as of December 31, 2022, the related statement of operations for the year ended December 31, 2022, the statements of changes in net assets for each of the two years in the period ended December 31, 2022, including the related notes, and the financial highlights for each of the five years in the period ended December 31, 2022 (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Portfolio as of December 31, 2022, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended December 31, 2022 and the financial highlights for each of the five years in the period ended December 31, 2022 in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Portfolio’s management. Our responsibility is to express an opinion on the Portfolio’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Portfolio in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of December 31, 2022 by correspondence with the custodian, transfer agent and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
/s/ PricewaterhouseCoopers LLP
New York, New York
February 15, 2023
We have served as the auditor of one or more investment companies in the JPMorgan Funds complex since 1993.
The Portfolio's Statement of Additional Information includes additional information about the Portfolio's Trustees and is available, without charge, upon request by calling 1-800-480-4111 or on the Portfolio's website at www.jpmorgan.com/variableinsuranceportfolios.
Name (Year of Birth);
Positions With
the Portfolio (1) | Principal Occupation
During Past 5 Years | Number of
Funds in Fund
Complex Overseen
by Trustee (2) | Other Directorships Held
During the Past 5 Years |
| | | |
John F. Finn (1947); Chair
since 2020; Trustee since 1998. | Chairman, Gardner, Inc. (supply chain management company serving industrial and consumer markets) (serving in various roles 1974-present). | | Director, Greif, Inc. (GEF) (industrial package products and services) (2007-present); Trustee, Columbus Association for the Performing Arts (1988-present). |
Stephen P. Fisher (1959);
Trustee since 2018. | Retired; Chairman and Chief Executive Officer, NYLIFE Distributors LLC (registered broker-dealer) (serving in various roles 2008-2013); Chairman, NYLIM Service Company LLC (transfer agent) (2008-2017); New York Life Investment Management LLC (registered investment adviser) (serving in various roles 2005-2017); Chairman, IndexIQ Advisors LLC (registered investment adviser for ETFs) (2014-2017); President, MainStay VP Funds Trust (2007-2017), MainStay DefinedTerm Municipal Opportunities Fund (2011-2017) and MainStay Funds Trust (2007-2017) (registered investment companies). | | Honors Program Advisory Board Member, The Zicklin School of Business, Baruch College, The City University of New York (2017-present). |
Gary L. French (1951);
Trustee since 2014. | Real Estate Investor (2011-2020); Investment management industry Consultant and Expert Witness (2011-present); Senior Consultant for The Regulatory Fundamentals Group LLC (2011-2017). | | Independent Trustee, The China Fund, Inc. (2013-2019); Exchange Traded Concepts Trust II (2012-2014); Exchange Traded Concepts Trust I (2011-2014). |
Kathleen M. Gallagher (1958);
Trustee since 2018. | Retired; Chief Investment Officer — Benefit Plans, Ford Motor Company (serving in various roles 1985-2016). | | Non- Executive Director, Legal & General Investment Management (Holdings) (2018-present); Non-Executive Director, Legal & General Investment Management America (U.S. Holdings) (financial services and insurance) (2017-present); Advisory Board Member, State Street Global Advisors Total Portfolio Solutions (2017-present); Member, Client Advisory Council, Financial Engines, LLC (registered investment adviser) (2011-2016); Director, Ford Pension Funds Investment Management Ltd. (2007-2016). |
Robert J. Grassi (1957);
Trustee since 2014. | Sole Proprietor, Academy Hills Advisors LLC (2012-present); Pension Director, Corning Incorporated (2002-2012). | | |
TRUSTEES
(Unaudited) (continued)
Name (Year of Birth); Positions With the Portfolio (1) | Principal Occupation During Past 5 Years | Number of Funds in Fund Complex Overseen by Trustee (2) | Other Directorships Held During the Past 5 Years |
Frankie D. Hughes (1952);
Trustee since 2008. | President, Ashland Hughes Properties (property management) (2014-present); President and Chief Investment Officer, Hughes Capital Management, Inc. (fixed income asset management) (1993-2014). | | |
Raymond Kanner (1953);
Trustee since 2017. | Retired; Managing Director and Chief Investment Officer, IBM Retirement Funds (2007-2016). | | Advisory Board Member, Penso Advisors, LLC (2020-present); Advisory Board Member, Los Angeles Capital (2018-present); Advisory Board Member, State Street Global Advisors Total Portfolio Solutions (2017- present); Acting Executive Director, Committee on Investment of Employee Benefit Assets (CIEBA) (2016-2017); Advisory Board Member, Betterment for Business (robo advisor) (2016- 2017); Advisory Board Member, BlueStar Indexes (index creator) (2013-2017); Director, Emerging Markets Growth Fund (registered investment company) (1997-2016); Member, Russell Index Client Advisory Board (2001-2015). |
Thomas P. Lemke (1954);
Trustee since 2014. | | | (1) Independent Trustee of Advisors’ Inner Circle III fund platform, consisting of the following: (i) the Advisors’ Inner Circle Fund III, (ii) the Gallery Trust, (iii) the Schroder Series Trust, (iv) the Delaware Wilshire Private Markets Fund (since 2020), (v) Chiron Capital Allocation Fund Ltd., and (vi) formerly the Winton Diversified Opportunities Fund (2014-2018); and (2) Independent Trustee of the Symmetry Panoramic Trust (since 2018). |
Lawrence R. Maffia (1950);
Trustee since 2014 | Retired; Director and President, ICI Mutual Insurance Company (2006-2013). | | Director, ICI Mutual Insurance Company (1999-2013). |
Mary E. Martinez (1960); Vice
Chair since 2021; Trustee since 2013. | Associate, Special Properties, a Christie’s International Real Estate Affiliate (2010-present); Managing Director, Bank of America (asset management) (2007-2008); Chief Operating Officer, U.S. Trust Asset Management, U.S. Trust Company (asset management) (2003-2007); President, Excelsior Funds (registered investment companies) (2004-2005). | | |
Marilyn McCoy (1948);
Trustee since 2005. | Vice President of Administration and Planning, Northwestern University (1985-present). | | |
Name (Year of Birth); Positions With the Portfolio (1) | Principal Occupation During Past 5 Years | Number of Funds in Fund Complex Overseen by Trustee (2) | Other Directorships Held During the Past 5 Years |
Dr. Robert A. Oden, Jr. (1946); Trustee
since 2005. | Retired; President, Carleton College (2002-2010); President, Kenyon College (1995-2002). | | Trustee, The Coldwater Conservation Fund (2017-present); Trustee, American Museum of Fly Fishing (2013-present); Trustee and Vice Chair, Trout Unlimited (2017-2021);Trustee, Dartmouth- Hitchcock MedicalCenter (2011-2020). |
Marian U. Pardo* (1946);
Trustee since 2013. | Managing Director and Founder, Virtual Capital Management LLC (investment consulting) (2007-present); Managing Director, Credit Suisse Asset Management (portfolio manager) (2003-2006). | | Board Chair and Member, Board of Governors, Columbus Citizens Foundation (not-for-profit supporting philanthropic and cultural programs) (2006-present). |
Emily A. Youssouf (1951);
Trustee since 2022. | Adjunct Professor (2011-present) and Clinical Professor (2009-2011), NYU Schack Institute of Real Estate; Board Member and Member of the Audit Committee (2013–present), Chair of Finance Committee (2019-present), Member of Related Parties Committee (2013-2018) and Member of the Enterprise Risk Committee (2015-2018), PennyMac Financial Services, Inc.; Board Member (2005-2018), Chair of Capital Committee (2006-2016), Chair of Audit Committee (2005-2018), Member of Finance Committee (2005-2018) and Chair of IT Committee (2016-2018), NYC Health and Hospitals Corporation. | | Trustee, NYC School Construction Authority (2009-present); Board Member, NYS Job Development Authority (2008-present); Trustee and Chair of the Audit Committee of the Transit Center Foundation (2015-2019). |
| | | |
Robert F. Deutsch** (1957);
Trustee since 2014. | Retired; Head of ETF Business for JPMorgan Asset Management (2013-2017); Head of Global Liquidity Business for JPMorgan Asset Management (2003-2013). | | Treasurer and Director of the JUST Capital Foundation (2017-present). |
Nina O. Shenker** (1957);
Trustee since 2022. | Vice Chair (2017-2021), General Counsel and Managing Director (2008-2016), Associate General Counsel and Managing Director (2004-2008), J.P. Morgan Asset & Wealth Management. | | Director and Member of Legal and Human Resources Subcommittees, American Jewish Joint Distribution Committee (2018-present). |
|
| The year shown is the first year in which a Trustee became a member of any of the following: the JPMorgan Mutual Fund Board, the JPMorgan ETF Board, the heritage J.P. Morgan Funds or the heritage One Group Mutual Funds. Trustees serve an indefinite term, until resignation, retirement, removal or death. The Board’s current retirement policy sets retirement at the end of the calendar year in which the Trustee attains the age of 75, provided that any Board member who was a member of the JPMorgan Mutual Fund Board prior to January 1, 2022 and was born prior to January 1, 1950 shall retire from the Board at the end of the calendar year in which the Trustee attains the age of 78. |
| A Fund Complex means two or more registered investment companies that hold themselves out to investors as related companies for purposes of investment and investor services or have a common investment adviser or have an investment adviser that is an affiliated person of the investment adviser of any of the other registered investment companies. The J.P. Morgan Funds Complex for which the Board of Trustees serves currently includes nine registered investment companies (179 J.P. Morgan Funds). |
| In connection with prior employment with JPMorgan Chase, Ms. Pardo was the recipient of non-qualified pension plan payments from JPMorgan Chase in the amount of approximately $2,055 per month, which she irrevocably waived effective January 1, 2013, and deferred compensation payments from JPMorgan Chase in the amount of approximately $7,294 per year, which ended in January 2013. In addition, Ms. Pardo receives payments from a fully-funded qualified plan, which is not an obligation of JPMorgan Chase. |
| Designation as an “Interested Trustee” is based on prior employment by the Adviser or an affiliate of the Adviser or interests in a control person of the Adviser. |
TRUSTEES
(Unaudited) (continued)
| The contact address for each of the Trustees is 277 Park Avenue, New York, NY 10172. |
Name (Year of Birth),
Positions Held with
the Trust (Since) | Principal Occupations During Past 5 Years |
Brian S. Shlissel (1964),
President and Principal Executive
Officer (2016)* | Managing Director and Chief Administrative Officer for J.P. Morgan pooled vehicles, J.P. Morgan Investment Management Inc. since 2014. |
Timothy J. Clemens (1975),
Treasurer and Principal Financial
Officer (2018) | Executive Director, J.P. Morgan Investment Management Inc. since February 2016. Mr. Clemens has been with J.P. Morgan Investment Management Inc. since 2013. |
Gregory S. Samuels (1980),
Secretary (2019) (formerly Assistant
Secretary 2010-2019) | Managing Director and Assistant General Counsel, JPMorgan Chase & Co. Mr. Samuels has been with JPMorgan Chase & Co. since 2010. |
Stephen M. Ungerman (1953),
Chief Compliance Officer (2005) | Managing Director, JPMorgan Chase & Co. Mr. Ungerman has been with JPMorgan Chase & Co. since 2000. |
Kiesha Astwood-Smith (1973),
Assistant Secretary (2021) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since June 2021; Senior Director and Counsel, Equitable Financial Life Insurance Company (formerly, AXA Equitable Life Insurance Company) from September 2015 through June 2021. |
Matthew Beck (1988),
Assistant Secretary (2021)** | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since May 2021; Senior Legal Counsel, Ultimus Fund Solutions from May 2018 through May 2021; General Counsel, The Nottingham Company from April 2014 through May 2018. |
Elizabeth A. Davin (1964),
Assistant Secretary (2005)** | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Ms. Davin has been with JPMorgan Chase & Co. (formerly Bank One Corporation) since 2004. |
Jessica K. Ditullio (1962)
Assistant Secretary (2005)** | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Ms. Ditullio has been with JPMorgan Chase & Co. (formerly Bank One Corporation) since 1990. |
Anthony Geron (1971),
Assistant Secretary (2018) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since September 2018; Lead Director and Counsel, AXA Equitable Life Insurance Company from 2015 to 2018 and Senior Director and Counsel, AXA Equitable Life Insurance Company from 2014 to 2015. |
Carmine Lekstutis (1980),
Assistant Secretary (2011) | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Mr. Lekstutis has been with JPMorgan Chase & Co. since 2011. |
Max Vogel (1990),
Assistant Secretary (2021) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since June 2021; Associate, Proskauer Rose LLP (law firm) from March 2017 to June 2021. |
Zachary E. Vonnegut-Gabovitch
(1986),
Assistant Secretary (2017) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since September 2016. |
Michael M. D’Ambrosio (1969),
Assistant Treasurer (2012) | Managing Director, J.P. Morgan Investment Management Inc. Mr. D’Ambrosio has been with J.P. Morgan Investment Management Inc. since 2012. |
Aleksandr Fleytekh (1972),
Assistant Treasurer (2019) | Vice President, J.P. Morgan Investment Management Inc. since February 2012. |
Shannon Gaines (1977),
Assistant Treasurer (2018)** | Vice President, J.P. Morgan Investment Management Inc. since January 2014. |
Jeffrey D. House (1972),
Assistant Treasurer (2017)** | Vice President, J.P. Morgan Investment Management Inc. since July 2006. |
Michael Mannarino (1985),
Assistant Treasurer (2020) | Vice President, J.P. Morgan Investment Management Inc. since 2014. |
Joseph Parascondola (1963),
Assistant Treasurer (2011)* | Executive Director, J.P. Morgan Investment Management, Inc. Mr. Parascondola has been with J.P. Morgan Investment Management Inc. since 2006. |
Gillian I. Sands (1969),
Assistant Treasurer (2012) | Executive Director, J.P. Morgan Investment Management Inc. Ms. Sands has been with J.P. Morgan Investment Management Inc. since 2012. |
|
The contact address for each of the officers, unless otherwise noted, is 277 Park Avenue, New York, NY 10172. |
OFFICERS
(Unaudited) (continued)
| The contact address for the officer is 575 Washington Boulevard, Jersey City, NJ 07310. |
| The contact address for the officer is 1111 Polaris Parkway, Columbus, OH 43240. |
SCHEDULE OF SHAREHOLDER EXPENSES
(Unaudited)
Hypothetical $1,000 Investment
As a shareholder of the Portfolio, you incur ongoing costs, including investment advisory fees, administration fees, distribution fees (for Class 2 Shares) and other Portfolio expenses. Because the Portfolio is a funding vehicle for Policies and Eligible Plans you may also incur sales charges and other fees relating to the Policies or Eligible Plans. The examples below are intended to help you understand your ongoing costs (in dollars) of investing in the Portfolio, but not the costs of the Policies or Eligible Plans, and to compare these ongoing costs with the ongoing costs of investing in other mutual funds. The examples assume that you had a $1,000 investment in each Class at the beginning of the reporting period, July 1, 2022, and continued to hold your shares at the end of the reporting period, December 31, 2022.
Actual Expenses
For each Class of the Portfolio in the table below, the first line provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line of each Class under the heading titled “Expenses Paid During the Period” to estimate the expenses you paid on your account during this period.
Hypothetical Example for Comparison Purposes
The second line of each Class in the table below provides information about hypothetical account values and hypothetical expenses based on the Class’ actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Class’ actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in each Class of the Portfolio and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds. Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs, such as sales charges (loads), or redemption fees , or the costs associated with the Policies and Eligible Plans through which the Portfolio is held. Therefore, the second line for each Class in the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transaction costs were included, your costs would have been higher. The examples also assume all dividends and distributions have been reinvested.
| Beginning
Account Value
July 1, 2022 | Ending
Account Value
December 31, 2022 | Expenses
Paid During
the Period* | |
JPMorgan Insurance Trust Core Bond Portfolio | | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
|
| Expenses are equal to each Class’ respective annualized expense ratio, multiplied by the average account value over the period, multiplied by 184/365 (to reflect the one-half year period). |
BOARD APPROVAL OF INVESTMENT ADVISORY AGREEMENT
(Unaudited)
The Board of Trustees (the “Board” or the “Trustees”) has established various standing committees composed of Trustees with diverse backgrounds, to which the Board has assigned specific subject matter responsibilities to further enhance the effectiveness of the Board’s oversight and decision making. Effective January 2022, the Board consolidated with the J.P. Morgan Exchange-Traded Fund Trust Board and now consists of Trustees from both Boards. The Board and its investment committees (Money Market and Alternative Products Committee, Equity Committee, and Fixed Income Committee) met regularly throughout the year and, at each meeting, considered factors that are relevant to their annual consideration of the continuation of the investment advisory agreements. The Board also met for the specific purpose of considering investment advisory agreement annual renewals. The Board held meetings on June 21-22, 2022 and August 9-11, 2022, at which the Trustees considered the continuation of the investment advisory agreement for the Portfolio whose annual report is contained herein (the “Advisory Agreement”). At the June meeting, the Board’s investment committees met to review and consider performance, expense and related information for the J.P. Morgan Funds. Each investment committee reported to the full Board, which then considered each investment committee’s preliminary findings. At the August meeting, the Trustees continued their review and consideration. The Trustees, including a majority of the Trustees who are not parties to the Advisory Agreement or “interested persons” (as defined in the Investment Company Act of 1940) of any party to the Advisory Agreement or any of their affiliates, approved the continuation of the Advisory Agreement on August 11, 2022.
As part of their review of the Advisory Agreement, the Trustees considered and reviewed performance and other information about the Portfolio received from the Adviser. This information includes the Portfolio’s performance as compared to the performance of its peers and benchmarks, and analyses by the Adviser of the Portfolio’s performance. In addition, at each of their regular meetings throughout the year, the Trustees considered reports on the performance of certain J.P. Morgan Funds (including certain ETFs, beginning in February 2022) provided by an independent investment consulting firm (“independent consultant”). In addition, in preparation for the June and August meetings, the Trustees requested, received and evaluated extensive materials from the Adviser, including performance and expense information compiled by Broadridge, using data from Lipper Inc. and/or Morningstar Inc., independent providers of investment company data (together, “Broadridge”). Before voting on the Advisory Agreement, the Trustees reviewed the Advisory Agreement with representatives of the Adviser, counsel to the Trust, and independent legal counsel and received a memorandum from independent legal counsel to the Trustees discussing the legal standards for their consideration of the Advisory Agreement. The Trustees also
discussed the Advisory Agreement with independent legal counsel in executive sessions at which no representatives of the Adviser were present.
A summary of the material factors evaluated by the Trustees in determining whether to approve the Advisory Agreement is provided below. Each Trustee attributed different weights to the various factors and no factor alone was considered determinative. The Trustees considered information provided with respect to the Portfolio throughout the year, including additional reporting and information provided in connection with the COVID-19 pandemic, as well as materials furnished specifically in connection with the annual review process. From year to year, the Trustees consider and place emphasis on relevant information in light of changing circumstances in market and economic conditions.
After considering and weighing the factors and information they had received, the Trustees found that the compensation to be received by the Adviser from the Portfolio under the Advisory Agreement was fair and reasonable under the circumstances, and determined that the continuance of the Advisory Agreement was in the best interests of the Portfolio and its shareholders.
Nature, Extent and Quality of Services Provided by the Adviser
The Trustees received and considered information regarding the nature, extent and quality of services provided to the Portfolio under the Advisory Agreement. The Trustees took into account information furnished throughout the year at Trustee meetings, as well as the materials furnished specifically in connection with this annual review process. Among other things, the Trustees considered:
(i)
The background and experience of the Adviser’s senior management and investment personnel, including personnel changes, if any;
(ii)
The qualifications, backgrounds and responsibilities of the portfolio management team primarily responsible for the day-to-day management of the Portfolio, including personnel changes, if any;
(iii)
The investment strategy for the Portfolio, and the infrastructure supporting the portfolio management team;
(iv)
Information about the structure and distribution strategy for the Portfolio and how it fits with the Trust’s other fund offerings;
(v)
The administration services provided by the Adviser in its role as Administrator;
(vi)
Their knowledge of the nature and quality of the services provided by the Adviser and its affiliates gained from their experience as Trustees of the Trust and in the financial industry generally;
(vii)
The overall reputation and capabilities of the Adviser and its affiliates;
(viii)
The commitment of the Adviser to provide high quality service to the Portfolio;
(ix)
Their overall confidence in the Adviser’s integrity;
(x)
The Adviser’s responsiveness to requests for additional information, questions or concerns raised by them, including the Adviser’s willingness to consider and implement organizational and operational changes designed to improve investment results and the services provided to the Portfolio; and
(xi)
The Adviser’s business continuity plan and steps the Adviser and its affiliates have taken to provide ongoing services to the Portfolio during the COVID-19 pandemic, and the Adviser’s and its affiliates’ success in continuing to provide services to the Portfolio and its shareholders throughout this period.
Based upon these considerations and other factors, the Trustees concluded that they were satisfied with the nature, extent and quality of the services provided to the Portfolio by the Adviser.
Costs of Services Provided and Profitability to the Adviser and its Affiliates
The Trustees received and considered information regarding the profitability to the Adviser and its affiliates from providing services to the Portfolio. The Trustees reviewed and discussed this information. The Trustees recognized that this information is not audited and represents the Adviser’s determination of its and its affiliates’ revenues from the contractual services provided to the Portfolio, less expenses of providing such services. Expenses include direct and indirect costs and are calculated using an allocation methodology developed by the Adviser and reviewed with the Board. The Trustees also recognized that it is difficult to make comparisons of profitability from fund investment advisory contracts because comparative information is not generally publicly available and is affected by numerous factors, including the structure of the particular adviser, the types of funds it manages, its business mix, numerous assumptions regarding allocations and the fact that publicly-traded fund managers’ operating profits and net income are net of distribution and marketing expenses. Based upon their review, and taking into consideration the factors noted above, the Trustees concluded that the profitability to the Adviser under the Advisory Agreement was not unreasonable in light of the services and benefits provided to the Portfolio.
The Trustees also considered that JPMDS, an affiliate of the Adviser, and the Adviser earn fees from the Portfolio for providing administration services. These fees were shown separately in the profitability analysis presented to the
Trustees. The Trustees also considered the payments of Rule 12b-1 fees to JPMDS, which also acts as the Portfolio’s distributor, and that these fees are in turn generally paid to insurance companies that use the Portfolio in connection with insurance products they issue, including financial intermediaries that are affiliates of the Adviser (although they are retained by JPMDS in certain instances). The Trustees also considered the fees earned by JPMorgan Chase Bank, N.A. (“JPMCB”), an affiliate of the Adviser, for custody, fund accounting and other related services for the Portfolio, and the profitability of the arrangements to JPMCB.
Fall-Out Benefits
The Trustees reviewed information regarding potential “fall-out” or ancillary benefits received by the Adviser and its affiliates as a result of their relationship with the Portfolio. The Trustees considered that the J.P. Morgan Funds’ operating accounts are held at JPMCB, which, as a result, will receive float benefits for certain J.P. Morgan Funds, as applicable. The Trustees also noted that the Adviser supports a diverse set of products and services, which benefits the Adviser by allowing it to leverage its infrastructure to serve additional clients, including benefits that may be received by the Adviser and its affiliates in connection with the Portfolio’s potential investments in other funds advised by the Adviser. The Trustees also reviewed the Adviser’s allocation of fund brokerage for the J.P. Morgan Funds complex, including allocations to brokers who provide research to the Adviser, as well as the Adviser’s use of affiliates to provide other services and the benefits to such affiliates of doing so.
Economies of Scale
The Trustees considered the extent to which the Portfolio may benefit from potential economies of scale. The Trustees considered that there may not be a direct relationship between economies of scale realized by the Portfolio and those realized by the Adviser as assets increase. The Trustees considered the extent to which the Portfolio was priced to scale and whether it would be appropriate to add advisory fee breakpoints, but noted that the Portfolio has implemented fee waivers and contractual expense limitations (“Fee Caps”) which allow the Portfolio’s shareholders to share potential economies of scale from its inception and that the fees remain satisfactory relative to peer funds. The Trustees considered the benefits to the Portfolio of the use of an affiliated distributor and custodian, including the ability to rely on existing infrastructure supporting distribution, custodial and transfer agent services, and the ability to negotiate competitive fees for the Portfolio. The Trustees further considered the Adviser’s and JPMDS’s ongoing investments in their business in support of the Portfolio, including the Adviser’s and/or JPMDS’s investments in trading systems, technology (including improvements to the J.P. Morgan Funds’ website, and cybersecurity improvements),
BOARD APPROVAL OF INVESTMENT ADVISORY AGREEMENT
(Unaudited) (continued)
retention of key talent, and regulatory support enhancements. The Trustees concluded that the current fee structure for the Portfolio, including Fee Caps that the Adviser has in place that serve to limit the overall net expense ratios of the Portfolio at competitive levels, was reasonable. The Trustees concluded that the Portfolio’s shareholders received the benefits of potential economies of scale through the Fee Caps and the Adviser’s reinvestment in its operations to serve the Portfolio and its shareholders. The Trustees noted that the Adviser’s reinvestment ensures sufficient resources in terms of personnel and infrastructure to support the Portfolio.
Fees Relative to Adviser’s Other Clients
The Trustees received and considered information about the nature and extent of investment advisory services and fee rates offered to other clients of the Adviser, including, to the extent applicable, institutional separate accounts, collective investment trusts, other registered investment companies and/or private funds sub-advised by the Adviser, for investment management styles substantially similar to that of the Portfolio. The Trustees considered the complexity of investment management for registered investment companies relative to the Adviser’s other clients and noted differences, as applicable, in the fee structure and the regulatory, legal and other risks and responsibilities of providing services to the different clients. The Trustees considered that serving as an adviser to a registered investment company involves greater responsibilities and risks than acting as a sub-adviser and observed that sub-advisory fees may be lower than those charged by the Adviser to the Portfolio. The Trustees also noted that the adviser, not the applicable investment company, typically bears the sub-advisory fee and that many responsibilities related to the advisory function are typically retained by the primary adviser. The Trustees concluded that the fee rates charged to the Portfolio in comparison to those charged to the Adviser’s other clients were reasonable.
Investment Performance
The Trustees receive and consider information about the Portfolio’s performance throughout the year. In addition, the Trustees received and considered absolute and/or relative performance information for the Portfolio in a report prepared by Broadridge. The Trustees considered the total return performance information, which included the ranking of the Portfolio within a performance universe comprised of funds with the same Broadridge investment classification and objective (the “Universe”), as well as a subset of funds within the Universe (the “Peer Group”), by total return for the applicable one-, three- and five-year periods. The Trustees reviewed a description of Broadridge’s methodology for selecting mutual funds in the Portfolio’s Universe and Peer Group and noted that Universe and Peer Group quintile rankings were not calculated if the number of funds in the
Universe and/or Peer Group did not meet a predetermined minimum. The Broadridge materials provided to the Trustees highlighted information with respect to a representative class to assist the Trustees in their review. As part of this review, the Trustees also reviewed the Portfolio’s performance against its benchmark and considered the performance information provided for the Portfolio at regular Board meetings by the Adviser. The Trustees also engaged with the Adviser to consider what steps might be taken to improve performance, as applicable. The Broadridge performance data noted by the Trustees as part of their review and the determinations made by the Trustees with respect to the Portfolio’s performance are summarized below:
The Trustees noted that the Portfolio’s performance for Class 1 shares was in the third, fourth and third quintiles of the Peer Group, and in the second, third and third quintiles of the Universe, for the one-, three- and five-year periods ended December 31, 2021, respectively. The Trustees noted that the Portfolio’s performance for Class 2 shares was in the fourth quintile of the Peer Group for each of the one-, three and five-year period ended December 31, 2021, and in the third, fourth and third quintiles of the Universe for the one-, three- and five-year periods ended December 31, 2021, respectively. The Trustees discussed the performance and investment strategy of the Portfolio with the Adviser and based upon this discussion and various other factors, concluded that the Portfolio’s performance was satisfactory under the circumstances.
Advisory Fees and Expense Ratios
The Trustees considered the contractual advisory fee rate and administration fee rate paid by the Portfolio to the Adviser and compared the combined rate to the information prepared by Broadridge concerning management fee rates paid by other funds in the same Broadridge category as the Portfolio. The Trustees recognized that Broadridge reported the Portfolio’s management fee rate as the combined contractual advisory fee and administration fee rates. The Trustees also reviewed information about other expenses and the expense ratios for the Portfolio and noted that Universe and Peer Group quintile rankings were not calculated if the number of funds in the Universe and/or Peer Groups did not meet a predetermined minimum. The Trustees considered the Fee Caps currently in place for the Portfolio, the net advisory fee rate after taking into account any waivers and/or reimbursements, and, where deemed appropriate by the Trustees, additional waivers and/or reimbursements. The Trustees recognized that it can be difficult to make comparisons of advisory fees because there are variations in the services that are included in the fees paid
by other funds. The Trustees’ determinations as a result of the review of the Portfolio’s advisory fees and expense ratios are summarized below:
The Trustees noted that the Portfolio’s net advisory fee and actual total expenses for Class 1 shares were both in the third and fourth quintiles of the Peer Group and Universe, respectively. The Trustees noted that the Portfolio’s net advisory fee
for Class 2 shares was in the third quintile of both the Peer Group and Universe, and that the actual total expenses for Class 2 shares were in the fourth quintile of both the Peer Group and Universe. After considering the factors identified above, in light of this information, the Trustees concluded that the advisory fee was satisfactory in light of the services provided to the Portfolio.
TAX LETTER
(Unaudited)
(Dollar values in thousands)
Long Term Capital Gain
The Portfolio distributed $2,434, or maximum allowable amount, of long-term capital gain dividends for the fiscal year ended December 31, 2022.
THIS PAGE IS INTENTIONALLY LEFT BLANK
J.P. Morgan Funds are distributed by JPMorgan Distribution Services, Inc., which is an affiliate of JPMorgan Chase & Co. Affiliates of JPMorgan Chase & Co. receive fees for providing various services to the funds.
Contact JPMorgan Distribution Services, Inc. at 1-800-480-4111 for a portfolio prospectus. You can also visit us at www.jpmorgan.com/variableinsuranceportfolios. Investors should carefully consider the investment objectives and risk as well as charges and expenses of the mutual fund before investing. The prospectus contains this and other information about the mutual fund. Read the prospectus carefully before investing.
Investors may obtain information about the Securities Investor Protection Corporation (SIPC), including the SIPC brochure, by visiting www.sipc.org or by calling SIPC at 202-371-8300.
The Portfolio files a complete schedule of its portfolio holdings for the first and third quarters of its fiscal year with the SEC as an exhibit to its report on Form N-PORT. The Portfolio’s Form N-PORT reports are available on the SEC’s website at http://www.sec.gov. The Portfolio's quarterly holdings can be found by visiting the Portfolio's website at www.jpmorgan.com/variableinsuranceportfolios.
A description of the Portfolio’s policies and procedures with respect to the disclosure of the Portfolio’s holdings is available in the prospectuses and Statement of Additional Information.
A copy of proxy policies and procedures is available without charge upon request by calling 1-800-480-4111 and on the Portfolio’s website at www.jpmorgan.com/variableinsuranceportfolios. A description of such policies and procedures is on the SEC’s website at www.sec.gov. The Trustees have delegated the authority to vote proxies for securities owned by the Portfolio to the Adviser. A copy of the Portfolio’s voting record for the most recent 12-month period ended June 30 is available on the SEC’s website at www.sec.gov or at the Portfolio’s website at www.jpmorgan.com/variableinsuranceportfolios no later than August 31 of each year. The Portfolio’s proxy voting record will include, among other things, a brief description of the matter voted on for each portfolio security, and will state how each vote was cast, for example, for or against the proposal.
J.P. Morgan Asset Management is the brand name for the asset management business of JPMorgan Chase & Co. and its affiliates worldwide.
© JPMorgan Chase & Co., 2022. All rights reserved. December 2022.
AN-JPMITCBP-1222
Annual Report
JPMorgan Insurance Trust
December 31, 2022
JPMorgan Insurance Trust Mid Cap Value Portfolio |
CONTENTS
Investments in the Portfolio are not deposits or obligations of, or guaranteed or endorsed by, any bank and are not insured or guaranteed by the FDIC, the Federal Reserve Board or any other government agency. You could lose money if you sell when the Portfolio’s share price is lower than when you invested.
Past performance is no guarantee of future performance. The general market views expressed in this report are opinions based on market and other conditions through the end of the reporting period and are subject to change without notice. These views are not intended to predict the future performance of the Portfolio or the securities markets.
This Portfolio is intended to be a funding vehicle for variable annuity contracts and variable life insurance policies (collectively “Policies”) offered by the separate accounts of various insurance companies. Portfolio shares may also be offered to qualified pension and retirement plans and accounts permitting accumulation of assets on a tax-deferred basis (“Eligible Plans”). Individuals may not purchase shares directly from the Portfolio.
Prospective investors should refer to the Portfolio’s prospectuses for a discussion of the Portfolio’s investment objective, strategies and risks. Call J.P. Morgan Funds Service Center at 1-800-480-4111 for a prospectus containing more complete information about the Portfolio, including management fees and other expenses. Please read it carefully before investing.
Letter to Shareholders
February 13, 2023 (Unaudited)
Dear Shareholder,
Financial markets have rebounded somewhat as the U.S. and other developed market economies have shown notable resilience in the face of higher inflation, rising interest rates and the ongoing war in Ukraine. While the factors that weighed on equity and bond markets in 2022 largely remain, there are signals that inflationary pressures may have peaked and the long-term economic outlook appears positive.
|
“Investors may face continued economic and geopolitical challenges in the year ahead. However, some of the acute risks encountered in 2022 appear to have receded and last year’s reset in asset prices may provide attractive investment opportunities.” — Brian S. Shlissel
|
While U.S. economic growth was surprisingly strong in the closing months of 2022, with broad gains in employment and consumer spending in the final months of the year, the U.S. Federal Reserve’s efforts to counter inflationary pressure through sharply higher interest rates could slow economic momentum in the months ahead.
Corporate earnings have been squeezed by higher costs for materials and labor, while the strong U.S. dollar has hindered export revenues. However, the impact of higher prices and interest rates has not landed on all sectors of the economy evenly. Energy sector profits have soared over the past year, while earnings in housing and construction sectors have declined.
Across Europe, the war in Ukraine has driven up prices for energy, food and a range of other goods and has fueled negative consumer sentiment. The prolonged nature of the conflict and its potential to spread remain key concerns among policymakers, diplomats, military planners, economists and investors. It is worth noting that Europe’s largest industrialized nations in concert with the European Union have moved swiftly to secure alternatives to Russian sources of natural gas and petroleum, which has eased an energy crisis that began last year.
Investors may face continued economic and geopolitical challenges in the year ahead. However, some of the acute risks encountered in 2022 appear to have receded and last year’s reset in asset prices may provide attractive investment opportunities. A long-term view and a properly diversified portfolio, in our opinion, remain key elements to a successful investment approach.
Our broad array of investment solutions seeks to provide investors with ability to build durable portfolios that can help them meet their financial goals.
Sincerely,
Brian S. Shlissel
President, J.P. Morgan Funds
J.P. Morgan Asset Management
1-800-480-4111 or www.jpmorganfunds.com for more information
JPMorgan Insurance Trust Mid Cap Value Portfolio
PORTFOLIO COMMENTARY
TWELVE MONTHS ENDED December 31, 2022 (Unaudited)
| |
Portfolio (Class 1 Shares)* | |
Russell Midcap Value Index | |
Net Assets as of 12/31/2022 (In Thousands) | |
INVESTMENT OBJECTIVE**
The JPMorgan Insurance Trust Mid Cap Value Portfolio (the “Portfolio”) seeks capital appreciation with the secondary goal of achieving current income by investing primarily in equity securities.
HOW DID THE MARKET PERFORM?
Overall, financial markets tumbled in the first three quarters of 2022, but rebounded moderately in the final months of the year. Equity markets turned in their worst first-half performance since 1970, amid accelerating inflation, pandemic lockdowns across China and Russia’s invasion of Ukraine.
The S&P 500 Index, which gauges the performance of U.S. large-cap equities, reached a new closing high on January 3, 2022, bolstered by record high corporate earnings, sales, cash flows, share repurchases and dividends. However, investor sentiment began to sour as accelerating inflation started to erode consumer confidence and raise expectations for an increase in benchmark interest rates by the U.S. Federal Reserve (the “Fed”).
Russia’s invasion of Ukraine at the end of February 2022 initiated a sell-off in global financial markets that was further fueled by the highest U.S. inflation rate in more than 40 years. Equity prices recovered somewhat in March 2022 amid better-than-expected corporate earnings. However, the general trend in global financial markets was downward throughout the year.
In response to accelerating inflationary pressure, the Fed raised its benchmark interest rate mid-March, the first increase since December 2018. The central bank followed with six more rate increases over the course of 2022. The Bank of England, which began raising interest rates in late 2021, also continued to raise interest rates throughout the year, while the European Central Bank waited until June before sharply raising interest rates for the first time in 11 years.
In the U.S., equity prices experienced a sharp sell-off in August and September 2022 that coincided with U.S. Federal Reserve policy guidance on further interest rate increases. However, corporate earnings for both the second and third quarters of 2022 generally were better than expected given a cooling economy and slower consumer spending. Meanwhile, the U.S. unemployment rate remained historically low - hovering
between 3.5% and 3.7% for the six-month period - and by the end of 2022 data indicated some inflationary pressures had eased.
Across Europe, the energy crisis that followed Russia’s invasion of Ukraine in late February 2022 eased somewhat in the second half of the year as both the U.K. and the EU obtained alternatives to Russian energy imports and global energy prices receded. A political crisis in the U.K. roiled financial markets in London but the ascension of Rishi Sunak to prime minister appeared to remove some investor uncertainty.
Emerging markets broadly declined during the period but there was wide variance among individual nations. Chinese equities continued to underperform amid investor concerns about the economic impact of the country’s strict anti-pandemic policies, as well as weakness within China’s real estate sector and changes in the global trade for information. While energy prices retreated from historically high levels in the second half of 2022, overall commodities prices remained elevated, which benefitted markets in exporting nations but hurt markets in net importing nations.
For the twelve-month period, leading equity and bond market indexes were mostly negative, with non-U.S. developed markets equities outperforming both U.S. and emerging markets generally equities.
WHAT WERE THE MAIN DRIVERS OF THE PORTFOLIO’S PERFORMANCE?
The Portfolio’s Class 1 Shares outperformed the Russell Midcap Value Index (the “Benchmark”) for the twelve months ended December 31, 2022.
The Portfolio’s security selection in the information technology and financials sectors was a leading contributor to performance relative to the Benchmark, while the Portfolio’s underweight position in the energy sector and its security selection in the communication services sector were leading detractors from relative performance.
Leading individual contributors to performance included the Portfolio’s overweight positions in Coterra Energy Inc., Diamondback Energy Inc. and AmerisourceBergen Corp. Shares of Coterra Energy and Diamondback Energy, both petroleum and natural gas producers, rose amid a sharp increase in global
energy prices during the first half of 2022. Shares of AmerisourceBergen, a pharmaceuticals and health care products distributor, rose after the company reported better-than-expected earnings and revenue for the third quarter of 2022.
Leading individual detractors from relative performance included the Portfolio’s overweight positions in IAC Inc., Liberty Broadband Corp. and Fortune Brands Innovations Inc.
Shares of IAC, a media and internet content provider, fell amid declining revenues and consecutive quarters of lower-than-expected earnings. Shares of Liberty Broadband, a cable and satellite TV provider, fell amid broad weakness in communications sector stocks. Shares of Fortune Brands Innovations, a building products manufacturer, fell amid broad weakness in the homebuilding industry as consumer mortgage applications fell to a 25-yerar low in the U.S.
HOW WAS THE PORTFOLIO POSITIONED?
The portfolio managers utilized a bottom-up approach to stock selection and sought to identify durable franchises possessing the ability to generate, in the portfolio managers’ view, sustainable levels of free cash flow. During the reporting period, the Portfolio maintained overweight positions in the financials and consumer discretionary sectors, while maintaining underweight positions in the materials and energy
sectors.
TOP TEN HOLDINGS OF THE
PORTFOLIO AS OF December 31, 2022 | PERCENT OF
TOTAL
INVESTMENTS |
| | |
| Ameriprise Financial, Inc. | |
| Laboratory Corp. of America Holdings | |
| | |
| Huntington Bancshares, Inc. | |
| | |
| | |
| | |
| | |
| | |
PORTFOLIO COMPOSITION BY SECTOR
AS OF December 31, 2022 | PERCENT OF
TOTAL
INVESTMENTS |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
*
The return shown is based on net asset values calculated for shareholder transactions and may differ from the return shown in the financial highlights, which reflects adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
**
The adviser seeks to achieve the Portfolio’s objective. There can be no guarantee it will be achieved.
JPMorgan Insurance Trust Mid Cap Value Portfolio
PORTFOLIO COMMENTARY
TWELVE MONTHS ENDED December 31, 2022 (Unaudited) (continued)
AVERAGE ANNUAL TOTAL RETURNS AS OF December 31, 2022
TEN YEAR PORTFOLIO PERFORMANCE (12/31/12 TO 12/31/22)
The performance quoted is past performance and is not a guarantee of future results. Mutual funds are subject to certain market risks. Investment returns and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance data shown. For up-to-date month-end performance information please call 1-800-480-4111.
The graph illustrates comparative performance for $10,000 invested in Class 1 Shares of the JPMorgan Insurance Trust Mid Cap Value Portfolio and the Russell Midcap Value Index from December 31, 2012 to December 31, 2022. The performance of the Portfolio assumes reinvestment of all dividends and capital gain distributions, if any. The performance of the Russell Midcap Value Index does not reflect the deduction of expenses associated with a mutual fund and has been adjusted to reflect reinvestment of all dividends and capital gain distributions of the securities included in the benchmark, if applicable. The
Russell Midcap Value Index is an unmanaged index which measures the performance of those Russell Midcap companies with lower price-to-book ratios and lower forecasted growth values. Investors cannot invest directly in an index.
Portfolio performance does not reflect any charges imposed by the Policies or Eligible Plans. If these charges were included, the returns would be lower than shown. Portfolio performance may reflect the waiver of the Portfolio’s fees and reimbursement of expenses for certain periods. Without these waivers and reimbursements, performance would have been lower.
The returns shown are based on net asset values calculated for shareholder transactions and may differ from the returns shown in the financial highlights, which reflect adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
JPMorgan Insurance Trust Mid Cap Value Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022
| | |
|
|
| | |
|
Citizens Financial Group, Inc. | | |
| | |
First Citizens BancShares, Inc., Class A | | |
Huntington Bancshares, Inc. | | |
| | |
| | |
| | |
| | |
|
Constellation Brands, Inc., Class A | | |
| | |
| | |
|
| | |
Fortune Brands Innovations, Inc. | | |
| | |
|
Ameriprise Financial, Inc. | | |
| | |
Raymond James Financial, Inc. | | |
| | |
T. Rowe Price Group, Inc. | | |
| | |
|
| | |
| | |
| | |
Communications Equipment — 1.3% |
| | |
Construction Materials — 1.1% |
Martin Marietta Materials, Inc. | | |
|
Discover Financial Services | | |
Containers & Packaging — 2.6% |
| | |
Packaging Corp. of America | | |
| | |
| | |
| | |
|
|
| | |
| | |
| | |
Diversified Financial Services — 0.6% |
| | |
Electric Utilities — 4.2% |
| | |
| | |
| | |
| | |
Electrical Equipment — 3.6% |
| | |
| | |
| | |
| | |
Electronic Equipment, Instruments & Components — 3.8% |
| | |
| | |
| | |
Teledyne Technologies, Inc.* | | |
| | |
|
Take-Two Interactive Software, Inc.* | | |
Equity Real Estate Investment Trusts (REITs) — 9.6% |
American Homes 4 Rent, Class A | | |
AvalonBay Communities, Inc. | | |
| | |
Brixmor Property Group, Inc. | | |
Essex Property Trust, Inc. | | |
Federal Realty Investment Trust | | |
Host Hotels & Resorts, Inc. | | |
| | |
| | |
Mid-America Apartment Communities, Inc. | | |
| | |
| | |
Rexford Industrial Realty, Inc. | | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Mid Cap Value Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Common Stocks — continued |
Equity Real Estate Investment Trusts (REITs) — continued |
| | |
| | |
| | |
Food & Staples Retailing — 1.5% |
| | |
| | |
| | |
|
| | |
|
| | |
Health Care Equipment & Supplies — 1.7% |
Globus Medical, Inc., Class A* | | |
Zimmer Biomet Holdings, Inc. | | |
| | |
Health Care Providers & Services — 5.8% |
| | |
| | |
Laboratory Corp. of America Holdings | | |
Universal Health Services, Inc., Class B | | |
| | |
Hotels, Restaurants & Leisure — 1.2% |
| | |
| | |
| | |
Household Durables — 1.4% |
| | |
| | |
| | |
Household Products — 0.5% |
| | |
|
| | |
| | |
Hartford Financial Services Group, Inc. (The) | | |
| | |
| | |
| | |
|
|
RenaissanceRe Holdings Ltd. (Bermuda) | | |
| | |
| | |
Interactive Media & Services — 0.8% |
| | |
|
FleetCor Technologies, Inc.* | | |
| | |
| | |
|
| | |
| | |
Lincoln Electric Holdings, Inc. | | |
| | |
| | |
| | |
| | |
|
Liberty Broadband Corp., Class C* | | |
Liberty Media Corp.-Liberty SiriusXM, Class C* | | |
| | |
|
| | |
|
| | |
|
| | |
| | |
| | |
| | |
Oil, Gas & Consumable Fuels — 2.6% |
| | |
| | |
Williams Cos., Inc. (The) | | |
| | |
|
| | |
|
Jazz Pharmaceuticals plc* | | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Common Stocks — continued |
Real Estate Management & Development — 0.9% |
CBRE Group, Inc., Class A* | | |
|
| | |
|
| | |
| | |
| | |
| | |
| | |
Textiles, Apparel & Luxury Goods — 2.7% |
| | |
| | |
| | |
| | |
Thrifts & Mortgage Finance — 0.6% |
| | |
Total Common Stocks
(Cost $298,454) | | |
| | |
Short-Term Investments — 2.3% |
Investment Companies — 2.3% |
JPMorgan U.S. Government Money Market Fund Class Institutional Shares, 4.07%(a) (b)
(Cost $10,078) | | |
Total Investments — 99.9%
(Cost $308,532) | | |
Other Assets Less Liabilities — 0.1% | | |
| | |
Percentages indicated are based on net assets. |
| Non-income producing security. |
| Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. |
| The rate shown is the current yield as of December 31, 2022. |
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF ASSETS AND LIABILITIES
AS OF December 31, 2022
(Amounts in thousands, except per share amounts)
| JPMorgan
Insurance
Trust Mid
Cap Value
|
| |
Investments in non-affiliates, at value | |
Investments in affiliates, at value | |
| |
| |
Dividends from non-affiliates | |
Dividends from affiliates | |
| |
| |
| |
Portfolio shares redeemed | |
| |
| |
| |
Custodian and accounting fees | |
| |
| |
| |
| |
| |
Total distributable earnings (loss) | |
| |
| |
| |
Outstanding units of beneficial interest (shares)
(unlimited number of shares authorized, no par value): | |
| |
| |
Class 1 — Offering and redemption price per share | |
Cost of investments in non-affiliates | |
Cost of investments in affiliates | |
(a)
Per share amounts may not recalculate due to rounding of net assets and/or shares outstanding.
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF OPERATIONS
FOR THE YEAR ENDED December 31, 2022
(Amounts in thousands)
| JPMorgan
Insurance
Trust Mid
Cap Value
|
| |
Dividend income from non-affiliates | |
Dividend income from affiliates | |
Income from securities lending (net) (See Note 2.B.) | |
| |
| |
| |
| |
Custodian and accounting fees | |
| |
Trustees’ and Chief Compliance Officer’s fees | |
Printing and mailing costs | |
| |
| |
| |
| |
Less expense reimbursements | |
| |
Net investment income (loss) | |
REALIZED/UNREALIZED GAINS (LOSSES): | |
Net realized gain (loss) on transactions from investments in non-affiliates | |
Change in net unrealized appreciation/depreciation on investments in non-affiliates | |
Net realized/unrealized gains (losses) | |
Change in net assets resulting from operations | |
(a)
Amount rounds to less than one thousand.
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENTS OF CHANGES IN NET ASSETS
FOR THE PERIODS INDICATED
(Amounts in thousands)
| JPMorgan Insurance Trust Mid Cap
Value Portfolio |
| Year Ended
December 31, 2022 | Year Ended
December 31, 2021 |
CHANGE IN NET ASSETS RESULTING FROM OPERATIONS: | | |
Net investment income (loss) | | |
| | |
Change in net unrealized appreciation/depreciation | | |
Change in net assets resulting from operations | | |
DISTRIBUTIONS TO SHAREHOLDERS: | | |
| | |
Total distributions to shareholders | | |
| | |
Change in net assets resulting from capital transactions | | |
| | |
| | |
| | |
| | |
| | |
| | |
Proceeds from shares issued | | |
| | |
| | |
Change in net assets resulting from Class 1 capital transactions | | |
| | |
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
THIS PAGE IS INTENTIONALLY LEFT BLANK
FINANCIAL HIGHLIGHTS
FOR THE PERIODS INDICATED
| Per share operating performance |
| | | |
| Net asset
value,
beginning
of period | Net
investment
income
(loss)(a) | Net realized
and unrealized
gains
(losses) on
investments | Total from
investment
operations | | | |
JPMorgan Insurance Trust Mid Cap Value Portfolio | | | | | | | |
| | | | | | | |
Year Ended December 31, 2022 | | | | | | | |
Year Ended December 31, 2021 | | | | | | | |
Year Ended December 31, 2020 | | | | | | | |
Year Ended December 31, 2019 | | | | | | | |
Year Ended December 31, 2018 | | | | | | | |
|
| Calculated based upon average shares outstanding. |
| Includes adjustments in accordance with accounting principles generally accepted in the United States of America and as such, the net asset values for financial reporting purposes and the returns based upon those net asset values may differ from the net asset values and returns for shareholder transactions. |
| Total returns do not include charges that will be imposed by variable insurance contracts or by Eligible Plans. If these charges were reflected, returns would be lower than those shown. |
| Includes earnings credits and interest expense, if applicable, each of which is less than 0.005% unless otherwise noted. |
SEE NOTES TO FINANCIAL STATEMENTS.
| |
| | | Ratios to average net assets |
Net asset
value,
end of
period | | Net assets,
end of
period
(000's) | | Net
investment
income
(loss) | Expenses without
waivers and reimbursements | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
SEE NOTES TO FINANCIAL STATEMENTS.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022
(Dollar values in thousands)
1. Organization
JPMorgan Insurance Trust (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company and is a Massachusetts business trust.
The following is a separate portfolio of the Trust (the “Portfolio”) covered by this report:
| | Diversification Classification |
JPMorgan Insurance Trust Mid Cap Value Portfolio | | |
The investment objective of the Portfolio is to seek capital appreciation with the secondary goal of achieving current income by investing primarily in equity securities.
Portfolio shares are offered only to separate accounts of participating insurance companies and Eligible Plans. Individuals may not purchase shares directly from the Portfolio.
J.P. Morgan Investment Management Inc. (“JPMIM”), an indirect, wholly-owned subsidiary of JPMorgan Chase & Co. (“JPMorgan”), acts as Adviser (the “Adviser”) and Administrator (the “Administrator”) to the Portfolio.
2. Significant Accounting Policies
The following is a summary of significant accounting policies followed by the Portfolio in the preparation of its financial statements. The Portfolio is an investment company and, accordingly, follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 946 — Investment Companies, which is part of U.S. generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) disclosure of contingent assets and liabilities at the date of the financial statements, and (iii) the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.
A. Valuation of Investments — Investments are valued in accordance with GAAP and the Portfolio's valuation policies set forth by, and under the supervision and responsibility of, the Board of Trustees of the Trust (the "Board"), which established the following approach to valuation, as described more fully below: (i) investments for which market quotations are readily available shall be valued at their market value and (ii) all other investments for which market quotations are not readily available shall be valued at their fair value as determined in good faith by the Board.
Under Section 2(a)(41) of the 1940 Act, the Board is required to determine fair value for securities that do not have readily available market quotations. Under SEC Rule 2a-5 (Good Faith Determinations of Fair Value), the Board may designate the performance of these fair valuation determinations to a valuation designee. The Board has designated the Adviser as the “Valuation Designee” to perform fair valuation determinations for the Portfolio on behalf of the Board subject to appropriate oversight by the Board. The Adviser, as Valuation Designee, leverages the J.P. Morgan Asset Management Americas Valuation Committee (“AVC”) to help oversee and carry out the policies for the valuation of Investments held in the Portfolio. The Adviser, as Valuation Designee, remains responsible for the valuation determinations.
This oversight by the AVC includes monitoring the appropriateness of fair values based on results of ongoing valuation oversight including, but not limited to, consideration of macro or security specific events, market events, and pricing vendor and broker due diligence. The Administrator is responsible for discussing and assessing the potential impacts to the fair values on an ongoing basis, and, at least on a quarterly basis, with the AVC and the Board.
Equities and other exchange-traded instruments are valued at the last sale price or official market closing price on the primary exchange on which the instrument is traded before the net asset value (“NAV”) of the Portfolio is calculated on a valuation date.
Investments in open-end investment companies (“Underlying Funds”) are valued at each Underlying Fund’s NAV per share as of the report date.
Valuations reflected in this report are as of the report date. As a result, changes in valuation due to market events and/or issuer-related events after the report date and prior to issuance of the report are not reflected herein.
The various inputs that are used in determining the valuation of the Portfolio's investments are summarized into the three broad levels listed below.
•
Level 1 — Unadjusted inputs using quoted prices in active markets for identical investments.
•
Level 2 — Other significant observable inputs including, but not limited to, quoted prices for similar investments, inputs other than quoted prices that are observable for investments (such as interest rates, prepayment speeds, credit risk, etc.) or other market corroborated inputs.
•
Level 3 — Significant inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Portfolio's assumptions in determining the fair value of investments).
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input, both individually and in the aggregate, that is significant to the fair value measurement. The inputs or methodology used for valuing instruments are not necessarily an indication of the risk associated with investing in those instruments.
The following table represents each valuation input as presented on the Schedule of Portfolio Investments ("SOI"):
| | | | |
| | Level 2
Other significant
observable inputs | Level 3
Significant
unobservable inputs | |
Total Investments in Securities(a) | | | | |
|
| Please refer to the SOI for specifics of portfolio holdings. |
B. Securities Lending — The Portfolio is authorized to engage in securities lending in order to generate additional income. The Portfolio is able to lend to approved borrowers. Citibank N.A. (“Citibank”) serves as lending agent for the Portfolio, pursuant to a Securities Lending Agency Agreement (the “Securities Lending Agency Agreement”). Securities loaned are collateralized by cash equal to at least 100% of the market value plus accrued interest on the securities lent, which is invested in the Class IM Shares of the JPMorgan U.S. Government Money Market Fund. The Portfolio retains the interest earned on cash collateral investments but is required to pay the borrower a rebate for the use of the cash collateral. In cases where the lent security is of high value to borrowers, there may be a negative rebate (i.e., a net payment from the borrower to the Portfolio). Upon termination of a loan, the Portfolio is required to return to the borrower an amount equal to the cash collateral, plus any rebate owed to the borrowers. The remaining maturities of the securities lending transactions are considered overnight and continuous. Loans are subject to termination by the Portfolio or the borrower at any time.
The net income earned on the securities lending (after payment of rebates and Citibank’s fee) is included on the Statement of Operations as Income from securities lending (net). The Portfolio also receives payments from the borrower during the period of the loan, equivalent to dividends and interest earned on the securities loaned, which are recorded as Dividend or Interest income, respectively, on the Statement of Operations.
Under the Securities Lending Agency Agreement, Citibank marks to market the loaned securities on a daily basis. In the event the cash received from the borrower is less than 102% of the value of the loaned securities (105% for loans of non-U.S. securities), Citibank requests additional cash from the borrower so as to maintain a collateralization level of at least 102% of the value of the loaned securities plus accrued interest (105% for loans of non-U.S. securities), subject to certain de minimis amounts.
The value of securities out on loan is recorded as an asset on the Statement of Assets and Liabilities. The value of the cash collateral received is recorded as a liability on the Statement of Assets and Liabilities and details of collateral investments are disclosed on the SOI.
The Portfolio bears the risk of loss associated with the collateral investments and is not entitled to additional collateral from the borrower to cover any such losses. To the extent that the value of the collateral investments declines below the amount owed to a borrower, the Portfolio may incur losses that exceed the amount it earned on lending the security. Upon termination of a loan, the Portfolio may use leverage (borrow money) to repay the borrower for cash collateral posted if the Adviser does not believe that it is prudent to sell the collateral investments to fund the payment of this liability. Securities lending activity is subject to master netting arrangements.
Securities lending also involves counterparty risks, including the risk that the loaned securities may not be returned in a timely manner or at all. Subject to certain conditions, Citibank has agreed to indemnify the Portfolio from losses resulting from a borrower’s failure to return a loaned security.
JPMIM voluntarily waived investment advisory fees charged to the Portfolio to reduce the impact of the cash collateral investment in the JPMorgan U.S. Government Money Market Fund from 0.13% to 0.06%. For the year ended December 31, 2022, JPMIM waived fees associated with the Portfolio's investment in the JPMorgan U.S. Government Money Market Fund as follows:
|
| Amount rounds to less than one thousand. |
The above waiver is included in the determination of earnings on cash collateral investment and in the calculation of Citibank’s compensation and is included on the Statement of Operations as Income from securities lending (net).
The Portfolio did not have any securities out on loan at December 31, 2022.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
C. Investment Transactions with Affiliates — The Portfolio invested in an Underlying Fund which is advised by the Adviser. An issuer which is under common control with the Portfolio may be considered an affiliate. For the purposes of the financial statements, the Portfolio assumes the issuer listed in the table below to be an affiliated issuer. The Underlying Fund's distributions may be reinvested into the Underlying Fund. Reinvestment amounts are included in the purchases at cost amounts in the table below.
|
For the year ended December 31, 2022 |
| | | | | Change in
Unrealized
Appreciation/
(Depreciation) | | Shares at
December 31,
2022 | | Capital Gain
Distributions |
JPMorgan U.S. Government Money Market Fund Class IM Shares, 4.12% | | | | | | | | | |
JPMorgan U.S. Government Money Market Fund Class Institutional Shares, 4.07% (b) (c) | | | | | | | | | |
| | | | | | | | | |
|
| Amount rounds to less than one thousand. |
| Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. |
| The rate shown is the current yield as of December 31, 2022. |
| Amount is included on the Statement of Operations as Income from securities lending (net) (after payments of rebates and Citibank’s fee). |
D. Security Transactions and Investment Income — Investment transactions are accounted for on the trade date (the date the order to buy or sell is executed). Securities gains and losses are calculated on a specifically identified cost basis.
Dividend income is recorded on the ex-dividend date or when the Portfolio first learns of the dividend.
To the extent such information is publicly available, the Portfolio records distributions received in excess of income earned from underlying investments as a reduction of cost of investments and/or realized gain. Such amounts are based on estimates if actual amounts are not available and actual amounts of income, realized gain and return of capital may differ from the estimated amounts. The Portfolio adjusts the estimated amounts of the components of distributions (and consequently its net investment income) as necessary, once the issuers provide information about the actual composition of the distributions.
E. Allocation of Expenses— Expenses directly attributable to the Portfolio are charged directly to the Portfolio, while the expenses attributable to more than one portfolio of the Trust are allocated among the applicable portfolios.
F. Federal Income Taxes— The Portfolio is treated as a separate taxable entity for Federal income tax purposes. The Portfolio’s policy is to comply with the provisions of the Internal Revenue Code (the “Code”) applicable to regulated investment companies and to distribute to shareholders all of its distributable net investment income and net realized capital gains on investments. Accordingly, no provision for Federal income tax is necessary. The Portfolio is also a segregated portfolio of assets for insurance purposes and intends to comply with the diversification requirements of Subchapter L of the Code. Management has reviewed the Portfolio’s tax positions for all open tax years and has determined that as of December 31, 2022, no liability for Federal income tax is required in the Portfolio’s financial statements for net unrecognized tax benefits. However, management’s conclusions may be subject to future review based on changes in, or the interpretation of, the accounting standards or tax laws and regulations. The Portfolio’s Federal tax returns for the prior three fiscal years remain subject to examination by the Internal Revenue Service.
G. Distributions to Shareholders — Distributions from net investment income, if any, are generally declared and paid at least annually. Net realized capital gains, if any, are distributed at least annually. The amount of distributions from net investment income and net realized capital gains is determined in accordance with Federal income tax regulations, which may differ from GAAP. To the extent these “book/tax” differences are permanent in nature (i.e., that they result from other than timing of recognition — “temporary differences”), such amounts are reclassified within the capital accounts based on their Federal tax basis treatment.
3. Fees and Other Transactions with Affiliates
A. Investment Advisory Fee — Pursuant to an Investment Advisory Agreement, the Adviser manages the investments of the Portfolio and for such services is paid a fee. The investment advisory fee is accrued daily and paid monthly at an annual rate of 0.65% of the Portfolio's average daily net assets.
The Adviser waived investment advisory fees and/or reimbursed expenses as outlined in Note 3.E.
B. Administration Fee — Pursuant to an Administration Agreement, the Administrator provides certain administration services to the Portfolio. In consideration of these services, the Administrator receives a fee accrued daily and paid monthly at an annual rate of 0.075% of the first $10 billion of the Portfolio's average daily net assets, plus 0.050% of the Portfolio's average daily net assets between $10 billion and $20 billion, plus 0.025% of the Portfolio's average daily net assets between $20 billion and $25 billion, plus 0.010% of the Portfolio's average daily net assets in excess of $25 billion. For the year ended December 31, 2022, the effective rate was 0.075% of the Portfolio's average daily net assets, notwithstanding any fee waivers and/or expense reimbursements.
The Administrator waived administration fees as outlined in Note 3.E.
JPMorgan Chase Bank, N.A. ("JPMCB"), a wholly-owned subsidiary of JPMorgan, serves as the Portfolio's sub-administrator (the “Sub-administrator”). For its services as Sub-administrator, JPMCB receives a portion of the fees payable to the Administrator.
C. Distribution Fees — Pursuant to a Distribution Agreement, JPMorgan Distribution Services, Inc. (“JPMDS”), an indirect, wholly-owned subsidiary of JPMorgan, serves as the Portfolio's principal underwriter and promotes and arranges for the sale of the Portfolio's shares.
D. Custodian and Accounting Fees — JPMCB provides portfolio custody and accounting services to the Portfolio. For performing these services, the Portfolio pays JPMCB transaction and asset-based fees that vary according to the number of transactions and positions, plus out-of-pocket expenses. The amounts paid directly to JPMCB by the Portfolio for custody and accounting services are included in Custodian and accounting fees on the Statement of Operations.
Interest income earned on cash balances at the custodian, if any, is included in Interest income from affiliates on the Statement of Operations.
Interest expense paid to the custodian related to cash overdrafts, if any, is included in Interest expense to affiliates on the Statement of Operations.
E. Waivers and Reimbursements — The Adviser and/or Administrator have contractually agreed to waive fees and/or reimburse the Portfolio to the extent that total annual operating expenses of the Portfolio (excluding acquired fund fees and expenses other than certain money market fund fees as described below, dividend and interest expenses related to short sales, interest, taxes, expenses related to litigation and potential litigation, expenses related to trustee elections and extraordinary expenses) exceed 0.90% of the Portfolio's average daily net assets.
The expense limitation agreement was in effect for the year ended December 31, 2022 and is in place until at least April 30, 2023.
For the year ended December 31, 2022, the Portfolio's service providers did not waive fees and/or reimburse expenses for the Portfolio.
Additionally, the Portfolio may invest in one or more money market funds advised by the Adviser (affiliated money market funds). The Adviser, Administrator and/or JPMDS, have contractually agreed to waive fees and/or reimburse expenses in an amount sufficient to offset the respective net fees each collects from the affiliated money market fund on the Portfolio's investment in such affiliated money market fund, except for investments of securities lending cash collateral. None of these parties expect the Portfolio to repay any such waived fees and/or reimbursed expenses in future years.
The amount of these waivers resulting from investments in these money market funds for the year ended December 31, 2022 was $15.
JPMIM voluntarily agreed to reimburse the Portfolio for the Trustee Fees paid to one of the interested Trustees. For the year ended December 31, 2022 the amount of this reimbursement was $2.
F. Other — Certain officers of the Trust are affiliated with the Adviser, the Administrator and JPMDS. Such officers, with the exception of the Chief Compliance Officer, receive no compensation from the Portfolio for serving in their respective roles.
The Board designated and appointed a Chief Compliance Officer to the Portfolio pursuant to Rule 38a-1 under the 1940 Act. The Portfolio, along with affiliated funds, makes reimbursement payments, on a pro-rata basis, to the Administrator for a portion of the fees associated with the office of the Chief Compliance Officer. Such fees are included in Trustees’ and Chief Compliance Officer’s fees on the Statement of Operations.
The Trust adopted a Trustee Deferred Compensation Plan (the “Plan”) which allows the independent Trustees to defer the receipt of all or a portion of compensation related to performance of their duties as Trustees. The deferred fees are invested in various J.P. Morgan Funds until distribution in accordance with the Plan.
The Securities and Exchange Commission ("SEC") has granted an exemptive order permitting the Portfolio to engage in principal transactions with J.P. Morgan Securities LLC, an affiliated broker, involving taxable money market instruments, subject to certain conditions.
4. Investment Transactions
During the year ended December 31, 2022, purchases and sales of investments (excluding short-term investments) were as follows:
| Purchases
(excluding
U.S. Government) | Sales
(excluding
U.S. Government) |
| | |
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
During the year ended December 31, 2022, there were no purchases or sales of U.S. Government securities.
5. Federal Income Tax Matters
For Federal income tax purposes, the estimated cost and unrealized appreciation (depreciation) in value of investments held at December 31, 2022 were as follows:
| | Gross
Unrealized
Appreciation | Gross
Unrealized
Depreciation | Net Unrealized
Appreciation
(Depreciation) |
| | | | |
The difference between book and tax basis appreciation (depreciation) on investments is primarily attributed to wash sale loss deferrals.
The tax character of distributions paid during the year ended December 31, 2022 was as follows:
| | Net
Long-Term
Capital Gains | |
| | | |
|
| Short-term gain distributions are treated as ordinary income for income tax purposes. |
The tax character of distributions paid during the year ended December 31, 2021 was as follows:
| | Net
Long-Term
Capital Gains | |
| | | |
|
| Short-term gain distributions are treated as ordinary income for income tax purposes. |
As of December 31, 2022, the estimated components of net assets (excluding paid-in-capital) on a tax basis were as follows:
| Current
Distributable
Ordinary
Income | Current
Distributable
Long-Term
Capital Gain
(Tax Basis Capital
Loss Carryover) | Unrealized
Appreciation
(Depreciation) |
| | | |
The cumulative timing differences primarily consist of wash sale loss deferrals.
As of December 31, 2022, the Portfolio did not have any net capital loss carryforwards.
6. Borrowings
The Portfolio relies upon an exemptive order granted by the SEC (the “Order”) permitting the establishment and operation of an Interfund Lending Facility (the “Facility”). The Facility allows the Portfolio to directly lend and borrow money to or from any other fund relying upon the Order at rates beneficial to both the borrowing and lending funds. Advances under the Facility are taken primarily for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities, and are subject to the Portfolio's borrowing restrictions. The interfund loan rate is determined, as specified in the Order, by averaging the current repurchase agreement rate and the current bank loan rate. The Order was granted to the Trust and may be relied upon by the Portfolio because the Portfolio and the series of the Trust are all investment companies in the same “group of investment companies” (as defined in Section 12(d)(1)(G) of the 1940 Act).
The Portfolio had no borrowings outstanding from another fund, or loans outstanding to another fund, during the year ended December 31, 2022.
The Trust and JPMCB have entered into a financing arrangement. Under this arrangement, JPMCB provides an unsecured, uncommitted credit facility in the aggregate amount of $100 million to certain of the J.P. Morgan Funds, including the Portfolio. Advances under the arrangement are taken
primarily for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities, and are subject to the Portfolio's borrowing restrictions. Interest on borrowings is payable at a rate determined by JPMCB at the time of borrowing. This agreement has been extended until October 30, 2023.
The Portfolio had no borrowings outstanding from the unsecured, uncommitted credit facility during the year ended December 31, 2022.
The Trust, along with certain other trusts for J.P. Morgan Funds (“Borrowers”), has entered into a joint syndicated senior unsecured revolving credit facility totaling $1.5 billion (“Credit Facility”) with various lenders and The Bank of New York Mellon, as administrative agent for the lenders. This Credit Facility provides a source of funds to the Borrowers for temporary and emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities. Under the terms of the Credit Facility, a borrowing portfolio must have a minimum of $25 million in adjusted net asset value and not exceed certain adjusted net asset coverage ratios prior to and during the time in which any borrowings are outstanding. If a portfolio does not comply with the aforementioned requirements, the portfolio must remediate within three business days with respect to the $25 million minimum adjusted net asset value or within one business day with respect to certain asset coverage ratios or the administrative agent at the request of, or with the consent of, the lenders may terminate the Credit Facility and declare any outstanding borrowings to be due and payable immediately.
Interest associated with any borrowing under the Credit Facility is charged to the borrowing portfolio at a rate of interest equal to 1.00% (the “Applicable Margin”), plus the greater of the federal funds effective rate or one month London Interbank Offered Rate ("LIBOR"). The annual commitment fee to maintain the Credit Facility is 0.15% and is incurred on the unused portion of the Credit Facility and is allocated to all participating portfolios pro rata based on their respective net assets. Effective August 9, 2022, the Credit Facility has been amended and restated for a term of 364 days, unless extended, and to include a change in the interest associated with any borrowing to the higher, on the day of the borrowing, of (a) the federal funds effective rate, or (b) the one-month Adjusted SOFR Rate plus the Applicable Margin.
The Portfolio did not utilize the Credit Facility during the year ended December 31, 2022.
7. Risks, Concentrations and Indemnifications
In the normal course of business, the Portfolio enters into contracts that contain a variety of representations which provide general indemnifications. The Portfolio's maximum exposure under these arrangements is unknown. The amount of exposure would depend on future claims that may be brought against the Portfolio. However, based on experience, the Portfolio expects the risk of loss to be remote.
As of December 31, 2022, the Portfolio had two individual shareholder and/or non-affiliated omnibus accounts each owning more than 10% of the Portfolio's outstanding shares, and, collectively owning 78.2% of the Portfolio's outstanding shares.
Significant shareholder transactions by these shareholders may impact the Portfolio's performance and liquidity.
The Portfolio's investments in real estate securities, including REITs, are subject to the same risks as direct investments in real estate and mortgages, and their value will depend on the value of the underlying real estate interests. These risks include default, prepayments, changes in value resulting from changes in interest rates and demand for real and rental property and the management skill and creditworthiness of each REIT. The Portfolio will indirectly bear their proportionate share of expenses, including management fees, paid by each REIT in which it invests, in addition to the expenses of the Funds. REITs may have limited financial resources, may trade less frequently and in limited volume may be more volatile than other securities.
LIBOR is intended to represent the rate at which contributing banks may obtain short-term borrowings from each other in the London interbank market. On March 5, 2021, the U.K. Financial Conduct Authority ("FCA") publicly announced that (i) immediately after December 31, 2021, publication of the 1-week and 2-month U.S. Dollar LIBOR settings will permanently cease; (ii) immediately after June 30, 2023, publication of the overnight and 12-month U.S. Dollar LIBOR settings will permanently cease; and (iii) immediately after June 30, 2023, the 1-month, 3-month and 6-month U.S. Dollar LIBOR settings will cease to be provided or, subject to the FCA's consideration of the case, be provided on a synthetic basis and no longer be representative of the underlying market and economic reality they are intended to measure and that representativeness will not be restored. There is no assurance that the dates announced by the FCA will not change or that the administrator of LIBOR and/or regulators will not take further action that could impact the availability, composition or characteristics of LIBOR or the currencies and/or tenors for which LIBOR is published. In addition, certain regulated entities ceased entering into most new LIBOR contracts in connection with regulatory guidance or prohibitions. Public and private sector industry initiatives are currently underway to implement new or alternative reference rates to be used in place of LIBOR. There is no assurance that any such alternative reference rate will be similar to or produce the same value or economic equivalence as LIBOR or that it will have the same volume or liquidity as did LIBOR prior to its discontinuance, unavailability or replacement, all of which may affect the value, volatility, liquidity or return on certain of the Portfolio's loans, notes, derivatives and other instruments or investments comprising some or all of the Portfolio's investments and result in costs incurred in connection with changing reference rates used for positions closing out positions and entering into new trades. Certain of the Portfolio's investments may transition from LIBOR prior to the dates announced by the FCA. The transition from LIBOR to alternative reference rates may result in operational issues for the Portfolio or its investments. No assurances can be given as to the impact of the LIBOR transition (and the timing of any such impact) on the Portfolio and its investments.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
The Portfolio is subject to infectious disease epidemics/pandemics risk. The worldwide outbreak of COVID-19 has negatively affected economies, markets and individual companies throughout the world. The effects of this COVID-19 pandemic to public health, and business and market conditions, including among other things, reduced consumer demand and economic output, supply chain disruptions and increased government spending may continue to have a significant negative impact on the performance of the Portfolio's investments, increase the Portfolio's volatility, exacerbate other pre-existing political, social and economic risks to the Portfolio and negatively impact broad segments of businesses and populations. In addition, governments, their regulatory agencies, or self-regulatory organizations have taken or may take actions in response to the pandemic that affect the instruments in which the Portfolio invests, or the issuers of such instruments, in ways that could also have a significant negative impact on the Portfolio's investment performance. The duration and extent of COVID-19 and associated economic and market conditions and uncertainty over the long-term cannot be reasonably estimated at this time. The ultimate impact of COVID-19 and the extent to which the associated conditions impact the Portfolio will also depend on future developments, which are highly uncertain, difficult to accurately predict and subject to frequent changes.
8. Other Matters
On December 12, 2022, the Board approved a proposal to reorganize the Portfolio into a newly organized series (the “Acquiring Fund") of Lincoln Variable Insurance Products Trust (the “Reorganization”).
The Acquiring Fund has the same investment objective and substantially identical principal investment strategies and principal risks as the Portfolio. The Acquiring Fund’s investment adviser will be Lincoln Investment Advisors Corporation, and it is anticipated that JPMIM will be retained as the sub-adviser to the Acquiring Fund upon consummation of the Reorganization. Upon the closing of the Reorganization, the Class 1 Shares of the Portfolio will be exchanged for the same value of Standard Class Shares of the Acquiring Fund.
The Reorganization is subject to the approval of the Portfolio’s shareholders at a special shareholder meeting to be held on or about March 15, 2023. If shareholder approval of the Reorganization is obtained, the Reorganization is expected to be effective on or about May 1, 2023. All costs related to the Reorganization will be borne by Lincoln Investment Advisors Corporation and JPMIM and not by the Portfolio or Acquiring Fund.
More detailed information about the reorganization was included in a proxy statement provided to shareholders.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Trustees of JPMorgan Insurance Trust and Shareholders of JPMorgan Insurance Trust Mid Cap Value Portfolio
Opinion on the Financial Statements
We have audited the accompanying statement of assets and liabilities, including the schedule of portfolio investments, of JPMorgan Insurance Trust Mid Cap Value Portfolio (one of the portfolios constituting JPMorgan Insurance Trust, referred to hereafter as the “Portfolio”) as of December 31, 2022, the related statement of operations for the year ended December 31, 2022, the statements of changes in net assets for each of the two years in the period ended December 31, 2022, including the related notes, and the financial highlights for each of the five years in the period ended December 31, 2022 (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Portfolio as of December 31, 2022, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended December 31, 2022 and the financial highlights for each of the five years in the period ended December 31, 2022 in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Portfolio’s management. Our responsibility is to express an opinion on the Portfolio’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Portfolio in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of December 31, 2022 by correspondence with the custodian and transfer agent. We believe that our audits provide a reasonable basis for our opinion.
/s/ PricewaterhouseCoopers LLP
New York, New York
February 15, 2023
We have served as the auditor of one or more investment companies in the JPMorgan Funds complex since 1993.
The Portfolio's Statement of Additional Information includes additional information about the Portfolio’s Trustees and is available, without charge, upon request by calling 1-800-480-4111 or on the Portfolio's website at www.jpmorgan.com/variableinsuranceportfolios.
Name (Year of Birth);
Positions With
the Portfolio (1) | Principal Occupation
During Past 5 Years | Number of
Funds in Fund
Complex Overseen
by Trustee (2) | Other Directorships Held
During the Past 5 Years |
| | | |
John F. Finn (1947); Chair
since 2020; Trustee since 1998. | Chairman, Gardner, Inc. (supply chain management company serving industrial and consumer markets) (serving in various roles 1974-present). | | Director, Greif, Inc. (GEF) (industrial package products and services) (2007-present); Trustee, Columbus Association for the Performing Arts (1988-present). |
Stephen P. Fisher (1959);
Trustee since 2018. | Retired; Chairman and Chief Executive Officer, NYLIFE Distributors LLC (registered broker-dealer) (serving in various roles 2008-2013); Chairman, NYLIM Service Company LLC (transfer agent) (2008-2017); New York Life Investment Management LLC (registered investment adviser) (serving in various roles 2005-2017); Chairman, IndexIQ Advisors LLC (registered investment adviser for ETFs) (2014-2017); President, MainStay VP Funds Trust (2007-2017), MainStay DefinedTerm Municipal Opportunities Fund (2011-2017) and MainStay Funds Trust (2007-2017) (registered investment companies). | | Honors Program Advisory Board Member, The Zicklin School of Business, Baruch College, The City University of New York (2017-present). |
Gary L. French (1951);
Trustee since 2014. | Real Estate Investor (2011-2020); Investment management industry Consultant and Expert Witness (2011-present); Senior Consultant for The Regulatory Fundamentals Group LLC (2011-2017). | | Independent Trustee, The China Fund, Inc. (2013-2019); Exchange Traded Concepts Trust II (2012-2014); Exchange Traded Concepts Trust I (2011-2014). |
Kathleen M. Gallagher (1958);
Trustee since 2018. | Retired; Chief Investment Officer — Benefit Plans, Ford Motor Company (serving in various roles 1985-2016). | | Non- Executive Director, Legal & General Investment Management (Holdings) (2018-present); Non-Executive Director, Legal & General Investment Management America (U.S. Holdings) (financial services and insurance) (2017-present); Advisory Board Member, State Street Global Advisors Total Portfolio Solutions (2017-present); Member, Client Advisory Council, Financial Engines, LLC (registered investment adviser) (2011-2016); Director, Ford Pension Funds Investment Management Ltd. (2007-2016). |
Robert J. Grassi (1957);
Trustee since 2014. | Sole Proprietor, Academy Hills Advisors LLC (2012-present); Pension Director, Corning Incorporated (2002-2012). | | |
Frankie D. Hughes (1952);
Trustee since 2008. | President, Ashland Hughes Properties (property management) (2014-present); President and Chief Investment Officer, Hughes Capital Management, Inc. (fixed income asset management) (1993-2014). | | |
Name (Year of Birth); Positions With the Portfolio (1) | Principal Occupation During Past 5 Years | Number of Funds in Fund Complex Overseen by Trustee (2) | Other Directorships Held During the Past 5 Years |
Raymond Kanner (1953);
Trustee since 2017. | Retired; Managing Director and Chief Investment Officer, IBM Retirement Funds (2007-2016). | | Advisory Board Member, Penso Advisors, LLC (2020-present); Advisory Board Member, Los Angeles Capital (2018-present); Advisory Board Member, State Street Global Advisors Total Portfolio Solutions (2017- present); Acting Executive Director, Committee on Investment of Employee Benefit Assets (CIEBA) (2016-2017); Advisory Board Member, Betterment for Business (robo advisor) (2016- 2017); Advisory Board Member, BlueStar Indexes (index creator) (2013-2017); Director, Emerging Markets Growth Fund (registered investment company) (1997-2016); Member, Russell Index Client Advisory Board (2001-2015). |
Thomas P. Lemke (1954);
Trustee since 2014. | | | (1) Independent Trustee of Advisors’ Inner Circle III fund platform, consisting of the following: (i) the Advisors’ Inner Circle Fund III, (ii) the Gallery Trust, (iii) the Schroder Series Trust, (iv) the Delaware Wilshire Private Markets Fund (since 2020), (v) Chiron Capital Allocation Fund Ltd., and (vi) formerly the Winton Diversified Opportunities Fund (2014-2018); and (2) Independent Trustee of the Symmetry Panoramic Trust (since 2018). |
Lawrence R. Maffia (1950);
Trustee since 2014 | Retired; Director and President, ICI Mutual Insurance Company (2006-2013). | | Director, ICI Mutual Insurance Company (1999-2013). |
Mary E. Martinez (1960); Vice
Chair since 2021; Trustee since 2013. | Associate, Special Properties, a Christie’s International Real Estate Affiliate (2010-present); Managing Director, Bank of America (asset management) (2007-2008); Chief Operating Officer, U.S. Trust Asset Management, U.S. Trust Company (asset management) (2003-2007); President, Excelsior Funds (registered investment companies) (2004-2005). | | |
Marilyn McCoy (1948);
Trustee since 2005. | Vice President of Administration and Planning, Northwestern University (1985-present). | | |
Dr. Robert A. Oden, Jr. (1946); Trustee
since 2005. | Retired; President, Carleton College (2002-2010); President, Kenyon College (1995-2002). | | Trustee, The Coldwater Conservation Fund (2017-present); Trustee, American Museum of Fly Fishing (2013-present); Trustee and Vice Chair, Trout Unlimited (2017-2021);Trustee, Dartmouth- Hitchcock MedicalCenter (2011-2020). |
TRUSTEES
(Unaudited) (continued)
Name (Year of Birth); Positions With the Portfolio (1) | Principal Occupation During Past 5 Years | Number of Funds in Fund Complex Overseen by Trustee (2) | Other Directorships Held During the Past 5 Years |
Marian U. Pardo* (1946);
Trustee since 2013. | Managing Director and Founder, Virtual Capital Management LLC (investment consulting) (2007-present); Managing Director, Credit Suisse Asset Management (portfolio manager) (2003-2006). | | Board Chair and Member, Board of Governors, Columbus Citizens Foundation (not-for-profit supporting philanthropic and cultural programs) (2006-present). |
Emily A. Youssouf (1951);
Trustee since 2022. | Adjunct Professor (2011-present) and Clinical Professor (2009-2011), NYU Schack Institute of Real Estate; Board Member and Member of the Audit Committee (2013–present), Chair of Finance Committee (2019-present), Member of Related Parties Committee (2013-2018) and Member of the Enterprise Risk Committee (2015-2018), PennyMac Financial Services, Inc.; Board Member (2005-2018), Chair of Capital Committee (2006-2016), Chair of Audit Committee (2005-2018), Member of Finance Committee (2005-2018) and Chair of IT Committee (2016-2018), NYC Health and Hospitals Corporation. | | Trustee, NYC School Construction Authority (2009-present); Board Member, NYS Job Development Authority (2008-present); Trustee and Chair of the Audit Committee of the Transit Center Foundation (2015-2019). |
| | | |
Robert F. Deutsch** (1957);
Trustee since 2014. | Retired; Head of ETF Business for JPMorgan Asset Management (2013-2017); Head of Global Liquidity Business for JPMorgan Asset Management (2003-2013). | | Treasurer and Director of the JUST Capital Foundation (2017-present). |
Nina O. Shenker** (1957);
Trustee since 2022. | Vice Chair (2017-2021), General Counsel and Managing Director (2008-2016), Associate General Counsel and Managing Director (2004-2008), J.P. Morgan Asset & Wealth Management. | | Director and Member of Legal and Human Resources Subcommittees, American Jewish Joint Distribution Committee (2018-present). |
|
| The year shown is the first year in which a Trustee became a member of any of the following: the JPMorgan Mutual Fund Board, the JPMorgan ETF Board, the heritage J.P. Morgan Funds or the heritage One Group Mutual Funds. Trustees serve an indefinite term, until resignation, retirement, removal or death. The Board’s current retirement policy sets retirement at the end of the calendar year in which the Trustee attains the age of 75, provided that any Board member who was a member of the JPMorgan Mutual Fund Board prior to January 1, 2022 and was born prior to January 1, 1950 shall retire from the Board at the end of the calendar year in which the Trustee attains the age of 78. |
| A Fund Complex means two or more registered investment companies that hold themselves out to investors as related companies for purposes of investment and investor services or have a common investment adviser or have an investment adviser that is an affiliated person of the investment adviser of any of the other registered investment companies. The J.P. Morgan Funds Complex for which the Board of Trustees serves currently includes nine registered investment companies (179 J.P. Morgan Funds). |
| In connection with prior employment with JPMorgan Chase, Ms. Pardo was the recipient of non-qualified pension plan payments from JPMorgan Chase in the amount of approximately $2,055 per month, which she irrevocably waived effective January 1, 2013, and deferred compensation payments from JPMorgan Chase in the amount of approximately $7,294 per year, which ended in January 2013. In addition, Ms. Pardo receives payments from a fully-funded qualified plan, which is not an obligation of JPMorgan Chase. |
| Designation as an “Interested Trustee” is based on prior employment by the Adviser or an affiliate of the Adviser or interests in a control person of the Adviser. |
| The contact address for each of the Trustees is 277 Park Avenue, New York, NY 10172. |
Name (Year of Birth),
Positions Held with
the Trust (Since) | Principal Occupations During Past 5 Years |
Brian S. Shlissel (1964),
President and Principal Executive
Officer (2016)* | Managing Director and Chief Administrative Officer for J.P. Morgan pooled vehicles, J.P. Morgan Investment Management Inc. since 2014. |
Timothy J. Clemens (1975),
Treasurer and Principal Financial
Officer (2018) | Executive Director, J.P. Morgan Investment Management Inc. since February 2016. Mr. Clemens has been with J.P. Morgan Investment Management Inc. since 2013. |
Gregory S. Samuels (1980),
Secretary (2019) (formerly Assistant
Secretary 2010-2019) | Managing Director and Assistant General Counsel, JPMorgan Chase & Co. Mr. Samuels has been with JPMorgan Chase & Co. since 2010. |
Stephen M. Ungerman (1953),
Chief Compliance Officer (2005) | Managing Director, JPMorgan Chase & Co. Mr. Ungerman has been with JPMorgan Chase & Co. since 2000. |
Kiesha Astwood-Smith (1973),
Assistant Secretary (2021) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since June 2021; Senior Director and Counsel, Equitable Financial Life Insurance Company (formerly, AXA Equitable Life Insurance Company) from September 2015 through June 2021. |
Matthew Beck (1988),
Assistant Secretary (2021)** | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since May 2021; Senior Legal Counsel, Ultimus Fund Solutions from May 2018 through May 2021; General Counsel, The Nottingham Company from April 2014 through May 2018. |
Elizabeth A. Davin (1964),
Assistant Secretary (2005)** | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Ms. Davin has been with JPMorgan Chase & Co. (formerly Bank One Corporation) since 2004. |
Jessica K. Ditullio (1962)
Assistant Secretary (2005)** | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Ms. Ditullio has been with JPMorgan Chase & Co. (formerly Bank One Corporation) since 1990. |
Anthony Geron (1971),
Assistant Secretary (2018) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since September 2018; Lead Director and Counsel, AXA Equitable Life Insurance Company from 2015 to 2018 and Senior Director and Counsel, AXA Equitable Life Insurance Company from 2014 to 2015. |
Carmine Lekstutis (1980),
Assistant Secretary (2011) | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Mr. Lekstutis has been with JPMorgan Chase & Co. since 2011. |
Max Vogel (1990),
Assistant Secretary (2021) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since June 2021; Associate, Proskauer Rose LLP (law firm) from March 2017 to June 2021. |
Zachary E. Vonnegut-Gabovitch
(1986),
Assistant Secretary (2017) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since September 2016. |
Michael M. D’Ambrosio (1969),
Assistant Treasurer (2012) | Managing Director, J.P. Morgan Investment Management Inc. Mr. D’Ambrosio has been with J.P. Morgan Investment Management Inc. since 2012. |
Aleksandr Fleytekh (1972),
Assistant Treasurer (2019) | Vice President, J.P. Morgan Investment Management Inc. since February 2012. |
Shannon Gaines (1977),
Assistant Treasurer (2018)** | Vice President, J.P. Morgan Investment Management Inc. since January 2014. |
Jeffrey D. House (1972),
Assistant Treasurer (2017)** | Vice President, J.P. Morgan Investment Management Inc. since July 2006. |
Michael Mannarino (1985),
Assistant Treasurer (2020) | Vice President, J.P. Morgan Investment Management Inc. since 2014. |
Joseph Parascondola (1963),
Assistant Treasurer (2011)* | Executive Director, J.P. Morgan Investment Management, Inc. Mr. Parascondola has been with J.P. Morgan Investment Management Inc. since 2006. |
Gillian I. Sands (1969),
Assistant Treasurer (2012) | Executive Director, J.P. Morgan Investment Management Inc. Ms. Sands has been with J.P. Morgan Investment Management Inc. since 2012. |
|
The contact address for each of the officers, unless otherwise noted, is 277 Park Avenue, New York, NY 10172. |
OFFICERS
(Unaudited) (continued)
| The contact address for the officer is 575 Washington Boulevard, Jersey City, NJ 07310. |
| The contact address for the officer is 1111 Polaris Parkway, Columbus, OH 43240. |
SCHEDULE OF SHAREHOLDER EXPENSES
(Unaudited)
Hypothetical $1,000 Investment
As a shareholder of the Portfolio, you incur ongoing costs, including investment advisory fees, administration fees and other Portfolio expenses. Because the Portfolio is a funding vehicle for Policies and Eligible Plans, you may also incur sales charges and other fees relating to the Policies or Eligible Plans. The examples below are intended to help you understand your ongoing costs (in dollars) of investing in the Portfolio, but not the costs of the Policies or Eligible Plans, and to compare these ongoing costs with the ongoing costs of investing in other mutual funds. The examples assume that you had a $1,000 investment in the Portfolio at the beginning of the reporting period, July 1, 2022, and continued to hold your shares at the end of the reporting period, December 31, 2022.
Actual Expenses
In the table below, the first line provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line under the heading titled “Expenses Paid During the Period” to estimate the expenses you paid on your account during this period.
Hypothetical Example for Comparison Purposes
The second line in the table below provides information about hypothetical account values and hypothetical expenses based on the actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Portfolio's’ actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Portfolio and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds. Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs, such as sales charges (loads), or redemption fees or the costs associated with the Policies and Eligible Plans through which the Portfolio is held. Therefore, the second line in the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transaction costs were included, your costs would have been higher. The examples also assume all dividends and distributions have been reinvested.
| Beginning
Account Value
July 1, 2022 | Ending
Account Value
December 31, 2022 | Expenses
Paid During
the Period* | |
JPMorgan Insurance Trust Mid Cap Value Portfolio | | | | |
| | | | |
| | | | |
| | | | |
|
| Expenses are equal to the Portfolio’s annualized expense ratio, multiplied by the average account value over the period, multiplied by 184/365 (to reflect the one-half year period). |
BOARD APPROVAL OF INVESTMENT ADVISORY AGREEMENT
(Unaudited)
The Board of Trustees (the “Board” or the “Trustees”) has established various standing committees composed of Trustees with diverse backgrounds, to which the Board has assigned specific subject matter responsibilities to further enhance the effectiveness of the Board’s oversight and decision making. Effective January 2022, the Board consolidated with the J.P. Morgan Exchange-Traded Fund Trust Board and now consists of Trustees from both Boards. The Board and its investment committees (Money Market and Alternative Products Committee, Equity Committee, and Fixed Income Committee) met regularly throughout the year and, at each meeting, considered factors that are relevant to their annual consideration of the continuation of the investment advisory agreements. The Board also met for the specific purpose of considering investment advisory agreement annual renewals. The Board held meetings on June 21-22, 2022 and August 9-11, 2022, at which the Trustees considered the continuation of the investment advisory agreement for the Portfolio whose annual report is contained herein (the “Advisory Agreement”). At the June meeting, the Board’s investment committees met to review and consider performance, expense and related information for the J.P. Morgan Funds. Each investment committee reported to the full Board, which then considered each investment committee’s preliminary findings. At the August meeting, the Trustees continued their review and consideration. The Trustees, including a majority of the Trustees who are not parties to the Advisory Agreement or “interested persons” (as defined in the Investment Company Act of 1940) of any party to the Advisory Agreement or any of their affiliates, approved the continuation of the Advisory Agreement on August 11, 2022.
As part of their review of the Advisory Agreement, the Trustees considered and reviewed performance and other information about the Portfolio received from the Adviser. This information includes the Portfolio’s performance as compared to the performance of its peers and benchmarks, and analyses by the Adviser of the Portfolio’s performance. In addition, at each of their regular meetings throughout the year, the Trustees considered reports on the performance of certain J.P. Morgan Funds (including certain ETFs, beginning in February 2022) provided by an independent investment consulting firm (“independent consultant”). In addition, in preparation for the June and August meetings, the Trustees requested, received and evaluated extensive materials from the Adviser, including performance and expense information compiled by Broadridge, using data from Lipper Inc. and/or Morningstar Inc., independent providers of investment company data (together, “Broadridge”). Before voting on the Advisory Agreement, the Trustees reviewed the Advisory Agreement with representatives of the Adviser, counsel to the Trust, and independent legal counsel and received a memorandum from independent legal counsel to the Trustees discussing the legal standards for their consideration of the Advisory Agreement. The Trustees also
discussed the Advisory Agreement with independent legal counsel in executive sessions at which no representatives of the Adviser were present.
A summary of the material factors evaluated by the Trustees in determining whether to approve the Advisory Agreement is provided below. Each Trustee attributed different weights to the various factors and no factor alone was considered determinative. The Trustees considered information provided with respect to the Portfolio throughout the year, including additional reporting and information provided in connection with the COVID-19 pandemic, as well as materials furnished specifically in connection with the annual review process. From year to year, the Trustees consider and place emphasis on relevant information in light of changing circumstances in market and economic conditions.
After considering and weighing the factors and information they had received, the Trustees found that the compensation to be received by the Adviser from the Portfolio under the Advisory Agreement was fair and reasonable under the circumstances and determined that the continuance of the Advisory Agreement was in the best interests of the Portfolio and its shareholders.
Nature, Extent and Quality of Services Provided by the Adviser
The Trustees received and considered information regarding the nature, extent and quality of services provided to the Portfolio under the Advisory Agreement. The Trustees took into account information furnished throughout the year at Trustee meetings, as well as the materials furnished specifically in connection with this annual review process. Among other things, the Trustees considered:
(i) The background and experience of the Adviser’s senior management and investment personnel, including personnel changes, if any;
(ii) The qualifications, backgrounds and responsibilities of the portfolio management team primarily responsible for the day-to-day management of the Portfolio, including personnel changes, if any;
(iii) The investment strategy for the Portfolio, and the infrastructure supporting the portfolio management team;
(iv) Information about the structure and distribution strategy for the Portfolio and how it fits with the Trust’s other fund offerings;
(v) The administration services provided by the Adviser in its role as Administrator;
(vi) Their knowledge of the nature and quality of the services provided by the Adviser and its affiliates gained from their experience as Trustees of the Trust and in the financial industry generally;
(vii) The overall reputation and capabilities of the Adviser and its affiliates;
(viii) The commitment of the Adviser to provide high quality
service to the Portfolio;
(ix) Their overall confidence in the Adviser’s integrity;
(x) The Adviser’s responsiveness to requests for additional information, questions or concerns raised by them, including the Adviser’s willingness to consider and implement organizational and operational changes designed to improve investment results and the services provided to the Portfolio; and
(xi) The Adviser’s business continuity plan and steps the Adviser and its affiliates have taken to provide ongoing services to the Portfolio during the COVID-19 pandemic, and the Adviser’s and its affiliates’ success in continuing to provide services to the Portfolio and its shareholders throughout this period.
Based upon these considerations and other factors, the Trustees concluded that they were satisfied with the nature, extent and quality of the services provided to the Portfolio by the Adviser.
Costs of Services Provided and Profitability to the Adviser and its Affiliates
The Trustees received and considered information regarding the profitability to the Adviser and its affiliates from providing services to the Portfolio. The Trustees reviewed and discussed this information. The Trustees recognized that this information is not audited and represents the Adviser’s determination of its and its affiliates’ revenues from the contractual services provided to the Portfolio, less expenses of providing such services. Expenses include direct and indirect costs and are calculated using an allocation methodology developed by the Adviser and reviewed with the Board. The Trustees also recognized that it is difficult to make comparisons of profitability from fund investment advisory contracts because comparative information is not generally publicly available and is affected by numerous factors, including the structure of the particular adviser, the types of funds it manages, its business mix, numerous assumptions regarding allocations and the fact that publicly-traded fund managers’ operating profits and net income are net of distribution and marketing expenses. Based upon their review, and taking into consideration the factors noted above, the Trustees concluded that the profitability to the Adviser under the Advisory Agreement was not unreasonable in light of the services and benefits provided to the Portfolio.
The Trustees also considered that JPMDS, an affiliate of the Adviser, and the Adviser earn fees from the Portfolio for providing administration services. These fees were shown separately in the profitability analysis presented to the Trustees. The Trustees also considered the payments of Rule 12b-1 fees to JPMDS, which also acts as the Portfolio’s distributor, and that these fees are in turn generally paid to insurance companies that use the Portfolio in connection with insurance products they issue, including financial intermediaries that are affiliates of the Adviser (although they are
retained by JPMDS in certain instances). The Trustees also considered the fees earned by JPMorgan Chase Bank, N.A. (“JPMCB”), an affiliate of the Adviser, for custody, fund accounting and other related services for the Portfolio, and the profitability of the arrangements to JPMCB.
Fall-Out Benefits
The Trustees reviewed information regarding potential “fall-out” or ancillary benefits received by the Adviser and its affiliates as a result of their relationship with the Portfolio. The Trustees considered that the J.P. Morgan Funds’ operating accounts are held at JPMCB, which, as a result, will receive float benefits for certain J.P. Morgan Funds, as applicable. The Trustees also noted that the Adviser supports a diverse set of products and services, which benefits the Adviser by allowing it to leverage its infrastructure to serve additional clients, including benefits that may be received by the Adviser and its affiliates in connection with the Portfolio’s potential investments in other funds advised by the Adviser. The Trustees also reviewed the Adviser’s allocation of fund brokerage for the J.P. Morgan Funds complex, including allocations to brokers who provide research to the Adviser, as well as the Adviser’s use of affiliates to provide other services and the benefits to such affiliates of doing so.
Economies of Scale
The Trustees considered the extent to which the Portfolio may benefit from potential economies of scale. The Trustees considered that there may not be a direct relationship between economies of scale realized by the Portfolio and those realized by the Adviser as assets increase. The Trustees considered the extent to which the Portfolio was priced to scale and whether it would be appropriate to add advisory fee breakpoints, but noted that the Portfolio has implemented fee waivers and contractual expense limitations (“Fee Caps”) which allow the Portfolio’s shareholders to share potential economies of scale from its inception and that the fees remain satisfactory relative to peer funds. The Trustees considered the benefits to the Portfolio of the use of an affiliated distributor and custodian, including the ability to rely on existing infrastructure supporting distribution, custodial and transfer agent services, and the ability to negotiate competitive fees for the Portfolio. The Trustees further considered the Adviser’s and JPMDS’s ongoing investments in their business in support of the Portfolio, including the Adviser’s and/or JPMDS’s investments in trading systems, technology (including improvements to the J.P. Morgan Funds’ website, and cybersecurity improvements), retention of key talent, and regulatory support enhancements. The Trustees concluded that the current fee structure for the Portfolio, including Fee Caps that the Adviser has in place that serve to limit the overall net expense ratios of the Portfolio at competitive levels, was reasonable. The Trustees concluded that the Portfolio’s shareholders received the benefits of
BOARD APPROVAL OF INVESTMENT ADVISORY AGREEMENT
(Unaudited) (continued)
potential economies of scale through the Fee Caps and the Adviser’s reinvestment in its operations to serve the Portfolio and its shareholders. The Trustees noted that the Adviser’s reinvestment ensures sufficient resources in terms of personnel and infrastructure to support the Portfolio.
Fees Relative to Adviser’s Other Clients
The Trustees received and considered information about the nature and extent of investment advisory services and fee rates offered to other clients of the Adviser, including to the extent applicable, institutional separate accounts, collective investment trusts, other registered investment companies and/or private funds sub-advised by the Adviser, for investment management styles substantially similar to that of the Portfolio. The Trustees considered the complexity of investment management for registered investment companies relative to the Adviser’s other clients and noted differences, as applicable, in the fee structure and the regulatory, legal and other risks and responsibilities of providing services to the different clients. The Trustees considered that serving as an adviser to a registered investment company involves greater responsibilities and risks than acting as a sub-adviser and observed that sub-advisory fees may be lower than those charged by the Adviser to the Portfolio. The Trustees also noted that the adviser, not the applicable investment company, typically bears the sub-advisory fee and that many responsibilities related to the advisory function are typically retained by the primary adviser. The Trustees concluded that the fee rates charged to the Portfolio in comparison to those charged to the Adviser’s other clients were reasonable.
Investment Performance
The Trustees receive and consider information about the Portfolio’s performance throughout the year. In addition, the Trustees received and considered absolute and/or relative performance information for the Portfolio in a report prepared by Broadridge. The Trustees considered the total return performance information, which included the ranking of the Portfolio within a performance universe comprised of funds with the same Broadridge investment classification and objective (the “Universe”), as well as a subset of funds within the Universe (the “Peer Group”), by total return for the applicable one-, three- and five-year periods. The Trustees reviewed a description of Broadridge’s methodology for selecting mutual funds in the Portfolio’s Universe and Peer Group and noted that Universe and Peer Group quintile rankings were not calculated if the number of funds in the Universe and/or Peer Group did not meet a predetermined minimum. The Broadridge materials provided to the Trustees highlighted information with respect to a representative class to assist the Trustees in their review. As part of this review, the
Trustees also reviewed the Portfolio’s performance against its benchmark and considered the performance information provided for the Portfolio at regular Board meetings by the Adviser. The Trustees also engaged with the Adviser to consider what steps might be taken to improve performance, as applicable. The Broadridge performance data noted by the Trustees as part of their review and the determinations made by the Trustees with respect to the Portfolio’s performance are summarized below:
The Trustees noted that the Portfolio’s performance for Class 1 shares was in the second, third and second quintiles of the Peer Group, and in the second, third and third quintiles of the Universe, for the one-, three- and five-year periods ended December 31, 2021, respectively. The Trustees discussed the performance and investment strategy of the Portfolio with the Adviser and based upon this discussion and various other factors, concluded that the Portfolio’s performance was satisfactory.
Advisory Fees and Expense Ratios
The Trustees considered the contractual advisory fee rate and administration fee rate paid by the Portfolio to the Adviser and compared the combined rate to the information prepared by Broadridge concerning management fee rates paid by other funds in the same Broadridge category as the Portfolio. The Trustees recognized that Broadridge reported the Portfolio’s management fee rate as the combined contractual advisory fee and administration fee rates. The Trustees also reviewed information about other expenses and the expense ratios for the Portfolio and noted that Universe and Peer Group quintile rankings were not calculated if the number of funds in the Universe and/or Peer Groups did not meet a predetermined minimum. The Trustees considered the Fee Caps currently in place for the Portfolio, the net advisory fee rate after taking into account any waivers and/or reimbursements and, where deemed appropriate by the Trustees, additional waivers and/or reimbursements. The Trustees recognized that it can be difficult to make comparisons of advisory fees because there are variations in the services that are included in the fees paid by other funds. The Trustees’ determinations as a result of the review of the Portfolio’s advisory fees and expense ratios are summarized below:
The Trustees noted that the Portfolio’s net advisory fee for Class 1 shares was in the second and third quintiles of the Peer Group and Universe, respectively, and that the actual total expenses for Class 1 shares were in the second quintile of both the Peer Group and Universe. After considering the factors identified above, in light of this information, the Trustees concluded that the advisory fee was satisfactory in light of the services provided to the Portfolio.
TAX LETTER
(Unaudited)
(Dollar values in thousands)
Dividends Received Deduction (DRD)
The Portfolio had 68.04%, or maximum allowable percentage, of ordinary income distributions eligible for the dividends received deduction for corporate shareholders for the fiscal year ended December 31, 2022.
Long Term Capital Gain
The Portfolio distributed $60,728, or maximum allowable amount, of long-term capital gain dividends for the fiscal year ended December 31, 2022.
THIS PAGE IS INTENTIONALLY LEFT BLANK
J.P. Morgan Funds are distributed by JPMorgan Distribution Services, Inc., which is an affiliate of JPMorgan Chase & Co. Affiliates of JPMorgan Chase & Co. receive fees for providing various services to the funds.
Contact JPMorgan Distribution Services, Inc. at 1-800-480-4111 for a portfolio prospectus. You can also visit us at www.jpmorgan.com/variableinsuranceportfolios. Investors should carefully consider the investment objectives and risk as well as charges and expenses of the mutual fund before investing. The prospectus contains this and other information about the mutual fund. Read the prospectus carefully before investing.
Investors may obtain information about the Securities Investor Protection Corporation (SIPC), including the SIPC brochure, by visiting www.sipc.org or by calling SIPC at 202-371-8300.
The Portfolio files a complete schedule of its portfolio holdings for the first and third quarters of its fiscal year with the SEC as an exhibit to its report on Form N-PORT. The Portfolio’s Form N-PORT reports are available on the SEC’s website at http://www.sec.gov. The Portfolio's quarterly holdings can be found by visiting the Portfolio's website at www.jpmorgan.com/variableinsuranceportfolios.
A description of the Portfolio’s policies and procedures with respect to the disclosure of the Portfolio’s holdings is available in the prospectuses and Statement of Additional Information.
A copy of proxy policies and procedures is available without charge upon request by calling 1-800-480-4111 and on the Portfolio’s website at www.jpmorgan.com/variableinsuranceportfolios. A description of such policies and procedures is on the SEC’s website at www.sec.gov. The Trustees have delegated the authority to vote proxies for securities owned by the Portfolio to the Adviser. A copy of the Portfolio’s voting record for the most recent 12-month period ended June 30 is available on the SEC’s website at www.sec.gov or at the Portfolio’s website at www.jpmorgan.com/variableinsuranceportfolios no later than August 31 of each year. The Portfolio’s proxy voting record will include, among other things, a brief description of the matter voted on for each portfolio security, and will state how each vote was cast, for example, for or against the proposal.
J.P. Morgan Asset Management is the brand name for the asset management business of JPMorgan Chase & Co. and its affiliates worldwide.
© JPMorgan Chase & Co., 2022. All rights reserved. December 2022.
AN-JPMITMCVP-1222
Annual Report
JPMorgan Insurance Trust
December 31, 2022
JPMorgan Insurance Trust Small Cap Core Portfolio |
CONTENTS
Investments in the Portfolio are not deposits or obligations of, or guaranteed or endorsed by, any bank and are not insured or guaranteed by the FDIC, the Federal Reserve Board or any other government agency. You could lose money if you sell when the Portfolio’s share price is lower than when you invested.
Past performance is no guarantee of future performance. The general market views expressed in this report are opinions based on market and other conditions through the end of the reporting period and are subject to change without notice. These views are not intended to predict the future performance of the Portfolio or the securities markets.
This Portfolio is intended to be a funding vehicle for variable annuity contracts and variable life insurance policies (collectively “Policies”) offered by the separate accounts of various insurance companies. Portfolio shares may also be offered to qualified pension and retirement plans and accounts permitting accumulation of assets on a tax-deferred basis (“Eligible Plans”). Individuals may not purchase shares directly from the Portfolio.
Prospective investors should refer to the Portfolio’s prospectuses for a discussion of the Portfolio’s investment objective, strategies and risks. Call J.P. Morgan Funds Service Center at 1-800-480-4111 for a prospectus containing more complete information about the Portfolio, including management fees and other expenses. Please read it carefully before investing.
Letter to Shareholders
February 13, 2023 (Unaudited)
Dear Shareholder,
Financial markets have rebounded somewhat as the U.S. and other developed market economies have shown notable resilience in the face of higher inflation, rising interest rates and the ongoing war in Ukraine. While the factors that weighed on equity and bond markets in 2022 largely remain, there are signals that inflationary pressures may have peaked and the long-term economic outlook appears positive.
|
“Investors may face continued economic and geopolitical challenges in the year ahead. However, some of the acute risks encountered in 2022 appear to have receded and last year’s reset in asset prices may provide attractive investment opportunities.” — Brian S. Shlissel
|
While U.S. economic growth was surprisingly strong in the closing months of 2022, with broad gains in employment and consumer spending in the final months of the year, the U.S. Federal Reserve’s efforts to counter inflationary pressure through sharply higher interest rates could slow economic momentum in the months ahead.
Corporate earnings have been squeezed by higher costs for materials and labor, while the strong U.S. dollar has hindered export revenues. However, the impact of higher prices and interest rates has not landed on all sectors of the economy evenly. Energy sector profits have soared over the past year, while earnings in housing and construction sectors have declined.
Across Europe, the war in Ukraine has driven up prices for energy, food and a range of other goods and has fueled negative consumer sentiment. The prolonged nature of the conflict and its potential to spread remain key concerns among policymakers, diplomats, military planners, economists and investors. It is worth noting that Europe’s largest industrialized nations in concert with the European Union have moved swiftly to secure alternatives to Russian sources of natural gas and petroleum, which has eased an energy crisis that began last year.
Investors may face continued economic and geopolitical challenges in the year ahead. However, some of the acute risks encountered in 2022 appear to have receded and last year’s reset in asset prices may provide attractive investment opportunities. A long-term view and a properly diversified portfolio, in our opinion, remain key elements to a successful investment approach.
Our broad array of investment solutions seeks to provide investors with ability to build durable portfolios that can help them meet their financial goals.
Sincerely,
Brian S. Shlissel
President - J.P. Morgan Funds
J.P. Morgan Asset Management
1-800-480-4111 or www.jpmorganfunds.com for more information
JPMorgan Insurance Trust Small Cap Core Portfolio
PORTFOLIO COMMENTARY
TWELVE MONTHS ENDED December 31, 2022 (Unaudited)
| |
Portfolio (Class 1 Shares)* | |
| |
Net Assets as of 12/31/2022 (In Thousands) | |
INVESTMENT OBJECTIVE**
The JPMorgan Insurance Trust Small Cap Core Portfolio (the “Portfolio”) seeks capital growth over the long term.
HOW DID THE MARKET PERFORM?
Overall, financial markets tumbled in the first three quarters of 2022, but rebounded moderately in the final months of the year. Equity markets turned in their worst first-half performance since 1970, amid accelerating inflation, pandemic lockdowns across China and Russia’s invasion of Ukraine.
The S&P 500 Index, which gauges the performance of U.S. large-cap equities, reached a new closing high on January 3, 2022, bolstered by record high corporate earnings, sales, cash flows, share repurchases and dividends. However, investor sentiment began to sour as accelerating inflation started to erode consumer confidence and raise expectations for an increase in benchmark interest rates by the U.S. Federal Reserve (the “Fed”).
Russia’s invasion of Ukraine at the end of February 2022 initiated a sell-off in global financial markets that was further fueled by the highest U.S. inflation rate in more than 40 years. Equity prices recovered somewhat in March 2022 amid better-than-expected corporate earnings. However, the general trend in global financial markets was downward throughout the year.
In response to accelerating inflationary pressure, the Fed raised its benchmark interest rate mid-March, the first increase since December 2018. The central bank followed with six more rate increases over the course of 2022. The Bank of England, which began raising interest rates in late 2021, also continued to raise interest rates throughout the year, while the European Central Bank waited until June before sharply raising interest rates for the first time in 11 years.
In the U.S., equity prices experienced a sharp sell-off in August and September 2022 that coincided with U.S. Federal Reserve policy guidance on further interest rate increases. However, corporate earnings for both the second and third quarters of 2022 generally were better than expected given a cooling economy and slower consumer spending. Meanwhile, the U.S. unemployment rate remained historically low - hovering between 3.5% and 3.7% for the six-month period - and by the end of 2022 data indicated some inflationary pressures had eased.
Across Europe, the energy crisis that followed Russia’s invasion of Ukraine in late February 2022 eased somewhat in the second half of the year as both the U.K. and the EU obtained alternatives to Russian energy imports and global energy prices receded. A political crisis in the U.K. roiled financial markets in London but the ascension of Rishi Sunak to prime minister appeared to remove some investor uncertainty.
Emerging markets broadly declined during the period but there was wide variance among individual nations. Chinese equities continued to underperform amid investor concerns about the economic impact of the country’s strict anti-pandemic policies, as well as weakness within China’s real estate sector and changes in the global trade for information. While energy prices retreated from historically high levels in the second half of 2022, overall commodities prices remained elevated, which benefitted markets in exporting nations but hurt markets in net importing nations.
For the twelve-month period, leading equity and bond market indexes were mostly negative, with non-U.S. developed markets equities outperforming both U.S. and emerging markets generally equities.
WHAT WERE THE MAIN DRIVERS OF THE PORTFOLIO’S PERFORMANCE?
The Portfolio’s Class 1 Shares outperformed the Russell 2000 Index (the “Benchmark”) for the twelve months ended December 31, 2022.
The Portfolio’s security selection in the consumer discretionary and industrials sectors was a leading contributor to performance relative to the Benchmark, while the Portfolio’s security selection in the financials and utilities sectors was a leading detractor from relative performance.
Leading individual contributors to relative performance included the Portfolio’s overweight positions in Super Micro Computer Inc. and Axsome Therapeutics Inc., and its out-of-Benchmark position in Deckers Outdoor Corp. Shares of Super Micro Computer, a maker of computer servers and data storage equipment, rose after the company reported consecutive quarters of better-than-expected earnings and revenue during the period. Shares of Axsome Therapeutics, a pharmaceuticals developer, rose after the company reported better-than-expected earnings for the third quarter of 2022 and its drug candidate for the treatment of Alzheimer’s disease met
its target in late-stage clinical trials. Shares of Deckers Outdoor, a footwear and apparel maker, rose after the company reported better-than-expected earnings and revenue for the third quarter of 2022.
Leading individual detractors from relative performance included the Portfolio’s overweight positions in Fate Therapeutics Inc. and Herbalife Nutrition Ltd., and its out-of-Benchmark position in Builders FirstSource Inc. Shares of Fate Therapeutics, a developer of immune-therapies, fell after the company reported disappointing pre-clinical data on its proposed treatment for leukemia. Shares of Herbalife, a nutritional supplements manufacturer, fell late in the period after the company unveiled plans to offer $250 million of convertible notes. Shares of Builders FirstSource, a construction materials manufacturer, fell early in the period amid investor concerns that rising interest rates and slower economic growth would hurt the homebuilding sector.
HOW WAS THE PORTFOLIO POSITIONED?
In accordance with the Portfolio’s investment process, the portfolio managers take limited sector bets and construct the Portfolio so that stock selection is typically the primary driver of its relative performance versus the Benchmark. The portfolio managers employ a bottom-up approach to stock selection, using quantitative screening and the adviser’s proprietary analysis to construct a portfolio of companies that the portfolio managers believe are attractively valued and possess strong momentum. During the reporting period, the Portfolio was managed and positioned in accordance with this investment process.
TOP TEN HOLDINGS OF THE
PORTFOLIO AS OF December 31, 2022 | PERCENT OF
TOTAL
INVESTMENTS |
| Inspire Medical Systems, Inc. | |
| Silicon Laboratories, Inc. | |
| | |
| | |
| | |
| | |
| | |
| | |
| Axsome Therapeutics, Inc. | |
| OceanFirst Financial Corp. | |
PORTFOLIO COMPOSITION BY SECTOR
AS OF December 31, 2022 | PERCENT OF
TOTAL
INVESTMENTS |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
*
The return shown is based on net asset values calculated for shareholder transactions and may differ from the return shown in the financial highlights, which reflects adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
**
The adviser seeks to achieve the Portfolio’s objective. There can be no guarantee it will be achieved.
JPMorgan Insurance Trust Small Cap Core Portfolio
PORTFOLIO COMMENTARY
TWELVE MONTHS ENDED December 31, 2022 (Unaudited) (continued)
AVERAGE ANNUAL TOTAL RETURNS AS OF December 31, 2022
TEN YEAR PORTFOLIO PERFORMANCE (12/31/12 TO 12/31/22)
The performance quoted is past performance and is not a guarantee of future results. Mutual funds are subject to certain market risks. Investment returns and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance data shown. For up-to-date month-end performance information please call 1-800-480-4111.
The graph illustrates comparative performance for $10,000 invested in Class 1 Shares of the JPMorgan Insurance Trust Small Cap Core Portfolio and the Russell 2000 Index from December 31, 2012 to December 31, 2022. The performance of the Portfolio assumes reinvestment of all dividends and capital gain distributions, if any. The performance of the Russell 2000 Index does not reflect the deduction of expenses associated with a mutual fund and has been adjusted to reflect reinvestment of all dividends and capital gain distributions of the securities included in the benchmark, if applicable.
The Russell 2000 Index is an unmanaged index which measures the performance of the 2000 smallest stocks (on the basis of capitalization) in the Russell 3000 Index. Investors cannot invest directly in an index.
Portfolio performance does not reflect any charges imposed by the Policies or Eligible Plans. If these charges were included, the returns would be lower than shown. Portfolio performance may reflect the waiver of the Portfolio’s fees and reimbursement of expenses for certain periods. Without these waivers and reimbursements, performance would have been lower.
The returns shown are based on net asset values calculated for shareholder transactions and may differ from the returns shown in the financial highlights, which reflect adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
JPMorgan Insurance Trust Small Cap Core Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022
| | |
|
Aerospace & Defense — 0.4% |
| | |
| | |
| | |
Air Freight & Logistics — 1.0% |
Atlas Air Worldwide Holdings, Inc.* | | |
| | |
Hub Group, Inc., Class A* | | |
| | |
| | |
|
| | |
|
American Axle & Manufacturing Holdings, Inc.* | | |
Goodyear Tire & Rubber Co. (The)* | | |
| | |
| | |
|
| | |
Atlantic Union Bankshares Corp. | | |
| | |
| | |
Bank of NT Butterfield & Son Ltd. (The) (Bermuda) | | |
Business First Bancshares, Inc. | | |
| | |
| | |
| | |
Capital City Bank Group, Inc. | | |
Capstar Financial Holdings, Inc. | | |
| | |
Central Pacific Financial Corp. | | |
| | |
Columbia Banking System, Inc. | | |
| | |
| | |
| | |
Dime Community Bancshares, Inc. | | |
| | |
Enterprise Financial Services Corp. | | |
| | |
Financial Institutions, Inc. | | |
| | |
First BanCorp (Puerto Rico) | | |
| | |
|
|
First Bancshares, Inc. (The) | | |
| | |
First Citizens BancShares, Inc., Class A | | |
First Commonwealth Financial Corp. | | |
| | |
| | |
| | |
First Interstate BancSystem, Inc., Class A | | |
| | |
First Western Financial, Inc.* | | |
| | |
| | |
| | |
| | |
| | |
| | |
HomeTrust Bancshares, Inc. | | |
| | |
Metropolitan Bank Holding Corp.* | | |
| | |
| | |
National Bank Holdings Corp., Class A | | |
OceanFirst Financial Corp. | | |
OFG Bancorp (Puerto Rico) | | |
| | |
| | |
| | |
Peapack-Gladstone Financial Corp. | | |
| | |
Pinnacle Financial Partners, Inc. | | |
Popular, Inc. (Puerto Rico) | | |
| | |
Republic Bancorp, Inc., Class A | | |
| | |
| | |
| | |
South Plains Financial, Inc. | | |
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Small Cap Core Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Common Stocks — continued |
|
| | |
| | |
| | |
|
Coca-Cola Consolidated, Inc. | | |
| | |
| | |
|
| | |
| | |
Allogene Therapeutics, Inc.* (a) | | |
Amicus Therapeutics, Inc.* | | |
| | |
Apellis Pharmaceuticals, Inc.* | | |
Arrowhead Pharmaceuticals, Inc.* | | |
Atara Biotherapeutics, Inc.* | | |
| | |
| | |
| | |
Blueprint Medicines Corp.* | | |
| | |
| | |
Catalyst Pharmaceuticals, Inc.* | | |
Chinook Therapeutics, Inc.* | | |
Coherus Biosciences, Inc.* | | |
| | |
Decibel Therapeutics, Inc.* (a) | | |
Enanta Pharmaceuticals, Inc.* | | |
| | |
Intellia Therapeutics, Inc.* | | |
| | |
Jounce Therapeutics, Inc.* | | |
| | |
| | |
Kymera Therapeutics, Inc.* | | |
| | |
| | |
PMV Pharmaceuticals, Inc.* | | |
Prothena Corp. plc (Ireland)* | | |
| | |
Relay Therapeutics, Inc.* | | |
REVOLUTION Medicines, Inc.* | | |
| | |
| | |
|
Biotechnology — continued |
Sarepta Therapeutics, Inc.* | | |
SpringWorks Therapeutics, Inc.* | | |
| | |
Syndax Pharmaceuticals, Inc.* | | |
Travere Therapeutics, Inc.* | | |
| | |
| | |
| | |
Y-mAbs Therapeutics, Inc.* | | |
| | |
|
| | |
Builders FirstSource, Inc.* | | |
Resideo Technologies, Inc.* | | |
| | |
| | |
|
AssetMark Financial Holdings, Inc.* | | |
| | |
| | |
Donnelley Financial Solutions, Inc.* | | |
Focus Financial Partners, Inc., Class A* | | |
| | |
| | |
PJT Partners, Inc., Class A | | |
| | |
| | |
Victory Capital Holdings, Inc., Class A | | |
Virtus Investment Partners, Inc. | | |
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Minerals Technologies, Inc. | | |
Orion Engineered Carbons SA (Germany) | | |
Tronox Holdings plc, Class A | | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Common Stocks — continued |
Commercial Services & Supplies — 1.8% |
| | |
| | |
| | |
Heritage-Crystal Clean, Inc.* | | |
| | |
| | |
| | |
Communications Equipment — 1.7% |
| | |
| | |
CommScope Holding Co., Inc.* | | |
| | |
Construction & Engineering — 1.8% |
| | |
Comfort Systems USA, Inc. | | |
Great Lakes Dredge & Dock Corp.* | | |
| | |
| | |
Sterling Infrastructure, Inc.* | | |
| | |
Construction Materials — 0.2% |
Summit Materials, Inc., Class A* | | |
|
Bread Financial Holdings, Inc. | | |
Encore Capital Group, Inc.* | | |
Enova International, Inc.* | | |
Green Dot Corp., Class A* | | |
| | |
| | |
Containers & Packaging — 0.2% |
| | |
| | |
| | |
Diversified Consumer Services — 0.9% |
| | |
| | |
| | |
| | |
Diversified Financial Services — 0.1% |
Jackson Financial, Inc., Class A | | |
| | |
|
Diversified Telecommunication Services — 1.1% |
Bandwidth, Inc., Class A* | | |
| | |
| | |
Liberty Latin America Ltd., Class A (Puerto Rico)* | | |
Liberty Latin America Ltd., Class C (Puerto Rico)* | | |
| | |
| | |
Electric Utilities — 0.8% |
| | |
Portland General Electric Co. | | |
| | |
| | |
Electrical Equipment — 1.9% |
| | |
| | |
Bloom Energy Corp., Class A* | | |
| | |
| | |
| | |
Electronic Equipment, Instruments & Components — 1.8% |
| | |
Benchmark Electronics, Inc. | | |
| | |
| | |
| | |
| | |
| | |
Energy Equipment & Services — 1.7% |
| | |
Liberty Energy, Inc., Class A | | |
NexTier Oilfield Solutions, Inc.* | | |
Patterson-UTI Energy, Inc. | | |
Select Energy Services, Inc., Class A | | |
Solaris Oilfield Infrastructure, Inc., Class A | | |
Weatherford International plc* | | |
| | |
|
| | |
Lions Gate Entertainment Corp., Class A* | | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Small Cap Core Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Common Stocks — continued |
Equity Real Estate Investment Trusts (REITs) — 5.0% |
| | |
| | |
Apple Hospitality REIT, Inc. | | |
Armada Hoffler Properties, Inc. | | |
| | |
Community Healthcare Trust, Inc. | | |
Corporate Office Properties Trust | | |
| | |
DiamondRock Hospitality Co. | | |
| | |
Essential Properties Realty Trust, Inc. | | |
First Industrial Realty Trust, Inc. | | |
| | |
Gladstone Commercial Corp. | | |
Global Medical REIT, Inc. | | |
Healthcare Realty Trust, Inc. | | |
Independence Realty Trust, Inc. | | |
Innovative Industrial Properties, Inc.(a) | | |
| | |
| | |
National Storage Affiliates Trust | | |
| | |
Phillips Edison & Co., Inc. | | |
| | |
Piedmont Office Realty Trust, Inc., Class A | | |
Plymouth Industrial REIT, Inc. | | |
| | |
Retail Opportunity Investments Corp. | | |
| | |
Ryman Hospitality Properties, Inc. | | |
Sabra Health Care REIT, Inc. | | |
| | |
| | |
| | |
| | |
| | |
Xenia Hotels & Resorts, Inc. | | |
| | |
Food & Staples Retailing — 1.4% |
| | |
BJ's Wholesale Club Holdings, Inc.* | | |
| | |
|
Food & Staples Retailing — continued |
| | |
Sprouts Farmers Market, Inc.* | | |
| | |
|
Darling Ingredients, Inc.* | | |
|
Chesapeake Utilities Corp. | | |
New Jersey Resources Corp. | | |
Northwest Natural Holding Co. | | |
| | |
Southwest Gas Holdings, Inc. | | |
| | |
| | |
Health Care Equipment & Supplies — 4.1% |
| | |
| | |
| | |
| | |
| | |
| | |
Inspire Medical Systems, Inc.* | | |
iRhythm Technologies, Inc.* | | |
| | |
| | |
| | |
| | |
| | |
| | |
Health Care Providers & Services — 2.4% |
| | |
| | |
| | |
| | |
| | |
National HealthCare Corp. | | |
Option Care Health, Inc.* | | |
| | |
| | |
Health Care Technology — 1.0% |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Common Stocks — continued |
Health Care Technology — continued |
| | |
| | |
| | |
Hotels, Restaurants & Leisure — 2.4% |
| | |
Bluegreen Vacations Holding Corp. | | |
| | |
Brinker International, Inc.* | | |
| | |
| | |
Hilton Grand Vacations, Inc.* | | |
Marriott Vacations Worldwide Corp. | | |
RCI Hospitality Holdings, Inc. | | |
SeaWorld Entertainment, Inc.* | | |
| | |
Household Durables — 2.4% |
| | |
| | |
| | |
| | |
Taylor Morrison Home Corp.* | | |
| | |
| | |
| | |
Household Products — 0.5% |
Central Garden & Pet Co., Class A* | | |
Independent Power and Renewable Electricity Producers — 0.8% |
| | |
Clearway Energy, Inc., Class C | | |
| | |
| | |
|
American Equity Investment Life Holding Co. | | |
BRP Group, Inc., Class A* | | |
| | |
James River Group Holdings Ltd. | | |
Kinsale Capital Group, Inc. | | |
| | |
Stewart Information Services Corp. | | |
| | |
| | |
|
Interactive Media & Services — 0.5% |
| | |
| | |
| | |
| | |
Internet & Direct Marketing Retail — 0.0% ^ |
| | |
|
DigitalOcean Holdings, Inc.* | | |
EVERTEC, Inc. (Puerto Rico) | | |
Information Services Group, Inc. | | |
International Money Express, Inc.* | | |
| | |
| | |
| | |
| | |
| | |
Life Sciences Tools & Services — 0.2% |
Adaptive Biotechnologies Corp.* | | |
| | |
| | |
| | |
|
Albany International Corp., Class A | | |
Greenbrier Cos., Inc. (The) | | |
Luxfer Holdings plc (United Kingdom) | | |
| | |
| | |
| | |
Watts Water Technologies, Inc., Class A | | |
| | |
|
| | |
|
| | |
| | |
| | |
|
Alpha Metallurgical Resources, Inc. | | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Small Cap Core Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Common Stocks — continued |
Metals & Mining — continued |
| | |
| | |
| | |
Schnitzer Steel Industries, Inc., Class A | | |
| | |
Mortgage Real Estate Investment Trusts (REITs) — 1.4% |
| | |
Ares Commercial Real Estate Corp.(a) | | |
Blackstone Mortgage Trust, Inc., Class A(a) | | |
| | |
Ellington Financial, Inc. | | |
Hannon Armstrong Sustainable Infrastructure Capital, Inc. | | |
KKR Real Estate Finance Trust, Inc. | | |
| | |
| | |
TPG RE Finance Trust, Inc. | | |
| | |
|
Dillard's, Inc., Class A(a) | | |
|
| | |
| | |
| | |
Oil, Gas & Consumable Fuels — 4.1% |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Magnolia Oil & Gas Corp., Class A | | |
| | |
| | |
| | |
PBF Energy, Inc., Class A | | |
| | |
| | |
REX American Resources Corp.* | | |
| | |
|
Oil, Gas & Consumable Fuels — continued |
| | |
| | |
| | |
Paper & Forest Products — 0.1% |
| | |
|
Edgewell Personal Care Co. | | |
| | |
Herbalife Nutrition Ltd.* (a) | | |
| | |
Nu Skin Enterprises, Inc., Class A | | |
| | |
|
Aclaris Therapeutics, Inc.* | | |
| | |
Axsome Therapeutics, Inc.* (a) | | |
| | |
NGM Biopharmaceuticals, Inc.* | | |
Phibro Animal Health Corp., Class A | | |
Revance Therapeutics, Inc.* | | |
| | |
Professional Services — 2.8% |
Barrett Business Services, Inc. | | |
Heidrick & Struggles International, Inc. | | |
| | |
Kelly Services, Inc., Class A | | |
| | |
| | |
| | |
| | |
Real Estate Management & Development — 0.2% |
Anywhere Real Estate, Inc.* | | |
| | |
Kennedy-Wilson Holdings, Inc. | | |
RMR Group, Inc. (The), Class A | | |
| | |
|
| | |
Semiconductors & Semiconductor Equipment — 2.9% |
Alpha & Omega Semiconductor Ltd.* | | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Common Stocks — continued |
Semiconductors & Semiconductor Equipment — continued |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Silicon Laboratories, Inc.* | | |
SMART Global Holdings, Inc.* | | |
| | |
Ultra Clean Holdings, Inc.* | | |
| | |
|
| | |
Asana, Inc., Class A* (a) | | |
| | |
| | |
| | |
| | |
Consensus Cloud Solutions, Inc.* | | |
| | |
| | |
| | |
| | |
| | |
Marathon Digital Holdings, Inc.* (a) | | |
MicroStrategy, Inc., Class A* (a) | | |
| | |
| | |
| | |
Riot Blockchain, Inc.* (a) | | |
Sprout Social, Inc., Class A* | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
| | |
| | |
|
Specialty Retail — continued |
Academy Sports & Outdoors, Inc. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Technology Hardware, Storage & Peripherals — 0.2% |
| | |
Textiles, Apparel & Luxury Goods — 1.7% |
| | |
| | |
G-III Apparel Group Ltd.* | | |
| | |
| | |
Thrifts & Mortgage Finance — 1.4% |
| | |
| | |
| | |
| | |
| | |
| | |
NMI Holdings, Inc., Class A* | | |
PennyMac Financial Services, Inc. | | |
| | |
| | |
Waterstone Financial, Inc. | | |
| | |
Trading Companies & Distributors — 3.8% |
Beacon Roofing Supply, Inc.* | | |
| | |
| | |
| | |
| | |
| | |
| | |
Rush Enterprises, Inc., Class A | | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Small Cap Core Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Common Stocks — continued |
Trading Companies & Distributors — continued |
| | |
WESCO International, Inc.* | | |
| | |
Wireless Telecommunication Services — 0.1% |
| | |
Total Common Stocks
(Cost $149,643) | | |
| | |
|
|
Contra Aduro Biotech I‡ * | | |
Textiles, Apparel & Luxury Goods — 0.0% ^ |
PLBY Group, Inc., expiring 1/17/2023* | | |
| | |
| | |
Short-Term Investments — 5.7% |
Investment Companies — 2.8% |
JPMorgan U.S. Government Money Market Fund Class Institutional Shares, 4.07%(b) (c)
(Cost $4,779) | | |
Investment of Cash Collateral from Securities Loaned — 2.9% |
JPMorgan Securities Lending Money Market Fund Agency SL Class Shares, 4.56%(b) (c) | | |
| | |
|
Investment of Cash Collateral from Securities Loaned — continued |
JPMorgan U.S. Government Money Market Fund Class IM Shares, 4.12%(b) (c) | | |
Total Investment of Cash Collateral from Securities Loaned
(Cost $4,793) | | |
Total Short-Term Investments
(Cost $9,572) | | |
Total Investments — 102.8%
(Cost $159,268) | | |
Liabilities in Excess of Other Assets — (2.8)% | | |
| | |
Percentages indicated are based on net assets. |
Amounts presented as a dash ("-") represent amounts that round to less than a thousand. |
| Amount rounds to less than 0.1% of net assets. |
| Value determined using significant unobservable inputs. | |
| Non-income producing security. | |
| The security or a portion of this security is on loan at December 31, 2022. The total value of securities on loan at December 31, 2022 is $4,681. | |
| Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. | |
| The rate shown is the current yield as of December 31, 2022. | |
Futures contracts outstanding as of December 31, 2022 (amounts in thousands, except number of contracts):
| | | | | VALUE AND
UNREALIZED
APPRECIATION
(DEPRECIATION) ($) |
| | | | | |
Russell 2000 E-Mini Index | | | | | |
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF ASSETS AND LIABILITIES
AS OF December 31, 2022
(Amounts in thousands, except per share amounts)
| JPMorgan
Insurance Trust
Small Cap Core
|
| |
Investments in non-affiliates, at value | |
Investments in affiliates, at value | |
Investments of cash collateral received from securities loaned, at value (See Note 2.B.) | |
| |
Deposits at broker for futures contracts | |
| |
Investment securities sold | |
| |
Dividends from non-affiliates | |
Dividends from affiliates | |
Securities lending income (See Note 2.B.) | |
| |
| |
| |
Investment securities purchased | |
Collateral received on securities loaned (See Note 2.B.) | |
Portfolio shares redeemed | |
Variation margin on futures contracts | |
| |
| |
| |
| |
Custodian and accounting fees | |
Trustees’ and Chief Compliance Officer’s fees | |
| |
| |
| |
(a)
Amount rounds to less than one thousand.
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF ASSETS AND LIABILITIES
AS OF December 31, 2022 (continued)
(Amounts in thousands, except per share amounts)
| JPMorgan Insurance Trust Small Cap Core |
| |
| |
Total distributable earnings (loss) | |
| |
| |
| |
| |
| |
Outstanding units of beneficial interest (shares)
(unlimited number of shares authorized, no par value): | |
| |
| |
| |
Class 1 — Offering and redemption price per share | |
Class 2 — Offering and redemption price per share | |
Cost of investments in non-affiliates | |
Cost of investments in affiliates | |
Investment securities on loan, at value (See Note 2.B.) | |
Cost of investment of cash collateral (See Note 2.B.) | |
(a)
Per share amounts may not recalculate due to rounding of net assets and/or shares outstanding.
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF OPERATIONS
FOR THE YEAR ENDED December 31, 2022
(Amounts in thousands)
| JPMorgan
Insurance Trust
Small Cap Core
Portfolio |
| |
Interest income from non-affiliates | |
Dividend income from non-affiliates | |
Dividend income from affiliates | |
Income from securities lending (net) (See Note 2.B.) | |
| |
| |
| |
| |
| |
| |
Custodian and accounting fees | |
| |
Trustees’ and Chief Compliance Officer’s fees | |
Printing and mailing costs | |
Transfer agency fees (See Note 2.F.) | |
| |
| |
| |
Less expense reimbursements | |
| |
Net investment income (loss) | |
REALIZED/UNREALIZED GAINS (LOSSES): | |
Net realized gain (loss) on transactions from: | |
Investments in non-affiliates | |
| |
| |
Change in net unrealized appreciation/depreciation on: | |
Investments in non-affiliates | |
Investments in affiliates | |
| |
Change in net unrealized appreciation/depreciation | |
Net realized/unrealized gains (losses) | |
Change in net assets resulting from operations | |
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENTS OF CHANGES IN NET ASSETS
FOR THE PERIODS INDICATED
(Amounts in thousands)
| JPMorgan Insurance Trust Small
Cap Core Portfolio |
| Year Ended
December 31, 2022 | Year Ended
December 31, 2021 |
CHANGE IN NET ASSETS RESULTING FROM OPERATIONS: | | |
Net investment income (loss) | | |
| | |
Change in net unrealized appreciation/depreciation | | |
Change in net assets resulting from operations | | |
DISTRIBUTIONS TO SHAREHOLDERS: | | |
| | |
| | |
Total distributions to shareholders | | |
| | |
Change in net assets resulting from capital transactions | | |
| | |
| | |
| | |
| | |
| | |
| | |
Proceeds from shares issued | | |
| | |
| | |
Change in net assets resulting from Class 1 capital transactions | | |
| | |
Proceeds from shares issued | | |
| | |
| | |
Change in net assets resulting from Class 2 capital transactions | | |
Total change in net assets resulting from capital transactions | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
| Amount rounds to less than one thousand. |
SEE NOTES TO FINANCIAL STATEMENTS.
THIS PAGE IS INTENTIONALLY LEFT BLANK
FINANCIAL HIGHLIGHTS
FOR THE PERIODS INDICATED
| Per share operating performance |
| | | |
| Net asset
value,
beginning
of period | Net
investment
income
(loss)(a) | Net realized
and unrealized
gains
(losses) on
investments | Total from
investment
operations | | | |
JPMorgan Insurance Trust Small Cap Core Portfolio | | | | | | | |
| | | | | | | |
Year Ended December 31, 2022 | | | | | | | |
Year Ended December 31, 2021 | | | | | | | |
Year Ended December 31, 2020 | | | | | | | |
Year Ended December 31, 2019 | | | | | | | |
Year Ended December 31, 2018 | | | | | | | |
| | | | | | | |
Year Ended December 31, 2022 | | | | | | | |
Year Ended December 31, 2021 | | | | | | | |
Year Ended December 31, 2020 | | | | | | | |
Year Ended December 31, 2019 | | | | | | | |
Year Ended December 31, 2018 | | | | | | | |
|
| Calculated based upon average shares outstanding. |
| Includes adjustments in accordance with accounting principles generally accepted in the United States of America and as such, the net asset values for financial reporting purposes and the returns based upon those net asset values may differ from the net asset values and returns for shareholder transactions. |
| Total returns do not include charges that will be imposed by variable insurance contracts or by Eligible Plans. If these charges were reflected, returns would be lower than those shown. |
| Includes earnings credits and interest expense, if applicable, each of which is less than 0.005% unless otherwise noted. |
SEE NOTES TO FINANCIAL STATEMENTS.
| |
| | | Ratios to average net assets |
Net asset
value,
end of
period | | Net assets,
end of
period
(000's) | | Net
investment
income
(loss) | Expenses without
waivers and reimbursements | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
SEE NOTES TO FINANCIAL STATEMENTS.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022
(Dollar values in thousands)
1. Organization
JPMorgan Insurance Trust (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company and is a Massachusetts business trust.
The following is a separate portfolio of the Trust (the ��Portfolio”) covered by this report:
| | Diversification Classification |
JPMorgan Insurance Trust Small Cap Core Portfolio | | |
The investment objective of the Portfolio is to seek capital growth over the long term.
Portfolio shares are offered only to separate accounts of participating insurance companies and Eligible Plans. Individuals may not purchase shares directly from the Portfolio.
All classes of shares have equal rights as to earnings, assets and voting privileges, except that each class may bear different transfer agency fees and distribution fees and each class has exclusive voting rights with respect to its distribution plan and administrative services plan.
J.P. Morgan Investment Management Inc. (“JPMIM”), an indirect, wholly-owned subsidiary of JPMorgan Chase & Co. (“JPMorgan”), acts as Adviser (the “Adviser”) and Administrator (the “Administrator”) to the Portfolio.
2. Significant Accounting Policies
The following is a summary of significant accounting policies followed by the Portfolio in the preparation of its financial statements. The Portfolio is an investment company and, accordingly, follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 946 — Investment Companies, which is part of U.S. generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) disclosure of contingent assets and liabilities at the date of the financial statements, and (iii) the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.
A. Valuation of Investments — Investments are valued in accordance with GAAP and the Portfolio's valuation policies set forth by, and under the supervision and responsibility of, the Board of Trustees of the Trust (the "Board"), which established the following approach to valuation, as described more fully below: (i) investments for which market quotations are readily available shall be valued at their market value and (ii) all other investments for which market quotations are not readily available shall be valued at their fair value as determined in good faith by the Board.
Under Section 2(a)(41) of the 1940 Act, the Board is required to determine fair value for securities that do not have readily available market quotations. Under SEC Rule 2a-5 (Good Faith Determinations of Fair Value), the Board may designate the performance of these fair valuation determinations to a valuation designee. The Board has designated the Adviser as the “Valuation Designee” to perform fair valuation determinations for the Portfolio on behalf of the Board subject to appropriate oversight by the Board. The Adviser, as Valuation Designee, leverages the J.P. Morgan Asset Management Americas Valuation Committee (“AVC”) to help oversee and carry out the policies for the valuation of Investments held in the Portfolio. The Adviser, as Valuation Designee, remains responsible for the valuation determinations.
This oversight by the AVC includes monitoring the appropriateness of fair values based on results of ongoing valuation oversight including, but not limited to, consideration of macro or security specific events, market events, and pricing vendor and broker due diligence. The Administrator is responsible for discussing and assessing the potential impacts to the fair values on an ongoing basis, and, at least on a quarterly basis, with the AVC and the Board.
A market-based approach is primarily used to value the Portfolio's investments. Investments for which market quotations are not readily available are fair valued using prices supplied by approved affiliated and/or unaffiliated pricing vendors or third party broker-dealers (collectively referred to as “Pricing Services”) or may be internally fair valued using methods set forth by the valuation policies approved by the Board. This may include the use of related or comparable assets or liabilities, recent transactions, market multiples, book values and other relevant information for the investment. An income-based valuation approach may be used in which the anticipated future cash flows of the investment are discounted to calculate the fair value. Discounts may also be applied due to the nature or duration of any restrictions on the disposition of the investments. Valuations may be based upon current market prices of securities that are comparable in coupon, rating, maturity and industry. It is possible that the estimated values may differ significantly from the values that would have been used had a ready market for the investments existed, and such differences could be material.
Equities and other exchange-traded instruments are valued at the last sale price or official market closing price on the primary exchange on which the instrument is traded before the net asset values ("NAV") of the Portfolio are calculated on a valuation date.
Investments in open-end investment companies (“Underlying Funds”) are valued at each Underlying Fund’s NAV per share as of the report date.
Futures contracts are generally valued on the basis of available market quotations.
Valuations reflected in this report are as of the report date. As a result, changes in valuation due to market events and/or issuer-related events after the report date and prior to issuance of the report are not reflected herein.
The various inputs that are used in determining the valuation of the Portfolio's investments are summarized into the three broad levels listed below.
•
Level 1 — Unadjusted inputs using quoted prices in active markets for identical investments.
•
Level 2 — Other significant observable inputs including, but not limited to, quoted prices for similar investments, inputs other than quoted prices that are observable for investments (such as interest rates, prepayment speeds, credit risk, etc.) or other market corroborated inputs.
•
Level 3 — Significant inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Portfolio's assumptions in determining the fair value of investments).
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input, both individually and in the aggregate, that is significant to the fair value measurement. The inputs or methodology used for valuing instruments are not necessarily an indication of the risk associated with investing in those instruments.
The following table represents each valuation input as presented on the Schedule of Portfolio Investments ("SOI"):
| | | | |
| | Level 2
Other significant
observable inputs | Level 3
Significant
unobservable inputs | |
Investments in Securities | | | | |
| | | | |
| | | | |
| | | | |
Textiles, Apparel & Luxury Goods | | | | |
| | | | |
| | | | |
| | | | |
Investment of Cash Collateral from Securities Loaned | | | | |
Total Short-Term Investments | | | | |
Total Investments in Securities | | | | |
Depreciation in Other Financial Instruments | | | | |
| | | | |
|
| Amount rounds to less than one thousand. |
B. Securities Lending — The Portfolio is authorized to engage in securities lending in order to generate additional income. The Portfolio is able to lend to approved borrowers. Citibank N.A. (“Citibank”) serves as lending agent for the Portfolio, pursuant to a Securities Lending Agency Agreement (the “Securities Lending Agency Agreement”). Securities loaned are collateralized by cash equal to at least 100% of the market value plus accrued interest on the securities lent, which is invested in the Class IM Shares of the JPMorgan U.S. Government Money Market Fund and the Agency SL Class Shares of the JPMorgan Security Lending Money Market Fund . The Portfolio retains the interest earned on cash collateral investments but is required to pay the borrower a rebate for the use of the cash collateral. In cases where the lent security is of high value to borrowers, there may be a negative rebate (i.e., a net payment from the borrower to the Portfolio). Upon termination of a loan, the Portfolio is required to return to the borrower an amount equal to the cash collateral, plus any rebate owed to the borrowers. The remaining maturities of the securities lending transactions are considered overnight and continuous. Loans are subject to termination by the Portfolio or the borrower at any time.
The net income earned on the securities lending (after payment of rebates and Citibank’s fee) is included on the Statement of Operations as Income from securities lending (net). The Portfolio also receives payments from the borrower during the period of the loan, equivalent to dividends and interest earned on the securities loaned, which are recorded as Dividend or Interest income, respectively, on the Statement of Operations.
Under the Securities Lending Agency Agreement, Citibank marks to market the loaned securities on a daily basis. In the event the cash received from the borrower is less than 102% of the value of the loaned securities (105% for loans of non-U.S. securities), Citibank requests additional cash from the borrower so as to maintain a collateralization level of at least 102% of the value of the loaned securities plus accrued interest (105% for loans of non-U.S. securities), subject to certain de minimis amounts.
The value of securities out on loan is recorded as an asset on the Statement of Assets and Liabilities. The value of the cash collateral received is recorded as a liability on the Statement of Assets and Liabilities and details of collateral investments are disclosed on the SOI.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
The Portfolio bears the risk of loss associated with the collateral investments and is not entitled to additional collateral from the borrower to cover any such losses. To the extent that the value of the collateral investments declines below the amount owed to a borrower, the Portfolio may incur losses that exceed the amount it earned on lending the security. Upon termination of a loan, the Portfolio may use leverage (borrow money) to repay the borrower for cash collateral posted if the Adviser does not believe that it is prudent to sell the collateral investments to fund the payment of this liability. Securities lending activity is subject to master netting arrangements.
The following table presents the Portfolio's value of the securities on loan with Citibank, net of amounts available for offset under the master netting arrangements and any related collateral received or posted by the Portfolio as of December 31, 2022.
| Investment Securities
on Loan, at value,
Presented on the
Statement of Assets
and Liabilities | Cash Collateral
Posted by Borrower* | Net Amount Due
to Counterparty
(not less than zero) |
| | | |
|
| Collateral posted reflects the value of securities on loan and does not include any additional amounts received from the borrower. |
Securities lending also involves counterparty risks, including the risk that the loaned securities may not be returned in a timely manner or at all. Subject to certain conditions, Citibank has agreed to indemnify the Portfolio from losses resulting from a borrower’s failure to return a loaned security.
JPMIM voluntarily waived investment advisory fees charged to the Portfolio to reduce the impact of the cash collateral investment in the JPMorgan U.S. Government Money Market Fund from 0.13% to 0.06%. For the year ended December 31, 2022, JPMIM waived fees associated with the Portfolio's investment in the JPMorgan U.S. Government Money Market Fund as follows:
The above waiver is included in the determination of earnings on cash collateral investment and in the calculation of Citibank’s compensation and is included on the Statement of Operations as Income from securities lending (net).
C. Investment Transactions with Affiliates — The Portfolio invested in Underlying Funds which are advised by the Adviser. An issuer which is under common control with the Portfolio may be considered an affiliate. For the purposes of the financial statements, the Portfolio assumes the issuers listed in the table below to be affiliated issuers. The Underlying Funds’ distributions may be reinvested into such Underlying Funds. Reinvestment amounts are included in the purchases at cost amounts in the table below.
|
For the year ended December 31, 2022 |
| | | | | Change in
Unrealized
Appreciation/
(Depreciation) | | Shares at
December 31,
2022 | | Capital Gain
Distributions |
JPMorgan Securities Lending Money Market Fund Agency SL Class Shares, 4.56% (a) (b) | | | | | | | | | |
JPMorgan U.S. Government Money Market Fund Class IM Shares, 4.12% (a) (b) | | | | | | | | | |
JPMorgan U.S. Government Money Market Fund Class Institutional Shares, 4.07% (a) (b) | | | | | | | | | |
| | | | | | | | | |
|
| Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. |
| The rate shown is the current yield as of December 31, 2022. |
| Amount is included on the Statement of Operations as Income from securities lending (net) (after payments of rebates and Citibank’s fee). |
D. Futures Contracts — The Portfolio used index futures contracts to gain or reduce exposure to the stock market, or maintain liquidity or minimize transaction costs. The Portfolio also purchased futures contracts to invest incoming cash in the market or sold futures in response to cash outflows, thereby simulating an invested position in the underlying index while maintaining a cash balance for liquidity.
Futures contracts provide for the delayed delivery of the underlying instrument at a fixed price or are settled for a cash amount based on the change in the value of the underlying instrument at a specific date in the future. Upon entering into a futures contract, the Portfolio is required to deposit with the broker, cash or securities in an amount equal to a certain percentage of the contract amount, which is referred to as the initial margin deposit. Subsequent payments, referred to as variation margin, are made or received by the Portfolio periodically and are based on changes in the market value of open futures contracts. Changes in the market value of open futures contracts are recorded as Change in net unrealized appreciation/depreciation on futures contracts on the Statement of Operations. Realized gains or losses, representing the difference between the value of the contract at the time it was opened and the value at the time it was closed, are reported on the Statement of Operations at the closing or expiration of the futures contract. Securities deposited as initial margin are designated on the SOI, while cash deposited, which is considered restricted, is recorded on the Statement of Assets and Liabilities. A receivable from and/or a payable to brokers for the daily variation margin is also recorded on the Statement of Assets and Liabilities.
The use of futures contracts exposes the Portfolio to equity risk. The Portfolio may be subject to the risk that the change in the value of the futures contract may not correlate perfectly with the underlying instrument. Use of long futures contracts subjects the Portfolio to risk of loss in excess of the amounts shown on the Statement of Assets and Liabilities, up to the notional amount of the futures contracts. Use of short futures contracts subjects the Portfolio to unlimited risk of loss. The Portfolio may enter into futures contracts only on exchanges or boards of trade. The exchange or board of trade acts as the counterparty to each futures transaction; therefore, the Portfolio's credit risk is limited to failure of the exchange or board of trade. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, which could effectively prevent liquidation of positions.
The Portfolio's futures contracts are not subject to master netting arrangements (the right to close out all transactions traded with a counterparty and net amounts owed or due across transactions).
The table below discloses the volume of the Portfolio's futures contracts activity during the year ended December 31, 2022:
| |
| |
Average Notional Balance Long | |
Ending Notional Balance Long | |
E. Security Transactions and Investment Income — Investment transactions are accounted for on the trade date (the date the order to buy or sell is executed). Securities gains and losses are calculated on a specifically identified cost basis.
Dividend income is recorded on the ex-dividend date or when the Portfolio first learns of the dividend.
To the extent such information is publicly available, the Portfolio records distributions received in excess of income earned from underlying investments as a reduction of cost of investments and/or realized gain. Such amounts are based on estimates if actual amounts are not available and actual amounts of income, realized gain and return of capital may differ from the estimated amounts. The Portfolio adjusts the estimated amounts of the components of distributions (and consequently its net investment income) as necessary, once the issuers provide information about the actual composition of the distributions.
F. Allocation of Income and Expenses— Expenses directly attributable to the Portfolio are charged directly to the Portfolio, while the expenses attributable to more than one portfolio of the Trust are allocated among the applicable portfolios. Investment income, realized and unrealized gains and losses and expenses, other than class-specific expenses, are allocated daily to each class of shares based upon the proportion of net assets of each class at the beginning of each day.
Transfer agency fees are class-specific expenses. The amount of the transfer agency fees charged to each share class of the Portfolio for the year ended December 31, 2022 are as follows:
|
| Amount rounds to less than one thousand. |
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
G. Federal Income Taxes — The Portfolio is treated as a separate taxable entity for Federal income tax purposes. The Portfolio's policy is to comply with the provisions of the Internal Revenue Code (the “Code”) applicable to regulated investment companies and to distribute to shareholders all of its distributable net investment income and net realized capital gains on investments. Accordingly, no provision for Federal income tax is necessary. The Portfolio is also a segregated portfolio of assets for insurance purposes and intends to comply with the diversification requirements of Sub-chapter L of the Code. Management has reviewed the Portfolio's tax positions for all open tax years and has determined that as of December 31, 2022, no liability for Federal income tax is required in the Portfolio's financial statements for net unrecognized tax benefits. However, management’s conclusions may be subject to future review based on changes in, or the interpretation of, the accounting standards or tax laws and regulations. The Portfolio's Federal tax returns for the prior three fiscal years remain subject to examination by the Internal Revenue Service.
H. Distributions to Shareholders — Distributions from net investment income, if any, are generally declared and paid at least annually and are declared separately for each class. No class has preferential dividend rights; differences in per share rates are due to differences in separate class expenses. Net realized capital gains, if any, are distributed at least annually. The amount of distributions from net investment income and net realized capital gains is determined in accordance with Federal income tax regulations, which may differ from GAAP. To the extent these “book/tax” differences are permanent in nature (i.e., that they result from other than timing of recognition — “temporary differences”), such amounts are reclassified within the capital accounts based on their Federal tax basis treatment.
The following amounts were reclassified within the capital accounts:
| | Accumulated
undistributed
(distributions in
excess of)
net investment
income | Accumulated
net realized
gains (losses) |
| | | |
|
| Amount rounds to less than one thousand. |
The reclassifications for the Portfolio relate primarily to tax adjustments on certain investments.
3. Fees and Other Transactions with Affiliates
A. Investment Advisory Fee — Pursuant to an Investment Advisory Agreement, the Adviser manages the investments of the Portfolio and for such services is paid a fee. The investment advisory fee is accrued daily and paid monthly at an annual rate of 0.65% of the Portfolio's average daily net assets.
The Adviser waived investment advisory fees and/or reimbursed expenses as outlined in Note 3.E.
B. Administration Fee — Pursuant to an Administration Agreement, the Administrator provides certain administration services to the Portfolio. In consideration of these services, the Administrator receives a fee accrued daily and paid monthly at an annual rate of 0.075% of the first $10 billion of the Portfolio's average daily net assets, plus 0.050% of the Portfolio's average daily net assets between $10 billion and $20 billion, plus 0.025% of the Portfolio's average daily net assets between $20 billion and $25 billion, plus 0.010% of the Portfolio's average daily net assets in excess of $25 billion. For the year ended December 31, 2022, the effective rate was 0.075% of the Portfolio's average daily net assets, notwithstanding any fee waivers and/or expense reimbursements.
The Administrator waived administration fees as outlined in Note 3.E.
JPMorgan Chase Bank, N.A. ("JPMCB"), a wholly-owned subsidiary of JPMorgan, serves as the Portfolio's sub-administrator (the “Sub-administrator”). For its services as Sub-administrator, JPMCB receives a portion of the fees payable to the Administrator.
C. Distribution Fees — Pursuant to a Distribution Agreement, JPMorgan Distribution Services, Inc. (“JPMDS”), an indirect, wholly-owned subsidiary of JPMorgan, serves as the Portfolio's principal underwriter and promotes and arranges for the sale of the Portfolio's shares.
The Board has adopted a Distribution Plan (the “Distribution Plan”) for Class 2 Shares of the Portfolio pursuant to Rule 12b-1 under the 1940 Act. Class 1 Shares of the Portfolio do not charge a distribution fee. The Distribution Plan provides that the Portfolio shall pay, with respect to the applicable share classes, distribution fees, including payments to JPMDS, at an annual rate of 0.25% of the average daily net assets of Class 2 Shares.
D. Custodian and Accounting Fees — JPMCB provides portfolio custody and accounting services to the Portfolio. For performing these services, the Portfolio pays JPMCB transaction and asset-based fees that vary according to the number of transactions and positions, plus out-of-pocket expenses. The amounts paid directly to JPMCB by the Portfolio for custody and accounting services are included in Custodian and accounting fees on the Statement of Operations.
Interest income earned on cash balances at the custodian, if any, is included in Interest income from affiliates on the Statement of Operations.
Interest expense paid to the custodian related to cash overdrafts, if any, is included in Interest expense to affiliates on the Statement of Operations.
E. Waivers and Reimbursements —The Adviser, Administrator and/or JPMDS have contractually agreed to waive fees and/or reimburse the Portfolio to the extent that total annual operating expenses (excluding acquired fund fees and expenses other than certain money market fund fees as described below, dividend and interest expenses related to short sales, interest, taxes, expenses related to litigation and potential litigation, expenses related to trustee elections and extraordinary expenses) exceed the percentages of the Portfolio's respective average daily net assets as shown in the table below:
The expense limitation agreement was in effect for the year ended December 31, 2022 and the contractual expense limitation percentages in the table above are in place until at least April 30, 2023.
For the year ended December 31, 2022, the Portfolio's service providers did not waive fees and/or reimburse expenses for the Portfolio.
Additionally, the Portfolio may invest in one or more money market funds advised by the Adviser (affiliated money market funds). The Adviser, Administrator and/or JPMDS, have contractually agreed to waive fees and/or reimburse expenses in an amount sufficient to offset the respective net fees each collects from the affiliated money market fund on the Portfolio's investment in such affiliated money market fund, except for investments of securities lending cash collateral. None of these parties expect the Portfolio to repay any such waived fees and/or reimbursed expenses in future years.
The amount of these waivers resulting from investments in these money market funds for the year ended December 31, 2022 was $6.
JPMIM voluntarily agreed to reimburse the Portfolio for the Trustee Fees paid to one of the interested Trustees. For the year ended December 31, 2022 the amount of this reimbursement was $2.
F. Other — Certain officers of the Trust are affiliated with the Adviser, the Administrator and JPMDS. Such officers, with the exception of the Chief Compliance Officer, receive no compensation from the Portfolio for serving in their respective roles.
The Board designated and appointed a Chief Compliance Officer to the Portfolio pursuant to Rule 38a-1 under the 1940 Act. The Portfolio, along with affiliated funds, makes reimbursement payments, on a pro-rata basis, to the Administrator for a portion of the fees associated with the office of the Chief Compliance Officer. Such fees are included in Trustees’ and Chief Compliance Officer’s fees on the Statement of Operations.
The Trust adopted a Trustee Deferred Compensation Plan (the “Plan”) which allows the independent Trustees to defer the receipt of all or a portion of compensation related to performance of their duties as Trustees. The deferred fees are invested in various J.P. Morgan Funds until distribution in accordance with the Plan.
The Securities and Exchange Commission ("SEC") has granted an exemptive order permitting the Portfolio to engage in principal transactions with J.P. Morgan Securities LLC, an affiliated broker, involving taxable money market instruments, subject to certain conditions.
4. Investment Transactions
During the year ended December 31, 2022, purchases and sales of investments (excluding short-term investments) were as follows:
| Purchases
(excluding
U.S. Government) | Sales
(excluding
U.S. Government) |
| | |
During the year ended December 31, 2022, there were no purchases or sales of U.S. Government securities.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
5. Federal Income Tax Matters
For Federal income tax purposes, the estimated cost and unrealized appreciation (depreciation) in value of investments held at December 31, 2022 were as follows:
| | Gross
Unrealized
Appreciation | Gross
Unrealized
Depreciation | Net Unrealized
Appreciation
(Depreciation) |
| | | | |
The difference between book and tax basis appreciation (depreciation) on investments is primarily attributed to wash sale loss deferrals.
The tax character of distributions paid during the year ended December 31, 2022 was as follows:
| | Net
Long-Term
Capital Gains | |
| | | |
|
| Short-term gain distributions are treated as ordinary income for income tax purposes. |
The tax character of distributions paid during the year ended December 31, 2021 was as follows:
| | Net
Long-Term
Capital Gains | |
| | | |
|
| Short-term gain distributions are treated as ordinary income for income tax purposes. |
As of December 31, 2022, the estimated components of net assets (excluding paid-in-capital) on a tax basis were as follows:
| Current
Distributable
Ordinary
Income | Current
Distributable
Long-Term
Capital Gain
(Tax Basis Capital
Loss Carryover) | Unrealized
Appreciation
(Depreciation) |
| | | |
The cumulative timing differences primarily consist of wash sale loss deferrals.
At December 31, 2022, the Portfolio did not have any net capital loss carryforwards.
6. Borrowings
The Portfolio relies upon an exemptive order granted by the SEC (the “Order”) permitting the establishment and operation of an Interfund Lending Facility (the “Facility”). The Facility allows the Portfolio to directly lend and borrow money to or from any other fund relying upon the Order at rates beneficial to both the borrowing and lending funds. Advances under the Facility are taken primarily for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities, and are subject to the Portfolio's borrowing restrictions. The interfund loan rate is determined, as specified in the Order, by averaging the current repurchase agreement rate and the current bank loan rate. The Order was granted to the Trust and may be relied upon by the Portfolio because the Portfolio and the series of the Trust are all investment companies in the same “group of investment companies” (as defined in Section 12(d)(1)(G) of the 1940 Act).
The Portfolio had no borrowings outstanding from another fund, or loans outstanding to another fund, during the year ended December 31, 2022.
The Trust and JPMCB have entered into a financing arrangement. Under this arrangement, JPMCB provides an unsecured, uncommitted credit facility in the aggregate amount of $100 million to certain of the J.P. Morgan Funds, including the Portfolio. Advances under the arrangement are taken
primarily for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities, and are subject to the Portfolio's borrowing restrictions. Interest on borrowings is payable at a rate determined by JPMCB at the time of borrowing. This agreement has been extended until October 30, 2023.
The Portfolio had no borrowings outstanding from the unsecured, uncommitted credit facility during the year ended December 31, 2022.
The Trust, along with certain other trusts for J.P. Morgan Funds (“Borrowers”), has entered into a joint syndicated senior unsecured revolving credit facility totaling $1.5 billion (“Credit Facility”) with various lenders and The Bank of New York Mellon, as administrative agent for the lenders. This Credit Facility provides a source of funds to the Borrowers for temporary and emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities. Under the terms of the Credit Facility, a borrowing portfolio must have a minimum of $25 million in adjusted net asset value and not exceed certain adjusted net asset coverage ratios prior to and during the time in which any borrowings are outstanding. If a portfolio does not comply with the aforementioned requirements, the portfolio must remediate within three business days with respect to the $25 million minimum adjusted net asset value or within one business day with respect to certain asset coverage ratios or the administrative agent at the request of, or with the consent of, the lenders may terminate the Credit Facility and declare any outstanding borrowings to be due and payable immediately.
Interest associated with any borrowing under the Credit Facility is charged to the borrowing portfolio at a rate of interest equal to 1.00% (the "Applicable Margin"), plus the greater of the federal funds effective rate or one month London Interbank Offered Rate ("LIBOR"). The annual commitment fee to maintain the Credit Facility is 0.15% and is incurred on the unused portion of the Credit Facility and is allocated to all participating portfolios pro rata based on their respective net assets. Effective August 9, 2022, the Credit Facility has been amended and restated for a term of 364 days, unless extended, and to include a change in the interest associated with any borrowing to the higher, on the day of the borrowing, of (a) the federal funds effective rate, or (b) the one-month Adjusted SOFR Rate plus the Applicable Margin.
The Portfolio did not utilize the Credit Facility during the year ended December 31, 2022.
7. Risks, Concentrations and Indemnifications
In the normal course of business, the Portfolio enters into contracts that contain a variety of representations which provide general indemnifications. The Portfolio's maximum exposure under these arrangements is unknown. The amount of exposure would depend on future claims that may be brought against the Portfolio. However, based on experience, the Portfolio expects the risk of loss to be remote.
As of December 31, 2022, the Portfolio had three individual shareholder and/or non-affiliated omnibus accounts, which collectively owned 69.5% of the Portfolio's outstanding shares.
Significant shareholder transactions by these shareholders may impact the Portfolio's performance and liquidity.
The Portfolio invests in companies with relatively small market capitalizations. Investments in companies with relatively small market capitalizations may involve greater risk than is usually associated with stocks of larger companies. These securities may have limited marketability and may be subject to more abrupt or erratic movements in price than securities of companies with larger capitalizations.
LIBOR is intended to represent the rate at which contributing banks may obtain short-term borrowings from each other in the London interbank market. On March 5, 2021, the U.K. Financial Conduct Authority ("FCA") publicly announced that (i) immediately after December 31, 2021, publication of the 1-week and 2-month U.S. Dollar LIBOR settings will permanently cease; (ii) immediately after June 30, 2023, publication of the overnight and 12-month U.S. Dollar LIBOR settings will permanently cease; and (iii) immediately after June 30, 2023, the 1-month, 3-month and 6-month U.S. Dollar LIBOR settings will cease to be provided or, subject to the FCA's consideration of the case, be provided on a synthetic basis and no longer be representative of the underlying market and economic reality they are intended to measure and that representativeness will not be restored. There is no assurance that the dates announced by the FCA will not change or that the administrator of LIBOR and/or regulators will not take further action that could impact the availability, composition or characteristics of LIBOR or the currencies and/or tenors for which LIBOR is published. In addition, certain regulated entities ceased entering into most new LIBOR contracts in connection with regulatory guidance or prohibitions. Public and private sector industry initiatives are currently underway to implement new or alternative reference rates to be used in place of LIBOR. There is no assurance that any such alternative reference rate will be similar to or produce the same value or economic equivalence as LIBOR or that it will have the same volume or liquidity as did LIBOR prior to its discontinuance, unavailability or replacement, all of which may affect the value, volatility, liquidity or return on certain of the Portfolio's loans, notes, derivatives and other instruments or investments comprising some or all of the Portfolio's investments and result in costs incurred in connection with changing reference rates used for positions closing out positions and entering into new trades. Certain of the Portfolio's investments may transition from LIBOR prior to the dates announced by the FCA. The transition from LIBOR to alternative reference rates may result in operational issues for the Portfolio or its investments. No assurances can be given as to the impact of the LIBOR transition (and the timing of any such impact) on the Portfolio and its investments.
The Portfolio is subject to infectious disease epidemics/pandemics risk. The worldwide outbreak of COVID-19 has negatively affected economies, markets and individual companies throughout the world. The effects of this COVID-19 pandemic to public health, and business and market conditions, including among other things, reduced consumer demand and economic output, supply chain disruptions and increased government spending may continue to have a significant negative impact on the performance of the Portfolio's investments, increase the Portfolio's volatility, exacerbate other pre-existing political, social and economic risks to the Portfolio and negatively impact broad segments of businesses and populations. In
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
addition, governments, their regulatory agencies, or self-regulatory organizations have taken or may take actions in response to the pandemic that affect the instruments in which the Portfolio invests, or the issuers of such instruments, in ways that could also have a significant negative impact on the Portfolio's investment performance. The duration and extent of COVID-19 and associated economic and market conditions and uncertainty over the long-term cannot be reasonably estimated at this time. The ultimate impact of COVID-19 and the extent to which the associated conditions impact the Portfolio will also depend on future developments, which are highly uncertain, difficult to accurately predict and subject to frequent changes.
8. Other Matters
On December 12, 2022, the Board approved a proposal to reorganize the Portfolio into a newly organized series (the “Acquiring Fund") of Lincoln Variable Insurance Products Trust (the “Reorganization”).
The Acquiring Fund has the same investment objective and substantially identical principal investment strategies and principal risks as the Portfolio. The Acquiring Fund’s investment adviser will be Lincoln Investment Advisors Corporation, and it is anticipated that JPMIM will be retained as the sub-adviser to the Acquiring Fund upon consummation of the Reorganization. Upon the closing of the Reorganization, the Class 1 Shares and Class 2 Shares of the Portfolio will be exchanged for the same value of Standard Class Shares and Service Class Shares, respectively, of the Acquiring Fund.
The Reorganization is subject to the approval of the Portfolio’s shareholders at a special shareholder meeting to be held on or about March 15, 2023. If shareholder approval of the Reorganization is obtained, the Reorganization is expected to be effective on or about May 1, 2023. All costs related to the Reorganization will be borne by Lincoln Investment Advisors Corporation and JPMIM and not by the Portfolio or Acquiring Fund.
More detailed information about the reorganization was included in a proxy statement provided to shareholders.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Trustees of JPMorgan Insurance Trust and Shareholders of JPMorgan Insurance Trust Small Cap Core Portfolio
Opinion on the Financial Statements
We have audited the accompanying statement of assets and liabilities, including the schedule of portfolio investments, of JPMorgan Insurance Trust Small Cap Core Portfolio (one of the portfolios constituting JPMorgan Insurance Trust, referred to hereafter as the “Portfolio”) as of December 31, 2022, the related statement of operations for the year ended December 31, 2022, the statements of changes in net assets for each of the two years in the period ended December 31, 2022, including the related notes, and the financial highlights for each of the five years in the period ended December 31, 2022 (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Portfolio as of December 31, 2022, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended December 31, 2022 and the financial highlights for each of the five years in the period ended December 31, 2022 in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Portfolio’s management. Our responsibility is to express an opinion on the Portfolio’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Portfolio in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of December 31, 2022 by correspondence with the custodian, transfer agent and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
/s/ PricewaterhouseCoopers LLP
New York, New York
February 15, 2023
We have served as the auditor of one or more investment companies in the JPMorgan Funds complex since 1993.
The Portfolio's Statement of Additional Information includes additional information about the Portfolio's Trustees and is available, without charge, upon request by calling 1-800-480-4111 or on the Portfolio's website at www.jpmorgan.com/variableinsuranceportfolios.
Name (Year of Birth);
Positions With
the Portfolio (1) | Principal Occupation
During Past 5 Years | Number of
Funds in Fund
Complex Overseen
by Trustee (2) | Other Directorships Held
During the Past 5 Years |
| | | |
John F. Finn (1947); Chair
since 2020; Trustee since 1998. | Chairman, Gardner, Inc. (supply chain management company serving industrial and consumer markets) (serving in various roles 1974-present). | | Director, Greif, Inc. (GEF) (industrial package products and services) (2007-present); Trustee, Columbus Association for the Performing Arts (1988-present). |
Stephen P. Fisher (1959);
Trustee since 2018. | Retired; Chairman and Chief Executive Officer, NYLIFE Distributors LLC (registered broker-dealer) (serving in various roles 2008-2013); Chairman, NYLIM Service Company LLC (transfer agent) (2008-2017); New York Life Investment Management LLC (registered investment adviser) (serving in various roles 2005-2017); Chairman, IndexIQ Advisors LLC (registered investment adviser for ETFs) (2014-2017); President, MainStay VP Funds Trust (2007-2017), MainStay DefinedTerm Municipal Opportunities Fund (2011-2017) and MainStay Funds Trust (2007-2017) (registered investment companies). | | Honors Program Advisory Board Member, The Zicklin School of Business, Baruch College, The City University of New York (2017-present). |
Gary L. French (1951);
Trustee since 2014. | Real Estate Investor (2011-2020); Investment management industry Consultant and Expert Witness (2011-present); Senior Consultant for The Regulatory Fundamentals Group LLC (2011-2017). | | Independent Trustee, The China Fund, Inc. (2013-2019); Exchange Traded Concepts Trust II (2012-2014); Exchange Traded Concepts Trust I (2011-2014). |
Kathleen M. Gallagher (1958);
Trustee since 2018. | Retired; Chief Investment Officer — Benefit Plans, Ford Motor Company (serving in various roles 1985-2016). | | Non- Executive Director, Legal & General Investment Management (Holdings) (2018-present); Non-Executive Director, Legal & General Investment Management America (U.S. Holdings) (financial services and insurance) (2017-present); Advisory Board Member, State Street Global Advisors Total Portfolio Solutions (2017-present); Member, Client Advisory Council, Financial Engines, LLC (registered investment adviser) (2011-2016); Director, Ford Pension Funds Investment Management Ltd. (2007-2016). |
Robert J. Grassi (1957);
Trustee since 2014. | Sole Proprietor, Academy Hills Advisors LLC (2012-present); Pension Director, Corning Incorporated (2002-2012). | | |
Name (Year of Birth); Positions With the Portfolio (1) | Principal Occupation During Past 5 Years | Number of Funds in Fund Complex Overseen by Trustee (2) | Other Directorships Held During the Past 5 Years |
Frankie D. Hughes (1952);
Trustee since 2008. | President, Ashland Hughes Properties (property management) (2014-present); President and Chief Investment Officer, Hughes Capital Management, Inc. (fixed income asset management) (1993-2014). | | |
Raymond Kanner (1953);
Trustee since 2017. | Retired; Managing Director and Chief Investment Officer, IBM Retirement Funds (2007-2016). | | Advisory Board Member, Penso Advisors, LLC (2020-present); Advisory Board Member, Los Angeles Capital (2018-present); Advisory Board Member, State Street Global Advisors Total Portfolio Solutions (2017- present); Acting Executive Director, Committee on Investment of Employee Benefit Assets (CIEBA) (2016-2017); Advisory Board Member, Betterment for Business (robo advisor) (2016- 2017); Advisory Board Member, BlueStar Indexes (index creator) (2013-2017); Director, Emerging Markets Growth Fund (registered investment company) (1997-2016); Member, Russell Index Client Advisory Board (2001-2015). |
Thomas P. Lemke (1954);
Trustee since 2014. | | | (1) Independent Trustee of Advisors’ Inner Circle III fund platform, consisting of the following: (i) the Advisors’ Inner Circle Fund III, (ii) the Gallery Trust, (iii) the Schroder Series Trust, (iv) the Delaware Wilshire Private Markets Fund (since 2020), (v) Chiron Capital Allocation Fund Ltd., and (vi) formerly the Winton Diversified Opportunities Fund (2014-2018); and (2) Independent Trustee of the Symmetry Panoramic Trust (since 2018). |
Lawrence R. Maffia (1950);
Trustee since 2014 | Retired; Director and President, ICI Mutual Insurance Company (2006-2013). | | Director, ICI Mutual Insurance Company (1999-2013). |
Mary E. Martinez (1960); Vice
Chair since 2021; Trustee since 2013. | Associate, Special Properties, a Christie’s International Real Estate Affiliate (2010-present); Managing Director, Bank of America (asset management) (2007-2008); Chief Operating Officer, U.S. Trust Asset Management, U.S. Trust Company (asset management) (2003-2007); President, Excelsior Funds (registered investment companies) (2004-2005). | | |
Marilyn McCoy (1948);
Trustee since 2005. | Vice President of Administration and Planning, Northwestern University (1985-present). | | |
TRUSTEES
(Unaudited) (continued)
Name (Year of Birth); Positions With the Portfolio (1) | Principal Occupation During Past 5 Years | Number of Funds in Fund Complex Overseen by Trustee (2) | Other Directorships Held During the Past 5 Years |
Dr. Robert A. Oden, Jr. (1946); Trustee
since 2005. | Retired; President, Carleton College (2002-2010); President, Kenyon College (1995-2002). | | Trustee, The Coldwater Conservation Fund (2017-present); Trustee, American Museum of Fly Fishing (2013-present); Trustee and Vice Chair, Trout Unlimited (2017-2021);Trustee, Dartmouth- Hitchcock MedicalCenter (2011-2020). |
Marian U. Pardo* (1946);
Trustee since 2013. | Managing Director and Founder, Virtual Capital Management LLC (investment consulting) (2007-present); Managing Director, Credit Suisse Asset Management (portfolio manager) (2003-2006). | | Board Chair and Member, Board of Governors, Columbus Citizens Foundation (not-for-profit supporting philanthropic and cultural programs) (2006-present). |
Emily A. Youssouf (1951);
Trustee since 2022. | Adjunct Professor (2011-present) and Clinical Professor (2009-2011), NYU Schack Institute of Real Estate; Board Member and Member of the Audit Committee (2013–present), Chair of Finance Committee (2019-present), Member of Related Parties Committee (2013-2018) and Member of the Enterprise Risk Committee (2015-2018), PennyMac Financial Services, Inc.; Board Member (2005-2018), Chair of Capital Committee (2006-2016), Chair of Audit Committee (2005-2018), Member of Finance Committee (2005-2018) and Chair of IT Committee (2016-2018), NYC Health and Hospitals Corporation. | | Trustee, NYC School Construction Authority (2009-present); Board Member, NYS Job Development Authority (2008-present); Trustee and Chair of the Audit Committee of the Transit Center Foundation (2015-2019). |
| | | |
Robert F. Deutsch** (1957);
Trustee since 2014. | Retired; Head of ETF Business for JPMorgan Asset Management (2013-2017); Head of Global Liquidity Business for JPMorgan Asset Management (2003-2013). | | Treasurer and Director of the JUST Capital Foundation (2017-present). |
Nina O. Shenker** (1957);
Trustee since 2022. | Vice Chair (2017-2021), General Counsel and Managing Director (2008-2016), Associate General Counsel and Managing Director (2004-2008), J.P. Morgan Asset & Wealth Management. | | Director and Member of Legal and Human Resources Subcommittees, American Jewish Joint Distribution Committee (2018-present). |
|
| The year shown is the first year in which a Trustee became a member of any of the following: the JPMorgan Mutual Fund Board, the JPMorgan ETF Board, the heritage J.P. Morgan Funds or the heritage One Group Mutual Funds. Trustees serve an indefinite term, until resignation, retirement, removal or death. The Board’s current retirement policy sets retirement at the end of the calendar year in which the Trustee attains the age of 75, provided that any Board member who was a member of the JPMorgan Mutual Fund Board prior to January 1, 2022 and was born prior to January 1, 1950 shall retire from the Board at the end of the calendar year in which the Trustee attains the age of 78. |
| A Fund Complex means two or more registered investment companies that hold themselves out to investors as related companies for purposes of investment and investor services or have a common investment adviser or have an investment adviser that is an affiliated person of the investment adviser of any of the other registered investment companies. The J.P. Morgan Funds Complex for which the Board of Trustees serves currently includes nine registered investment companies (179 J.P. Morgan Funds). |
| In connection with prior employment with JPMorgan Chase, Ms. Pardo was the recipient of non-qualified pension plan payments from JPMorgan Chase in the amount of approximately $2,055 per month, which she irrevocably waived effective January 1, 2013, and deferred compensation payments from JPMorgan Chase in the amount of approximately $7,294 per year, which ended in January 2013. In addition, Ms. Pardo receives payments from a fully-funded qualified plan, which is not an obligation of JPMorgan Chase. |
| Designation as an “Interested Trustee” is based on prior employment by the Adviser or an affiliate of the Adviser or interests in a control person of the Adviser. |
| The contact address for each of the Trustees is 277 Park Avenue, New York, NY 10172. |
Name (Year of Birth),
Positions Held with
the Trust (Since) | Principal Occupations During Past 5 Years |
Brian S. Shlissel (1964),
President and Principal Executive
Officer (2016)* | Managing Director and Chief Administrative Officer for J.P. Morgan pooled vehicles, J.P. Morgan Investment Management Inc. since 2014. |
Timothy J. Clemens (1975),
Treasurer and Principal Financial
Officer (2018) | Executive Director, J.P. Morgan Investment Management Inc. since February 2016. Mr. Clemens has been with J.P. Morgan Investment Management Inc. since 2013. |
Gregory S. Samuels (1980),
Secretary (2019) (formerly Assistant
Secretary 2010-2019) | Managing Director and Assistant General Counsel, JPMorgan Chase & Co. Mr. Samuels has been with JPMorgan Chase & Co. since 2010. |
Stephen M. Ungerman (1953),
Chief Compliance Officer (2005) | Managing Director, JPMorgan Chase & Co. Mr. Ungerman has been with JPMorgan Chase & Co. since 2000. |
Kiesha Astwood-Smith (1973),
Assistant Secretary (2021) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since June 2021; Senior Director and Counsel, Equitable Financial Life Insurance Company (formerly, AXA Equitable Life Insurance Company) from September 2015 through June 2021. |
Matthew Beck (1988),
Assistant Secretary (2021)** | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since May 2021; Senior Legal Counsel, Ultimus Fund Solutions from May 2018 through May 2021; General Counsel, The Nottingham Company from April 2014 through May 2018. |
Elizabeth A. Davin (1964),
Assistant Secretary (2005)** | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Ms. Davin has been with JPMorgan Chase & Co. (formerly Bank One Corporation) since 2004. |
Jessica K. Ditullio (1962)
Assistant Secretary (2005)** | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Ms. Ditullio has been with JPMorgan Chase & Co. (formerly Bank One Corporation) since 1990. |
Anthony Geron (1971),
Assistant Secretary (2018) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since September 2018; Lead Director and Counsel, AXA Equitable Life Insurance Company from 2015 to 2018 and Senior Director and Counsel, AXA Equitable Life Insurance Company from 2014 to 2015. |
Carmine Lekstutis (1980),
Assistant Secretary (2011) | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Mr. Lekstutis has been with JPMorgan Chase & Co. since 2011. |
Max Vogel (1990),
Assistant Secretary (2021) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since June 2021; Associate, Proskauer Rose LLP (law firm) from March 2017 to June 2021. |
Zachary E. Vonnegut-Gabovitch
(1986),
Assistant Secretary (2017) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since September 2016. |
Michael M. D’Ambrosio (1969),
Assistant Treasurer (2012) | Managing Director, J.P. Morgan Investment Management Inc. Mr. D’Ambrosio has been with J.P. Morgan Investment Management Inc. since 2012. |
Aleksandr Fleytekh (1972),
Assistant Treasurer (2019) | Vice President, J.P. Morgan Investment Management Inc. since February 2012. |
Shannon Gaines (1977),
Assistant Treasurer (2018)** | Vice President, J.P. Morgan Investment Management Inc. since January 2014. |
Jeffrey D. House (1972),
Assistant Treasurer (2017)** | Vice President, J.P. Morgan Investment Management Inc. since July 2006. |
Michael Mannarino (1985),
Assistant Treasurer (2020) | Vice President, J.P. Morgan Investment Management Inc. since 2014. |
Joseph Parascondola (1963),
Assistant Treasurer (2011)* | Executive Director, J.P. Morgan Investment Management, Inc. Mr. Parascondola has been with J.P. Morgan Investment Management Inc. since 2006. |
Gillian I. Sands (1969),
Assistant Treasurer (2012) | Executive Director, J.P. Morgan Investment Management Inc. Ms. Sands has been with J.P. Morgan Investment Management Inc. since 2012. |
|
The contact address for each of the officers, unless otherwise noted, is 277 Park Avenue, New York, NY 10172. |
| The contact address for the officer is 575 Washington Boulevard, Jersey City, NJ 07310. |
| The contact address for the officer is 1111 Polaris Parkway, Columbus, OH 43240. |
SCHEDULE OF SHAREHOLDER EXPENSES
(Unaudited)
Hypothetical $1,000 Investment
As a shareholder of the Portfolio, you incur ongoing costs, including investment advisory fees, administration fees, distribution fees (for Class 2 Shares) and other Portfolio expenses. Because the Portfolio is a funding vehicle for Policies and Eligible Plans you may also incur sales charges and other fees relating to the Policies or Eligible Plans. The examples below are intended to help you understand your ongoing costs (in dollars) of investing in the Portfolio, but not the costs of the Policies or Eligible Plans, and to compare these ongoing costs with the ongoing costs of investing in other mutual funds. The examples assume that you had a $1,000 investment in each Class at the beginning of the reporting period, July 1, 2022, and continued to hold your shares at the end of the reporting period, December 31, 2022.
Actual Expenses
For each Class of the Portfolio in the table below, the first line provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line of each Class under the heading titled “Expenses Paid During the Period” to estimate the expenses you paid on your account during this period.
Hypothetical Example for Comparison Purposes
The second line of each Class in the table below provides information about hypothetical account values and hypothetical expenses based on the Class’ actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Class’ actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in each Class of the Portfolio and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds. Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs, such as sales charges (loads), or redemption fees , or the costs associated with the Policies and Eligible Plans through which the Portfolio is held. Therefore, the second line for each Class in the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transaction costs were included, your costs would have been higher. The examples also assume all dividends and distributions have been reinvested.
| Beginning
Account Value
July 1, 2022 | Ending
Account Value
December 31, 2022 | Expenses
Paid During
the Period* | |
JPMorgan Insurance Trust Small Cap Core Portfolio | | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
|
| Expenses are equal to each Class’ respective annualized expense ratio, multiplied by the average account value over the period, multiplied by 184/365 (to reflect the one-half year period). |
BOARD APPROVAL OF INVESTMENT ADVISORY AGREEMENT
(Unaudited)
The Board of Trustees (the “Board” or the “Trustees”) has established various standing committees composed of Trustees with diverse backgrounds, to which the Board has assigned specific subject matter responsibilities to further enhance the effectiveness of the Board’s oversight and decision making. Effective January 2022, the Board consolidated with the J.P. Morgan Exchange-Traded Fund Trust Board and now consists of Trustees from both Boards. The Board and its investment committees (Money Market and Alternative Products Committee, Equity Committee, and Fixed Income Committee) met regularly throughout the year and, at each meeting, considered factors that are relevant to their annual consideration of the continuation of the investment advisory agreements. The Board also met for the specific purpose of considering investment advisory agreement annual renewals. The Board held meetings on June 21-22, 2022 and August 9-11, 2022, at which the Trustees considered the continuation of the investment advisory agreement for the Portfolio whose annual report is contained herein (the “Advisory Agreement”). At the June meeting, the Board’s investment committees met to review and consider performance, expense and related information for the J.P. Morgan Funds. Each investment committee reported to the full Board, which then considered each investment committee’s preliminary findings. At the August meeting, the Trustees continued their review and consideration. The Trustees, including a majority of the Trustees who are not parties to the Advisory Agreement or “interested persons” (as defined in the Investment Company Act of 1940) of any party to the Advisory Agreement or any of their affiliates, approved the continuation of the Advisory Agreement on August 11, 2022.
As part of their review of the Advisory Agreement, the Trustees considered and reviewed performance and other information about the Portfolio received from the Adviser. This information includes the Portfolio’s performance as compared to the performance of its peers and benchmarks, and analyses by the Adviser of the Portfolio’s performance. In addition, at each of their regular meetings throughout the year, the Trustees considered reports on the performance of certain J.P. Morgan Funds (including certain ETFs, beginning in February 2022) provided by an independent investment consulting firm (“independent consultant”). In addition, in preparation for the June and August meetings, the Trustees requested, received and evaluated extensive materials from the Adviser, including performance and expense information compiled by Broadridge, using data from Lipper Inc. and/or Morningstar Inc., independent providers of investment company data (together, “Broadridge”). Before voting on the Advisory Agreement, the Trustees reviewed the Advisory Agreement with representatives of the Adviser, counsel to the Trust, and independent legal counsel and received a memorandum from independent legal counsel to the Trustees discussing the legal standards for their consideration of the Advisory Agreement. The Trustees also
discussed the Advisory Agreement with independent legal counsel in executive sessions at which no representatives of the Adviser were present.
A summary of the material factors evaluated by the Trustees in determining whether to approve the Advisory Agreement is provided below. Each Trustee attributed different weights to the various factors and no factor alone was considered determinative. The Trustees considered information provided with respect to the Portfolio throughout the year, including additional reporting and information provided in connection with the COVID-19 pandemic, as well as materials furnished specifically in connection with the annual review process. From year to year, the Trustees consider and place emphasis on relevant information in light of changing circumstances in market and economic conditions.
After considering and weighing the factors and information they had received, the Trustees found that the compensation to be received by the Adviser from the Portfolio under the Advisory Agreement was fair and reasonable under the circumstances and determined that the continuance of the Advisory Agreement was in the best interests of the Portfolio and its shareholders.
Nature, Extent and Quality of Services Provided by the Adviser
The Trustees received and considered information regarding the nature, extent and quality of services provided to the Portfolio under the Advisory Agreement. The Trustees took into account information furnished throughout the year at Trustee meetings, as well as the materials furnished specifically in connection with this annual review process. Among other things, the Trustees considered:
(i)
The background and experience of the Adviser’s senior management and investment personnel, including personnel changes, if any;
(ii)
The qualifications, backgrounds and responsibilities of the portfolio management team primarily responsible for the day-to-day management of the Portfolio, including personnel changes, if any;
(iii)
The investment strategy for the Portfolio, and the infrastructure supporting the portfolio management team;
(iv)
Information about the structure and distribution strategy for the Portfolio and how it fits with the Trust’s other fund offerings;
(v)
The administration services provided by the Adviser in its role as Administrator;
(vi)
Their knowledge of the nature and quality of the services provided by the Adviser and its affiliates gained from their experience as Trustees of the Trust and in the financial industry generally;
BOARD APPROVAL OF INVESTMENT ADVISORY AGREEMENT
(Unaudited) (continued)
(vii)
The overall reputation and capabilities of the Adviser and its affiliates;
(viii)
The commitment of the Adviser to provide high quality service to the Portfolio;
(ix)
Their overall confidence in the Adviser’s integrity;
(x)
The Adviser’s responsiveness to requests for additional information, questions or concerns raised by them, including the Adviser’s willingness to consider and implement organizational and operational changes designed to improve investment results and the services provided to the Portfolio; and
(xi)
The Adviser’s business continuity plan and steps the Adviser and its affiliates have taken to provide ongoing services to the Portfolio during the COVID-19 pandemic, and the Adviser’s and its affiliates’ success in continuing to provide services to the Portfolio and its shareholders throughout this period.
Based upon these considerations and other factors, the Trustees concluded that they were satisfied with the nature, extent and quality of the services provided to the Portfolio by the Adviser.
Costs of Services Provided and Profitability to the Adviser and its Affiliates
The Trustees received and considered information regarding the profitability to the Adviser and its affiliates from providing services to the Portfolio. The Trustees reviewed and discussed this information. The Trustees recognized that this information is not audited and represents the Adviser’s determination of its and its affiliates’ revenues from the contractual services provided to the Portfolio, less expenses of providing such services. Expenses include direct and indirect costs and are calculated using an allocation methodology developed by the Adviser and reviewed with the Board. The Trustees also recognized that it is difficult to make comparisons of profitability from fund investment advisory contracts because comparative information is not generally publicly available and is affected by numerous factors, including the structure of the particular adviser, the types of funds it manages, its business mix, numerous assumptions regarding allocations and the fact that publicly-traded fund managers’ operating profits and net income are net of distribution and marketing expenses. Based upon their review, and taking into consideration the factors noted above, the Trustees concluded that the profitability to the Adviser under the Advisory Agreement was not unreasonable in light of the services and benefits provided to the Portfolio.
The Trustees also considered that JPMDS, an affiliate of the Adviser, and the Adviser earn fees from the Portfolio for providing administration services. These fees were shown separately in the profitability analysis presented to the
Trustees. The Trustees also considered the payments of Rule 12b-1 fees to JPMDS, which also acts as the Portfolio’s distributor, and that these fees are in turn generally paid to insurance companies that use the Portfolio in connection with insurance products they issue, including financial intermediaries that are affiliates of the Adviser (although they are retained by JPMDS in certain instances). The Trustees also considered the fees earned by JPMorgan Chase Bank, N.A. (“JPMCB”), an affiliate of the Adviser, for custody, fund accounting and other related services for the Portfolio, and the profitability of the arrangements to JPMCB.
Fall-Out Benefits
The Trustees reviewed information regarding potential “fall-out” or ancillary benefits received by the Adviser and its affiliates as a result of their relationship with the Portfolio. The Trustees considered that the J.P. Morgan Funds’ operating accounts are held at JPMCB, which, as a result, will receive float benefits for certain J.P. Morgan Funds, as applicable. The Trustees also noted that the Adviser supports a diverse set of products and services, which benefits the Adviser by allowing it to leverage its infrastructure to serve additional clients, including benefits that may be received by the Adviser and its affiliates in connection with the Portfolio’s potential investments in other funds advised by the Adviser. The Trustees also reviewed the Adviser’s allocation of fund brokerage for the J.P. Morgan Funds complex, including allocations to brokers who provide research to the Adviser, as well as the Adviser’s use of affiliates to provide other services and the benefits to such affiliates of doing so.
Economies of Scale
The Trustees considered the extent to which the Portfolio may benefit from potential economies of scale. The Trustees considered that there may not be a direct relationship between economies of scale realized by the Portfolio and those realized by the Adviser as assets increase. The Trustees considered the extent to which the Portfolio was priced to scale and whether it would be appropriate to add advisory fee breakpoints, but noted that the Portfolio has implemented fee waivers and contractual expense limitations (“Fee Caps”) which allow the Portfolio’s shareholders to share potential economies of scale from its inception and that the fees remain satisfactory relative to peer funds. The Trustees considered the benefits to the Portfolio of the use of an affiliated distributor and custodian, including the ability to rely on existing infrastructure supporting distribution, custodial and transfer agent services, and the ability to negotiate competitive fees for the Portfolio. The Trustees further considered the Adviser’s and JPMDS’s ongoing investments in their business in support of the Portfolio, including the Adviser’s and/or JPMDS’s investments in trading systems, technology (including improvements to the J.P. Morgan Funds’ website, and cybersecurity improvements),
retention of key talent, and regulatory support enhancements. The Trustees concluded that the current fee structure for the Portfolio, including Fee Caps that the Adviser has in place that serve to limit the overall net expense ratios of the Portfolio at competitive levels, was reasonable. The Trustees concluded that the Portfolio’s shareholders received the benefits of potential economies of scale through the Fee Caps and the Adviser’s reinvestment in its operations to serve the Portfolio and its shareholders. The Trustees noted that the Adviser’s reinvestment ensures sufficient resources in terms of personnel and infrastructure to support the Portfolio.
Fees Relative to Adviser’s Other Clients
The Trustees received and considered information about the nature and extent of investment advisory services and fee rates offered to other clients of the Adviser, including, to the extent applicable, institutional separate accounts, collective investment trusts, other registered investment companies and/or private funds sub-advised by the Adviser, for investment management styles substantially similar to that of the Portfolio. The Trustees considered the complexity of investment management for registered investment companies relative to the Adviser’s other clients and noted differences, as applicable, in the fee structure and the regulatory, legal and other risks and responsibilities of providing services to the different clients. The Trustees considered that serving as an adviser to a registered investment company involves greater responsibilities and risks than acting as a sub-adviser and observed that sub-advisory fees may be lower than those charged by the Adviser to the Portfolio. The Trustees also noted that the adviser, not the applicable investment company, typically bears the sub-advisory fee and that many responsibilities related to the advisory function are typically retained by the primary adviser. The Trustees concluded that the fee rates charged to the Portfolio in comparison to those charged to the Adviser’s other clients were reasonable.
Investment Performance
The Trustees receive and consider information about the Portfolio’s performance throughout the year. In addition, the Trustees received and considered absolute and/or relative performance information for the Portfolio in a report prepared by Broadridge. The Trustees considered the total return performance information, which included the ranking of the Portfolio within a performance universe comprised of funds with the same Broadridge investment classification and objective (the “Universe”), as well as a subset of funds within the Universe (the “Peer Group”), by total return for the applicable one-, three- and five-year periods. The Trustees reviewed a description of Broadridge’s methodology for selecting mutual funds in the Portfolio’s Universe and Peer Group and noted that Universe and Peer Group quintile rankings were not calculated if the number of funds in the
Universe and/or Peer Group did not meet a predetermined minimum. The Broadridge materials provided to the Trustees highlighted information with respect to a representative class to assist the Trustees in their review. As part of this review, the Trustees also reviewed the Portfolio’s performance against its benchmark and considered the performance information provided for the Portfolio at regular Board meetings by the Adviser. The Trustees also engaged with the Adviser to consider what steps might be taken to improve performance, as applicable. The Broadridge performance data noted by the Trustees as part of their review and the determinations made by the Trustees with respect to the Portfolio’s performance are summarized below:
The Trustees noted that the Portfolio’s performance for Class 1 shares was in the fourth, third and second quintiles of the Peer Group, and in the third, second and second quintiles of the Universe, for the one-, three and five-year periods ended December 31, 2021, respectively. The Trustees noted that the Portfolio’s performance for Class 2 shares was in the third, fourth and second quintiles of the Peer Group, for the one-, three and five-year periods ended December 31, 2021, respectively, and in the third quintile of the Universe, for each of the one-, three and five-year periods ended December 31, 2021, respectively. The Trustees discussed the performance and investment strategy of the Portfolio with the Adviser and based upon this discussion and various other factors, concluded that the Portfolio’s performance was satisfactory under the circumstances.
Advisory Fees and Expense Ratios
The Trustees considered the contractual advisory fee rate and administration fee rate paid by the Portfolio to the Adviser and compared the combined rate to the information prepared by Broadridge concerning management fee rates paid by other funds in the same Broadridge category as the Portfolio. The Trustees recognized that Broadridge reported the Portfolio’s management fee rate as the combined contractual advisory fee and administration fee rates. The Trustees also reviewed information about other expenses and the expense ratios for the Portfolio and noted that Universe and Peer Group quintile rankings were not calculated if the number of funds in the Universe and/or Peer Groups did not meet a predetermined minimum. The Trustees considered the Fee Caps currently in place for the Portfolio, the net advisory fee rate after taking into account any waivers and/or reimbursements, and, where deemed appropriate by the Trustees, additional waivers and/or reimbursements. The Trustees recognized that it can be difficult to make comparisons of advisory fees because there are variations in the services that are included in the fees paid
BOARD APPROVAL OF INVESTMENT ADVISORY AGREEMENT
(Unaudited) (continued)
by other funds. The Trustees’ determinations as a result of the review of the Portfolio’s advisory fees and expense ratios are summarized below:
The Trustees noted that the Portfolio’s net advisory fee for Class 1 shares was in the first and second quintiles of the Peer Group and Universe, respectively, and that the actual total expenses for Class 1 shares were in the first and third quintiles of the Peer Group and Universe, respectively. The Trustees
noted that the Portfolio’s net advisory fee for Class 2 shares was in the second quintile of both the Peer Group and Universe, and that the actual total expenses for Class 2 shares were in the fourth quintile of both the Peer Group and Universe. After considering the factors identified above, in light of this information, the Trustees concluded that the advisory fee was satisfactory in light of the services provided to the Portfolio.
TAX LETTER
(Unaudited)
(Dollar values in thousands)
Dividends Received Deduction (DRD)
The Portfolio had 12.85%, or maximum allowable percentage, of ordinary income distributions eligible for the dividends received deduction for corporate shareholders for the fiscal year ended December 31, 2022.
Long Term Capital Gain
The Portfolio distributed $25,623, or maximum allowable amount, of long-term capital gain dividends for the fiscal year ended December 31, 2022.
THIS PAGE IS INTENTIONALLY LEFT BLANK
THIS PAGE IS INTENTIONALLY LEFT BLANK
J.P. Morgan Funds are distributed by JPMorgan Distribution Services, Inc., which is an affiliate of JPMorgan Chase & Co. Affiliates of JPMorgan Chase & Co. receive fees for providing various services to the funds.
Contact JPMorgan Distribution Services, Inc. at 1-800-480-4111 for a portfolio prospectus. You can also visit us at www.jpmorgan.com/variableinsuranceportfolios. Investors should carefully consider the investment objectives and risk as well as charges and expenses of the mutual fund before investing. The prospectus contains this and other information about the mutual fund. Read the prospectus carefully before investing.
Investors may obtain information about the Securities Investor Protection Corporation (SIPC), including the SIPC brochure, by visiting www.sipc.org or by calling SIPC at 202-371-8300.
The Portfolio files a complete schedule of its portfolio holdings for the first and third quarters of its fiscal year with the SEC as an exhibit to its report on Form N-PORT. The Portfolio’s Form N-PORT reports are available on the SEC’s website at http://www.sec.gov. The Portfolio's quarterly holdings can be found by visiting the Portfolio's website at www.jpmorgan.com/variableinsuranceportfolios.
A description of the Portfolio’s policies and procedures with respect to the disclosure of the Portfolio’s holdings is available in the prospectuses and Statement of Additional Information.
A copy of proxy policies and procedures is available without charge upon request by calling 1-800-480-4111 and on the Portfolio’s website at www.jpmorgan.com/variableinsuranceportfolios. A description of such policies and procedures is on the SEC’s website at www.sec.gov. The Trustees have delegated the authority to vote proxies for securities owned by the Portfolio to the Adviser. A copy of the Portfolio’s voting record for the most recent 12-month period ended June 30 is available on the SEC’s website at www.sec.gov or at the Portfolio’s website at www.jpmorgan.com/variableinsuranceportfolios no later than August 31 of each year. The Portfolio’s proxy voting record will include, among other things, a brief description of the matter voted on for each portfolio security, and will state how each vote was cast, for example, for or against the proposal.
J.P. Morgan Asset Management is the brand name for the asset management business of JPMorgan Chase & Co. and its affiliates worldwide.
© JPMorgan Chase & Co., 2022. All rights reserved. December 2022.
AN-JPMITSCCP-1222
Annual Report
JPMorgan Insurance Trust
December 31, 2022
JPMorgan Insurance Trust U.S. Equity Portfolio |
CONTENTS
Investments in the Portfolio are not deposits or obligations of, or guaranteed or endorsed by, any bank and are not insured or guaranteed by the FDIC, the Federal Reserve Board or any other government agency. You could lose money if you sell when the Portfolio’s share price is lower than when you invested.
Past performance is no guarantee of future performance. The general market views expressed in this report are opinions based on market and other conditions through the end of the reporting period and are subject to change without notice. These views are not intended to predict the future performance of the Portfolio or the securities markets.
This Portfolio is intended to be a funding vehicle for variable annuity contracts and variable life insurance policies (collectively “Policies”) offered by the separate accounts of various insurance companies. Portfolio shares may also be offered to qualified pension and retirement plans and accounts permitting accumulation of assets on a tax-deferred basis (“Eligible Plans”). Individuals may not purchase shares directly from the Portfolio.
Prospective investors should refer to the Portfolio’s prospectuses for a discussion of the Portfolio’s investment objective, strategies and risks. Call J.P. Morgan Funds Service Center at 1-800-480-4111 for a prospectus containing more complete information about the Portfolio, including management fees and other expenses. Please read it carefully before investing.
Letter to Shareholders
February 13, 2023 (Unaudited)
Dear Shareholder,
Financial markets have rebounded somewhat as the U.S. and other developed market economies have shown notable resilience in the face of higher inflation, rising interest rates and the ongoing war in Ukraine. While the factors that weighed on equity and bond markets in 2022 largely remain, there are signals that inflationary pressures may have peaked and the long-term economic outlook appears positive.
|
“Investors may face continued economic and geopolitical challenges in the year ahead. However, some of the acute risks encountered in 2022 appear to have receded and last year’s reset in asset prices may provide attractive investment opportunities.” — Brian S. Shlissel
|
While U.S. economic growth was surprisingly strong in the closing months of 2022, with broad gains in employment and consumer spending in the final months of the year, the U.S. Federal Reserve’s efforts to counter inflationary pressure through sharply higher interest rates could slow economic momentum in the months ahead.
Corporate earnings have been squeezed by higher costs for materials and labor, while the strong U.S. dollar has hindered export revenues. However, the impact of higher prices and interest rates has not landed on all sectors of the economy evenly. Energy sector profits have soared over the past year, while earnings in housing and construction sectors have declined.
Across Europe, the war in Ukraine has driven up prices for energy, food and a range of other goods and has fueled negative consumer sentiment. The prolonged nature of the conflict and its potential to spread remain key concerns among policymakers, diplomats, military planners, economists and investors. It is worth noting that Europe’s largest industrialized nations in concert with the European Union have moved swiftly to secure alternatives to Russian sources of natural gas and petroleum, which has eased an energy crisis that began last year.
Investors may face continued economic and geopolitical challenges in the year ahead. However, some of the acute risks encountered in 2022 appear to have receded and last year’s reset in asset prices may provide attractive investment opportunities. A long-term view and a properly diversified portfolio, in our opinion, remain key elements to a successful investment approach.
Our broad array of investment solutions seeks to provide investors with ability to build durable portfolios that can help them meet their financial goals.
Sincerely,
Brian S. Shlissel
President - J.P. Morgan Funds
J.P. Morgan Asset Management
1-800-480-4111 or www.jpmorganfunds.com for more information
JPMorgan Insurance Trust U.S. Equity Portfolio
PORTFOLIO COMMENTARY
TWELVE MONTHS ENDED December 31, 2022 (Unaudited)
| |
Portfolio (Class 1 Shares)* | |
| |
Net Assets as of 12/31/2022 (In Thousands) | |
INVESTMENT OBJECTIVE***
The JPMorgan Insurance Trust U.S. Equity Portfolio (the “Portfolio”) seeks to provide high total return from a portfolio of selected equity securities.
HOW DID THE MARKET PERFORM?
Overall, financial markets tumbled in the first three quarters of 2022, but rebounded moderately in the final months of the year. Equity markets turned in their worst first-half performance since 1970, amid accelerating inflation, pandemic lockdowns across China and Russia’s invasion of Ukraine.
The S&P 500 Index, which gauges the performance of U.S. large-cap equities, reached a new closing high on January 3, 2022, bolstered by record high corporate earnings, sales, cash flows, share repurchases and dividends. However, investor sentiment began to sour as accelerating inflation started to erode consumer confidence and raise expectations for an increase in benchmark interest rates by the U.S. Federal Reserve (the “Fed”).
Russia’s invasion of Ukraine at the end of February 2022 initiated a sell-off in global financial markets that was further fueled by the highest U.S. inflation rate in more than 40 years. Equity prices recovered somewhat in March 2022 amid better-than-expected corporate earnings. However, the general trend in global financial markets was downward throughout the year.
In response to accelerating inflationary pressure, the Fed raised its benchmark interest rate mid-March, the first increase since December 2018. The central bank followed with six more rate increases over the course of 2022. The Bank of England, which began raising interest rates in late 2021, also continued to raise interest rates throughout the year, while the European Central Bank waited until June before sharply raising interest rates for the first time in 11 years.
In the U.S., equity prices experienced a sharp sell-off in August and September 2022 that coincided with U.S. Federal Reserve policy guidance on further interest rate increases. However, corporate earnings for both the second and third quarters of 2022 generally were better than expected given a cooling economy and slower consumer spending. Meanwhile, the U.S.
unemployment rate remained historically low - hovering between 3.5% and 3.7% for the six-month period - and by the end of 2022 data indicated some inflationary pressures had eased.
For the twelve-month period, leading equity and bond market indexes were mostly negative, with non-U.S. developed markets equities outperforming both U.S. and emerging markets generally equities.
WHAT WERE THE MAIN DRIVERS OF THE PORTFOLIO’S PERFORMANCE?
The Portfolio’s Class 1 Shares underperformed the S&P 500 Index (the “Benchmark”) for the twelve months ended December 31, 2022.
The Portfolio’s underweight position in the commodities sector and its overweight position in the media sector were leading detractors from performance relative to the Benchmark, while the Portfolio’s security selection in the pharmaceutical/medical technology sector and the industrial cyclical sector was a leading contributor to relative performance.
Leading individual detractors from relative performance included the Portfolio’s out-of-Benchmark positions in Shopify Inc. and Snap Inc., and its overweight position in Advance Micro Devices Inc. Shares of Shopify, an e-commerce platform provider, fell early in the period after the company reported lower-than-expected earnings and revenue for the second quarter of 2022. Shares of Snap, an internet camera and communications service, fell amid declines in company revenue during the period. Shares of Advanced Micro Devices, a semiconductor manufacturer, fell along with the broader semiconductor sub-sector amid lower industry growth forecasts and changes in global technology supply chains.
Leading individual contributors to relative performance included the Portfolio’s overweight positions in AbbVie Inc., Norfolk Southern Co. and Mastercard Inc. Shares of AbbVie, a pharmaceuticals developer and manufacturer, rose amid a string of regulatory approvals for various drug candidates late in the period. Shares of Norfolk Southern, a freight railroad operator, rose as labor negotiations avoided a strike during the period. Shares of Mastercard, a credit card and financials
transactions processor, rose after the company increased its quarterly dividend and unveiled a $9 billion share repurchase plan.
HOW WAS THE PORTFOLIO POSITIONED?
The portfolio managers employed a bottom-up fundamental approach to stock selection, researching companies to determine what the portfolio managers believed to be each company’s underlying value and potential for future earnings growth. As a result of the portfolio managers’ bottom-up fundamental approach to stock selection, the Portfolio’s largest overweight positions relative to the Benchmark were in the big banks & brokers and utilities sectors and its largest underweight positions were in the consumer staples and
software & services sectors.
TOP TEN HOLDINGS OF THE
PORTFOLIO AS OF December 31, 2022 | PERCENT OF
TOTAL
INVESTMENTS |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| Mastercard, Inc., Class A | |
| NXP Semiconductors NV (China) | |
| | |
PORTFOLIO COMPOSITION BY SECTOR
AS OF December 31, 2022 | PERCENT OF
TOTAL
INVESTMENTS |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
*
The return shown is based on net asset values calculated for shareholder transactions and may differ from the return shown in the financial highlights, which reflects adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
**
"S&P 500 Index" is a registered service mark of Standard & Poor's Corporation, which does not sponsor, and is in no way affiliated with, the Portfolio.
***
The adviser seeks to achieve the Portfolio’s objective. There can be no guarantee it will be achieved.
JPMorgan Insurance Trust U.S. Equity Portfolio
PORTFOLIO COMMENTARY
TWELVE MONTHS ENDED December 31, 2022 (Unaudited) (continued)
AVERAGE ANNUAL TOTAL RETURNS AS OF December 31, 2022
TEN YEAR PORTFOLIO PERFORMANCE (12/31/12 TO 12/31/22)
The performance quoted is past performance and is not a guarantee of future results. Mutual funds are subject to certain market risks. Investment returns and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance data shown. For up-to-date month-end performance information please call 1-800-480-4111.
The graph illustrates comparative performance for $10,000 invested in Class 1 Shares of the JPMorgan Insurance Trust U.S. Equity Portfolio and the S&P 500 Index from December 31, 2012 to December 31, 2022. The performance of the Portfolio assumes reinvestment of all dividends and capital gain distributions, if any. The performance of the S&P 500 Index does not reflect the deduction of expenses associated with a mutual fund and has been adjusted to reflect reinvestment of all dividends and capital gain distributions of the securities
included in the benchmark, if applicable. The S&P 500 Index is an unmanaged index generally representative of the performance of large companies in the U.S. stock market. Investors cannot invest directly in an index.
Portfolio performance does not reflect any charges imposed by the Policies or Eligible Plans. If these charges were included, the returns would be lower than shown. Portfolio performance may reflect the waiver of the Portfolio’s fees and reimbursement of expenses for certain periods. Without these waivers and reimbursements, performance would have been lower.
The returns shown are based on net asset values calculated for shareholder transactions and may differ from the returns shown in the financial highlights, which reflect adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
JPMorgan Insurance Trust U.S. Equity Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022
| | |
|
Aerospace & Defense — 1.8% |
| | |
| | |
Raytheon Technologies Corp. | | |
| | |
| | |
Air Freight & Logistics — 0.2% |
United Parcel Service, Inc., Class B | | |
|
| | |
|
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
|
| | |
Constellation Brands, Inc., Class A | | |
| | |
| | |
|
| | |
| | |
BioMarin Pharmaceutical, Inc.* | | |
Neurocrine Biosciences, Inc.* | | |
Regeneron Pharmaceuticals, Inc.* | | |
Sarepta Therapeutics, Inc.* | | |
Vertex Pharmaceuticals, Inc.* | | |
| | |
|
| | |
|
Ameriprise Financial, Inc. | | |
Charles Schwab Corp. (The) | | |
| | |
| | |
Raymond James Financial, Inc. | | |
| | |
| | |
| | |
|
|
| | |
| | |
Linde plc (United Kingdom) | | |
| | |
| | |
Construction Materials — 0.8% |
| | |
Diversified Telecommunication Services — 0.8% |
Verizon Communications, Inc. | | |
Electric Utilities — 4.1% |
| | |
| | |
| | |
| | |
Electrical Equipment — 2.0% |
| | |
Electronic Equipment, Instruments & Components — 0.2% |
Keysight Technologies, Inc.* | | |
Energy Equipment & Services — 1.7% |
| | |
|
Endeavor Group Holdings, Inc., Class A* | | |
| | |
| | |
Equity Real Estate Investment Trusts (REITs) — 2.8% |
| | |
| | |
| | |
| | |
Health Care Equipment & Supplies — 3.0% |
Baxter International, Inc. | | |
| | |
Intuitive Surgical, Inc.* | | |
| | |
Health Care Providers & Services — 3.7% |
| | |
| | |
| | |
Hotels, Restaurants & Leisure — 3.2% |
| | |
Chipotle Mexican Grill, Inc.* | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust U.S. Equity Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Common Stocks — continued |
Hotels, Restaurants & Leisure — continued |
| | |
Marriott International, Inc., Class A | | |
| | |
| | |
| | |
Household Products — 0.4% |
| | |
Procter & Gamble Co. (The) | | |
| | |
Industrial Conglomerates — 0.4% |
Honeywell International, Inc. | | |
|
| | |
| | |
| | |
Interactive Media & Services — 4.5% |
| | |
| | |
Meta Platforms, Inc., Class A* | | |
| | |
Internet & Direct Marketing Retail — 3.2% |
| | |
|
Affirm Holdings, Inc.* (a) | | |
FleetCor Technologies, Inc.* | | |
Mastercard, Inc., Class A | | |
| | |
Life Sciences Tools & Services — 0.5% |
Thermo Fisher Scientific, Inc. | | |
|
| | |
| | |
| | |
| | |
|
Charter Communications, Inc., Class A* | | |
| | |
| | |
|
| | |
| | |
|
|
| | |
| | |
Public Service Enterprise Group, Inc. | | |
| | |
Oil, Gas & Consumable Fuels — 3.6% |
| | |
| | |
| | |
| | |
| | |
Pioneer Natural Resources Co. | | |
| | |
|
| | |
Elanco Animal Health, Inc.* | | |
| | |
| | |
| | |
| | |
Professional Services — 0.9% |
Booz Allen Hamilton Holding Corp. | | |
| | |
| | |
|
| | |
| | |
| | |
| | |
Semiconductors & Semiconductor Equipment — 6.6% |
Advanced Micro Devices, Inc.* | | |
| | |
ASML Holding NV (Registered), NYRS (Netherlands) | | |
| | |
NXP Semiconductors NV (China) | | |
| | |
| | |
|
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Common Stocks — continued |
|
| | |
| | |
| | |
|
| | |
| | |
O'Reilly Automotive, Inc.* | | |
| | |
| | |
Technology Hardware, Storage & Peripherals — 4.7% |
| | |
Seagate Technology Holdings plc | | |
| | |
Textiles, Apparel & Luxury Goods — 0.8% |
| | |
Wireless Telecommunication Services — 0.2% |
| | |
Total Common Stocks
(Cost $79,710) | | |
Short-Term Investments — 1.1% |
Investment Companies — 1.0% |
JPMorgan U.S. Government Money Market Fund Class Institutional Shares, 4.07%(b) (c)
(Cost $1,218) | | |
| | |
|
Investment of Cash Collateral from Securities Loaned — 0.1% |
JPMorgan U.S. Government Money Market Fund Class IM Shares, 4.12%(b) (c)
(Cost $51) | | |
Total Short-Term Investments
(Cost $1,269) | | |
Total Investments — 100.3%
(Cost $80,979) | | |
Liabilities in Excess of Other Assets — (0.3)% | | |
| | |
Percentages indicated are based on net assets. |
Amounts presented as a dash ("-") represent amounts that round to less than a thousand. |
| Non-income producing security. |
| The security or a portion of this security is on loan at December 31, 2022. The total value of securities on loan at December 31, 2022 is $49. |
| Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. |
| The rate shown is the current yield as of December 31, 2022. |
Futures contracts outstanding as of December 31, 2022 (amounts in thousands, except number of contracts):
| | | | | VALUE AND
UNREALIZED
APPRECIATION
(DEPRECIATION) ($) |
| | | | | |
| | | | | |
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF ASSETS AND LIABILITIES
AS OF December 31, 2022
(Amounts in thousands, except per share amounts)
| JPMorgan
Insurance
Trust U.S.
Equity
|
| |
Investments in non-affiliates, at value | |
Investments in affiliates, at value | |
Investments of cash collateral received from securities loaned, at value (See Note 2.B.) | |
Deposits at broker for futures contracts | |
| |
Investment securities sold | |
| |
Dividends from non-affiliates | |
Dividends from affiliates | |
Securities lending income (See Note 2.B.) | |
| |
| |
| |
Investment securities purchased | |
Collateral received on securities loaned (See Note 2.B.) | |
Portfolio shares redeemed | |
Variation margin on futures contracts | |
| |
| |
| |
| |
Custodian and accounting fees | |
Trustees’ and Chief Compliance Officer’s fees | |
| |
| |
| |
(a)
Amount rounds to less than one thousand.
SEE NOTES TO FINANCIAL STATEMENTS.
| JPMorgan Insurance Trust U.S. Equity |
| |
| |
Total distributable earnings (loss) | |
| |
| |
| |
| |
| |
Outstanding units of beneficial interest (shares)
(unlimited number of shares authorized, no par value): | |
| |
| |
| |
Class 1 — Offering and redemption price per share | |
Class 2 — Offering and redemption price per share | |
Cost of investments in non-affiliates | |
Cost of investments in affiliates | |
Investment securities on loan, at value (See Note 2.B.) | |
Cost of investment of cash collateral (See Note 2.B.) | |
(a)
Per share amounts may not recalculate due to rounding of net assets and/or shares outstanding.
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF OPERATIONS
FOR THE YEAR ENDED December 31, 2022
(Amounts in thousands)
| JPMorgan
Insurance
Trust U.S.
Equity
|
| |
Interest income from non-affiliates | |
Dividend income from non-affiliates | |
Dividend income from affiliates | |
Income from securities lending (net) (See Note 2.B.) | |
| |
| |
| |
| |
| |
| |
Custodian and accounting fees | |
| |
Trustees’ and Chief Compliance Officer’s fees | |
Printing and mailing costs | |
Transfer agency fees (See Note 2.F.) | |
| |
| |
| |
Less expense reimbursements | |
| |
Net investment income (loss) | |
REALIZED/UNREALIZED GAINS (LOSSES): | |
Net realized gain (loss) on transactions from: | |
Investments in non-affiliates | |
| |
| |
Change in net unrealized appreciation/depreciation on: | |
Investments in non-affiliates | |
| |
Change in net unrealized appreciation/depreciation | |
Net realized/unrealized gains (losses) | |
Change in net assets resulting from operations | |
(a)
Amount rounds to less than one thousand.
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENTS OF CHANGES IN NET ASSETS
FOR THE PERIODS INDICATED
(Amounts in thousands)
| JPMorgan Insurance Trust
U.S. Equity Portfolio |
| Year Ended
December 31, 2022 | Year Ended
December 31, 2021 |
CHANGE IN NET ASSETS RESULTING FROM OPERATIONS: | | |
Net investment income (loss) | | |
| | |
Change in net unrealized appreciation/depreciation | | |
Change in net assets resulting from operations | | |
DISTRIBUTIONS TO SHAREHOLDERS: | | |
| | |
| | |
Total distributions to shareholders | | |
| | |
Change in net assets resulting from capital transactions | | |
| | |
| | |
| | |
| | |
| | |
| | |
Proceeds from shares issued | | |
| | |
| | |
Change in net assets resulting from Class 1 capital transactions | | |
| | |
Proceeds from shares issued | | |
| | |
| | |
Change in net assets resulting from Class 2 capital transactions | | |
Total change in net assets resulting from capital transactions | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
FINANCIAL HIGHLIGHTS
FOR THE PERIODS INDICATED
| Per share operating performance |
| | | |
| Net asset
value,
beginning
of period | Net
investment
income
(loss)(a) | Net realized
and unrealized
gains
(losses) on
investments | Total from
investment
operations | | | |
JPMorgan Insurance Trust U.S. Equity Portfolio | | | | | | | |
| | | | | | | |
Year Ended December 31, 2022 | | | | | | | |
Year Ended December 31, 2021 | | | | | | | |
Year Ended December 31, 2020 | | | | | | | |
Year Ended December 31, 2019 | | | | | | | |
Year Ended December 31, 2018 | | | | | | | |
| | | | | | | |
Year Ended December 31, 2022 | | | | | | | |
Year Ended December 31, 2021 | | | | | | | |
Year Ended December 31, 2020 | | | | | | | |
Year Ended December 31, 2019 | | | | | | | |
Year Ended December 31, 2018 | | | | | | | |
|
| Calculated based upon average shares outstanding. |
| Includes adjustments in accordance with accounting principles generally accepted in the United States of America and as such, the net asset values for financial reporting purposes and the returns based upon those net asset values may differ from the net asset values and returns for shareholder transactions. |
| Total returns do not include charges that will be imposed by variable insurance contracts or by Eligible Plans. If these charges were reflected, returns would be lower than those shown. |
| Includes earnings credits and interest expense, if applicable, each of which is less than 0.005% unless otherwise noted. |
SEE NOTES TO FINANCIAL STATEMENTS.
| |
| | | Ratios to average net assets |
Net asset
value,
end of
period | | Net assets,
end of
period
(000's) | | Net
investment
income
(loss) | Expenses without
waivers and reimbursements | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
SEE NOTES TO FINANCIAL STATEMENTS.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022
(Dollar values in thousands)
1. Organization
JPMorgan Insurance Trust (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company and is a Massachusetts business trust.
The following is a separate portfolio of the Trust (the “Portfolio”) covered by this report:
| | Diversification Classification |
JPMorgan Insurance Trust U.S. Equity Portfolio | | |
The investment objective of the Portfolio is to seek to provide high total return from a portfolio of selected equity securities.
Portfolio shares are offered only to separate accounts of participating insurance companies and Eligible Plans. Individuals may not purchase shares directly from the Portfolio.
All classes of shares have equal rights as to earnings, assets and voting privileges, except that each class may bear different transfer agency fees and distribution fees and each class has exclusive voting rights with respect to its distribution plan and administrative services plan.
J.P. Morgan Investment Management Inc. (“JPMIM”), an indirect, wholly-owned subsidiary of JPMorgan Chase & Co. (“JPMorgan”), acts as Adviser (the “Adviser”) and Administrator (the “Administrator”) to the Portfolio.
2. Significant Accounting Policies
The following is a summary of significant accounting policies followed by the Portfolio in the preparation of its financial statements. The Portfolio is an investment company and, accordingly, follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 946 — Investment Companies, which is part of U.S. generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) disclosure of contingent assets and liabilities at the date of the financial statements, and (iii) the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.
A. Valuation of Investments — Investments are valued in accordance with GAAP and the Portfolio's valuation policies set forth by, and under the supervision and responsibility of, the Board of Trustees of the Trust (the "Board"), which established the following approach to valuation, as described more fully below: (i) investments for which market quotations are readily available shall be valued at their market value and (ii) all other investments for which market quotations are not readily available shall be valued at their fair value as determined in good faith by the Board.
Under Section 2(a)(41) of the 1940 Act, the Board is required to determine fair value for securities that do not have readily available market quotations. Under SEC Rule 2a-5 (Good Faith Determinations of Fair Value), the Board may designate the performance of these fair valuation determinations to a valuation designee. The Board has designated the Adviser as the “Valuation Designee” to perform fair valuation determinations for the Portfolio on behalf of the Board subject to appropriate oversight by the Board. The Adviser, as Valuation Designee, leverages the J.P. Morgan Asset Management Americas Valuation Committee (“AVC”) to help oversee and carry out the policies for the valuation of Investments held in the Portfolio. The Adviser, as Valuation Designee, remains responsible for the valuation determinations.
This oversight by the AVC includes monitoring the appropriateness of fair values based on results of ongoing valuation oversight including, but not limited to, consideration of macro or security specific events, market events, and pricing vendor and broker due diligence. The Administrator is responsible for discussing and assessing the potential impacts to the fair values on an ongoing basis, and, at least on a quarterly basis, with the AVC and the Board.
Equities and other exchange-traded instruments are valued at the last sale price or official market closing price on the primary exchange on which the instrument is traded before the net asset values (“NAV”) of the Portfolio are calculated on a valuation date.
Investments in open-end investment companies (“Underlying Funds”) are valued at each Underlying Fund’s NAV per share as of the report date.
Futures contracts are generally valued on the basis of available market quotations.
Valuations reflected in this report are as of the report date. As a result, changes in valuation due to market events and/or issuer-related events after the report date and prior to issuance of the report are not reflected herein.
The various inputs that are used in determining the valuation of the Portfolio's investments are summarized into the three broad levels listed below.
•
Level 1 — Unadjusted inputs using quoted prices in active markets for identical investments.
•
Level 2 — Other significant observable inputs including, but not limited to, quoted prices for similar investments, inputs other than quoted prices that are observable for investments (such as interest rates, prepayment speeds, credit risk, etc.) or other market corroborated inputs.
•
Level 3 — Significant inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Portfolio's assumptions in determining the fair value of investments).
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input, both individually and in the aggregate, that is significant to the fair value measurement. The inputs or methodology used for valuing instruments are not necessarily an indication of the risk associated with investing in those instruments.
The following table represents each valuation input as presented on the Schedule of Portfolio Investments ("SOI"):
| | | | |
| | Level 2
Other significant
observable inputs | Level 3
Significant
unobservable inputs | |
Total Investments in Securities (a) | | | | |
Depreciation in Other Financial Instruments | | | | |
| | | | |
|
| Please refer to the SOI for specifics of portfolio holdings. |
B. Securities Lending — The Portfolio is authorized to engage in securities lending in order to generate additional income. The Portfolio is able to lend to approved borrowers. Citibank N.A. (“Citibank”) serves as lending agent for the Portfolio, pursuant to a Securities Lending Agency Agreement (the “Securities Lending Agency Agreement”). Securities loaned are collateralized by cash equal to at least 100% of the market value plus accrued interest on the securities lent, which is invested in Class IM Shares of the JPMorgan U.S. Government Money Market Fund and the Agency SL Class Shares of the JPMorgan Securities Lending Money Market Fund. The Portfolio retains the interest earned on cash collateral investments but is required to pay the borrower a rebate for the use of the cash collateral. In cases where the lent security is of high value to borrowers, there may be a negative rebate (i.e., a net payment from the borrower to the Portfolio). Upon termination of a loan, the Portfolio is required to return to the borrower an amount equal to the cash collateral, plus any rebate owed to the borrowers. The remaining maturities of the securities lending transactions are considered overnight and continuous. Loans are subject to termination by the Portfolio or the borrower at any time.
The net income earned on the securities lending (after payment of rebates and Citibank’s fee) is included on the Statement of Operations as Income from securities lending (net). The Portfolio also receives payments from the borrower during the period of the loan, equivalent to dividends and interest earned on the securities loaned, which are recorded as Dividend or Interest income, respectively, on the Statement of Operations.
Under the Securities Lending Agency Agreement, Citibank marks to market the loaned securities on a daily basis. In the event the cash received from the borrower is less than 102% of the value of the loaned securities (105% for loans of non-U.S. securities), Citibank requests additional cash from the borrower so as to maintain a collateralization level of at least 102% of the value of the loaned securities plus accrued interest (105% for loans of non-U.S. securities), subject to certain de minimis amounts.
The value of securities out on loan is recorded as an asset on the Statement of Assets and Liabilities. The value of the cash collateral received is recorded as a liability on the Statement of Assets and Liabilities and details of collateral investments are disclosed on the SOI.
The Portfolio bears the risk of loss associated with the collateral investments and is not entitled to additional collateral from the borrower to cover any such losses. To the extent that the value of the collateral investments declines below the amount owed to a borrower, the Portfolio may incur losses that exceed the amount it earned on lending the security. Upon termination of a loan, the Portfolio may use leverage (borrow money) to repay the borrower for cash collateral posted if the Adviser does not believe that it is prudent to sell the collateral investments to fund the payment of this liability. Securities lending activity is subject to master netting arrangements.
The following table presents the Portfolio's value of the securities on loan with Citibank, net of amounts available for offset under the master netting arrangements and any related collateral received or posted by the Portfolio as of December 31, 2022.
| Investment Securities
on Loan, at value,
Presented on the
Statement of Assets
and Liabilities | Cash Collateral
Posted by Borrower* | Net Amount Due
to Counterparty
(not less than zero) |
| | | |
|
| Collateral posted reflects the value of securities on loan and does not include any additional amounts received from the borrower. |
Securities lending also involves counterparty risks, including the risk that the loaned securities may not be returned in a timely manner or at all. Subject to certain conditions, Citibank has agreed to indemnify the Portfolio from losses resulting from a borrower’s failure to return a loaned security.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
JPMIM voluntarily waived investment advisory fees charged to the Portfolio to reduce the impact of the cash collateral investment in the JPMorgan U.S. Government Money Market Fund from 0.13% to 0.06%. For the year ended December 31, 2022, JPMIM waived fees associated with the Portfolio's investment in the JPMorgan U.S. Government Money Market Fund as follows:
|
| Amount rounds to less than one thousand. |
The above waiver is included in the determination of earnings on cash collateral investment and in the calculation of Citibank’s compensation and is included on the Statement of Operations as Income from securities lending (net).
C. Investment Transactions with Affiliates — The Portfolio invested in Underlying Funds which are advised by the Adviser. An issuer which is under common control with the Portfolio may be considered an affiliate. For the purposes of the financial statements, the Portfolio assumes the issuers listed in the table below to be affiliated issuers. The Underlying Funds’ distributions may be reinvested into such Underlying Funds. Reinvestment amounts are included in the purchases at cost amounts in the table below.
|
For the year ended December 31, 2022 |
| | | | | Change in
Unrealized
Appreciation/
(Depreciation) | | Shares at
December 31,
2022 | | Capital Gain
Distributions |
JPMorgan U.S. Government Money Market Fund Class IM Shares, 4.12% (a) (b) | | | | | | | | | |
JPMorgan U.S. Government Money Market Fund Class Institutional Shares, 4.07% (a) (b) | | | | | | | | | |
| | | | | | | | | |
|
| Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. |
| The rate shown is the current yield as of December 31, 2022. |
| Amount is included on the Statement of Operations as Income from securities lending (net) (after payments of rebates and Citibank’s fee). |
D. Futures Contracts — The Portfolio used index futures contracts to gain or reduce exposure to the stock market, or maintain liquidity or minimize transaction costs. The Portfolio also purchased futures contracts to invest incoming cash in the market or sold futures in response to cash outflows, thereby simulating an invested position in the underlying index while maintaining a cash balance for liquidity.
Futures contracts provide for the delayed delivery of the underlying instrument at a fixed price or are settled for a cash amount based on the change in the value of the underlying instrument at a specific date in the future. Upon entering into a futures contract, the Portfolio is required to deposit with the broker, cash or securities in an amount equal to a certain percentage of the contract amount, which is referred to as the initial margin deposit. Subsequent payments, referred to as variation margin, are made or received by the Portfolio periodically and are based on changes in the market value of open futures contracts. Changes in the market value of open futures contracts are recorded as Change in net unrealized appreciation/depreciation on futures contracts on the Statement of Operations. Realized gains or losses, representing the difference between the value of the contract at the time it was opened and the value at the time it was closed, are reported on the Statement of Operations at the closing or expiration of the futures contract. Securities deposited as initial margin are designated on the SOI, while cash deposited, which is considered restricted, is recorded on the Statement of Assets and Liabilities. A receivable from and/or a payable to brokers for the daily variation margin is also recorded on the Statement of Assets and Liabilities.
The use of futures contracts exposes the Portfolio to equity risk. The Portfolio may be subject to the risk that the change in the value of the futures contract may not correlate perfectly with the underlying instrument. Use of long futures contracts subjects the Portfolio to risk of loss in excess of the amounts shown on the Statement of Assets and Liabilities, up to the notional amount of the futures contracts. Use of short futures contracts subjects the Portfolio to unlimited risk of loss. The Portfolio may enter into futures contracts only on exchanges or boards of trade. The exchange or board of trade acts as the counterparty to each futures transaction; therefore, the Portfolio's credit risk is limited to failure of the exchange or board of trade. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, which could effectively prevent liquidation of positions.
The Portfolio's futures contracts are not subject to master netting arrangements (the right to close out all transactions traded with a counterparty and net amounts owed or due across transactions).
The table below discloses the volume of the Portfolio's futures contracts activity during the year ended December 31, 2022:
| |
| |
Average Notional Balance Long | |
Ending Notional Balance Long | |
E. Security Transactions and Investment Income — Investment transactions are accounted for on the trade date (the date the order to buy or sell is executed). Securities gains and losses are calculated on a specifically identified cost basis.
Dividend income, net of foreign taxes withheld, if any, is recorded on the ex-dividend date or when the Portfolio first learns of the dividend.
To the extent such information is publicly available, the Portfolio records distributions received in excess of income earned from underlying investments as a reduction of cost of investments and/or realized gain. Such amounts are based on estimates if actual amounts are not available and actual amounts of income, realized gain and return of capital may differ from the estimated amounts. The Portfolio adjusts the estimated amounts of the components of distributions (and consequently its net investment income) as necessary, once the issuers provide information about the actual composition of the distributions.
F. Allocation of Income and Expenses— Expenses directly attributable to the Portfolio are charged directly to the Portfolio, while the expenses attributable to more than one portfolio of the Trust are allocated among the applicable portfolios. Investment income, realized and unrealized gains and losses and expenses, other than class-specific expenses, are allocated daily to each class of shares based upon the proportion of net assets of each class at the beginning of each day.
Transfer agency fees are class-specific expenses. The amount of the transfer agency fees charged to each share class of the Portfolio for the year ended December 31, 2022 are as follows:
|
| Amount rounds to less than one thousand. |
G. Federal Income Taxes — The Portfolio is treated as a separate taxable entity for Federal income tax purposes. The Portfolio's policy is to comply with the provisions of the Internal Revenue Code (the “Code”) applicable to regulated investment companies and to distribute to shareholders all of its distributable net investment income and net realized capital gains on investments. Accordingly, no provision for Federal income tax is necessary. The Portfolio is also a segregated portfolio of assets for insurance purposes and intends to comply with the diversification requirements of Sub-chapter L of the Code. Management has reviewed the Portfolio's tax positions for all open tax years and has determined that as of December 31, 2022, no liability for Federal income tax is required in the Portfolio's financial statements for net unrecognized tax benefits. However, management’s conclusions may be subject to future review based on changes in, or the interpretation of, the accounting standards or tax laws and regulations. The Portfolio's Federal tax returns for the prior three fiscal years remain subject to examination by the Internal Revenue Service.
H. Distributions to Shareholders — Distributions from net investment income, if any, are generally declared and paid at least annually and are declared separately for each class. No class has preferential dividend rights; differences in per share rates are due to differences in separate class expenses. Net realized capital gains, if any, are distributed at least annually. The amount of distributions from net investment income and net realized capital gains is determined in accordance with Federal income tax regulations, which may differ from GAAP. To the extent these “book/tax” differences are permanent in nature (i.e., that they result from other than timing of recognition — “temporary differences”), such amounts are reclassified within the capital accounts based on their Federal tax basis treatment.
The following amounts were reclassified within the capital accounts:
| | Accumulated
undistributed
(distributions in
excess of)
net investment
income | Accumulated
net realized
gains (losses) |
| | | |
|
| Amount rounds to less than one thousand. |
The reclassifications for the Portfolio relate primarily to tax adjustments on certain investments.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
3. Fees and Other Transactions with Affiliates
A. Investment Advisory Fee — Pursuant to an Investment Advisory Agreement, the Adviser manages the investments of the Portfolio and for such services is paid a fee. The investment advisory fee is accrued daily and paid monthly at an annual rate of 0.55% of the Portfolio's average daily net assets.
The Adviser waived investment advisory fees and/or reimbursed expenses as outlined in Note 3.E.
B. Administration Fee — Pursuant to an Administration Agreement, the Administrator provides certain administration services to the Portfolio. In consideration of these services, the Administrator receives a fee accrued daily and paid monthly at an annual rate of 0.075% of the first $10 billion of the Portfolio's average daily net assets, plus 0.050% of the Portfolio's average daily net assets between $10 billion and $20 billion, plus 0.025% of the Portfolio's average daily net assets between $20 billion and $25 billion, plus 0.010% of the Portfolio's average daily net assets in excess of $25 billion. For the year ended December 31, 2022, the effective rate was 0.075% of the Portfolio's average daily net assets, notwithstanding any fee waivers and/or expense reimbursements.
The Administrator waived administration fees as outlined in Note 3.E.
JPMorgan Chase Bank, N.A. ("JPMCB"), a wholly-owned subsidiary of JPMorgan, serves as the Portfolio's sub-administrator (the “Sub-administrator”). For its services as Sub-administrator, JPMCB receives a portion of the fees payable to the Administrator.
C. Distribution Fees — Pursuant to a Distribution Agreement, JPMorgan Distribution Services, Inc. (“JPMDS”), an indirect, wholly-owned subsidiary of JPMorgan, serves as the Portfolio's principal underwriter and promotes and arranges for the sale of the Portfolio's shares.
The Board has adopted a Distribution Plan (the “Distribution Plan”) for Class 2 Shares of the Portfolio pursuant to Rule 12b-1 under the 1940 Act. Class 1 Shares of the Portfolio do not charge a distribution fee. The Distribution Plan provides that the Portfolio shall pay, with respect to the applicable share classes, distribution fees, including payments to JPMDS, at an annual rate of 0.25% of the average daily net assets of Class 2 Shares.
D. Custodian and Accounting Fees — JPMCB provides portfolio custody and accounting services to the Portfolio. For performing these services, the Portfolio pays JPMCB transaction and asset-based fees that vary according to the number of transactions and positions, plus out-of-pocket expenses. The amounts paid directly to JPMCB by the Portfolio for custody and accounting services are included in Custodian and accounting fees on the Statement of Operations.
Interest income earned on cash balances at the custodian, if any, is included in Interest income from affiliates on the Statement of Operations.
Interest expense paid to the custodian related to cash overdrafts, if any, is included in Interest expense to affiliates on the Statement of Operations.
E. Waivers and Reimbursements —The Adviser (for all share classes), Administrator (for all share classes) and/or JPMDS (for Class 2 Shares) have contractually agreed to waive fees and/or reimburse the Portfolio to the extent that total annual operating expenses of the Portfolio (excluding acquired fund fees and expenses other than certain money market fund fees as described below, dividend and interest expenses related to short sales, interest, taxes, expenses related to litigation and potential litigation, expenses related to trustee elections and extraordinary expenses) exceed the percentages of the Portfolio's respective average daily net assets as shown in the table below:
The expense limitation agreement was in effect for the year ended December 31, 2022 and the contractual expense limitation percentages in the table above are in place until at least April 30, 2023.
For the year ended December 31, 2022, the Portfolio's service providers did not waive fees and/or reimburse expenses for the Portfolio.
Additionally, the Portfolio may invest in one or more money market funds advised by the Adviser (affiliated money market funds). The Adviser, Administrator and/or JPMDS, have contractually agreed to waive fees and/or reimburse expenses in an amount sufficient to offset the respective net fees each collects from the affiliated money market fund on the Portfolio's investment in such affiliated money market fund, except for investments of securities lending cash collateral. None of these parties expect the Portfolio to repay any such waived fees and/or reimbursed expenses in future years.
The amount of these waivers resulting from investments in these money market funds for the year ended December 31, 2022 was $3.
JPMIM voluntarily agreed to reimburse the Portfolio for the Trustee Fees paid to one of the interested Trustees. For the year ended December 31, 2022 the amount of this reimbursement was $1.
F. Other — Certain officers of the Trust are affiliated with the Adviser, the Administrator and JPMDS. Such officers, with the exception of the Chief Compliance Officer, receive no compensation from the Portfolio for serving in their respective roles.
The Board designated and appointed a Chief Compliance Officer to the Portfolio pursuant to Rule 38a-1 under the 1940 Act. The Portfolio, along with affiliated funds, makes reimbursement payments, on a pro-rata basis, to the Administrator for a portion of the fees associated with the office of the Chief Compliance Officer. Such fees are included in Trustees’ and Chief Compliance Officer’s fees on the Statement of Operations.
The Trust adopted a Trustee Deferred Compensation Plan (the “Plan”) which allows the independent Trustees to defer the receipt of all or a portion of compensation related to performance of their duties as Trustees. The deferred fees are invested in various J.P. Morgan Funds until distribution in accordance with the Plan.
The Securities and Exchange Commission ("SEC") has granted an exemptive order permitting the Portfolio to engage in principal transactions with J.P. Morgan Securities LLC, an affiliated broker, involving taxable money market instruments, subject to certain conditions.
4. Investment Transactions
During the year ended December 31, 2022, purchases and sales of investments (excluding short-term investments) were as follows:
| Purchases
(excluding
U.S. Government) | Sales
(excluding
U.S. Government) |
| | |
During the year ended December 31, 2022, there were no purchases or sales of U.S. Government securities.
5. Federal Income Tax Matters
For Federal income tax purposes, the estimated cost and unrealized appreciation (depreciation) in value of investments held at December 31, 2022 were as follows:
| | Gross
Unrealized
Appreciation | Gross
Unrealized
Depreciation | Net Unrealized
Appreciation
(Depreciation) |
| | | | |
The difference between book and tax basis appreciation (depreciation) on investments is primarily attributed to tax adjustments on certain investments and wash sale loss deferrals.
The tax character of distributions paid during the year ended December 31, 2022 was as follows:
| | Net
Long-Term
Capital Gains | |
| | | |
|
| Short-term gain distributions are treated as ordinary income for income tax purposes. |
The tax character of distributions paid during the year ended December 31, 2021 was as follows:
| | Net
Long-Term
Capital Gains | |
| | | |
|
| Short-term gain distributions are treated as ordinary income for income tax purposes. |
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
As of December 31, 2022, the estimated components of net assets (excluding paid-in-capital) on a tax basis were as follows:
| Current
Distributable
Ordinary
Income | Current
Distributable
Long-Term
Capital Gain
(Tax Basis Capital
Loss Carryover) | Unrealized
Appreciation
(Depreciation) |
| | | |
The cumulative timing differences primarily consist of tax adjustments on certain investments and wash sale loss deferrals.
As of December 31, 2022, the Portfolio did not have any net capital loss carryforwards.
6. Borrowings
The Portfolio relies upon an exemptive order granted by the SEC (the “Order”) permitting the establishment and operation of an Interfund Lending Facility (the “Facility”). The Facility allows the Portfolio to directly lend and borrow money to or from any other fund relying upon the Order at rates beneficial to both the borrowing and lending funds. Advances under the Facility are taken primarily for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities, and are subject to the Portfolio's borrowing restrictions. The interfund loan rate is determined, as specified in the Order, by averaging the current repurchase agreement rate and the current bank loan rate. The Order was granted to the Trust and may be relied upon by the Portfolio because the Portfolio and the series of the Trust are all investment companies in the same “group of investment companies” (as defined in Section 12(d)(1)(G) of the 1940 Act).
The Portfolio had no borrowings outstanding from another fund, or loans outstanding to another fund, during the year ended December 31, 2022.
The Trust and JPMCB have entered into a financing arrangement. Under this arrangement, JPMCB provides an unsecured, uncommitted credit facility in the aggregate amount of $100 million to certain of the J.P. Morgan Funds, including the Portfolio. Advances under the arrangement are taken primarily for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities, and are subject to the Portfolio's borrowing restrictions. Interest on borrowings is payable at a rate determined by JPMCB at the time of borrowing. This agreement has been extended until October 30, 2023.
The Portfolio had no borrowings outstanding from the unsecured, uncommitted credit facility during the year ended December 31, 2022.
The Trust, along with certain other trusts for J.P. Morgan Funds (“Borrowers”), has entered into a joint syndicated senior unsecured revolving credit facility totaling $1.5 billion (“Credit Facility”) with various lenders and The Bank of New York Mellon, as administrative agent for the lenders. This Credit Facility provides a source of funds to the Borrowers for temporary and emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities. Under the terms of the Credit Facility, a borrowing portfolio must have a minimum of $25 million in adjusted net asset value and not exceed certain adjusted net asset coverage ratios prior to and during the time in which any borrowings are outstanding. If a portfolio does not comply with the aforementioned requirements, the portfolio must remediate within three business days with respect to the $25 million minimum adjusted net asset value or within one business day with respect to certain asset coverage ratios or the administrative agent at the request of, or with the consent of, the lenders may terminate the Credit Facility and declare any outstanding borrowings to be due and payable immediately.
Interest associated with any borrowing under the Credit Facility is charged to the borrowing portfolio at a rate of interest equal to 1.00% (the "Applicable Margin"), plus the greater of the federal funds effective rate or one month London Interbank Offered Rate ("LIBOR"). The annual commitment fee to maintain the Credit Facility is 0.15% and is incurred on the unused portion of the Credit Facility and is allocated to all participating portfolios pro rata based on their respective net assets. Effective August 9, 2022, the Credit Facility has been amended and restated for a term of 364 days, unless extended, and to include a change in the interest associated with any borrowing to the higher, on the day of the borrowing, of (a) the federal funds effective rate, or (b) the one-month Adjusted SOFR Rate plus the Applicable Margin.
The Portfolio did not utilize the Credit Facility during the year ended December 31, 2022.
7. Risks, Concentrations and Indemnifications
In the normal course of business, the Portfolio enters into contracts that contain a variety of representations which provide general indemnifications. The Portfolio's maximum exposure under these arrangements is unknown. The amount of exposure would depend on future claims that may be brought against the Portfolio. However, based on experience, the Portfolio expects the risk of loss to be remote.
As of December 31, 2022, the Portfolio had three individual shareholder and/or non-affiliated omnibus accounts each owning more than 10% of the Portfolio's outstanding shares, and, collectively owning 63.8% of the Portfolio's outstanding shares.
Significant shareholder transactions by these shareholders may impact the Portfolio's performance and liquidity.
LIBOR is intended to represent the rate at which contributing banks may obtain short-term borrowings from each other in the London interbank market. On March 5, 2021, the U.K. Financial Conduct Authority ("FCA") publicly announced that (i) immediately after December 31, 2021, publication of the 1-week and 2-month U.S. Dollar LIBOR settings will permanently cease; (ii) immediately after June 30, 2023, publication of the overnight and 12-month U.S. Dollar LIBOR settings will permanently cease; and (iii) immediately after June 30, 2023, the 1-month, 3-month and 6-month U.S. Dollar LIBOR settings will cease to be provided or, subject to the FCA's consideration of the case, be provided on a synthetic basis and no longer be representative of the underlying market and economic reality they are intended to measure and that representativeness will not be restored. There is no assurance that the dates announced by the FCA will not change or that the administrator of LIBOR and/or regulators will not take further action that could impact the availability, composition or characteristics of LIBOR or the currencies and/or tenors for which LIBOR is published. In addition, certain regulated entities ceased entering into most new LIBOR contracts in connection with regulatory guidance or prohibitions. Public and private sector industry initiatives are currently underway to implement new or alternative reference rates to be used in place of LIBOR. There is no assurance that any such alternative reference rate will be similar to or produce the same value or economic equivalence as LIBOR or that it will have the same volume or liquidity as did LIBOR prior to its discontinuance, unavailability or replacement, all of which may affect the value, volatility, liquidity or return on certain of the Portfolio's loans, notes, derivatives and other instruments or investments comprising some or all of the Portfolio's investments and result in costs incurred in connection with changing reference rates used for positions closing out positions and entering into new trades. Certain of the Portfolio's investments may transition from LIBOR prior to the dates announced by the FCA. The transition from LIBOR to alternative reference rates may result in operational issues for the Portfolio or its investments. No assurances can be given as to the impact of the LIBOR transition (and the timing of any such impact) on the Portfolio and its investments.
The Portfolio is subject to infectious disease epidemics/pandemics risk. The worldwide outbreak of COVID-19 has negatively affected economies, markets and individual companies throughout the world. The effects of this COVID-19 pandemic to public health, and business and market conditions, including among other things, reduced consumer demand and economic output, supply chain disruptions and increased government spending may continue to have a significant negative impact on the performance of the Portfolio's investments, increase the Portfolio's volatility, exacerbate other pre-existing political, social and economic risks to the Portfolio and negatively impact broad segments of businesses and populations. In addition, governments, their regulatory agencies, or self-regulatory organizations have taken or may take actions in response to the pandemic that affect the instruments in which the Portfolio invests, or the issuers of such instruments, in ways that could also have a significant negative impact on the Portfolio's investment performance. The duration and extent of COVID-19 and associated economic and market conditions and uncertainty over the long-term cannot be reasonably estimated at this time. The ultimate impact of COVID-19 and the extent to which the associated conditions impact the Portfolio will also depend on future developments, which are highly uncertain, difficult to accurately predict and subject to frequent changes.
8. Other Matters
On December 12, 2022, the Board approved a proposal to reorganize the Portfolio into a newly organized series (the “Acquiring Fund") of Lincoln Variable Insurance Products Trust (the “Reorganization”).
The Acquiring Fund has the same investment objective and substantially identical principal investment strategies and principal risks as the Portfolio. The Acquiring Fund’s investment adviser will be Lincoln Investment Advisors Corporation, and it is anticipated that JPMIM will be retained as the sub-adviser to the Acquiring Fund upon consummation of the Reorganization. Upon the closing of the Reorganization, the Class 1 Shares and Class 2 Shares of the Portfolio will be exchanged for the same value of Standard Class Shares and Service Class Shares, respectively, of the Acquiring Fund.
The Reorganization is subject to the approval of the Portfolio’s shareholders at a special shareholder meeting to be held on or about March 15, 2023. If shareholder approval of the Reorganization is obtained, the Reorganization is expected to be effective on or about May 1, 2023. All costs related to the Reorganization will be borne by Lincoln Investment Advisors Corporation and JPMIM and not by the Portfolio or Acquiring Fund.
More detailed information about the reorganization was included in a proxy statement provided to shareholders.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Trustees of JPMorgan Insurance Trust and Shareholders of JPMorgan Insurance Trust U.S. Equity Portfolio
Opinion on the Financial Statements
We have audited the accompanying statement of assets and liabilities, including the schedule of portfolio investments, of JPMorgan Insurance Trust U.S. Equity Portfolio (one of the portfolios constituting JPMorgan Insurance Trust, referred to hereafter as the “Portfolio”) as of December 31, 2022, the related statement of operations for the year ended December 31, 2022, the statements of changes in net assets for each of the two years in the period ended December 31, 2022, including the related notes, and the financial highlights for each of the five years in the period ended December 31, 2022 (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Portfolio as of December 31, 2022, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended December 31, 2022 and the financial highlights for each of the five years in the period ended December 31, 2022 in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Portfolio’s management. Our responsibility is to express an opinion on the Portfolio’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Portfolio in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of December 31, 2022 by correspondence with the custodian, transfer agent and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
/s/ PricewaterhouseCoopers LLP
New York, New York
February 15, 2023
We have served as the auditor of one or more investment companies in the JPMorgan Funds complex since 1993.
The Portfolio's Statement of Additional Information includes additional information about the Portfolio's Trustees and is available, without charge, upon request by calling 1-800-480-4111 or on the Portfolio's website at www.jpmorgan.com/variableinsuranceportfolios.
Name (Year of Birth);
Positions With
the Portfolio (1) | Principal Occupation
During Past 5 Years | Number of
Funds in Fund
Complex Overseen
by Trustee (2) | Other Directorships Held
During the Past 5 Years |
| | | |
John F. Finn (1947); Chair
since 2020; Trustee since 1998. | Chairman, Gardner, Inc. (supply chain management company serving industrial and consumer markets) (serving in various roles 1974-present). | | Director, Greif, Inc. (GEF) (industrial package products and services) (2007-present); Trustee, Columbus Association for the Performing Arts (1988-present). |
Stephen P. Fisher (1959);
Trustee since 2018. | Retired; Chairman and Chief Executive Officer, NYLIFE Distributors LLC (registered broker-dealer) (serving in various roles 2008-2013); Chairman, NYLIM Service Company LLC (transfer agent) (2008-2017); New York Life Investment Management LLC (registered investment adviser) (serving in various roles 2005-2017); Chairman, IndexIQ Advisors LLC (registered investment adviser for ETFs) (2014-2017); President, MainStay VP Funds Trust (2007-2017), MainStay DefinedTerm Municipal Opportunities Fund (2011-2017) and MainStay Funds Trust (2007-2017) (registered investment companies). | | Honors Program Advisory Board Member, The Zicklin School of Business, Baruch College, The City University of New York (2017-present). |
Gary L. French (1951);
Trustee since 2014. | Real Estate Investor (2011-2020); Investment management industry Consultant and Expert Witness (2011-present); Senior Consultant for The Regulatory Fundamentals Group LLC (2011-2017). | | Independent Trustee, The China Fund, Inc. (2013-2019); Exchange Traded Concepts Trust II (2012-2014); Exchange Traded Concepts Trust I (2011-2014). |
Kathleen M. Gallagher (1958);
Trustee since 2018. | Retired; Chief Investment Officer — Benefit Plans, Ford Motor Company (serving in various roles 1985-2016). | | Non- Executive Director, Legal & General Investment Management (Holdings) (2018-present); Non-Executive Director, Legal & General Investment Management America (U.S. Holdings) (financial services and insurance) (2017-present); Advisory Board Member, State Street Global Advisors Total Portfolio Solutions (2017-present); Member, Client Advisory Council, Financial Engines, LLC (registered investment adviser) (2011-2016); Director, Ford Pension Funds Investment Management Ltd. (2007-2016). |
Robert J. Grassi (1957);
Trustee since 2014. | Sole Proprietor, Academy Hills Advisors LLC (2012-present); Pension Director, Corning Incorporated (2002-2012). | | |
TRUSTEES
(Unaudited) (continued)
Name (Year of Birth); Positions With the Portfolio (1) | Principal Occupation During Past 5 Years | Number of Funds in Fund Complex Overseen by Trustee (2) | Other Directorships Held During the Past 5 Years |
Frankie D. Hughes (1952);
Trustee since 2008. | President, Ashland Hughes Properties (property management) (2014-present); President and Chief Investment Officer, Hughes Capital Management, Inc. (fixed income asset management) (1993-2014). | | |
Raymond Kanner (1953);
Trustee since 2017. | Retired; Managing Director and Chief Investment Officer, IBM Retirement Funds (2007-2016). | | Advisory Board Member, Penso Advisors, LLC (2020-present); Advisory Board Member, Los Angeles Capital (2018-present); Advisory Board Member, State Street Global Advisors Total Portfolio Solutions (2017- present); Acting Executive Director, Committee on Investment of Employee Benefit Assets (CIEBA) (2016-2017); Advisory Board Member, Betterment for Business (robo advisor) (2016- 2017); Advisory Board Member, BlueStar Indexes (index creator) (2013-2017); Director, Emerging Markets Growth Fund (registered investment company) (1997-2016); Member, Russell Index Client Advisory Board (2001-2015). |
Thomas P. Lemke (1954);
Trustee since 2014. | | | (1) Independent Trustee of Advisors’ Inner Circle III fund platform, consisting of the following: (i) the Advisors’ Inner Circle Fund III, (ii) the Gallery Trust, (iii) the Schroder Series Trust, (iv) the Delaware Wilshire Private Markets Fund (since 2020), (v) Chiron Capital Allocation Fund Ltd., and (vi) formerly the Winton Diversified Opportunities Fund (2014-2018); and (2) Independent Trustee of the Symmetry Panoramic Trust (since 2018). |
Lawrence R. Maffia (1950);
Trustee since 2014 | Retired; Director and President, ICI Mutual Insurance Company (2006-2013). | | Director, ICI Mutual Insurance Company (1999-2013). |
Mary E. Martinez (1960); Vice
Chair since 2021; Trustee since 2013. | Associate, Special Properties, a Christie’s International Real Estate Affiliate (2010-present); Managing Director, Bank of America (asset management) (2007-2008); Chief Operating Officer, U.S. Trust Asset Management, U.S. Trust Company (asset management) (2003-2007); President, Excelsior Funds (registered investment companies) (2004-2005). | | |
Marilyn McCoy (1948);
Trustee since 2005. | Vice President of Administration and Planning, Northwestern University (1985-present). | | |
Name (Year of Birth); Positions With the Portfolio (1) | Principal Occupation During Past 5 Years | Number of Funds in Fund Complex Overseen by Trustee (2) | Other Directorships Held During the Past 5 Years |
Dr. Robert A. Oden, Jr. (1946); Trustee
since 2005. | Retired; President, Carleton College (2002-2010); President, Kenyon College (1995-2002). | | Trustee, The Coldwater Conservation Fund (2017-present); Trustee, American Museum of Fly Fishing (2013-present); Trustee and Vice Chair, Trout Unlimited (2017-2021);Trustee, Dartmouth- Hitchcock MedicalCenter (2011-2020). |
Marian U. Pardo* (1946);
Trustee since 2013. | Managing Director and Founder, Virtual Capital Management LLC (investment consulting) (2007-present); Managing Director, Credit Suisse Asset Management (portfolio manager) (2003-2006). | | Board Chair and Member, Board of Governors, Columbus Citizens Foundation (not-for-profit supporting philanthropic and cultural programs) (2006-present). |
Emily A. Youssouf (1951);
Trustee since 2022. | Adjunct Professor (2011-present) and Clinical Professor (2009-2011), NYU Schack Institute of Real Estate; Board Member and Member of the Audit Committee (2013–present), Chair of Finance Committee (2019-present), Member of Related Parties Committee (2013-2018) and Member of the Enterprise Risk Committee (2015-2018), PennyMac Financial Services, Inc.; Board Member (2005-2018), Chair of Capital Committee (2006-2016), Chair of Audit Committee (2005-2018), Member of Finance Committee (2005-2018) and Chair of IT Committee (2016-2018), NYC Health and Hospitals Corporation. | | Trustee, NYC School Construction Authority (2009-present); Board Member, NYS Job Development Authority (2008-present); Trustee and Chair of the Audit Committee of the Transit Center Foundation (2015-2019). |
| | | |
Robert F. Deutsch** (1957);
Trustee since 2014. | Retired; Head of ETF Business for JPMorgan Asset Management (2013-2017); Head of Global Liquidity Business for JPMorgan Asset Management (2003-2013). | | Treasurer and Director of the JUST Capital Foundation (2017-present). |
Nina O. Shenker** (1957);
Trustee since 2022. | Vice Chair (2017-2021), General Counsel and Managing Director (2008-2016), Associate General Counsel and Managing Director (2004-2008), J.P. Morgan Asset & Wealth Management. | | Director and Member of Legal and Human Resources Subcommittees, American Jewish Joint Distribution Committee (2018-present). |
|
| The year shown is the first year in which a Trustee became a member of any of the following: the JPMorgan Mutual Fund Board, the JPMorgan ETF Board, the heritage J.P. Morgan Funds or the heritage One Group Mutual Funds. Trustees serve an indefinite term, until resignation, retirement, removal or death. The Board’s current retirement policy sets retirement at the end of the calendar year in which the Trustee attains the age of 75, provided that any Board member who was a member of the JPMorgan Mutual Fund Board prior to January 1, 2022 and was born prior to January 1, 1950 shall retire from the Board at the end of the calendar year in which the Trustee attains the age of 78. |
| A Fund Complex means two or more registered investment companies that hold themselves out to investors as related companies for purposes of investment and investor services or have a common investment adviser or have an investment adviser that is an affiliated person of the investment adviser of any of the other registered investment companies. The J.P. Morgan Funds Complex for which the Board of Trustees serves currently includes nine registered investment companies (179 J.P. Morgan Funds). |
| In connection with prior employment with JPMorgan Chase, Ms. Pardo was the recipient of non-qualified pension plan payments from JPMorgan Chase in the amount of approximately $2,055 per month, which she irrevocably waived effective January 1, 2013, and deferred compensation payments from JPMorgan Chase in the amount of approximately $7,294 per year, which ended in January 2013. In addition, Ms. Pardo receives payments from a fully-funded qualified plan, which is not an obligation of JPMorgan Chase. |
| Designation as an “Interested Trustee” is based on prior employment by the Adviser or an affiliate of the Adviser or interests in a control person of the Adviser. |
TRUSTEES
(Unaudited) (continued)
| The contact address for each of the Trustees is 277 Park Avenue, New York, NY 10172. |
Name (Year of Birth),
Positions Held with
the Trust (Since) | Principal Occupations During Past 5 Years |
Brian S. Shlissel (1964),
President and Principal Executive
Officer (2016)* | Managing Director and Chief Administrative Officer for J.P. Morgan pooled vehicles, J.P. Morgan Investment Management Inc. since 2014. |
Timothy J. Clemens (1975),
Treasurer and Principal Financial
Officer (2018) | Executive Director, J.P. Morgan Investment Management Inc. since February 2016. Mr. Clemens has been with J.P. Morgan Investment Management Inc. since 2013. |
Gregory S. Samuels (1980),
Secretary (2019) (formerly Assistant
Secretary 2010-2019) | Managing Director and Assistant General Counsel, JPMorgan Chase & Co. Mr. Samuels has been with JPMorgan Chase & Co. since 2010. |
Stephen M. Ungerman (1953),
Chief Compliance Officer (2005) | Managing Director, JPMorgan Chase & Co. Mr. Ungerman has been with JPMorgan Chase & Co. since 2000. |
Kiesha Astwood-Smith (1973),
Assistant Secretary (2021) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since June 2021; Senior Director and Counsel, Equitable Financial Life Insurance Company (formerly, AXA Equitable Life Insurance Company) from September 2015 through June 2021. |
Matthew Beck (1988),
Assistant Secretary (2021)** | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since May 2021; Senior Legal Counsel, Ultimus Fund Solutions from May 2018 through May 2021; General Counsel, The Nottingham Company from April 2014 through May 2018. |
Elizabeth A. Davin (1964),
Assistant Secretary (2005)** | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Ms. Davin has been with JPMorgan Chase & Co. (formerly Bank One Corporation) since 2004. |
Jessica K. Ditullio (1962)
Assistant Secretary (2005)** | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Ms. Ditullio has been with JPMorgan Chase & Co. (formerly Bank One Corporation) since 1990. |
Anthony Geron (1971),
Assistant Secretary (2018) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since September 2018; Lead Director and Counsel, AXA Equitable Life Insurance Company from 2015 to 2018 and Senior Director and Counsel, AXA Equitable Life Insurance Company from 2014 to 2015. |
Carmine Lekstutis (1980),
Assistant Secretary (2011) | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Mr. Lekstutis has been with JPMorgan Chase & Co. since 2011. |
Max Vogel (1990),
Assistant Secretary (2021) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since June 2021; Associate, Proskauer Rose LLP (law firm) from March 2017 to June 2021. |
Zachary E. Vonnegut-Gabovitch
(1986),
Assistant Secretary (2017) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since September 2016. |
Michael M. D’Ambrosio (1969),
Assistant Treasurer (2012) | Managing Director, J.P. Morgan Investment Management Inc. Mr. D’Ambrosio has been with J.P. Morgan Investment Management Inc. since 2012. |
Aleksandr Fleytekh (1972),
Assistant Treasurer (2019) | Vice President, J.P. Morgan Investment Management Inc. since February 2012. |
Shannon Gaines (1977),
Assistant Treasurer (2018)** | Vice President, J.P. Morgan Investment Management Inc. since January 2014. |
Jeffrey D. House (1972),
Assistant Treasurer (2017)** | Vice President, J.P. Morgan Investment Management Inc. since July 2006. |
Michael Mannarino (1985),
Assistant Treasurer (2020) | Vice President, J.P. Morgan Investment Management Inc. since 2014. |
Joseph Parascondola (1963),
Assistant Treasurer (2011)* | Executive Director, J.P. Morgan Investment Management, Inc. Mr. Parascondola has been with J.P. Morgan Investment Management Inc. since 2006. |
Gillian I. Sands (1969),
Assistant Treasurer (2012) | Executive Director, J.P. Morgan Investment Management Inc. Ms. Sands has been with J.P. Morgan Investment Management Inc. since 2012. |
|
The contact address for each of the officers, unless otherwise noted, is 277 Park Avenue, New York, NY 10172. |
OFFICERS
(Unaudited) (continued)
| The contact address for the officer is 575 Washington Boulevard, Jersey City, NJ 07310. |
| The contact address for the officer is 1111 Polaris Parkway, Columbus, OH 43240. |
SCHEDULE OF SHAREHOLDER EXPENSES
(Unaudited)
Hypothetical $1,000 Investment
As a shareholder of the Portfolio, you incur ongoing costs, including investment advisory fees, administration fees, distribution fees (for Class 2 Shares) and other Portfolio expenses. Because the Portfolio is a funding vehicle for Policies and Eligible Plans you may also incur sales charges and other fees relating to the Policies or Eligible Plans. The examples below are intended to help you understand your ongoing costs (in dollars) of investing in the Portfolio, but not the costs of the Policies or Eligible Plans, and to compare these ongoing costs with the ongoing costs of investing in other mutual funds. The examples assume that you had a $1,000 investment in each Class at the beginning of the reporting period, July 1, 2022, and continued to hold your shares at the end of the reporting period, December 31, 2022.
Actual Expenses
For each Class of the Portfolio in the table below, the first line provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line of each Class under the heading titled “Expenses Paid During the Period” to estimate the expenses you paid on your account during this period.
Hypothetical Example for Comparison Purposes
The second line of each Class in the table below provides information about hypothetical account values and hypothetical expenses based on the Class’ actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Class’ actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in each Class of the Portfolio and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds. Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs, such as sales charges (loads), or redemption fees , or the costs associated with the Policies and Eligible Plans through which the Portfolio is held. Therefore, the second line for each Class in the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transaction costs were included, your costs would have been higher. The examples also assume all dividends and distributions have been reinvested.
| Beginning
Account Value
July 1, 2022 | Ending
Account Value
December 31, 2022 | Expenses
Paid During
the Period* | |
JPMorgan Insurance Trust U.S. Equity Portfolio | | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
|
| Expenses are equal to each Class’ respective annualized expense ratio, multiplied by the average account value over the period, multiplied by 184/365 (to reflect the one-half year period). |
BOARD APPROVAL OF INVESTMENT ADVISORY AGREEMENT
(Unaudited)
The Board of Trustees (the “Board” or the “Trustees”) has established various standing committees composed of Trustees with diverse backgrounds, to which the Board has assigned specific subject matter responsibilities to further enhance the effectiveness of the Board’s oversight and decision making. Effective January 2022, the Board consolidated with the J.P. Morgan Exchange-Traded Fund Trust Board and now consists of Trustees from both Boards. The Board and its investment committees (Money Market and Alternative Products Committee, Equity Committee, and Fixed Income Committee) met regularly throughout the year and, at each meeting, considered factors that are relevant to their annual consideration of the continuation of the investment advisory agreements. The Board also met for the specific purpose of considering investment advisory agreement annual renewals. The Board held meetings on June 21-22, 2022 and August 9-11, 2022, at which the Trustees considered the continuation of the investment advisory agreement for the Portfolio whose annual report is contained herein (the “Advisory Agreement”). At the June meeting, the Board’s investment committees met to review and consider performance, expense and related information for the J.P. Morgan Funds. Each investment committee reported to the full Board, which then considered each investment committee’s preliminary findings. At the August meeting, the Trustees continued their review and consideration. The Trustees, including a majority of the Trustees who are not parties to the Advisory Agreement or “interested persons” (as defined in the Investment Company Act of 1940) of any party to the Advisory Agreement or any of their affiliates, approved the continuation of the Advisory Agreement on August 11, 2022.
As part of their review of the Advisory Agreement, the Trustees considered and reviewed performance and other information about the Portfolio received from the Adviser. This information includes the Portfolio’s performance as compared to the performance of its peers and benchmarks, and analyses by the Adviser of the Portfolio’s performance. In addition, at each of their regular meetings throughout the year, the Trustees considered reports on the performance of certain J.P. Morgan Funds (including certain ETFs, beginning in February 2022) provided by an independent investment consulting firm (“independent consultant”). In addition, in preparation for the June and August meetings, the Trustees requested, received and evaluated extensive materials from the Adviser, including performance and expense information compiled by Broadridge, using data from Lipper Inc. and/or Morningstar Inc., independent providers of investment company data (together, “Broadridge”). Before voting on the Advisory Agreement, the Trustees reviewed the Advisory Agreement with representatives of the Adviser, counsel to the Trust, and independent legal counsel and received a memorandum from independent legal counsel to the Trustees discussing the legal standards for their consideration of the Advisory Agreement. The Trustees also
discussed the Advisory Agreement with independent legal counsel in executive sessions at which no representatives of the Adviser were present.
A summary of the material factors evaluated by the Trustees in determining whether to approve the Advisory Agreement is provided below. Each Trustee attributed different weights to the various factors and no factor alone was considered determinative. The Trustees considered information provided with respect to the Portfolio throughout the year, including additional reporting and information provided in connection with the COVID-19 pandemic, as well as materials furnished specifically in connection with the annual review process. From year to year, the Trustees consider and place emphasis on relevant information in light of changing circumstances in market and economic conditions.
After considering and weighing the factors and information they had received, the Trustees found that the compensation to be received by the Adviser from the Portfolio under the Advisory Agreement was fair and reasonable under the circumstances, and determined that the continuance of the Advisory Agreement was in the best interests of the Portfolio and its shareholders.
Nature, Extent and Quality of Services Provided by the Adviser
The Trustees received and considered information regarding the nature, extent and quality of services provided to the Portfolio under the Advisory Agreement. The Trustees took into account information furnished throughout the year at Trustee meetings, as well as the materials furnished specifically in connection with this annual review process. Among other things, the Trustees considered:
(i) The background and experience of the Adviser’s senior management and investment personnel, including personnel changes, if any;
(ii) The qualifications, backgrounds and responsibilities of the portfolio management team primarily responsible for the day-to-day management of the Portfolio, including personnel changes, if any;
(iii) The investment strategy for the Portfolio, and the infrastructure supporting the portfolio management team;
(iv) Information about the structure and distribution strategy for the Portfolio and how it fits with the Trust’s other fund offerings;
(v) The administration services provided by the Adviser in its role as Administrator;
(vi) Their knowledge of the nature and quality of the services provided by the Adviser and its affiliates gained from their experience as Trustees of the Trust and in the financial industry generally;
(vii) The overall reputation and capabilities of the Adviser and its affiliates;
(viii) The commitment of the Adviser to provide high quality
service to the Portfolio;
(ix) Their overall confidence in the Adviser’s integrity;
(x) The Adviser’s responsiveness to requests for additional information, questions or concerns raised by them, including the Adviser’s willingness to consider and implement organizational and operational changes designed to improve investment results and the services provided to the Portfolio; and
(xi) The Adviser’s business continuity plan and steps the Adviser and its affiliates have taken to provide ongoing services to the Portfolio during the COVID-19 pandemic, and the Adviser’s and its affiliates’ success in continuing to provide services to the Portfolio and its shareholders throughout this period.
Based upon these considerations and other factors, the Trustees concluded that they were satisfied with the nature, extent and quality of the services provided to the Portfolio by the Adviser.
Costs of Services Provided and Profitability to the Adviser and its Affiliates
The Trustees received and considered information regarding the profitability to the Adviser and its affiliates from providing services to the Portfolio. The Trustees reviewed and discussed this information. The Trustees recognized that this information is not audited and represents the Adviser’s determination of its and its affiliates’ revenues from the contractual services provided to the Portfolio, less expenses of providing such services. Expenses include direct and indirect costs and are calculated using an allocation methodology developed by the Adviser and reviewed with the Board. The Trustees also recognized that it is difficult to make comparisons of profitability from fund investment advisory contracts because comparative information is not generally publicly available and is affected by numerous factors, including the structure of the particular adviser, the types of funds it manages, its business mix, numerous assumptions regarding allocations and the fact that publicly-traded fund managers’ operating profits and net income are net of distribution and marketing expenses. Based upon their review, and taking into consideration the factors noted above, the Trustees concluded that the profitability to the Adviser under the Advisory Agreement was not unreasonable in light of the services and benefits provided to the Portfolio.
The Trustees also considered that JPMDS, an affiliate of the Adviser, and the Adviser earn fees from the Portfolio for providing administration services. These fees were shown separately in the profitability analysis presented to the Trustees. The Trustees also considered the payments of Rule 12b-1 fees to JPMDS, which also acts as the Portfolio’s distributor, and that these fees are in turn generally paid to insurance companies that use the Portfolio in connection with insurance products they issue, including financial intermediaries that are affiliates of the Adviser (although they are
retained by JPMDS in certain instances). The Trustees also considered the fees earned by JPMorgan Chase Bank, N.A. (“JPMCB”), an affiliate of the Adviser, for custody, fund accounting and other related services for the Portfolio, and the profitability of the arrangements to JPMCB.
Fall-Out Benefits
The Trustees reviewed information regarding potential “fall-out” or ancillary benefits received by the Adviser and its affiliates as a result of their relationship with the Portfolio. The Trustees considered that the J.P. Morgan Funds’ operating accounts are held at JPMCB, which, as a result, will receive float benefits for certain J.P. Morgan Funds, as applicable. The Trustees also noted that the Adviser supports a diverse set of products and services, which benefits the Adviser by allowing it to leverage its infrastructure to serve additional clients, including benefits that may be received by the Adviser and its affiliates in connection with the Portfolio’s potential investments in other funds advised by the Adviser. The Trustees also reviewed the Adviser’s allocation of fund brokerage for the J.P. Morgan Funds complex, including allocations to brokers who provide research to the Adviser, as well as the Adviser’s use of affiliates to provide other services and the benefits to such affiliates of doing so.
Economies of Scale
The Trustees considered the extent to which the Portfolio may benefit from potential economies of scale. The Trustees considered that there may not be a direct relationship between economies of scale realized by the Portfolio and those realized by the Adviser as assets increase. The Trustees considered the extent to which the Portfolio was priced to scale and whether it would be appropriate to add advisory fee breakpoints, but noted that the Portfolio has implemented fee waivers and contractual expense limitations (“Fee Caps”) which allow the Portfolio’s shareholders to share potential economies of scale from its inception and that the fees remain satisfactory relative to peer funds. The Trustees considered the benefits to the Portfolio of the use of an affiliated distributor and custodian, including the ability to rely on existing infrastructure supporting distribution, custodial and transfer agent services, and the ability to negotiate competitive fees for the Portfolio. The Trustees further considered the Adviser’s and JPMDS’s ongoing investments in their business in support of the Portfolio, including the Adviser’s and/or JPMDS’s investments in trading systems, technology (including improvements to the J.P. Morgan Funds’ website, and cybersecurity improvements), retention of key talent, and regulatory support enhancements. The Trustees concluded that the current fee structure for the Portfolio, including Fee Caps that the Adviser has in place that serve to limit the overall net expense ratios of the Portfolio at competitive levels, was reasonable. The Trustees concluded that the Portfolio’s shareholders received the benefits of
BOARD APPROVAL OF INVESTMENT ADVISORY AGREEMENT
(Unaudited) (continued)
potential economies of scale through the Fee Caps and the Adviser’s reinvestment in its operations to serve the Portfolio and its shareholders. The Trustees noted that the Adviser’s reinvestment ensures sufficient resources in terms of personnel and infrastructure to support the Portfolio.
Fees Relative to Adviser’s Other Clients
The Trustees received and considered information about the nature and extent of investment advisory services and fee rates offered to other clients of the Adviser, including, to the extent applicable, institutional separate accounts, collective investment trusts, other registered investment companies and/or private funds sub-advised by the Adviser, for investment management styles substantially similar to that of the Portfolio. The Trustees considered the complexity of investment management for registered investment companies relative to the Adviser’s other clients and noted differences, as applicable, in the fee structure and the regulatory, legal and other risks and responsibilities of providing services to the different clients. The Trustees considered that serving as an adviser to a registered investment company involves greater responsibilities and risks than acting as a sub-adviser and observed that sub-advisory fees may be lower than those charged by the Adviser to the Portfolio. The Trustees also noted that the adviser, not the applicable investment company, typically bears the sub-advisory fee and that many responsibilities related to the advisory function are typically retained by the primary adviser. The Trustees concluded that the fee rates charged to the Portfolio in comparison to those charged to the Adviser’s other clients were reasonable.
Investment Performance
The Trustees receive and consider information about the Portfolio’s performance throughout the year. In addition, the Trustees received and considered absolute and/or relative performance information for the Portfolio in a report prepared by Broadridge. The Trustees considered the total return performance information, which included the ranking of the Portfolio within a performance universe comprised of funds with the same Broadridge investment classification and objective (the “Universe”), as well as a subset of funds within the Universe (the “Peer Group”), by total return for the applicable one-, three- and five-year periods. The Trustees reviewed a description of Broadridge’s methodology for selecting mutual funds in the Portfolio’s Universe and Peer Group and noted that Universe and Peer Group quintile rankings were not calculated if the number of funds in the Universe and/or Peer Group did not meet a predetermined minimum. The Broadridge materials provided to the Trustees highlighted information with respect to a representative class to assist the Trustees in their review. As part of this review, the Trustees also reviewed the Portfolio’s performance against its benchmark and considered the performance information
provided for the Portfolio at regular Board meetings by the Adviser. The Trustees also engaged with the Adviser to consider what steps might be taken to improve performance, as applicable. The Broadridge performance data noted by the Trustees as part of their review and the determinations made by the Trustees with respect to the Portfolio’s performance are summarized below:
The Trustees noted that the Portfolio’s performance for Class 1 and Class 2 shares was in the first quintile of both the Peer Group and the Universe for each of the one-, three- and five-year periods ended December 31, 2021. The Trustees discussed the performance and investment strategy of the Portfolio with the Adviser and based upon this discussion and various other factors, concluded that the Portfolio’s performance was satisfactory.
Advisory Fees and Expense Ratios
The Trustees considered the contractual advisory fee rate and administration fee rate paid by the Portfolio to the Adviser and compared the combined rate to the information prepared by Broadridge concerning management fee rates paid by other funds in the same Broadridge category as the Portfolio. The Trustees recognized that Broadridge reported the Portfolio’s management fee rate as the combined contractual advisory fee and administration fee rates. The Trustees also reviewed information about other expenses and the expense ratios for the Portfolio and noted that Universe and Peer Group quintile rankings were not calculated if the number of funds in the Universe and/or Peer Groups did not meet a predetermined minimum. The Trustees considered the Fee Caps currently in place for the Portfolio, the net advisory fee rate after taking into account any waivers and/or reimbursements and, where deemed appropriate by the Trustees, additional waivers and/or reimbursements. The Trustees recognized that it can be difficult to make comparisons of advisory fees because there are variations in the services that are included in the fees paid by other funds. The Trustees’ determinations as a result of the review of the Portfolio’s advisory fees and expense ratios are summarized below:
The Trustees noted that the Portfolio’s net advisory fee for Class 1 shares was in the third quintile of both the Peer Group and Universe, and that the actual total expenses for Class 1 shares were in the fourth quintiles of both the Peer Group and Universe. The Trustees noted that the Portfolio’s net advisory fee for Class 2 shares was in the second and fourth quintiles of the Peer Group and Universe, respectively, and that the actual total expenses for Class 2 shares were in the third and fourth quintile of the Peer Group and Universe, respectively. After considering the factors identified above, in light of this information, the Trustees concluded that the advisory fee was satisfactory in light of the services provided to the Portfolio.
TAX LETTER
(Unaudited)
(Dollar values in thousands)
Dividends Received Deduction (DRD)
The Portfolio had 23.31%, or maximum allowable percentage, of ordinary income distributions eligible for the dividends received deduction for corporate shareholders for the fiscal year ended December 31, 2022.
Long Term Capital Gain
The Portfolio distributed $12,352, or maximum allowable amount, of long-term capital gain dividends for the fiscal year ended December 31, 2022.
THIS PAGE IS INTENTIONALLY LEFT BLANK
THIS PAGE IS INTENTIONALLY LEFT BLANK
THIS PAGE IS INTENTIONALLY LEFT BLANK
J.P. Morgan Funds are distributed by JPMorgan Distribution Services, Inc., which is an affiliate of JPMorgan Chase & Co. Affiliates of JPMorgan Chase & Co. receive fees for providing various services to the funds.
Contact JPMorgan Distribution Services, Inc. at 1-800-480-4111 for a portfolio prospectus. You can also visit us at www.jpmorgan.com/variableinsuranceportfolios. Investors should carefully consider the investment objectives and risk as well as charges and expenses of the mutual fund before investing. The prospectus contains this and other information about the mutual fund. Read the prospectus carefully before investing.
Investors may obtain information about the Securities Investor Protection Corporation (SIPC), including the SIPC brochure, by visiting www.sipc.org or by calling SIPC at 202-371-8300.
The Portfolio files a complete schedule of its portfolio holdings for the first and third quarters of its fiscal year with the SEC as an exhibit to its report on Form N-PORT. The Portfolio’s Form N-PORT reports are available on the SEC’s website at http://www.sec.gov. The Portfolio's quarterly holdings can be found by visiting the Portfolio's website at www.jpmorgan.com/variableinsuranceportfolios.
A description of the Portfolio’s policies and procedures with respect to the disclosure of the Portfolio’s holdings is available in the prospectuses and Statement of Additional Information.
A copy of proxy policies and procedures is available without charge upon request by calling 1-800-480-4111 and on the Portfolio’s website at www.jpmorgan.com/variableinsuranceportfolios. A description of such policies and procedures is on the SEC’s website at www.sec.gov. The Trustees have delegated the authority to vote proxies for securities owned by the Portfolio to the Adviser. A copy of the Portfolio’s voting record for the most recent 12-month period ended June 30 is available on the SEC’s website at www.sec.gov or at the Portfolio’s website at www.jpmorgan.com/variableinsuranceportfolios no later than August 31 of each year. The Portfolio’s proxy voting record will include, among other things, a brief description of the matter voted on for each portfolio security, and will state how each vote was cast, for example, for or against the proposal.
J.P. Morgan Asset Management is the brand name for the asset management business of JPMorgan Chase & Co. and its affiliates worldwide.
© JPMorgan Chase & Co., 2022. All rights reserved. December 2022.
AN-JPMITUSEP-1222
Annual Report
JPMorgan Insurance Trust
December 31, 2022
JPMorgan Insurance Trust Income Builder Portfolio |
CONTENTS
Investments in the Portfolio are not deposits or obligations of, or guaranteed or endorsed by, any bank and are not insured or guaranteed by the FDIC, the Federal Reserve Board or any other government agency. You could lose money if you sell when the Portfolio’s share price is lower than when you invested.
Past performance is no guarantee of future performance. The general market views expressed in this report are opinions based on market and other conditions through the end of the reporting period and are subject to change without notice. These views are not intended to predict the future performance of the Portfolio or the securities markets.
This Portfolio is intended to be a funding vehicle for variable annuity contracts and variable life insurance policies (collectively “Policies”) offered by the separate accounts of various insurance companies. Portfolio shares may also be offered to qualified pension and retirement plans and accounts permitting accumulation of assets on a tax-deferred basis (“Eligible Plans”). Individuals may not purchase shares directly from the Portfolio.
Prospective investors should refer to the Portfolio’s prospectuses for a discussion of the Portfolio’s investment objective, strategies and risks. Call J.P. Morgan Funds Service Center at 1-800-480-4111 for a prospectus containing more complete information about the Portfolio, including management fees and other expenses. Please read it carefully before investing.
Letter to Shareholders
February 13, 2023 (Unaudited)
Dear Shareholder,
Financial markets have rebounded somewhat as the U.S. and other developed market economies have shown notable resilience in the face of higher inflation, rising interest rates and the ongoing war in Ukraine. While the factors that weighed on equity and bond markets in 2022 largely remain, there are signals that inflationary pressures may have peaked and the long-term economic outlook appears positive.
|
“Investors may face continued economic and geopolitical challenges in the year ahead. However, some of the acute risks encountered in 2022 appear to have receded and last year’s reset in asset prices may provide attractive investment opportunities.” — Brian S. Shlissel
|
While U.S. economic growth was surprisingly strong in the closing months of 2022, with broad gains in employment and consumer spending in the final months of the year, the U.S. Federal Reserve’s efforts to counter inflationary pressure through sharply higher interest rates could slow economic momentum in the months ahead.
Corporate earnings have been squeezed by higher costs for materials and labor, while the strong U.S. dollar has hindered export revenues. However, the impact of higher prices and interest rates has not landed on all sectors of the economy evenly. Energy sector profits have soared over the past year, while earnings in housing and construction sectors have declined.
Across Europe, the war in Ukraine has driven up prices for energy, food and a range of other goods and has fueled negative consumer sentiment. The prolonged nature of the conflict and its potential to spread remain key concerns among policymakers, diplomats, military planners, economists and investors. It is worth noting that Europe’s largest industrialized nations in concert with the European Union have moved swiftly to secure alternatives to Russian sources of natural gas and petroleum, which has eased an energy crisis that began last year.
Investors may face continued economic and geopolitical challenges in the year ahead. However, some of the acute risks encountered in 2022 appear to have receded and last year’s reset in asset prices may provide attractive investment opportunities. A long-term view and a properly diversified portfolio, in our opinion, remain key elements to a successful investment approach.
Our broad array of investment solutions seeks to provide investors with ability to build durable portfolios that can help them meet their financial goals.
Sincerely,
Brian S. Shlissel
President - J.P. Morgan Funds
J.P. Morgan Asset Management
1-800-480-4111 or www.jpmorganfunds.com for more information
JPMorgan Insurance Trust Income Builder Portfolio
PORTFOLIO COMMENTARY
TWELVE MONTHS ENDED December 31, 2022 (Unaudited)
| |
Portfolio (Class 2 Shares)* | |
MSCI World Index (net total return) | |
60% MSCI World Index (net total return) / 40% Bloomberg U.S. Aggregate Index (formerly known as Income Builder Composite Benchmark) | |
Net Assets as of 12/31/2022 (In Thousands) | |
INVESTMENT OBJECTIVE**
The JPMorgan Insurance Trust Income Builder Portfolio (the “Portfolio”) seeks to maximize income while maintaining prospects for capital appreciation.
HOW DID THE MARKET PERFORM?
Overall, financial markets tumbled in the first three quarters of 2022, but rebounded moderately in the final months of the year. Equity markets turned in their worst first-half performance since 1970, amid accelerating inflation, pandemic lockdowns across China and Russia’s invasion of Ukraine. While bond markets also slumped, investor demand for U.S. Treasury bonds and core U.S. corporate debt provided some support for the Bloomberg U.S. Aggregate Index, which broadly tr acks the performance of the U.S. investment-grade bond market.
The S&P 500 Index, which gauges the performance of U.S. large-cap equities, reached a new closing high on January 3, 2022, bolstered by record high corporate earnings, sales, cash flows, share repurchases and dividends. However, investor sentiment began to sour as accelerating inflation started to erode consumer confidence and raise expectations for an increase in benchmark interest rates by the U.S. Federal Reserve (the “Fed”).
Russia’s invasion of Ukraine at the end of February 2022 initiated a sell-off in global financial markets that was further fueled by the highest U.S. inflation rate in more than 40 years. Equity prices recovered somewhat in March 2022 amid better-than-expected corporate earnings. However, the general trend in global financial markets was downward throughout the year.
In response to accelerating inflationary pressure, the Fed raised its benchmark interest rate mid-March, the first increase since December 2018. The central bank followed with six more rate increases over the course of 2022. The Bank of England, which began raising interest rates in late 2021, also continued to raise interest rates throughout the year, while the European Central Bank waited until June before sharply raising interest rates for the first time in 11 years.
In the U.S., equity prices experienced a sharp sell-off in August and September 2022 that coincided with U.S. Federal Reserve policy guidance on further interest rate increases. However, corporate earnings for both the second and third quarters of 2022 generally were better than expected given a cooling economy and slower consumer spending. Meanwhile, the U.S. unemployment rate remained historically low - hovering between 3.5% and 3.7% for the six-month period - and by the end of 2022 data indicated some inflationary pressures had eased.
Across Europe, the energy crisis that followed Russia’s invasion of Ukraine in late February 2022 eased somewhat in the second half of the year as both the U.K. and the EU obtained alternatives to Russian energy imports and global energy prices receded. A political crisis in the U.K. roiled financial markets in London but the ascension of Rishi Sunak to prime minister appeared to remove some investor uncertainty.
Emerging markets broadly declined during the period but there was wide variance among individual nations. Chinese equities continued to underperform amid investor concerns about the economic impact of the country’s strict anti-pandemic policies, as well as weakness within China’s real estate sector and changes in the global trade for information. While energy prices retreated from historically high levels in the second half of 2022, overall commodities prices remained elevated, which benefitted markets in exporting nations but hurt markets in net importing nations.
For the twelve-month period, leading equity and bond market indexes were mostly negative, with non-U.S. developed markets equities outperforming both U.S. and emerging markets generally equities. Bonds in both developed and emerging markets also generally declined for the year.
WHAT WERE THE MAIN DRIVERS OF THE PORTFOLIO’S PERFORMANCE?
The Portfolio’s Class 2 Shares outperformed both the MSCI World Index (net total return) (the “Benchmark”) and the combined 60% MSCI World Index / 40% Bloomberg
U.S. Aggregate Index (the “Composite”), for the twelve months ended December 31, 2022.
The Portfolio’s allocation to debt securities helped performance relative to the Benchmark, given the general underperformance of equities in 2022.
Relative to the Composite, the Portfolio’s allocation to non-U.S. equities and its allocation to global real estate investment trusts were leading detractors from performance. The Portfolio’s overweight allocation to high-dividend stocks in the U.S. was a leading contributor to relative performance, as those asset classes generally outperformed emerging markets equity and fixed income assets, including government bonds, in 2022.
HOW WAS THE PORTFOLIO POSITIONED?
During the reporting period, the Portfolio was positioned to tactically pursue income. During the majority of the reporting period, the portfolio managers decreased the Portfolio’s overall equity allocation, specifically within US equities. The portfolio managers also increased their allocation to equity-linked notes, focusing on notes linked to the U.S. large cap index, and maintained their allocation to credit. Within fixed income, the Portfolio added to its U.S. investment grade corporates allocation in order to improve liquidity and quality in its credit allocation.
TOP TEN POSITIONS OF THE
PORTFOLIO AS OF December 31, 2022 | PERCENT OF
TOTAL
INVESTMENTS |
| JPMorgan Equity Premium Income ETF | |
| JPMorgan Equity Income Fund, Class R6 | |
| JPMorgan Managed Income Fund, Class L | |
| U.S. Treasury Notes 0.13%, 1/31/2023 | |
| JPMorgan High Yield Research Enhanced ETF | |
| JPMorgan Floating Rate Income Fund, Class R6 | |
| National Bank of Canada, ELN, 9.00%, 4/4/2023, (linked to Nasdaq-100 Index) (Canada) | |
| BNP Paribas, ELN, 9.00%, 3/23/2023, (linked to Nasdaq-100 Index) (France) | |
| BNP Paribas, ELN, 8.50%, 3/16/2023, (linked to Nasdaq-100 Index) (France) | |
| Societe Generale SA, ELN, 9.00%, 3/1/2023, (linked to Nasdaq-100 Index) (France) | |
PORTFOLIO COMPOSITION BY ASSET CLASS
AS OF December 31, 2022 | PERCENT OF
TOTAL
INVESTMENTS |
| |
| |
| |
| |
| |
Commercial Mortgage-Backed Securities | |
U.S. Treasury Obligations | |
Others (each less than 1.0%) | |
| |
ELN Equity-Linked Note
ETF Exchange-Traded Fund
*
The return shown is based on net asset values calculated for shareholder transactions and may differ from the return shown in the financial highlights, which reflects adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
**
The adviser seeks to achieve the Portfolio’s objective. There can be no guarantee it will be achieved.
JPMorgan Insurance Trust Income Builder Portfolio
PORTFOLIO COMMENTARY
TWELVE MONTHS ENDED December 31, 2022 (Unaudited) (continued)
AVERAGE ANNUAL TOTAL RETURNS AS OF December 31, 2022
LIFE OF PORTFOLIO PERFORMANCE (12/9/14 TO 12/31/22)
The performance quoted is past performance and is not a guarantee of future results. Mutual funds are subject to certain market risks. Investment returns and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance data shown. For up-to-date month-end performance information please call 1-800-480-4111.
The Portfolio commenced operations on December 9, 2014.
The graph illustrates comparative performance for $10,000 invested in Class 2 Shares of the JPMorgan Insurance Trust Income Builder Portfolio, the MSCI World Index (net total return), the Bloomberg U.S. Aggregate Index and the 60% MSCI World Index (net total return) / 40% Bloomberg U.S. Aggregate Index from December 9, 2014 to June 30, 2022. The performance of the Portfolio assumes reinvestment of all dividends and capital gain distributions, if any. The performance of the MSCI World Index (net total return), the Bloomberg U.S. Aggregate Index and the 60% MSCI World Index (net total return) / 40% Bloomberg U.S. Aggregate Index do not reflect the deduction of expenses associated with a mutual fund and have been adjusted to reflect reinvestment of all dividends and capital gain distributions of the securities included in the
benchmarks, if applicable. The MSCI World Index (net total return) is a free float-adjusted market capitalization weighted index that is designed to measure the equity market performance of developed markets. The Bloomberg U.S. Aggregate Index is an unmanaged index that represents securities that are SEC-registered, taxable, and dollar denominated. The index covers the U.S. investment grade fixed rate bond market, with index components for government and corporate securities, mortgage pass-through securities, and asset-backed securities. The 60% MSCI World Index (net total return) / 40% Bloomberg U.S. Aggregate Index is a customized blend of unmanaged indices.
Portfolio performance does not reflect any charges imposed by the Policies or Eligible Plans. If these charges were included, the returns would be lower than shown. Portfolio performance may reflect the waiver of the Portfolio’s fees and reimbursement of expenses for certain periods since the inception date. Without these waivers and reimbursements, performance would have been lower. The returns shown are based on net asset values calculated for shareholder transactions and may differ from the returns shown in the financial highlights, which reflect adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
JPMorgan Insurance Trust Income Builder Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022
| | |
|
|
| | |
| | |
Bendigo & Adelaide Bank Ltd. | | |
| | |
Charter Hall Long Wale, REIT | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Woodside Energy Group Ltd. | | |
| | |
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
Warehouses De Pauw CVA, REIT | | |
| | |
|
B3 SA - Brasil Bolsa Balcao | | |
BB Seguridade Participacoes SA | | |
EDP - Energias do Brasil SA | | |
Itau Unibanco Holding SA (Preference) | | |
| | |
|
Algonquin Power & Utilities Corp. | | |
| | |
|
|
| | |
| | |
| | |
Bank of Nova Scotia (The) | | |
| | |
| | |
Canadian Imperial Bank of Commerce | | |
Canadian Natural Resources Ltd. | | |
Canadian Tire Corp. Ltd., Class A | | |
Canadian Utilities Ltd., Class A | | |
| | |
Chartwell Retirement Residences | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Restaurant Brands International, Inc. | | |
Shaw Communications, Inc., Class B | | |
Sienna Senior Living, Inc. | | |
| | |
| | |
| | |
Toronto-Dominion Bank (The) | | |
TransAlta Renewables, Inc. | | |
| | |
|
Banco Santander Chile, ADR | | |
|
China Construction Bank Corp., Class H | | |
China Construction Bank Corp., Class H | | |
China Merchants Bank Co. Ltd., Class H | | |
China Petroleum & Chemical Corp., Class H | | |
China Resources Gas Group Ltd. | | |
China Resources Land Ltd. | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Income Builder Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Common Stocks — continued |
|
Fuyao Glass Industry Group Co. Ltd., Class A | | |
Fuyao Glass Industry Group Co. Ltd., Class H(a) | | |
Guangdong Investment Ltd. | | |
Haier Smart Home Co. Ltd., Class H | | |
Huayu Automotive Systems Co. Ltd., Class A | | |
Inner Mongolia Yili Industrial Group Co. Ltd., Class A | | |
Joyoung Co. Ltd., Class A | | |
Midea Group Co. Ltd., Class A | | |
| | |
| | |
Ping An Insurance Group Co. of China Ltd., Class H | | |
Tingyi Cayman Islands Holding Corp. | | |
Topsports International Holdings Ltd.(a) | | |
Wuliangye Yibin Co. Ltd., Class A | | |
Xinyi Glass Holdings Ltd. | | |
| | |
Zhejiang Supor Co. Ltd., Class A | | |
| | |
|
AP Moller - Maersk A/S, Class B | | |
| | |
| | |
Novo Nordisk A/S, Class B | | |
| | |
| | |
|
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
| | |
| | |
|
|
| | |
| | |
Cie Generale des Etablissements Michelin SCA | | |
| | |
| | |
| | |
| | |
Gaztransport Et Technigaz SA | | |
| | |
La Francaise des Jeux SAEM(a) | | |
LVMH Moet Hennessy Louis Vuitton SE | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
| | |
| | |
| | |
Bayerische Motoren Werke AG | | |
| | |
Deutsche Post AG (Registered) | | |
Deutsche Telekom AG (Registered) | | |
| | |
| | |
| | |
| | |
Muenchener Rueckversicherungs-Gesellschaft AG (Registered) | | |
| | |
Telefonica Deutschland Holding AG | | |
| | |
| | |
|
| | |
CK Infrastructure Holdings Ltd. | | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Common Stocks — continued |
|
| | |
| | |
HK Electric Investments & HK Electric Investments Ltd.(a) | | |
| | |
| | |
Hong Kong Exchanges & Clearing Ltd. | | |
| | |
New World Development Co. Ltd. | | |
Orient Overseas International Ltd. | | |
| | |
Power Assets Holdings Ltd. | | |
| | |
| | |
Yue Yuen Industrial Holdings Ltd. | | |
| | |
|
| | |
|
Bank Rakyat Indonesia Persero Tbk. PT | | |
Telkom Indonesia Persero Tbk. PT, ADR | | |
| | |
|
| | |
| | |
Assicurazioni Generali SpA | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Mediobanca Banca di Credito Finanziario SpA | | |
| | |
| | |
Terna - Rete Elettrica Nazionale | | |
| | |
| | |
| | |
| | |
|
|
| | |
| | |
| | |
| | |
Chubu Electric Power Co., Inc. | | |
Chugoku Electric Power Co., Inc. (The) | | |
Comforia Residential REIT, Inc., REIT | | |
Dai Nippon Printing Co. Ltd. | | |
Daiwa House REIT Investment Corp., REIT | | |
Electric Power Development Co. Ltd. | | |
| | |
| | |
Frontier Real Estate Investment Corp., REIT | | |
Hokkaido Electric Power Co., Inc. | | |
| | |
Japan Metropolitan Fund Invest, REIT | | |
Japan Post Holdings Co. Ltd. | | |
| | |
Kansai Electric Power Co., Inc. (The) | | |
| | |
Kenedix Office Investment Corp., REIT | | |
| | |
Mitsubishi Chemical Group Corp. | | |
Mitsui Fudosan Logistics Park, Inc., REIT | | |
Nippon Accommodations Fund, Inc., REIT | | |
Nippon Prologis REIT, Inc., REIT | | |
| | |
Nippon Telegraph & Telephone Corp. | | |
Okinawa Electric Power Co., Inc. (The) | | |
| | |
| | |
Shin-Etsu Chemical Co. Ltd. | | |
| | |
Sumitomo Forestry Co. Ltd. | | |
Takeda Pharmaceutical Co. Ltd. | | |
Tohoku Electric Power Co., Inc. | | |
Tokio Marine Holdings, Inc. | | |
| | |
| | |
| | |
United Urban Investment Corp., REIT | | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Income Builder Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Common Stocks — continued |
|
| | |
| | |
| | |
|
Bolsa Mexicana de Valores SAB de CV | | |
Grupo Financiero Banorte SAB de CV, Class O | | |
| | |
Kimberly-Clark de Mexico SAB de CV, Class A | | |
| | |
Wal-Mart de Mexico SAB de CV | | |
| | |
|
| | |
| | |
| | |
BE Semiconductor Industries NV | | |
| | |
Koninklijke Ahold Delhaize NV | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
| | |
| | |
| | |
|
| | |
| | |
| | |
| | |
| | |
Gjensidige Forsikring ASA | | |
| | |
| | |
| | |
| | |
| | |
|
|
Powszechny Zaklad Ubezpieczen SA | | |
|
EDP - Energias de Portugal SA | | |
| | |
| | |
| | |
| | |
Redes Energeticas Nacionais SGPS SA | | |
| | |
|
Moscow Exchange MICEX-RTS PJSC‡ * | | |
Severstal PAO, GDR‡ * (a) | | |
Severstal PAO, GDR‡ * (a) | | |
| | |
|
| | |
|
| | |
CapitaLand Ascendas, REIT | | |
CapitaLand Integrated Commercial Trust, REIT | | |
| | |
Digital Core REIT Management Pte. Ltd., REIT | | |
Keppel Infrastructure Trust | | |
| | |
Singapore Telecommunications Ltd. | | |
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
ESR Kendall Square REIT Co. Ltd., REIT | | |
Hana Financial Group, Inc. | | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Common Stocks — continued |
|
| | |
| | |
Samsung Electronics Co. Ltd. | | |
Shinhan Financial Group Co. Ltd. | | |
| | |
| | |
| | |
|
ACS Actividades de Construccion y Servicios SA | | |
Atlantica Sustainable Infrastructure plc | | |
Banco Bilbao Vizcaya Argentaria SA | | |
| | |
| | |
| | |
Cia de Distribucion Integral Logista Holdings SA | | |
| | |
| | |
| | |
Industria de Diseno Textil SA | | |
| | |
Merlin Properties Socimi SA, REIT | | |
| | |
| | |
| | |
| | |
| | |
|
| | |
| | |
| | |
Skandinaviska Enskilda Banken AB, Class A | | |
| | |
Svenska Handelsbanken AB, Class A | | |
| | |
| | |
| | |
| | |
|
| | |
Cie Financiere Richemont SA (Registered) | | |
| | |
| | |
| | |
|
|
| | |
UBS Group AG (Registered) | | |
Zurich Insurance Group AG | | |
| | |
|
| | |
ASE Technology Holding Co. Ltd. | | |
Chailease Holding Co. Ltd. | | |
| | |
| | |
Mega Financial Holding Co. Ltd. | | |
Novatek Microelectronics Corp. | | |
President Chain Store Corp. | | |
| | |
Realtek Semiconductor Corp. | | |
Taiwan Semiconductor Manufacturing Co. Ltd., ADR | | |
Taiwan Semiconductor Manufacturing Co. Ltd. | | |
Vanguard International Semiconductor Corp. | | |
| | |
| | |
|
| | |
Siam Cement PCL (The) (Registered) | | |
| | |
|
| | |
| | |
| | |
| | |
| | |
Berkeley Group Holdings plc | | |
Big Yellow Group plc, REIT | | |
| | |
British American Tobacco plc | | |
| | |
| | |
Coca-Cola Europacific Partners plc | | |
| | |
| | |
Direct Line Insurance Group plc | | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Income Builder Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Common Stocks — continued |
United Kingdom — continued |
| | |
| | |
| | |
InterContinental Hotels Group plc | | |
| | |
Legal & General Group plc | | |
| | |
LondonMetric Property plc, REIT | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Reckitt Benckiser Group plc | | |
| | |
Safestore Holdings plc, REIT | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
UNITE Group plc (The), REIT | | |
United Utilities Group plc | | |
| | |
| | |
| | |
|
| | |
| | |
AGNC Investment Corp., REIT | | |
Alexandria Real Estate Equities, Inc., REIT | | |
| | |
American Electric Power Co., Inc. | | |
American Tower Corp., REIT | | |
Americold Realty Trust, Inc., REIT | | |
| | |
| | |
Annaly Capital Management, Inc., REIT | | |
| | |
|
United States — continued |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Boston Properties, Inc., REIT | | |
| | |
Camden Property Trust, REIT | | |
| | |
| | |
| | |
CF Industries Holdings, Inc. | | |
| | |
| | |
| | |
| | |
Clear Channel Outdoor Holdings, Inc.* | | |
Clearway Energy, Inc., Class C | | |
| | |
| | |
| | |
Cogent Communications Holdings, Inc. | | |
| | |
| | |
Consolidated Edison, Inc. | | |
| | |
| | |
| | |
| | |
| | |
Digital Realty Trust, Inc., REIT | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Common Stocks — continued |
United States — continued |
| | |
Equitrans Midstream Corp. | | |
Equity LifeStyle Properties, Inc. | | |
| | |
| | |
| | |
Federal Realty Investment Trust, REIT | | |
| | |
| | |
Frontier Communications Parent, Inc.* | | |
| | |
| | |
| | |
| | |
| | |
| | |
Hawaiian Electric Industries, Inc. | | |
Healthpeak Properties, Inc., REIT | | |
Hewlett Packard Enterprise Co. | | |
Host Hotels & Resorts, Inc., REIT | | |
| | |
iHeartMedia, Inc., Class A* | | |
| | |
International Business Machines Corp. | | |
| | |
Interpublic Group of Cos., Inc. (The) | | |
| | |
Iron Mountain, Inc., REIT | | |
| | |
| | |
| | |
| | |
| | |
Kilroy Realty Corp., REIT | | |
| | |
| | |
| | |
Kite Realty Group Trust, REIT | | |
| | |
Laureate Education, Inc., Class A | | |
| | |
LyondellBasell Industries NV, Class A | | |
| | |
| | |
| | |
|
United States — continued |
| | |
| | |
National Retail Properties, Inc., REIT | | |
| | |
| | |
| | |
| | |
| | |
| | |
Nordic American Tankers Ltd. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Park Hotels & Resorts, Inc., REIT | | |
Philip Morris International, Inc. | | |
| | |
Pinnacle West Capital Corp. | | |
Pioneer Natural Resources Co. | | |
| | |
Procter & Gamble Co. (The) | | |
| | |
| | |
Prudential Financial, Inc. | | |
Public Service Enterprise Group, Inc. | | |
| | |
Raytheon Technologies Corp. | | |
| | |
Regency Centers Corp., REIT | | |
Rexford Industrial Realty, Inc., REIT | | |
| | |
Seagate Technology Holdings plc | | |
Shenandoah Telecommunications Co. | | |
Simon Property Group, Inc., REIT | | |
Sirius XM Holdings, Inc.(b) | | |
| | |
| | |
| | |
Sun Communities, Inc., REIT | | |
T. Rowe Price Group, Inc. | | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Income Builder Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Common Stocks — continued |
United States — continued |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
United Parcel Service, Inc., Class B | | |
| | |
| | |
| | |
Verizon Communications, Inc. | | |
| | |
| | |
VICI Properties, Inc., REIT | | |
| | |
Vornado Realty Trust, REIT | | |
Walgreens Boots Alliance, Inc. | | |
| | |
| | |
| | |
| | |
Williams Cos., Inc. (The) | | |
| | |
| | |
Total Common Stocks
(Cost $31,263) | | |
| | |
|
|
Australia & New Zealand Banking Group Ltd. (USD ICE Swap Rate 5 Year + 5.17%), 6.75%, 6/15/2026(c) (d) (e) (f) | | |
FMG Resources August 2006 Pty. Ltd. 4.50%, 9/15/2027(c) | | |
| | |
| | |
| | |
| | |
| | |
|
|
| | |
Macquarie Group Ltd. 6.21%, 11/22/2024(c) | | |
| | |
|
Anheuser-Busch InBev Worldwide, Inc. | | |
| | |
| | |
| | |
|
1011778 BC ULC 3.88%, 1/15/2028(c) | | |
Bank of Montreal Series H, 4.70%, 9/14/2027 | | |
Bank of Nova Scotia (The) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 4.55%), 4.90%, 6/4/2025(d) (e) (f) | | |
| | |
Baytex Energy Corp. 8.75%, 4/1/2027(c) | | |
Bell Canada (The) Series US-5, 2.15%, 2/15/2032 | | |
Bombardier, Inc. 7.50%, 3/15/2025(c) | | |
Canadian Pacific Railway Co. 2.90%, 2/1/2025 | | |
Emera, Inc. (ICE LIBOR USD 3 Month + 5.44%), 6.75%, 6/15/2076(f) | | |
| | |
Series 16-A, (ICE LIBOR USD 3 Month + 3.89%), 6.00%, 1/15/2077(f) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 5.31%), 5.75%, 7/15/2080(f) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 4.42%), 7.63%, 1/15/2083(f) | | |
Fortis, Inc. 3.06%, 10/4/2026 | | |
GFL Environmental, Inc. 3.50%, 9/1/2028(c) | | |
| | |
| | |
| | |
| | |
Precision Drilling Corp. 7.13%, 1/15/2026(c) | | |
Quebecor Media, Inc. 5.75%, 1/15/2023 | | |
Rogers Communications, Inc. | | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Corporate Bonds — continued |
|
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.59%), 5.25%, 3/15/2082(c) (f) | | |
Toronto-Dominion Bank (The) | | |
| | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 4.08%), 8.12%, 10/31/2082(f) | | |
| | |
Series 16-A, (ICE LIBOR USD 3 Month + 4.64%), 5.87%, 8/15/2076(f) | | |
(SOFR + 4.42%), 5.50%, 9/15/2079(f) | | |
Videotron Ltd. 5.13%, 4/15/2027(c) | | |
| | |
|
Global Aircraft Leasing Co. Ltd. 6.50% (PIK), 9/14/2024(c) (g) | | |
|
| | |
| | |
| | |
| | |
|
Altice France SA 8.13%, 2/1/2027(c) | | |
Credit Agricole SA (USD Swap Semi 5 Year + 6.19%), 8.12%, 12/23/2025(c) (d) (e) (f) | | |
| | |
|
Deutsche Telekom International Finance BV 8.75%, 6/15/2030(h) | | |
|
AerCap Holdings NV (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 4.54%), 5.87%, 10/10/2079(f) | | |
Avolon Holdings Funding Ltd. | | |
| | |
| | |
| | |
| | |
Park Aerospace Holdings Ltd. | | |
| | |
| | |
| | |
| | |
|
|
Telecom Italia Capital SA | | |
| | |
| | |
| | |
|
Intelsat Jackson Holdings SA 6.50%, 3/15/2030(c) | | |
|
Sands China Ltd. 5.63%, 8/8/2025(h) | | |
|
ING Groep NV (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.86%), 3.88%, 5/16/2027(d) (e) (f) | | |
Shell International Finance BV 2.75%, 4/6/2030 | | |
Trivium Packaging Finance BV 5.50%, 8/15/2026(c) (h) | | |
| | |
|
Svenska Handelsbanken AB (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 4.05%), 4.75%, 3/1/2031(a) (d) (e) (f) | | |
|
Cloverie plc for Zurich Insurance Co. Ltd. (ICE LIBOR USD 3 Month + 4.92%), 5.63%, 6/24/2046(a) (f) | | |
UBS Group AG (USD Swap Semi 5 Year + 4.87%), 7.00%, 2/19/2025(a) (d) (e) (f) | | |
| | |
|
| | |
| | |
| | |
| | |
| | |
(EUR Swap Annual 5 Year + 4.12%), 3.63%, 3/22/2029(a) (d) (e) (f) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 4.40%), 4.88%, 3/22/2030(d) (e) (f) | | |
HSBC Holdings plc (SOFR + 0.58%), 1.16%, 11/22/2024(f) | | |
NatWest Group plc (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 5.63%), 6.00%, 12/29/2025(d) (e) (f) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Income Builder Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Corporate Bonds — continued |
United Kingdom — continued |
| | |
| | |
(USD Swap Semi 5 Year + 4.87%), 7.00%, 4/4/2079(f) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.77%), 4.12%, 6/4/2081(f) | | |
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Acadia Healthcare Co., Inc. 5.50%, 7/1/2028(c) | | |
ACCO Brands Corp. 4.25%, 3/15/2029(c) | | |
Activision Blizzard, Inc. 1.35%, 9/15/2030 | | |
| | |
| | |
| | |
Advanced Drainage Systems, Inc. 5.00%, 9/30/2027(c) | | |
| | |
Aetna, Inc. 3.88%, 8/15/2047 | | |
| | |
| | |
| | |
| | |
| | |
| | |
Alabama Power Co. 3.75%, 9/1/2027 | | |
Albemarle Corp. 4.65%, 6/1/2027(b) | | |
| | |
| | |
| | |
Alcoa Nederland Holding BV 6.13%, 5/15/2028(c) | | |
Alexandria Real Estate Equities, Inc., REIT 2.75%, 12/15/2029 | | |
Allied Universal Holdco LLC | | |
| | |
| | |
| | |
|
United States — continued |
Allison Transmission, Inc. | | |
| | |
| | |
| | |
| | |
| | |
Series C, (US Treasury Yield Curve Rate T Note Constant Maturity 7 Year + 3.48%), 4.70%, 5/15/2028(d) (e) (f) | | |
| | |
| | |
| | |
| | |
AMC Entertainment Holdings, Inc. 10.00% (Cash), 6/14/2026(b) (c) (g) | | |
Ameren Corp. 3.50%, 1/15/2031 | | |
| | |
| | |
| | |
American Axle & Manufacturing, Inc. | | |
| | |
| | |
American Electric Power Co., Inc. | | |
| | |
| | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.68%), 3.88%, 2/15/2062(f) | | |
American International Group, Inc. (ICE LIBOR USD 3 Month + 2.87%), 5.75%, 4/1/2048(f) | | |
American Tower Corp., REIT | | |
| | |
| | |
| | |
| | |
| | |
Amgen, Inc. 2.00%, 1/15/2032 | | |
Amkor Technology, Inc. 6.63%, 9/15/2027(c) | | |
Amsted Industries, Inc. 5.63%, 7/1/2027(c) | | |
Antero Midstream Partners LP | | |
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Corporate Bonds — continued |
United States — continued |
Apple, Inc. 4.50%, 2/23/2036 | | |
Aramark Services, Inc. 5.00%, 2/1/2028(c) | | |
Arches Buyer, Inc. 4.25%, 6/1/2028(c) | | |
Archrock Partners LP 6.88%, 4/1/2027(c) | | |
Arconic Corp. 6.00%, 5/15/2025(c) | | |
Ardagh Packaging Finance plc 4.13%, 8/15/2026(c) | | |
Asbury Automotive Group, Inc. 4.63%, 11/15/2029(c) | | |
| | |
| | |
| | |
| | |
Athene Global Funding 0.95%, 1/8/2024(c) | | |
ATI, Inc. 5.88%, 12/1/2027 | | |
Audacy Capital Corp. 6.50%, 5/1/2027(c) | | |
Avantor Funding, Inc. 4.63%, 7/15/2028(c) | | |
Avient Corp. 7.13%, 8/1/2030(c) | | |
Avis Budget Car Rental LLC 5.75%, 7/15/2027(b) (c) | | |
B&G Foods, Inc. 5.25%, 4/1/2025 | | |
Baker Hughes Holdings LLC 3.14%, 11/7/2029 | | |
| | |
Series X, (ICE LIBOR USD 3 Month + 3.71%), 6.25%, 9/5/2024(d) (e) (f) | | |
Series Z, (ICE LIBOR USD 3 Month + 4.17%), 6.50%, 10/23/2024(d) (e) (f) | | |
(SOFR + 0.74%), 0.81%, 10/24/2024(f) | | |
(ICE LIBOR USD 3 Month + 0.97%), 3.46%, 3/15/2025(f) | | |
Series AA, (ICE LIBOR USD 3 Month + 3.90%), 6.10%, 3/17/2025(d) (e) (f) | | |
(SOFR + 0.91%), 0.98%, 9/25/2025(f) | | |
(SOFR + 0.65%), 1.53%, 12/6/2025(f) | | |
Series DD, (ICE LIBOR USD 3 Month + 4.55%), 6.30%, 3/10/2026(d) (e) (f) | | |
(SOFR + 1.75%), 4.83%, 7/22/2026(b) (f) | | |
Series RR, (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.76%), 4.38%, 1/27/2027(d) (e) (f) | | |
Series N, (SOFR + 0.91%), 1.66%, 3/11/2027(f) | | |
Series TT, (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.23%), 6.13%, 4/27/2027(d) (e) (f) | | |
(SOFR + 0.96%), 1.73%, 7/22/2027(f) | | |
| | |
|
United States — continued |
Series FF, (ICE LIBOR USD 3 Month + 2.93%), 5.87%, 3/15/2028(d) (e) (f) | | |
(SOFR + 1.21%), 2.57%, 10/20/2032(f) | | |
Bank of New York Mellon Corp. (The) | | |
Series F, (ICE LIBOR USD 3 Month + 3.13%), 4.62%, 9/20/2026(d) (e) (f) | | |
(SOFRINDX + 2.07%), 5.83%, 10/25/2033(f) | | |
Bath & Body Works, Inc. 7.50%, 6/15/2029(b) | | |
Bausch Health Americas, Inc. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Becton Dickinson and Co. 2.82%, 5/20/2030 | | |
| | |
| | |
| | |
| | |
| | |
| | |
Block, Inc. 3.50%, 6/1/2031(b) | | |
Blue Racer Midstream LLC 6.63%, 7/15/2026(c) | | |
Boston Properties LP, REIT 2.45%, 10/1/2033 | | |
Boyd Gaming Corp. 4.75%, 12/1/2027(b) | | |
BP Capital Markets America, Inc. | | |
| | |
| | |
Brink's Co. (The) 4.63%, 10/15/2027(c) | | |
Bristol-Myers Squibb Co. 4.13%, 6/15/2039 | | |
Broadcom, Inc. 4.30%, 11/15/2032 | | |
Buckeye Partners LP 3.95%, 12/1/2026 | | |
Builders FirstSource, Inc. 4.25%, 2/1/2032(c) | | |
Bunge Ltd. Finance Corp. 1.63%, 8/17/2025 | | |
BWX Technologies, Inc. 4.13%, 4/15/2029(c) | | |
Caesars Entertainment, Inc. 6.25%, 7/1/2025(c) | | |
Callon Petroleum Co. 6.38%, 7/1/2026 | | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Income Builder Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Corporate Bonds — continued |
United States — continued |
Capital One Financial Corp. | | |
(SOFR + 0.69%), 1.34%, 12/6/2024(f) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.16%), 3.95%, 9/1/2026(d) (e) (f) | | |
Carnival Corp. 9.88%, 8/1/2027(c) | | |
Catalent Pharma Solutions, Inc. 5.00%, 7/15/2027(b) (c) | | |
| | |
| | |
| | |
| | |
| | |
| | |
Cedar Fair LP 5.25%, 7/15/2029 | | |
Celanese US Holdings LLC 6.05%, 3/15/2025 | | |
Centene Corp. 3.38%, 2/15/2030 | | |
CenterPoint Energy, Inc. (ICE LIBOR USD 3 Month + 3.27%), 6.13%, 9/1/2023(d) (e) (f) | | |
Central Garden & Pet Co. 5.13%, 2/1/2028 | | |
CF Industries, Inc. 4.50%, 12/1/2026(c) | | |
Charles Schwab Corp. (The) | | |
Series G, (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 4.97%), 5.38%, 6/1/2025(d) (e) (f) | | |
Series H, (US Treasury Yield Curve Rate T Note Constant Maturity 10 Year + 3.08%), 4.00%, 12/1/2030(d) (e) (f) | | |
| | |
| | |
| | |
Cheniere Energy Partners LP | | |
| | |
| | |
Chesapeake Energy Corp. 6.75%, 4/15/2029(c) | | |
Chevron Corp. 2.24%, 5/11/2030 | | |
Cigna Corp. 4.38%, 10/15/2028 | | |
| | |
(ICE LIBOR USD 3 Month + 4.07%), 5.95%, 1/30/2023(d) (e) (f) | | |
Series M, (ICE LIBOR USD 3 Month + 3.42%), 6.30%, 5/15/2024(d) (e) (f) | | |
Series U, (SOFR + 3.81%), 5.00%, 9/12/2024(d) (e) (f) | | |
(SOFR + 0.69%), 0.78%, 10/30/2024(f) | | |
| | |
|
United States — continued |
Series V, (SOFR + 3.23%), 4.70%, 1/30/2025(d) (e) (f) | | |
(ICE LIBOR USD 3 Month + 0.90%), 3.35%, 4/24/2025(f) | | |
(SOFR + 0.67%), 0.98%, 5/1/2025(f) | | |
Series P, (ICE LIBOR USD 3 Month + 3.91%), 5.95%, 5/15/2025(d) (e) (f) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.60%), 4.00%, 12/10/2025(d) (e) (f) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.42%), 3.88%, 2/18/2026(d) (e) (f) | | |
(ICE LIBOR USD 3 Month + 4.52%), 6.25%, 8/15/2026(d) (e) (f) | | |
(SOFR + 1.55%), 5.61%, 9/29/2026(f) | | |
(SOFR + 0.77%), 1.46%, 6/9/2027(f) | | |
Citizens Financial Group, Inc. | | |
(ICE LIBOR USD 3 Month + 3.00%), 6.00%, 7/6/2023(d) (e) (f) | | |
(ICE LIBOR USD 3 Month + 3.16%), 6.37%, 4/6/2024(d) (e) (f) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.22%), 4.00%, 10/6/2026(d) (e) (f) | | |
Clarivate Science Holdings Corp. 3.88%, 7/1/2028(c) | | |
Clear Channel Outdoor Holdings, Inc. 5.13%, 8/15/2027(c) | | |
Cleveland-Cliffs, Inc. 5.88%, 6/1/2027 | | |
CMS Energy Corp. (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 4.12%), 4.75%, 6/1/2050(f) | | |
CNX Resources Corp. 7.25%, 3/14/2027(c) | | |
Coinbase Global, Inc. 3.38%, 10/1/2028(b) (c) | | |
| | |
| | |
| | |
| | |
| | |
CommScope Technologies LLC | | |
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Corporate Bonds — continued |
United States — continued |
| | |
Community Health Systems, Inc. 8.00%, 3/15/2026(c) | | |
Comstock Resources, Inc. 6.75%, 3/1/2029(c) | | |
Constellation Brands, Inc. 2.25%, 8/1/2031 | | |
Corebridge Financial, Inc. | | |
| | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.85%), 6.87%, 12/15/2052(c) (f) | | |
Cox Communications, Inc. 4.80%, 2/1/2035(c) | | |
Crestwood Midstream Partners LP | | |
| | |
| | |
| | |
Crown Americas LLC 4.75%, 2/1/2026 | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Dana, Inc. 5.38%, 11/15/2027 | | |
Darling Ingredients, Inc. 5.25%, 4/15/2027(c) | | |
DaVita, Inc. 4.63%, 6/1/2030(c) | | |
| | |
| | |
| | |
DH Europe Finance II Sarl 2.20%, 11/15/2024 | | |
Diamond Sports Group LLC 5.38%, 8/15/2026(b) (c) | | |
Directv Financing LLC 5.88%, 8/15/2027(c) | | |
Discover Financial Services 3.75%, 3/4/2025 | | |
Discovery Communications LLC 3.63%, 5/15/2030 | | |
| | |
|
United States — continued |
| | |
| | |
| | |
| | |
| | |
Series B, (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.99%), 4.65%, 12/15/2024(d) (e) (f) | | |
Series C, (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.20%), 4.35%, 1/15/2027(d) (e) (f) | | |
Series C, 2.25%, 8/15/2031 | | |
DT Midstream, Inc. 4.13%, 6/15/2029(c) | | |
| | |
| | |
| | |
| | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.32%), 3.25%, 1/15/2082(f) | | |
Dycom Industries, Inc. 4.50%, 4/15/2029(b) (c) | | |
Edgewell Personal Care Co. 5.50%, 6/1/2028(c) | | |
| | |
| | |
Series B, (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.90%), 5.00%, 12/15/2026(d) (e) (f) | | |
Element Solutions, Inc. 3.88%, 9/1/2028(c) | | |
| | |
| | |
| | |
Embarq Corp. 8.00%, 6/1/2036 | | |
Emergent BioSolutions, Inc. 3.88%, 8/15/2028(c) | | |
Encompass Health Corp. 4.50%, 2/1/2028 | | |
Energizer Holdings, Inc. 4.75%, 6/15/2028(c) | | |
| | |
| | |
| | |
| | |
EnLink Midstream Partners LP | | |
| | |
| | |
| | |
Entegris, Inc. 3.63%, 5/1/2029(b) (c) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Income Builder Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Corporate Bonds — continued |
United States — continued |
Entergy Louisiana LLC 0.95%, 10/1/2024 | | |
Entergy Texas, Inc. 1.75%, 3/15/2031 | | |
Enterprise Products Operating LLC Series E, (ICE LIBOR USD 3 Month + 3.03%), 5.25%, 8/16/2077(f) | | |
Envision Healthcare Corp. 8.75%, 10/15/2026(c) | | |
EOG Resources, Inc. 5.10%, 1/15/2036 | | |
EQM Midstream Partners LP 7.50%, 6/1/2027(c) | | |
Equitable Financial Life Global Funding 5.50%, 12/2/2025(c) | | |
Equitable Holdings, Inc. Series B, (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 4.74%), 4.95%, 9/15/2025(d) (e) (f) | | |
ESC Co., Intelsat Jackson Holdings, Ltd. 9.75%, 7/15/2025‡ (i) | | |
Evergy, Inc. 2.90%, 9/15/2029 | | |
| | |
| | |
| | |
Exela Intermediate LLC 11.50%, 7/15/2026(c) | | |
Exelon Corp. 2.75%, 3/15/2027(c) | | |
Fidelity National Information Services, Inc. | | |
| | |
| | |
| | |
Fifth Third Bancorp (SOFR + 0.69%), 1.71%, 11/1/2027(f) | | |
First Student Bidco, Inc. 4.00%, 7/31/2029(c) | | |
First-Citizens Bank & Trust Co. 6.13%, 3/9/2028 | | |
| | |
| | |
| | |
Ford Motor Credit Co. LLC | | |
| | |
| | |
| | |
Freeport-McMoRan, Inc. 5.00%, 9/1/2027 | | |
Frontier Communications Holdings LLC 5.88%, 11/1/2029 | | |
Gannett Holdings LLC 6.00%, 11/1/2026(b) (c) | | |
Gap, Inc. (The) 3.63%, 10/1/2029(c) | | |
Gartner, Inc. 4.50%, 7/1/2028(c) | | |
General Electric Co. (ICE LIBOR USD 3 Month + 3.33%), 8.10%, 3/15/2023(d) (e) (f) | | |
General Motors Co. 6.13%, 10/1/2025 | | |
| | |
|
United States — continued |
General Motors Financial Co., Inc. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Go Daddy Operating Co. LLC 5.25%, 12/1/2027(c) | | |
Goldman Sachs Capital II (ICE LIBOR USD 3 Month + 0.77%), 5.53%, 1/30/2023(d) (e) (f) | | |
Goldman Sachs Group, Inc. (The) | | |
(SOFR + 0.51%), 0.66%, 9/10/2024(f) | | |
(SOFR + 0.49%), 0.92%, 10/21/2024(f) | | |
Series S, (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.85%), 4.40%, 2/10/2025(d) (e) (f) | | |
Series R, (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.22%), 4.95%, 2/10/2025(d) (e) (f) | | |
Series T, (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.97%), 3.80%, 5/10/2026(d) (e) (f) | | |
Series U, (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.92%), 3.65%, 8/10/2026(d) (e) (f) | | |
Series O, (ICE LIBOR USD 3 Month + 3.83%), 5.30%, 11/10/2026(d) (e) (f) | | |
(SOFR + 0.82%), 1.54%, 9/10/2027(f) | | |
(SOFR + 0.91%), 1.95%, 10/21/2027(f) | | |
(SOFR + 1.85%), 3.62%, 3/15/2028(f) | | |
(SOFR + 1.26%), 2.65%, 10/21/2032(f) | | |
Goodyear Tire & Rubber Co. (The) | | |
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Corporate Bonds — continued |
United States — continued |
Griffon Corp. 5.75%, 3/1/2028 | | |
Gulfport Energy Corp. 8.00%, 5/17/2026(c) | | |
Hanesbrands, Inc. 4.88%, 5/15/2026(c) | | |
Harsco Corp. 5.75%, 7/31/2027(c) | | |
| | |
| | |
| | |
| | |
| | |
Herc Holdings, Inc. 5.50%, 7/15/2027(c) | | |
Hertz Corp. (The) 4.63%, 12/1/2026(c) | | |
Hilcorp Energy I LP 5.75%, 2/1/2029(c) | | |
Hilton Domestic Operating Co., Inc. 4.88%, 1/15/2030 | | |
Hilton Worldwide Finance LLC 4.88%, 4/1/2027 | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Hughes Satellite Systems Corp. 6.63%, 8/1/2026 | | |
Huntington Bancshares, Inc. Series E, (ICE LIBOR USD 3 Month + 2.88%), 5.70%, 4/15/2023(d) (e) (f) | | |
| | |
| | |
| | |
| | |
| | |
| | |
iHeartCommunications, Inc. | | |
| | |
| | |
| | |
ILFC E-Capital Trust I 6.29%, 12/21/2065(c) (j) | | |
Imola Merger Corp. 4.75%, 5/15/2029(c) | | |
Intel Corp. 2.00%, 8/12/2031 | | |
IQVIA, Inc. 5.00%, 5/15/2027(c) | | |
Iron Mountain, Inc., REIT | | |
| | |
| | |
| | |
|
United States — continued |
| | |
| | |
| | |
| | |
JB Poindexter & Co., Inc. 7.13%, 4/15/2026(c) | | |
JBS USA LUX SA 5.50%, 1/15/2030(c) | | |
JELD-WEN, Inc. 4.88%, 12/15/2027(b) (c) | | |
Jersey Central Power & Light Co. 4.70%, 4/1/2024(c) | | |
John Deere Capital Corp. 4.15%, 9/15/2027 | | |
Kaiser Aluminum Corp. 4.63%, 3/1/2028(c) | | |
Kennedy-Wilson, Inc. 4.75%, 3/1/2029 | | |
Keurig Dr Pepper, Inc. 3.20%, 5/1/2030 | | |
KeyCorp (SOFRINDX + 2.06%), 4.79%, 6/1/2033(f) | | |
Kilroy Realty LP, REIT 3.45%, 12/15/2024 | | |
Kinetik Holdings LP 5.88%, 6/15/2030(c) | | |
Kraft Heinz Foods Co. 3.75%, 4/1/2030 | | |
Kroger Co. (The) 1.70%, 1/15/2031 | | |
L3Harris Technologies, Inc. 1.80%, 1/15/2031 | | |
LABL, Inc. 6.75%, 7/15/2026(c) | | |
Ladder Capital Finance Holdings LLLP, REIT 5.25%, 10/1/2025(c) | | |
Lamar Media Corp. 4.88%, 1/15/2029(b) | | |
Lamb Weston Holdings, Inc. 4.13%, 1/31/2030(c) | | |
Lear Corp. 2.60%, 1/15/2032 | | |
| | |
| | |
| | |
| | |
| | |
| | |
Liberty Interactive LLC 8.25%, 2/1/2030 | | |
Lincoln National Corp. 4.00%, 9/1/2023 | | |
Live Nation Entertainment, Inc. | | |
| | |
| | |
| | |
| | |
| | |
Lowe's Cos., Inc. 3.35%, 4/1/2027 | | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Income Builder Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Corporate Bonds — continued |
United States — continued |
Series G, 6.88%, 1/15/2028(b) | | |
Madison IAQ LLC 4.13%, 6/30/2028(c) | | |
| | |
| | |
| | |
Matador Resources Co. 5.88%, 9/15/2026 | | |
Mauser Packaging Solutions Holding Co. 5.50%, 4/15/2024(c) | | |
McCormick & Co., Inc. 3.15%, 8/15/2024 | | |
McKesson Corp. 1.30%, 8/15/2026 | | |
MDC Holdings, Inc. 2.50%, 1/15/2031 | | |
Medline Borrower LP 3.88%, 4/1/2029(c) | | |
Mellon Capital IV (ICE LIBOR USD 3 Month + 0.57%), 5.31%, 1/30/2023(d) (e) (f) | | |
MetLife Capital Trust IV 7.88%, 12/15/2037(c) | | |
MetLife, Inc. Series G, (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.58%), 3.85%, 9/15/2025(d) (e) (f) | | |
MGM Resorts International 4.63%, 9/1/2026 | | |
Midcontinent Communications 5.38%, 8/15/2027(c) | | |
Mondelez International, Inc. | | |
| | |
| | |
| | |
(SOFR + 0.46%), 0.53%, 1/25/2024(f) | | |
(SOFR + 0.62%), 0.73%, 4/5/2024(f) | | |
(SOFR + 0.51%), 0.79%, 1/22/2025(f) | | |
(SOFR + 1.15%), 2.72%, 7/22/2025(f) | | |
(SOFR + 0.56%), 1.16%, 10/21/2025(f) | | |
(SOFR + 0.94%), 2.63%, 2/18/2026(f) | | |
Series M, (ICE LIBOR USD 3 Month + 4.44%), 5.87%, 9/15/2026(d) (e) (f) | | |
(SOFR + 0.86%), 1.51%, 7/20/2027(f) | | |
| | |
| | |
| | |
| | |
| | |
National Rural Utilities Cooperative Finance Corp. | | |
| | |
(ICE LIBOR USD 3 Month + 3.63%), 5.25%, 4/20/2046(f) | | |
Nationstar Mortgage Holdings, Inc. 6.00%, 1/15/2027(c) | | |
| | |
|
United States — continued |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Newell Brands, Inc. 4.45%, 4/1/2026(h) | | |
| | |
| | |
| | |
NextEra Energy Capital Holdings, Inc. | | |
| | |
| | |
| | |
(ICE LIBOR USD 3 Month + 2.07%), 5.81%, 10/1/2066(f) | | |
(ICE LIBOR USD 3 Month + 2.13%), 6.89%, 6/15/2067(f) | | |
(ICE LIBOR USD 3 Month + 3.16%), 5.65%, 5/1/2079(f) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.55%), 3.80%, 3/15/2082(f) | | |
NextEra Energy Operating Partners LP | | |
| | |
| | |
| | |
Niagara Mohawk Power Corp. 3.51%, 10/1/2024(c) | | |
| | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.84%), 5.65%, 6/15/2023(d) (e) (f) | | |
| | |
| | |
Nissan Motor Acceptance Co. LLC 2.45%, 9/15/2028(c) | | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Corporate Bonds — continued |
United States — continued |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Occidental Petroleum Corp. | | |
| | |
| | |
Oceaneering International, Inc. 6.00%, 2/1/2028 | | |
ON Semiconductor Corp. 3.88%, 9/1/2028(c) | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Organon & Co. 5.13%, 4/30/2031(c) | | |
Outfront Media Capital LLC 5.00%, 8/15/2027(c) | | |
Pactiv Evergreen Group Issuer, Inc. 4.00%, 10/15/2027(c) | | |
Par Pharmaceutical, Inc. 7.50%, 4/1/2027(c) (h) | | |
| | |
| | |
(ICE LIBOR USD 3 Month + 3.90%), 6.25%, 2/28/2057(f) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 4.00%), 6.37%, 3/30/2062(f) | | |
Parker-Hannifin Corp. 3.65%, 6/15/2024 | | |
PBF Logistics LP 6.88%, 5/15/2023 | | |
Penske Automotive Group, Inc. 3.75%, 6/15/2029 | | |
Penske Truck Leasing Co. LP | | |
| | |
| | |
| | |
|
United States — continued |
Performance Food Group, Inc. 5.50%, 10/15/2027(c) | | |
PG&E Corp. 5.00%, 7/1/2028 | | |
Philip Morris International, Inc. | | |
| | |
| | |
Pilgrim's Pride Corp. 5.88%, 9/30/2027(c) | | |
PNC Financial Services Group, Inc. (The) | | |
Series R, (ICE LIBOR USD 3 Month + 3.04%), 4.85%, 6/1/2023(d) (e) (f) | | |
Series T, (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.60%), 3.40%, 9/15/2026(d) (e) (f) | | |
Series V, (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.24%), 6.20%, 9/15/2027(d) (e) (f) | | |
(SOFR + 1.62%), 5.35%, 12/2/2028(f) | | |
| | |
| | |
| | |
PPL Capital Funding, Inc. Series A, (ICE LIBOR USD 3 Month + 2.67%), 7.39%, 3/30/2067(f) | | |
Prime Security Services Borrower LLC | | |
| | |
| | |
Principal Life Global Funding II 1.25%, 6/23/2025(c) | | |
Progressive Corp. (The) Series B, (ICE LIBOR USD 3 Month + 2.54%), 5.38%, 3/15/2023(d) (e) (f) | | |
Prudential Financial, Inc. | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.16%), 5.12%, 3/1/2052(f) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.23%), 6.00%, 9/1/2052(f) | | |
Public Service Co. of Oklahoma Series J, 2.20%, 8/15/2031 | | |
Public Service Enterprise Group, Inc. 5.85%, 11/15/2027 | | |
QUALCOMM, Inc. 5.40%, 5/20/2033 | | |
| | |
| | |
| | |
Range Resources Corp. 4.88%, 5/15/2025 | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Income Builder Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Corporate Bonds — continued |
United States — continued |
Regeneron Pharmaceuticals, Inc. 1.75%, 9/15/2030 | | |
RHP Hotel Properties LP, REIT 4.75%, 10/15/2027 | | |
Rite Aid Corp. 8.00%, 11/15/2026(c) | | |
Rocket Mortgage LLC 3.88%, 3/1/2031(c) | | |
Royal Caribbean Cruises Ltd. 11.50%, 6/1/2025(c) | | |
Royalty Pharma plc 2.15%, 9/2/2031 | | |
| | |
| | |
| | |
Sabine Pass Liquefaction LLC 5.63%, 3/1/2025 | | |
Sabre GLBL, Inc. 9.25%, 4/15/2025(c) | | |
SBA Communications Corp., REIT 3.13%, 2/1/2029 | | |
Scotts Miracle-Gro Co. (The) 5.25%, 12/15/2026(b) | | |
Scripps Escrow II, Inc. 3.88%, 1/15/2029(c) | | |
Scripps Escrow, Inc. 5.88%, 7/15/2027(c) | | |
Seagate HDD Cayman 4.88%, 6/1/2027 | | |
Sealed Air Corp. 5.13%, 12/1/2024(c) | | |
| | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 4.55%), 4.88%, 10/15/2025(d) (e) (f) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.87%), 4.12%, 4/1/2052(f) | | |
| | |
| | |
| | |
Service Corp. International | | |
| | |
| | |
Shire Acquisitions Investments Ireland DAC 3.20%, 9/23/2026 | | |
| | |
| | |
| | |
Six Flags Entertainment Corp. | | |
| | |
| | |
| | |
| | |
| | |
|
United States — continued |
| | |
Sonic Automotive, Inc. 4.63%, 11/15/2029(c) | | |
Southern California Edison Co. | | |
Series E, (ICE LIBOR USD 3 Month + 4.20%), 8.64%, 1/30/2023(d) (e) (f) | | |
| | |
Southern California Gas Co. | | |
| | |
| | |
Southern Co. Gas Capital Corp. Series 20-A, 1.75%, 1/15/2031 | | |
Southwestern Energy Co. 7.75%, 10/1/2027 | | |
| | |
| | |
| | |
Sprint Capital Corp. 8.75%, 3/15/2032 | | |
| | |
| | |
| | |
| | |
| | |
SS&C Technologies, Inc. 5.50%, 9/30/2027(c) | | |
Stagwell Global LLC 5.63%, 8/15/2029(c) | | |
Standard Industries, Inc. | | |
| | |
| | |
| | |
| | |
| | |
Starbucks Corp. 2.55%, 11/15/2030 | | |
| | |
(ICE LIBOR USD 3 Month + 2.54%), 5.63%, 12/15/2023(d) (e) (f) | | |
(SOFR + 0.73%), 2.20%, 2/7/2028(b) (f) | | |
Station Casinos LLC 4.50%, 2/15/2028(c) | | |
Steel Dynamics, Inc. 5.00%, 12/15/2026 | | |
Stericycle, Inc. 3.88%, 1/15/2029(c) | | |
Summit Materials LLC 6.50%, 3/15/2027(c) | | |
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Corporate Bonds — continued |
United States — continued |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.20%), 4.00%, 5/15/2026(d) (e) (f) | | |
Series D, (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.07%), 4.25%, 11/15/2026(d) (e) (f) | | |
| | |
| | |
| | |
Take-Two Interactive Software, Inc. | | |
| | |
| | |
Tallgrass Energy Partners LP 5.50%, 1/15/2028(c) | | |
Targa Resources Partners LP 6.50%, 7/15/2027 | | |
Tempur Sealy International, Inc. 4.00%, 4/15/2029(c) | | |
| | |
| | |
| | |
| | |
| | |
| | |
TerraForm Power Operating LLC 5.00%, 1/31/2028(c) | | |
Thermo Fisher Scientific, Inc. 4.80%, 11/21/2027 | | |
| | |
| | |
| | |
Toyota Motor Credit Corp. 3.05%, 3/22/2027 | | |
TransDigm, Inc. 6.25%, 3/15/2026(c) | | |
Transocean Pontus Ltd. 6.13%, 8/1/2025(c) | | |
Transocean Poseidon Ltd. 6.88%, 2/1/2027(b) (c) | | |
Transocean Proteus Ltd. 6.25%, 12/1/2024(c) | | |
| | |
| | |
| | |
| | |
TriMas Corp. 4.13%, 4/15/2029(c) | | |
Trinseo Materials Operating SCA 5.38%, 9/1/2025(c) | | |
| | |
|
United States — continued |
| | |
Series M, (ICE LIBOR USD 3 Month + 2.79%), 5.12%, 12/15/2027(d) (e) (f) | | |
Series Q, (US Treasury Yield Curve Rate T Note Constant Maturity 10 Year + 4.35%), 5.10%, 3/1/2030(d) (e) (f) | | |
Uber Technologies, Inc. 7.50%, 5/15/2025(c) | | |
UDR, Inc., REIT 3.20%, 1/15/2030 | | |
| | |
| | |
| | |
United Airlines Holdings, Inc. | | |
| | |
| | |
United Airlines, Inc. 4.38%, 4/15/2026(c) | | |
United Rentals North America, Inc. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Univision Communications, Inc. 4.50%, 5/1/2029(c) | | |
| | |
Series V, 2.38%, 7/22/2026 | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 2.54%), 3.70%, 1/15/2027(d) (e) (f) | | |
Series J, (ICE LIBOR USD 3 Month + 2.91%), 5.30%, 4/15/2027(d) (e) (f) | | |
| | |
| | |
| | |
Verizon Communications, Inc. | | |
| | |
| | |
| | |
| | |
| | |
Vistra Corp. (US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 5.74%), 7.00%, 12/15/2026(c) (d) (e) (f) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Income Builder Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Corporate Bonds — continued |
United States — continued |
Vistra Operations Co. LLC | | |
| | |
| | |
| | |
| | |
| | |
Walt Disney Co. (The) 3.70%, 9/15/2024 | | |
Warnermedia Holdings, Inc. | | |
| | |
| | |
| | |
| | |
| | |
| | |
Weekley Homes LLC 4.88%, 9/15/2028(c) | | |
| | |
Series S, (ICE LIBOR USD 3 Month + 3.11%), 5.90%, 6/15/2024(d) (e) (f) | | |
(SOFR + 0.51%), 0.80%, 5/19/2025(f) | | |
(ICE LIBOR USD 3 Month + 3.99%), 5.87%, 6/15/2025(d) (e) (f) | | |
(ICE LIBOR USD 3 Month + 0.75%), 2.16%, 2/11/2026(f) | | |
(US Treasury Yield Curve Rate T Note Constant Maturity 5 Year + 3.45%), 3.90%, 3/15/2026(d) (e) (f) | | |
(SOFR + 1.51%), 3.53%, 3/24/2028(f) | | |
Welltower, Inc., REIT 3.63%, 3/15/2024 | | |
| | |
| | |
| | |
Western Midstream Operating LP 4.75%, 8/15/2028 | | |
William Carter Co. (The) 5.63%, 3/15/2027(c) | | |
Williams Cos., Inc. (The) 2.60%, 3/15/2031 | | |
WP Carey, Inc., REIT 2.40%, 2/1/2031 | | |
Wynn Las Vegas LLC 5.50%, 3/1/2025(c) | | |
Wynn Resorts Finance LLC 5.13%, 10/1/2029(c) | | |
Xerox Corp. 4.62%, 3/15/2023(h) | | |
Yum! Brands, Inc. 4.75%, 1/15/2030(c) | | |
Zayo Group Holdings, Inc. 4.00%, 3/1/2027(c) | | |
Zimmer Biomet Holdings, Inc. 2.60%, 11/24/2031 | | |
| | |
|
United States — continued |
| | |
| | |
| | |
| | |
Total Corporate Bonds
(Cost $35,965) | | |
Equity Linked Notes — 5.0% |
|
National Bank of Canada, ELN, 9.00%, 4/4/2023, (linked to Nasdaq-100 Index)* (c) | | |
|
BNP Paribas, ELN, 8.50%, 3/16/2023, (linked to Nasdaq-100 Index)* (a) | | |
BNP Paribas, ELN, 9.00%, 3/23/2023, (linked to Nasdaq-100 Index)* (c) | | |
Societe Generale SA, ELN, 9.00%, 3/1/2023, (linked to Nasdaq-100 Index)* (a) | | |
| | |
|
Barclays Bank plc, ELN, 8.50%, 3/9/2023, (linked to Nasdaq-100 Index)* (a) | | |
Total Equity Linked Notes
(Cost $4,484) | | |
| | |
Investment Companies — 4.6% |
|
JPMorgan Equity Income Fund, Class R6(k) | | |
JPMorgan Floating Rate Income Fund, Class R6(k) | | |
JPMorgan Managed Income Fund, Class L(k) | | |
| | |
Total Investment Companies
(Cost $3,432) | | |
Exchange-Traded Funds — 3.9% |
|
JPMorgan Equity Premium Income ETF(k) | | |
JPMorgan High Yield Research Enhanced ETF(k) | | |
| | |
Total Exchange-Traded Funds
(Cost $3,728) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Commercial Mortgage-Backed Securities — 2.1% |
|
BANK Series 2017-BNK7, Class D, 2.71%, 9/15/2060(c) | | |
Benchmark Mortgage Trust Series 2019-B11, Class D, 3.00%, 5/15/2052(c) | | |
BX Commercial Mortgage Trust Series 2020-VIV2, Class C, 3.54%, 3/9/2044(c) (j) | | |
Citigroup Commercial Mortgage Trust | | |
Series 2012-GC8, Class D, 4.91%, 9/10/2045(c) (j) | | |
Series 2016-P6, Class D, 3.25%, 12/10/2049(c) | | |
Series 2017-P7, Class D, 3.25%, 4/14/2050(c) | | |
Series 2017-P7, Class B, 4.14%, 4/14/2050(j) | | |
Commercial Mortgage Trust Series 2016-CR28, Class C, 4.60%, 2/10/2049(j) | | |
CSAIL Commercial Mortgage Trust Series 2019-C15, Class C, 4.98%, 3/15/2052(j) | | |
DBGS Mortgage Trust Series 2018-5BP, Class B, 5.30%, 6/15/2033(c) (j) | | |
FHLMC Multiclass Certificates Series 2020-RR05, Class X, IO, 2.01%, 1/27/2029 | | |
FHLMC, Multi-Family Structured Pass-Through Certificates | | |
Series K734, Class X3, IO, 2.24%, 7/25/2026(j) | | |
Series Q012, Class X, IO, 4.12%, 9/25/2035(j) | | |
Series K726, Class X3, IO, 2.15%, 7/25/2044(j) | | |
Series K729, Class X3, IO, 1.97%, 11/25/2044(j) | | |
Series K728, Class X3, IO, 2.02%, 11/25/2045(j) | | |
Series K071, Class X3, IO, 2.08%, 11/25/2045(j) | | |
Series K088, Class X3, IO, 2.43%, 2/25/2047(j) | | |
Series K108, Class X3, IO, 3.61%, 4/25/2048(j) | | |
FREMF Series 2018-KF46, Class B, 6.09%, 3/25/2028(c) (j) | | |
| | |
Series 2017-KF31, Class B, 7.04%, 4/25/2024(c) (j) | | |
Series 2017-KF32, Class B, 6.69%, 5/25/2024(c) (j) | | |
Series 2018-KF45, Class B, 6.09%, 3/25/2025(c) (j) | | |
| | |
|
United States — continued |
Series 2018-KF47, Class B, 6.14%, 5/25/2025(c) (j) | | |
Series 2018-KC02, Class B, 4.10%, 7/25/2025(c) (j) | | |
Series 2018-KF53, Class B, 6.19%, 10/25/2025(j) | | |
Series 2019-KC03, Class B, 4.38%, 1/25/2026(c) (j) | | |
Series 2019-KF62, Class B, 6.19%, 4/25/2026(c) (j) | | |
Series 2018-KF43, Class B, 6.29%, 1/25/2028(c) (j) | | |
Series 2018-KF50, Class B, 6.04%, 7/25/2028(c) (j) | | |
Series 2018-K82, Class B, 4.13%, 9/25/2028(c) (j) | | |
Series 2019-KF63, Class B, 6.49%, 5/25/2029(c) (j) | | |
Series 2017-K65, Class B, 4.08%, 7/25/2050(c) (j) | | |
Series 2018-K75, Class B, 3.98%, 4/25/2051(c) (j) | | |
Series 2020-K737, Class B, 3.30%, 1/25/2053(c) (j) | | |
Series 2020-K737, Class C, 3.30%, 1/25/2053(c) (j) | | |
| | |
Series 2016-71, Class QI, IO, 0.94%, 11/16/2057(j) | | |
Series 2020-14, IO, 0.59%, 2/16/2062(j) | | |
Series 2020-23, IO, 0.66%, 4/16/2062(j) | | |
| | |
Series 2019-LIC, Class E, 3.24%, 10/14/2039(c) (j) | | |
Series 2019-LIC, Class F, 3.24%, 10/14/2039(c) (j) | | |
LB-UBS Commercial Mortgage Trust Series 2006-C6, Class AJ, 5.45%, 9/15/2039(j) | | |
Morgan Stanley Bank of America Merrill Lynch Trust Series 2016-C31, Class B, 3.88%, 11/15/2049(j) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Income Builder Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Commercial Mortgage-Backed Securities — continued |
United States — continued |
Morgan Stanley Capital I Trust | | |
Series 2018-MP, Class D, 4.28%, 7/11/2040(c) (j) | | |
Series 2020-HR8, Class XA, IO, 1.84%, 7/15/2053(j) | | |
Total Commercial Mortgage-Backed Securities
(Cost $2,112) | | |
U.S. Treasury Obligations — 1.2% |
|
| | |
| | |
| | |
Total U.S. Treasury Obligations
(Cost $1,029) | | |
Collateralized Mortgage Obligations — 0.8% |
|
Banc of America Funding Trust Series 2006-A, Class 1A1, 3.96%, 2/20/2036(j) | | |
Citigroup Mortgage Loan Trust, Inc. Series 2005-6, Class A1, 6.08%, 9/25/2035(j) | | |
Connecticut Avenue Securities Trust Series 2019-R06, Class 2M2, 6.49%, 9/25/2039(c) (j) | | |
| | |
Series 4703, Class SA, IF, IO, 1.83%, 7/15/2047(j) | | |
Series 4937, Class MS, IF, IO, 1.66%, 12/25/2049(j) | | |
Series 4839, Class WS, IF, IO, 1.78%, 8/15/2056(j) | | |
| | |
Series 316, Class S7, IF, IO, 1.78%, 11/15/2043(j) | | |
Series 356, Class S5, IF, IO, 1.68%, 9/15/2047(j) | | |
FNMA, Connecticut Avenue Securities Series 2017-C02, Class 2B1, 9.89%, 9/25/2029(j) | | |
| | |
Series 2012-75, Class DS, IF, IO, 1.56%, 7/25/2042(j) | | |
Series 2016-1, Class SJ, IF, IO, 1.76%, 2/25/2046(j) | | |
Series 2018-67, Class SN, IF, IO, 1.81%, 9/25/2048(j) | | |
Series 2018-73, Class SC, IF, IO, 1.81%, 10/25/2048(j) | | |
| | |
|
United States — continued |
| | |
Series 2017-67, Class ST, IF, IO, 1.85%, 5/20/2047(j) | | |
Series 2017-112, Class S, IF, IO, 1.85%, 7/20/2047(j) | | |
Series 2018-36, Class SG, IF, IO, 1.85%, 3/20/2048(j) | | |
Series 2019-22, Class SM, IF, IO, 1.70%, 2/20/2049(j) | | |
Series 2019-42, Class SJ, IF, IO, 1.70%, 4/20/2049(j) | | |
| | |
Series 2004-7, Class 1A2, 5.31%, 11/25/2034(j) | | |
Series 2005-8, Class 1AM, 5.09%, 2/25/2036(j) | | |
Morgan Stanley Mortgage Loan Trust Series 2004-5AR, Class 4A, 3.84%, 7/25/2034(j) | | |
New Residential Mortgage Loan Trust Series 2019-NQM4, Class M1, 2.99%, 9/25/2059(c) (j) | | |
Structured Adjustable Rate Mortgage Loan Trust Series 2007-9, Class 1A1, 6.71%, 10/25/2037(j) | | |
WaMu Mortgage Pass-Through Certificates Trust Series 2005-AR5, Class A6, 3.31%, 5/25/2035(j) | | |
Total Collateralized Mortgage Obligations
(Cost $944) | | |
| | |
|
|
Allstate Corp. (The) Series H, 5.10%, 10/15/2024 ($25 par value)(b) (m) | | |
| | |
Series KK, 5.38%, 6/25/2024 ($25 par value)(m) | | |
Series LL, 5.00%, 9/17/2024 ($25 par value)(m) | | |
Energy Transfer LP Series E, 7.60%, 5/15/2024(m) | | |
| | |
Series K, 5.85%, 4/15/2027 ($25 par value)(b) (m) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Preferred Stocks — continued |
United States — continued |
Series P, 6.50%, 10/15/2027 ($25 par value)(b) (m) | | |
MYT Holding LLC Series A, 10.00%, 6/6/2029‡ | | |
SCE Trust VI 5.00%, 6/26/2022 ($25 par value) | | |
Sempra Energy 5.75%, 7/1/2079 ($25 par value) | | |
Southern Co. (The) Series 2020, 4.95%, 1/30/2080 ($25 par value) | | |
State Street Corp. Series G, 5.35%, 3/15/2026 ($25 par value)(m) | | |
Truist Financial Corp. Series R, 4.75%, 9/1/2025 ($25 par value)(m) | | |
| | |
Series Y, 5.63%, 12/15/2022 ($25 par value)(m) | | |
Series Z, 4.75%, 3/15/2025 ($25 par value)(m) | | |
Total Preferred Stocks
(Cost $514) | | |
| | |
Mortgage-Backed Securities — 0.4% |
|
| | |
Pool # MA4398, 2.00%, 8/1/2051 | | |
Pool # MA4465, 2.00%, 11/1/2051 | | |
Pool # MA4563, 2.50%, 3/1/2052 | | |
Pool # MA4564, 3.00%, 3/1/2052 | | |
Pool # MA4733, 4.50%, 9/1/2052 | | |
GNMA II, 30 Year Pool # MA7534, 2.50%, 8/20/2051 | | |
Total Mortgage-Backed Securities
(Cost $475) | | |
Asset-Backed Securities — 0.3% |
|
GSAMP Trust Series 2003-SEA, Class A1, 5.19%, 2/25/2033(j) | | |
Morgan Stanley ABS Capital I, Inc. Trust | | |
Series 2003-SD1, Class M1, 6.64%, 3/25/2033(j) | | |
Series 2003-NC10, Class M1, 5.41%, 10/25/2033(j) | | |
Prestige Auto Receivables Trust Series 2018-1A, Class D, 4.14%, 10/15/2024(c) | | |
| | |
|
United States — continued |
Securitized Asset-Backed Receivables LLC Trust Series 2004-OP2, Class M3, 6.41%, 8/25/2034(j) | | |
Total Asset-Backed Securities
(Cost $220) | | |
Loan Assignments — 0.1%(f) (n) |
|
CenturyLink, Inc., 1st Lien Term Loan B ( ICE LIBOR USD 1 Month + 2.25%), 6.00%, 3/15/2027 | | |
Nexstar Broadcasting, Inc., 1st Lien Term Loan B ( ICE LIBOR USD 1 Month + 2.50%), 6.88%, 9/18/2026 | | |
UFC Holdings LLC, 1st Lien Term Loan B-3 ( ICE LIBOR USD 3 Month + 2.75%), 7.11%, 4/29/2026 | | |
WMG Acquisition Corp., 1st Lien Term Loan G ( ICE LIBOR USD 1 Month + 2.13%), 6.51%, 1/20/2028 | | |
Total Loan Assignments
(Cost $102) | | |
| | |
|
|
Nmg Research Ltd. expiring 9/24/2027, price 1.00 USD‡ * | | |
|
Windstream Holdings, Inc. expiring 12/31/2049, price 10.75 USD‡ * | | |
| | |
| | |
Convertible Bonds — 0.0% ^ |
|
| | |
| | |
| | |
Total Convertible Bonds
(Cost $4) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Income Builder Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
|
|
Intelsat Jackson Holdings SA, expiring 12/5/2025‡ *(Cost $—) | | |
| | |
Short-Term Investments — 6.0% |
Investment Companies — 4.1% |
JPMorgan Prime Money Market Fund Class IM Shares, 4.49%(k) (o) | | |
JPMorgan Prime Money Market Fund Class Institutional Shares, 4.42%(k) (o) | | |
Total Investment Companies
(Cost $3,587) | | |
Investment of Cash Collateral from Securities Loaned — 1.9% |
JPMorgan Securities Lending Money Market Fund Agency SL Class Shares, 4.56%(k) (o) | | |
JPMorgan U.S. Government Money Market Fund Class IM Shares, 4.12%(k) (o) | | |
Total Investment of Cash Collateral from Securities Loaned
(Cost $1,657) | | |
Total Short-Term Investments
(Cost $5,244) | | |
Total Investments — 100.1%
(Cost $89,516) | | |
Liabilities in Excess of Other Assets — (0.1)% | | |
| | |
Percentages indicated are based on net assets. |
Amounts presented as a dash ("-") represent amounts that round to less than a thousand. |
| |
| |
| American Depositary Receipt |
| |
| |
| |
| |
| Federal Home Loan Mortgage Corp. |
| Federal National Mortgage Association |
| Global Depositary Receipt |
| Government National Mortgage Association |
| Intercontinental Exchange |
| Inverse Floaters represent securities that pay interest at a rate that increases (decreases) with a decline (incline) in a specified index or have an interest rate that adjusts periodically based on changes in current interest rates and prepayments on the underlying pool of assets. The interest rate shown is the rate in effect as of December 31, 2022. The rate may be subject to a cap and floor. |
| Interest Only represents the right to receive the monthly interest payments on an underlying pool of mortgage loans. The principal amount shown represents the par value on the underlying pool. The yields on these securities are subject to accelerated principal paydowns as a result of prepayment or refinancing of the underlying pool of mortgage instruments. As a result, interest income may be reduced considerably. |
| London Interbank Offered Rate |
| |
| |
| Public Joint Stock Company |
| A special type of equity investment that shares in the earnings of the company, has limited voting rights, and may have a dividend preference. Preference shares may also have liquidation preference. |
| Limited liability company |
| Real Estate Investment Trust |
| Real Estate Mortgage Investment Conduit |
| |
| Limited partnership with share capital |
| |
| Secured Overnight Financing Rate |
| Compounding index of the Secured Overnight Financing Rate |
| Separate Trading of Registered Interest and Principal of Securities. The STRIPS Program lets investors hold and trade individual interest and principal components of eligible notes and bonds as separate securities. |
| Uniform Mortgage-Backed Securities |
| |
| Amount rounds to less than 0.1% of net assets. |
| Value determined using significant unobservable inputs. | |
| Non-income producing security. | |
| Security exempt from registration pursuant to Regulation S under the Securities Act of 1933, as amended. Regulation S applies to securities offerings that are made outside of the United States and do not involve direct selling efforts in the United States and as such may have restrictions on resale. | |
| The security or a portion of this security is on loan at December 31, 2022. The total value of securities on loan at December 31, 2022 is $1,602. | |
| Securities exempt from registration under Rule 144A or section 4(a)(2), of the Securities Act of 1933, as amended. | |
| Security is an interest bearing note with preferred security characteristics. | |
SEE NOTES TO FINANCIAL STATEMENTS.
| Security is perpetual and thus, does not have a predetermined maturity date. The coupon rate for this security is fixed for a period of time and may be structured to adjust thereafter. The date shown, if applicable, reflects the next call date. The coupon rate shown is the rate in effect as of December 31, 2022. | |
| Variable or floating rate security, linked to the referenced benchmark. The interest rate shown is the current rate as of December 31, 2022. | |
| Security has the ability to pay in kind (“PIK”) or pay income in cash. When applicable, separate rates of such payments are disclosed. | |
| Step bond. Interest rate is a fixed rate for an initial period that either resets at a specific date or may reset in the future contingent upon a predetermined trigger. The interest rate shown is the current rate as of December 31, 2022. | |
| | |
| Variable or floating rate security, the interest rate of which adjusts periodically based on changes in current interest rates and prepayments on the underlying pool of assets. The interest rate shown is the current rate as of December 31, 2022. | |
| Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. | |
| All or a portion of this security is deposited with the broker as initial margin for futures contracts. | |
| The date shown reflects the next call date on which the issuer may redeem the security at par value. The coupon rate for this security is based on par value and is in effect as of December 31, 2022. | |
| Loan assignments are presented by obligor. Each series or loan tranche underlying each obligor may have varying terms. | |
| The rate shown is the current yield as of December 31, 2022. | |
Summary of Investments by Industry, December 31, 2022
The following table represents the portfolio investments of the Portfolio by industry classifications as a percentage of total investments:
PORTFOLIO COMPOSITION BY ASSET CLASS
AS OF December 31, 2022 | PERCENT OF
TOTAL
INVESTMENTS |
| |
Oil, Gas & Consumable Fuels | |
| |
| |
Equity Real Estate Investment Trusts (REITs) | |
Diversified Telecommunication Services | |
| |
| |
| |
| |
| |
Health Care Providers & Services | |
| |
Hotels, Restaurants & Leisure | |
Commercial Mortgage-Backed Securities | |
| |
Semiconductors & Semiconductor Equipment | |
| |
| |
Wireless Telecommunication Services | |
| |
| |
| |
| |
| |
Commercial Services & Supplies | |
| |
Others (each less than 1.0%) | |
| |
Detailed information about investment portfolios of the underlying funds and ETFs can be found in shareholder reports filed with the Securities and Exchange Commission (SEC) by each such underlying fund semi-annually on Form N-CSR and in portfolio holdings filed quarterly on Form N-PORT, and are available for download from both the SEC’s as well as each respective underlying fund’s website. Detailed information about underlying J.P. Morgan Funds can also be found at www.jpmorganfunds.com or by calling 1-800-480-4111.
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Income Builder Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
Futures contracts outstanding as of December 31, 2022 (amounts in thousands, except number of contracts):
| | | | | VALUE AND
UNREALIZED
APPRECIATION
(DEPRECIATION) ($) |
| | | | | |
| | | | | |
U.S. Treasury 10 Year Note | | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| Amount rounds to less than one thousand. |
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF ASSETS AND LIABILITIES
AS OF December 31, 2022
(Amounts in thousands, except per share amounts)
| JPMorgan
Insurance Trust
Income Builder
|
| |
Investments in non-affiliates, at value | |
Investments in affiliates, at value | |
Investments of cash collateral received from securities loaned, at value (See Note 2.E.) | |
| |
Foreign currency, at value | |
Deposits at broker for futures contracts | |
| |
Investment securities sold | |
| |
Interest from non-affiliates | |
Dividends from non-affiliates | |
Dividends from affiliates | |
| |
Securities lending income (See Note 2.E.) | |
Variation margin on futures contracts | |
| |
| |
| |
Investment securities purchased | |
Collateral received on securities loaned (See Note 2.E.) | |
Portfolio shares redeemed | |
| |
| |
| |
| |
Custodian and accounting fees | |
Trustees’ and Chief Compliance Officer’s fees | |
| |
| |
| |
(a)
Amount rounds to less than one thousand.
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF ASSETS AND LIABILITIES
AS OF December 31, 2022 (continued)
(Amounts in thousands, except per share amounts)
| JPMorgan Insurance Trust Income Builder |
| |
| |
Total distributable earnings (loss) | |
| |
| |
| |
| |
| |
Outstanding units of beneficial interest (shares)
(unlimited number of shares authorized, no par value): | |
| |
| |
| |
Class 1 — Offering and redemption price per share | |
Class 2 — Offering and redemption price per share | |
Cost of investments in non-affiliates | |
Cost of investments in affiliates | |
| |
Investment securities on loan, at value (See Note 2.E.) | |
Cost of investment of cash collateral (See Note 2.E.) | |
(a)
Per share amounts may not recalculate due to rounding of net assets and/or shares outstanding.
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF OPERATIONS
FOR THE YEAR ENDED December 31, 2022
(Amounts in thousands)
| JPMorgan
Insurance Trust
Income Builder
|
| |
Interest income from non-affiliates | |
Interest income from affiliates | |
Dividend income from non-affiliates | |
Dividend income from affiliates | |
Income from securities lending (net) (See Note 2.E.) | |
Foreign taxes withheld (net) | |
| |
| |
| |
| |
| |
| |
Custodian and accounting fees | |
Interest expense to affiliates | |
| |
Trustees’ and Chief Compliance Officer’s fees | |
Printing and mailing costs | |
Transfer agency fees (See Note 2.L.) | |
| |
| |
| |
Less expense reimbursements | |
| |
Net investment income (loss) | |
REALIZED/UNREALIZED GAINS (LOSSES): | |
Net realized gain (loss) on transactions from: | |
Investments in non-affiliates | |
Investments in affiliates | |
| |
Foreign currency transactions | |
| |
Distribution of capital gains received from investment company affiliates | |
Change in net unrealized appreciation/depreciation on: | |
Investments in non-affiliates | |
Investments in affiliates | |
| |
Foreign currency translations | |
Change in net unrealized appreciation/depreciation | |
Net realized/unrealized gains (losses) | |
Change in net assets resulting from operations | |
(a)
Amount rounds to less than one thousand.
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENTS OF CHANGES IN NET ASSETS
FOR THE PERIODS INDICATED
(Amounts in thousands)
| JPMorgan Insurance Trust Income Builder Portfolio |
| Year Ended
December 31, 2022 | Year Ended
December 31, 2021 |
CHANGE IN NET ASSETS RESULTING FROM OPERATIONS: | | |
Net investment income (loss) | | |
| | |
Distributions of capital gains received from investment company affiliates | | |
Change in net unrealized appreciation/depreciation | | |
Change in net assets resulting from operations | | |
DISTRIBUTIONS TO SHAREHOLDERS: | | |
| | |
| | |
Total distributions to shareholders | | |
| | |
Change in net assets resulting from capital transactions | | |
| | |
| | |
| | |
| | |
| | |
| | |
Proceeds from shares issued | | |
| | |
| | |
Change in net assets resulting from Class 1 capital transactions | | |
| | |
Proceeds from shares issued | | |
| | |
| | |
Change in net assets resulting from Class 2 capital transactions | | |
Total change in net assets resulting from capital transactions | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
THIS PAGE IS INTENTIONALLY LEFT BLANK
FINANCIAL HIGHLIGHTS
FOR THE PERIODS INDICATED
| Per share operating performance |
| | | |
| Net asset
value,
beginning
of period | Net
investment
income
(loss)(a)(b) | Net realized
and unrealized
gains
(losses) on
investments | Total from
investment
operations | | | |
JPMorgan Insurance Trust Income Builder Portfolio | | | | | | | |
| | | | | | | |
Year Ended December 31, 2022 | | | | | | | |
Year Ended December 31, 2021 | | | | | | | |
Year Ended December 31, 2020 | | | | | | | |
Year Ended December 31, 2019 | | | | | | | |
Year Ended December 31, 2018 | | | | | | | |
| | | | | | | |
Year Ended December 31, 2022 | | | | | | | |
Year Ended December 31, 2021 | | | | | | | |
Year Ended December 31, 2020 | | | | | | | |
Year Ended December 31, 2019 | | | | | | | |
Year Ended December 31, 2018 | | | | | | | |
|
| Net investment income (loss) is affected by the timing of distributions from Underlying Funds. |
| Calculated based upon average shares outstanding. |
| Includes adjustments in accordance with accounting principles generally accepted in the United States of America and as such, the net asset values for financial reporting purposes and the returns based upon those net asset values may differ from the net asset values and returns for shareholder transactions. |
| Total returns do not include charges that will be imposed by variable insurance contracts or by Eligible Plans. If these charges were reflected, returns would be lower than those shown. |
| Does not include expenses of Underlying Funds. |
| Includes earnings credits and interest expense, if applicable, each of which is less than 0.005% unless otherwise noted. |
SEE NOTES TO FINANCIAL STATEMENTS.
| |
| | | Ratios to average net assets |
Net asset
value,
end of
period | | Net assets,
end of
period
(000's) | | Net
investment
income
(loss)(a) | Expenses without
waivers and reimbursements(e) | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
SEE NOTES TO FINANCIAL STATEMENTS.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022
(Dollar values in thousands)
1. Organization
JPMorgan Insurance Trust (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company and is a Massachusetts business trust.
The following is a separate portfolio of the Trust (the “Portfolio”) covered by this report:
| | Diversification Classification |
JPMorgan Insurance Trust Income Builder Portfolio | | |
The investment objective of the Portfolio is to seek to maximize income while maintaining prospects for capital appreciation.
On December 12, 2022, the Board of Trustees of the Trust (the “Board”) approved the liquidation of the Portfolio which is expected to occur on or about April 25, 2023.
Portfolio shares are offered only to separate accounts of participating insurance companies and Eligible Plans. Individuals may not purchase shares directly from the Portfolio. For existing separate accounts of participating insurance companies and Eligible Plans who were shareholders of the Portfolio as of December 21, 2022, additional purchase of Portfolio shares will be accepted up through and including April 21, 2023. For other investors, purchases of Portfolio shares were no longer accepted as of December 21, 2022.
All classes of shares have equal rights as to earnings, assets and voting privileges, except that each class may bear different transfer agency fees and distribution fees and each class has exclusive voting rights with respect to its distribution plan and administrative services plan.
J.P. Morgan Investment Management Inc. (“JPMIM”), an indirect, wholly-owned subsidiary of JPMorgan Chase & Co. (“JPMorgan”), acts as Adviser (the “Adviser”) and Administrator (the “Administrator”) to the Portfolio.
2. Significant Accounting Policies
The following is a summary of significant accounting policies followed by the Portfolio in the preparation of its financial statements. The Portfolio is an investment company and, accordingly, follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 946 — Investment Companies, which is part of U.S. generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) disclosure of contingent assets and liabilities at the date of the financial statements, and (iii) the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.
A. Valuation of Investments — Investments are valued in accordance with GAAP and the Portfolio's valuation policies set forth by, and under the supervision and responsibility of, the Board, which established the following approach to valuation, as described more fully below: (i) investments for which market quotations are readily available shall be valued at their market value and (ii) all other investments for which market quotations are not readily available shall be valued at their fair value as determined in good faith by the Board.
Under Section 2(a)(41) of the 1940 Act, the Board is required to determine fair value for securities that do not have readily available market quotations. Under SEC Rule 2a-5 (Good Faith Determinations of Fair Value), the Board may designate the performance of these fair valuation determinations to a valuation designee. The Board has designated the Adviser as the “Valuation Designee” to perform fair valuation determinations for the Portfolio on behalf of the Board subject to appropriate oversight by the Board. The Adviser, as Valuation Designee, leverages the J.P. Morgan Asset Management Americas Valuation Committee (“AVC”) to help oversee and carry out the policies for the valuation of Investments held in the Portfolio. The Adviser, as Valuation Designee, remains responsible for the valuation determinations.
This oversight by the AVC includes monitoring the appropriateness of fair values based on results of ongoing valuation oversight including, but not limited to, consideration of macro or security specific events, market events, and pricing vendor and broker due diligence. The Administrator is responsible for discussing and assessing the potential impacts to the fair values on an ongoing basis, and, at least on a quarterly basis, with the AVC and the Board.
A market-based approach is primarily used to value the Portfolio's investments. Investments for which market quotations are not readily available are fair valued using prices supplied by approved affiliated and/or unaffiliated pricing vendors or third party broker-dealers (collectively referred to as “Pricing Services”) or may be internally fair valued using methods set forth by the valuation policies approved by the Board. This may include the use of related or comparable assets or liabilities, recent transactions, market multiples, book values and other relevant information for the investment. An income-based valuation approach may be used in which the anticipated future cash flows of the investment are discounted to calculate the fair value. Discounts may also be applied due to the nature or duration of any restrictions on the disposition of the investments. Valuations may be based upon current market prices of securities that are comparable in coupon, rating, maturity and industry. It is possible that the estimated values may differ significantly from the values that would have been used had a ready market for the investments existed, and such differences could be material.
Fixed income instruments are valued based on prices received from Pricing Services. The Pricing Services use multiple valuation techniques to determine the valuation of fixed income instruments. In instances where sufficient market activity exists, the Pricing Services may utilize a market-based approach through which trades or quotes from market makers are used to determine the valuation of these instruments. In instances where sufficient market activity may not exist, the Pricing Services also utilize proprietary valuation models which may consider market transactions in comparable securities and the various relationships between securities in determining fair value and/or market characteristics in order to estimate the relevant cash flows, which are then discounted to calculate the fair values.
Equities and other exchange-traded instruments are valued at the last sale price or official market closing price on the primary exchange on which the instrument is traded before the net asset values (“NAV”) of the Portfolio are calculated on a valuation date.
Certain foreign equity instruments, as well as certain derivatives with foreign equity reference obligations, are valued by applying international fair value factors provided by approved Pricing Services. The factors seek to adjust the local closing price for movements of local markets post-closing, but prior to the time the NAVs are calculated.
Investments in open-end investment companies, excluding exchange-traded funds (“ETFs”) (“Underlying Funds”), are valued at each Underlying Fund’s NAV per share as of the report date.
Futures contracts are generally valued on the basis of available market quotations.
Valuations reflected in this report are as of the report date. As a result, changes in valuation due to market events and/or issuer-related events after the report date and prior to issuance of the report are not reflected herein.
The various inputs that are used in determining the valuation of the Portfolio's investments are summarized into the three broad levels listed below.
•
Level 1 — Unadjusted inputs using quoted prices in active markets for identical investments.
•
Level 2 — Other significant observable inputs including, but not limited to, quoted prices for similar investments, inputs other than quoted prices that are observable for investments (such as interest rates, prepayment speeds, credit risk, etc.) or other market corroborated inputs.
•
Level 3 — Significant inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Portfolio's assumptions in determining the fair value of investments).
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input, both individually and in the aggregate, that is significant to the fair value measurement. The inputs or methodology used for valuing instruments are not necessarily an indication of the risk associated with investing in those instruments.
The following table represents each valuation input as presented on the Schedule of Portfolio Investments ("SOI"):
| | |
| | Level 2
Other significant
observable inputs | Level 3
Significant
unobservable inputs | |
Investments in Securities | | | | |
| | | | |
Collateralized Mortgage Obligations | | | | |
Commercial Mortgage-Backed Securities | | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
| | |
| | Level 2 Other significant observable inputs | Level 3 Significant unobservable inputs | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
Mortgage-Backed Securities | | | | |
| | | | |
| | | | |
| | |
| | Level 2 Other significant observable inputs | Level 3 Significant unobservable inputs | |
| | | | |
U.S. Treasury Obligations | | | | |
| | | | |
| | | | |
| | | | |
Investment of Cash Collateral from Securities Loaned | | | | |
Total Short-Term Investments | | | | |
Total Investments in Securities | | | | |
Appreciation in Other Financial Instruments | | | | |
| | | | |
Depreciation in Other Financial Instruments | | | | |
| | | | |
Total Net Appreciation/ Depreciation in Other Financial Instruments | | | | |
|
| Amount rounds to less than one thousand. |
| Balance as of
December 31,
2021 | | Change in net
unrealized
appreciation
(depreciation) | Net
accretion
(amortization) | | | | | Balance as of
December 31,
2022 |
Investments in Securities: | | | | | | | | | |
| | | | | | | | | |
Collateralized Mortgage Obligations | | | | | | | | | |
Commercial Mortgage-Backed Securities | | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
|
| Purchases include all purchases of securities and securities received in corporate actions. |
| Sales include all sales of securities, maturities, paydowns and securities tendered in corporate actions. |
| Amount rounds to less than one thousand. |
The changes in net unrealized appreciation (depreciation) attributable to securities owned at December 31, 2022, which were valued using significant unobservable inputs (level 3) amounted to $(110). This amount is included in Change in net unrealized appreciation/depreciation on investments in non-affiliates on the Statement of Operations.
For the year ended December 31, 2022, transfers in and out of level 3 were the result of decreased or increased transparency of market activity and observability of certain inputs used in determining fair value. This change in observability and resulting changes in levels does not impact liquidity or fair value of the Portfolio's investments or reflect any change in the investment strategy of the Portfolio.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
B. Restricted Securities — Certain securities held by the Portfolio may be subject to legal or contractual restrictions on resale. Restricted securities generally are resold in transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). Disposal of these securities may involve time-consuming negotiations and expense. Prompt sale at the current valuation may be difficult and could adversely affect the NAVs of the Portfolio.
As of December 31, 2022, the Portfolio had no investments in restricted securities other than securities sold to the Portfolio under Rule 144A and/or Regulation S under the Securities Act.
C. Loan Assignments — The Portfolio invested in debt instruments that are interests in amounts owed to lenders or lending syndicates (a “Lender”) by corporate, governmental or other borrowers (a “Borrower”). A loan is often administered by a bank or other financial institution (the “Agent”) that acts as Agent for all holders. The Agent administers the terms of the loan, as specified in the loan agreement. The Portfolio invests in loan assignments of all or a portion of the loans. When the Portfolio purchases a loan assignment, the Portfolio has direct rights against the Borrower on a loan, provided, however, the Portfolio's rights may be more limited than the Lender from which it acquired the assignment and the Portfolio may be able to enforce its rights only through the Agent. As a result, the Portfolio assumes the credit risk of the Borrower as well as any other persons interpositioned between the Portfolio and the Borrower (“Intermediate Participants”). The Portfolio may incur certain costs and delays in realizing payment on a loan assignment or suffer a loss of principal and/or interest if assets or interests held by the Agent or other Intermediate Participants are determined to be subject to the claims by their creditors. In addition, it is unclear whether loan assignments and other forms of direct indebtedness offer securities law protections against fraud and misrepresentation. Also, because JPMIM may wish to invest in publicly traded securities of a Borrower, it may not have access to material non-public information regarding the Borrower to which other investors have access. Although certain loan assignments are secured by collateral, the Portfolio could experience delays or limitations in realizing the value on such collateral or have its interest subordinated to other indebtedness of the Borrower.
Loan assignments are vulnerable to market conditions such that economic conditions or other events may reduce the demand for assignments and certain assignments which were liquid when purchased, may become illiquid and difficult to value. In addition, the settlement period for loans is uncertain as there is no standardized settlement schedule applicable to such investments. Therefore, the Portfolio may not receive the proceeds from a sale of such investments for a period after the sale.
Certain loan assignments are also subject to the risks associated with high yield securities described under Note 7.
D. When-Issued Securities, Delayed Delivery Securities and Forward Commitments — The Portfolio purchased when-issued securities, including To Be Announced ("TBA") securities, and entered into contracts to purchase or sell securities for a fixed price that may be settled a month or more after the trade date, or purchased delayed delivery securities which generally settle seven days after the trade date. When-issued securities are securities that have been authorized, but not issued in the market. A forward commitment involves entering into a contract to purchase or sell securities for a fixed price at a future date that may be settled a month or more after the trade date. A delayed delivery security is agreed upon in advance between the buyer and the seller of the security and is generally delivered beyond seven days of the agreed upon date. The purchase of securities on a when-issued, delayed delivery or forward commitment basis involves the risk that the value of the security to be purchased declines before the settlement date. The sale of securities on a forward commitment basis involves the risk that the value of the securities sold may increase before the settlement date. The Portfolio may be exposed to credit risk if the counterparty fails to perform under the terms of the transaction. Interest income for securities purchased on a when-issued, delayed delivery or forward commitment basis is not accrued until the settlement date.
E. Securities Lending — The Portfolio is authorized to engage in securities lending in order to generate additional income. The Portfolio is able to lend to approved borrowers. Citibank N.A. (“Citibank”) serves as lending agent for the Portfolio, pursuant to a Securities Lending Agency Agreement (the “Securities Lending Agency Agreement”). Securities loaned are collateralized by cash equal to at least 100% of the market value plus accrued interest on the securities lent, which is invested in the Class IM Shares of the JPMorgan U.S. Government Money Market Fund and the Agency SL Class Shares of the JPMorgan Securities Lending Money Market Fund. The Portfolio retains the interest earned on cash collateral investments but is required to pay the borrower a rebate for the use of the cash collateral. In cases where the lent security is of high value to borrowers, there may be a negative rebate (i.e., a net payment from the borrower to the Portfolio). Upon termination of a loan, the Portfolio is required to return to the borrower an amount equal to the cash collateral, plus any rebate owed to the borrowers. The remaining maturities of the securities lending transactions are considered overnight and continuous. Loans are subject to termination by the Portfolio or the borrower at any time.
The net income earned on the securities lending (after payment of rebates and Citibank’s fee) is included on the Statement of Operations as Income from securities lending (net). The Portfolio also receives payments from the borrower during the period of the loan, equivalent to dividends and interest earned on the securities loaned, which are recorded as Dividend or Interest income, respectively, on the Statement of Operations.
Under the Securities Lending Agency Agreement, Citibank marks to market the loaned securities on a daily basis. In the event the cash received from the borrower is less than 102% of the value of the loaned securities (105% for loans of non-U.S. securities), Citibank requests additional cash from the borrower so as to maintain a collateralization level of at least 102% of the value of the loaned securities plus accrued interest (105% for loans of non-U.S. securities), subject to certain de minimis amounts.
The value of securities out on loan is recorded as an asset on the Statement of Assets and Liabilities. The value of the cash collateral received is recorded as a liability on the Statement of Assets and Liabilities and details of collateral investments are disclosed on the SOI.
The Portfolio bears the risk of loss associated with the collateral investments and is not entitled to additional collateral from the borrower to cover any such losses. To the extent that the value of the collateral investments declines below the amount owed to a borrower, the Portfolio may incur losses that exceed the amount it earned on lending the security. Upon termination of a loan, the Portfolio may use leverage (borrow money) to repay the borrower for cash collateral posted if the Adviser does not believe that it is prudent to sell the collateral investments to fund the payment of this liability. Securities lending activity is subject to master netting arrangements.
The following table presents the Portfolio's value of the securities on loan with Citibank, net of amounts available for offset under the master netting arrangements and any related collateral received or posted by the Portfolio as of December 31, 2022.
| Investment Securities
on Loan, at value,
Presented on the
Statement of Assets
and Liabilities | Cash Collateral
Posted by Borrower* | Net Amount Due
to Counterparty
(not less than zero) |
| | | |
|
| Collateral posted reflects the value of securities on loan and does not include any additional amounts received from the borrower. |
Securities lending also involves counterparty risks, including the risk that the loaned securities may not be returned in a timely manner or at all. Subject to certain conditions, Citibank has agreed to indemnify the Portfolio from losses resulting from a borrower’s failure to return a loaned security.
JPMIM voluntarily waived investment advisory fees charged to the Portfolio to reduce the impact of the cash collateral investment in the JPMorgan U.S. Government Money Market Fund from 0.13% to 0.06%. For the year ended December 31, 2022, JPMIM waived fees associated with the Portfolio's investment in the JPMorgan U.S. Government Money Market Fund as follows:
The above waiver is included in the determination of earnings on cash collateral investment and in the calculation of Citibank’s compensation and is included on the Statement of Operations as Income from securities lending (net).
F. Investment Transactions with Affiliates — The Portfolio invested in Underlying Funds and ETFs, which are advised by the Adviser. An issuer which is under common control with the Portfolio may be considered an affiliate. For the purposes of the financial statements, the Portfolio assumes the issuers listed in the table below to be affiliated issuers. The Underlying Funds’ and ETFs' distributions may be reinvested into such Underlying Funds and ETFs. Reinvestment amounts are included in the purchases at cost amounts in the table below.
|
For the year ended December 31, 2022 |
| | | | | Change in
Unrealized
Appreciation/
(Depreciation) | | Shares at
December 31,
2022 | | Capital Gain
Distributions |
JPMorgan Emerging Markets Strategic Debt Fund Class R6 Shares (a) | | | | | | | | | |
JPMorgan Equity Income Fund Class R6 Shares (a) | | | | | | | | | |
JPMorgan Equity Premium Income ETF (a) | | | | | | | | | |
JPMorgan Floating Rate Income Fund Class R6 Shares (a) | | | | | | | | | |
JPMorgan High Yield Research Enhanced ETF (a) | | | | | | | | | |
JPMorgan Managed Income Fund Class L Shares (a) | | | | | | | | | |
JPMorgan Prime Money Market Fund Class IM Shares, 4.49% (a) (b) | | | | | | | | | |
JPMorgan Prime Money Market Fund Class Institutional Shares, 4.42% (a) (b) | | | | | | | | | |
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
|
For the year ended December 31, 2022 |
| | | | | Change in Unrealized Appreciation/ (Depreciation) | | Shares at December 31, 2022 | | Capital Gain Distributions |
JPMorgan Securities Lending Money Market Fund Agency SL Class Shares, 4.56% (a) (b) | | | | | | | | | |
JPMorgan U.S. Government Money Market Fund Class IM Shares, 4.12% (a) (b) | | | | | | | | | |
| | | | | | | | | |
|
| Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. |
| The rate shown is the current yield as of December 31, 2022. |
| Amount rounds to less than one thousand. |
| Amount is included on the Statement of Operations as Income from securities lending (net) (after payments of rebates and Citibank’s fee). |
G. Foreign Currency Translation — The books and records of the Portfolio are maintained in U.S. dollars. Foreign currency amounts are translated into U.S. dollars at the prevailing exchange rates of such currencies against the U.S. dollar. The market value of investment securities and other assets and liabilities are translated at the exchange rate as of the valuation date. Purchases and sales of investment securities, income and expenses are translated at the exchange rate prevailing on the respective dates of such transactions.
The Portfolio does not isolate the effect of changes in foreign exchange rates from changes in market prices on securities held. Accordingly, such changes are included within Change in net unrealized appreciation/depreciation on investments in non-affiliates on the Statement of Operations.
Reported realized foreign currency gains and losses arise from the disposition of foreign currency, currency gains or losses realized between the trade and settlement dates on securities transactions, and the difference between the amounts of dividends, interest and foreign withholding taxes recorded on the Portfolio's books on the transaction date and the U.S. dollar equivalent of the amounts actually received or paid. These reported realized foreign currency gains and losses are included in Net realized gain (loss) on foreign currency transactions on the Statement of Operations. Unrealized foreign currency gains and losses arise from changes (due to changes in exchange rates) in the value of foreign currency and other assets and liabilities denominated in foreign currencies, which are held at year end and are included in Change in net unrealized appreciation/depreciation on foreign currency translations on the Statement of Operations.
H. Futures Contracts — The Portfolio used index, treasury or other financial futures contracts to manage and hedge interest rate risk associated with portfolio investments and to gain or reduce exposure to particular countries or regions. The Portfolio also used futures contracts to lengthen or shorten the duration of the overall investment portfolio.
Futures contracts provide for the delayed delivery of the underlying instrument at a fixed price or are settled for a cash amount based on the change in the value of the underlying instrument at a specific date in the future. Upon entering into a futures contract, the Portfolio is required to deposit with the broker, cash or securities in an amount equal to a certain percentage of the contract amount, which is referred to as the initial margin deposit. Subsequent payments, referred to as variation margin, are made or received by the Portfolio periodically and are based on changes in the market value of open futures contracts. Changes in the market value of open futures contracts are recorded as Change in net unrealized appreciation/depreciation on futures contracts on the Statement of Operations. Realized gains or losses, representing the difference between the value of the contract at the time it was opened and the value at the time it was closed, are reported on the Statement of Operations at the closing or expiration of the futures contract. Securities deposited as initial margin are designated on the SOI, while cash deposited, which is considered restricted, is recorded on the Statement of Assets and Liabilities. A receivable from and/or a payable to brokers for the daily variation margin is also recorded on the Statement of Assets and Liabilities.
The use of futures contracts exposes the Portfolio to equity price, foreign exchange and interest rate risks. The Portfolio may be subject to the risk that the change in the value of the futures contract may not correlate perfectly with the underlying instrument. Use of long futures contracts subjects the Portfolio to risk of loss in excess of the amounts shown on the Statement of Assets and Liabilities, up to the notional amount of the futures contracts. Use of short futures contracts subjects the Portfolio to unlimited risk of loss. The Portfolio may enter into futures contracts only on exchanges or boards of trade. The exchange or board of trade acts as the counterparty to each futures transaction; therefore, the Portfolio's credit risk is limited to failure of the exchange or board of trade. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, which could effectively prevent liquidation of positions.
The Portfolio's futures contracts are not subject to master netting arrangements (the right to close out all transactions traded with a counterparty and net amounts owed or due across transactions).
The table below discloses the volume of the Portfolio's futures contracts activity during the year ended December 31, 2022:
| |
| |
Average Notional Balance Long | |
Average Notional Balance Short | |
Ending Notional Balance Long | |
Ending Notional Balance Short | |
I. Summary of Derivatives Information —The following table presents the value of derivatives held as of December 31, 2022, by its primary underlying risk exposure and respective location on the Statement of Assets and Liabilities:
| |
Unrealized Appreciation on Futures Contracts* | |
Unrealized Depreciation on Futures Contracts* | |
Interest Rate Risk Exposure: | |
Unrealized Depreciation on Futures Contracts* | |
Net Fair Value of Derivative Contracts: | |
Unrealized Appreciation (Depreciation) on Futures Contracts* | |
|
| Includes cumulative appreciation/(depreciation) on futures contracts, if any, as reported on the SOI. Only current day’s variation margin is reported within the Statement of Assets and Liabilities. |
| Amount rounds to less than one thousand. |
The following table presents the effect of derivatives on the Statement of Operations for the year ended December 31, 2022, by primary underlying risk exposure:
Realized Gain (Loss) on Derivatives Recognized as a Result From Operations: | |
| |
| |
Interest Rate Risk Exposure: | |
| |
Net Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized as a Result of Operations: | |
| |
| |
Interest Rate Risk Exposure: | |
| |
J. Equity-Linked Notes — The Portfolio invested in Equity-Linked Notes (“ELNs”). These are hybrid instruments which combine both debt and equity characteristics into a single note form. ELNs' values are linked to the performance of an underlying index. ELNs are unsecured debt obligations of an issuer and may not be publicly listed or traded on an exchange. ELNs are valued daily, under procedures adopted by the Board, based on values provided by an approved pricing source. These notes have a coupon which is accrued and recorded as interest income on the Statement of Operations. Changes in the market value of ELNs are recorded as Change in net unrealized appreciation or depreciation on the Statement of Operations. The Portfolio realizes a gain or loss when an ELN is sold or matures, which is recorded as Net realized gain (loss) on transactions from investments in non-affiliates on the Statement of Operations.
As of December 31, 2022, The Portfolio had outstanding ELNs as listed on the SOI.
K. Security Transactions and Investment Income — Investment transactions are accounted for on the trade date (the date the order to buy or sell is executed). Securities gains and losses are calculated on a specifically identified cost basis.
Interest income is determined on the basis of coupon interest accrued using the effective interest method, which adjusts for amortization of premiums and accretion of discounts.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
Dividend income, net of foreign taxes withheld, if any, and distributions of net investment income and realized capital gains from the Underlying Funds, if any, are recorded on the ex-dividend date or when the Portfolio first learns of the dividend. The Portfolio may receive other income from investment in loan assignments and/or unfunded commitments, including amendment fees, consent fees and commitment fees. These fees are recorded as income when received by the Portfolio. These amounts are included in Interest income from non-affiliates on the Statement of Operations.
To the extent such information is publicly available, the Portfolio records distributions received in excess of income earned from underlying investments as a reduction of cost of investments and/or realized gain. Such amounts are based on estimates if actual amounts are not available and actual amounts of income, realized gain and return of capital may differ from the estimated amounts. The Portfolio adjusts the estimated amounts of the components of distributions (and consequently its net investment income) as necessary, once the issuers provide information about the actual composition of the distributions.
L. Allocation of Income and Expenses— Expenses directly attributable to the Portfolio are charged directly to the Portfolio, while the expenses attributable to more than one portfolio of the Trust are allocated among the applicable portfolios. Investment income, realized and unrealized gains and losses and expenses, other than class-specific expenses, are allocated daily to each class of shares based upon the proportion of net assets of each class at the beginning of each day.
Transfer agency fees are class-specific expenses. The amount of the transfer agency fees charged to each share class of the Portfolio for the year ended December 31, 2022 are as follows:
|
| Amount rounds to less than one thousand. |
The Portfolio invested in Underlying Funds and ETFs and, as a result bear a portion of the expenses incurred by these Underlying Funds and ETFs. These expenses are not reflected in the expenses shown on the Statement of Operations and are not included in the ratios to average net assets shown in the Financial Highlights. Certain expenses of affiliated Underlying Funds and ETFs are waived as described in Note 3.E.
M. Federal Income Taxes — The Portfolio is treated as a separate taxable entity for Federal income tax purposes. The Portfolio's policy is to comply with the provisions of the Internal Revenue Code (the “Code”) applicable to regulated investment companies and to distribute to shareholders all of its distributable net investment income and net realized capital gains on investments. Accordingly, no provision for Federal income tax is necessary. The Portfolio is also a segregated portfolio of assets for insurance purposes and intends to comply with the diversification requirements of Sub-chapter L of the Code. Management has reviewed the Portfolio's tax positions for all open tax years and has determined that as of December 31, 2022, no liability for Federal income tax is required in the Portfolio's financial statements for net unrecognized tax benefits. However, management’s conclusions may be subject to future review based on changes in, or the interpretation of, the accounting standards or tax laws and regulations. The Portfolio's Federal tax returns for the prior three fiscal years remain subject to examination by the Internal Revenue Service.
N. Foreign Taxes —The Portfolio may be subject to foreign taxes on income, gains on investments or currency purchases/repatriation, a portion of which may be recoverable. The Portfolio will accrue such taxes and recoveries as applicable, based upon its current interpretation of tax rules and regulations that exist in the markets in which it invests. When a capital gains tax is determined to apply, the Portfolio records an estimated deferred tax liability in an amount that would be payable if the securities were disposed of on the valuation date.
O. Distributions to Shareholders — Distributions from net investment income, if any, are generally declared and paid at least annually and are declared separately for each class. No class has preferential dividend rights; differences in per share rates are due to differences in separate class expenses. Net realized capital gains, if any, are distributed at least annually. The amount of distributions from net investment income and net realized capital gains is determined in accordance with Federal income tax regulations, which may differ from GAAP. To the extent these “book/tax” differences are permanent in nature (i.e., that they result from other than timing of recognition — “temporary differences”), such amounts are reclassified within the capital accounts based on their Federal tax basis treatment.
The following amounts were reclassified within the capital accounts:
| | Accumulated
undistributed
(distributions in
excess of)
net investment
income | Accumulated
net realized
gains (losses) |
| | | |
The reclassifications for the Portfolio relate primarily to foreign currency gains or losses and tax adjustments on certain investments.
3. Fees and Other Transactions with Affiliates
A. Investment Advisory Fee — Pursuant to an Investment Advisory Agreement, the Adviser manages the investments of the Portfolio and for such services is paid a fee. The investment advisory fee is accrued daily and paid monthly at an annual rate of 0.42% of the Portfolio's average daily net assets.
The Adviser waived investment advisory fees and/or reimbursed expenses as outlined in Note 3.E.
B. Administration Fee — Pursuant to an Administration Agreement, the Administrator provides certain administration services to the Portfolio. In consideration of these services, the Administrator receives a fee accrued daily and paid monthly at an annual rate of 0.075% of the first $10 billion of the Portfolio's average daily net assets, plus 0.050% of the Portfolio's average daily net assets between $10 billion and $20 billion, plus 0.025% of the Portfolio's average daily net assets between $20 billion and $25 billion, plus 0.010% of the Portfolio's average daily net assets in excess of $25 billion. For the year ended December 31, 2022, the effective rate was 0.075% of the Portfolio's average daily net assets, notwithstanding any fee waivers and/or expense reimbursements.
The Administrator waived administration fees as outlined in Note 3.E.
JPMorgan Chase Bank, N.A. ("JPMCB"), a wholly-owned subsidiary of JPMorgan, serves as the Portfolio's sub-administrator (the “Sub-administrator”). For its services as Sub-administrator, JPMCB receives a portion of the fees payable to the Administrator.
C. Distribution Fees — Pursuant to a Distribution Agreement, JPMorgan Distribution Services, Inc. (“JPMDS”), an indirect, wholly-owned subsidiary of JPMorgan, serves as the Portfolio's principal underwriter and promotes and arranges for the sale of the Portfolio's shares.
The Board has adopted a Distribution Plan (the “Distribution Plan”) for Class 2 Shares of the Portfolio pursuant to Rule 12b-1 under the 1940 Act. Class 1 Shares of the Portfolio do not charge a distribution fee. The Distribution Plan provides that the Portfolio shall pay, with respect to the applicable share classes, distribution fees, including payments to JPMDS, at an annual rate of 0.25% of the average daily net assets of Class 2 Shares.
D. Custodian and Accounting Fees — JPMCB provides portfolio custody and accounting services to the Portfolio. For performing these services, the Portfolio pays JPMCB transaction and asset-based fees that vary according to the number of transactions and positions, plus out-of-pocket expenses. The amounts paid directly to JPMCB by the Portfolio for custody and accounting services are included in Custodian and accounting fees on the Statement of Operations.
Interest income earned on cash balances at the custodian, if any, is included in Interest income from affiliates on the Statement of Operations.
Interest expense paid to the custodian related to cash overdrafts, if any, is included in Interest expense to affiliates on the Statement of Operations.
E. Waivers and Reimbursements — The Adviser (for all share classes), Administrator (for all share classes) and/or JPMDS (for Class 2 Shares) have contractually agreed to waive fees and/or reimburse the Portfolio to the extent that total annual operating expenses of the Portfolio (excluding acquired fund fees and expenses other than certain money market fund fees as described below, dividend and interest expenses related to short sales, interest, taxes, expenses related to litigation and potential litigation, expenses related to trustee elections and extraordinary expenses) exceed the percentages of the Portfolio's respective average daily net assets as shown in the table below:
The expense limitation agreement was in effect for the year ended December 31, 2022 and the contractual expense limitation percentages in the table above are in place until at least April 30, 2023.
The Underlying Funds may impose separate advisory fees. The Adviser has agreed to voluntarily waive the Portfolio’s investment advisory fees in the weighted average pro-rata amount of the advisory fees charged by the affiliated Underlying Funds. During the year ended December 31, 2022, the Adviser waived $0. These waivers may be in addition to any waivers required to meet the Portfolio’s contractual expense limitations, but will not exceed the Portfolio’s advisory fee.
For the year ended December 31, 2022, the Portfolio's service providers waived fees and/or reimbursed expenses for the Portfolio as follows. None of these parties expect the Portfolio to repay any such waived fees and/or reimbursed expenses in future years.
| | |
| | | | Contractual
Reimbursements |
| | | | |
Additionally, the Portfolio may invest in one or more money market funds advised by the Adviser (affiliated money market funds). The Adviser, Administrator and/or JPMDS, have contractually agreed to waive fees and/or reimburse expenses in an amount sufficient to offset the respective net
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
fees each collects from the affiliated money market fund on the Portfolio's investment in such affiliated money market fund, except for investments of securities lending cash collateral. None of these parties expect the Portfolio to repay any such waived fees and/or reimbursed expenses in future years.
The amount of these waivers resulting from investments in these money market funds for the year ended December 31, 2022 was $4.
JPMIM voluntarily agreed to reimburse the Portfolio for the Trustee Fees paid to one of the interested Trustees. For the year ended December 31, 2022 the amount of this reimbursement was $2.
F. Other — Certain officers of the Trust are affiliated with the Adviser, the Administrator and JPMDS. Such officers, with the exception of the Chief Compliance Officer, receive no compensation from the Portfolio for serving in their respective roles.
The Board designated and appointed a Chief Compliance Officer to the Portfolio pursuant to Rule 38a-1 under the 1940 Act. The Portfolio, along with affiliated funds, makes reimbursement payments, on a pro-rata basis, to the Administrator for a portion of the fees associated with the office of the Chief Compliance Officer. Such fees are included in Trustees’ and Chief Compliance Officer’s fees on the Statement of Operations.
The Trust adopted a Trustee Deferred Compensation Plan (the “Plan”) which allows the independent Trustees to defer the receipt of all or a portion of compensation related to performance of their duties as Trustees. The deferred fees are invested in various J.P. Morgan Funds until distribution in accordance with the Plan.
During the year ended December 31, 2022, the Portfolio purchased securities from an underwriting syndicate in which the principal underwriter or members of the syndicate were affiliated with the Adviser.
The Securities and Exchange Commission ("SEC") has granted an exemptive order permitting the Portfolio to engage in principal transactions with J.P. Morgan Securities LLC, an affiliated broker, involving taxable money market instruments, subject to certain conditions.
4. Investment Transactions
During the year ended December 31, 2022, purchases and sales of investments (excluding short-term investments) were as follows:
| Purchases
(excluding
U.S. Government) | Sales
(excluding
U.S. Government) | Purchases
of U.S.
Government | |
| | | | |
5. Federal Income Tax Matters
For Federal income tax purposes, the estimated cost and unrealized appreciation (depreciation) in value of investments held at December 31, 2022 were as follows:
| | Gross
Unrealized
Appreciation | Gross
Unrealized
Depreciation | Net Unrealized
Appreciation
(Depreciation) |
| | | | |
The difference between book and tax basis appreciation (depreciation) on investments is primarily attributed to certain derivatives, tax adjustments on certain investments and wash sale loss deferrals.
The tax character of distributions paid during the year ended December 31, 2022 was as follows:
| | Net
Long-Term
Capital Gains | |
| | | |
|
| Short-term gain distributions are treated as ordinary income for income tax purposes. |
The tax character of distributions paid during the year ended December 31, 2021 was as follows:
| | Net
Long-Term
Capital Gains | |
| | | |
|
| Short-term gain distributions are treated as ordinary income for income tax purposes. |
As of December 31, 2022, the estimated components of net assets (excluding paid-in-capital) on a tax basis were as follows:
| Current
Distributable
Ordinary
Income | Current
Distributable
Long-Term
Capital Gain
(Tax Basis Capital
Loss Carryover) | Unrealized
Appreciation
(Depreciation) |
| | | |
The cumulative timing differences primarily consist of certain derivatives, tax adjustments on certain investments and wash sale loss deferrals.
At December 31, 2022, the Portfolio had net capital loss carryforwards which are available to offset future realized gains:
| Capital Loss Carryforward Character |
| | |
| | |
6. Borrowings
The Portfolio relies upon an exemptive order granted by the SEC (the “Order”) permitting the establishment and operation of an Interfund Lending Facility (the “Facility”). The Facility allows the Portfolio to directly lend and borrow money to or from any other fund relying upon the Order at rates beneficial to both the borrowing and lending funds. Advances under the Facility are taken primarily for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities, and are subject to the Portfolio's borrowing restrictions. The interfund loan rate is determined, as specified in the Order, by averaging the current repurchase agreement rate and the current bank loan rate. The Order was granted to the Trust and may be relied upon by the Portfolio because the Portfolio and the series of the Trust are all investment companies in the same “group of investment companies” (as defined in Section 12(d)(1)(G) of the 1940 Act).
The Portfolio had no borrowings outstanding from another fund, or loans outstanding to another fund, during the year ended December 31, 2022.
The Trust and JPMCB have entered into a financing arrangement. Under this arrangement, JPMCB provides an unsecured, uncommitted credit facility in the aggregate amount of $100 million to certain of the J.P. Morgan Funds, including the Portfolio. Advances under the arrangement are taken primarily for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities, and are subject to the Portfolio's borrowing restrictions. Interest on borrowings is payable at a rate determined by JPMCB at the time of borrowing. This agreement has been extended until October 30, 2023.
The Portfolio had no borrowings outstanding from the unsecured, uncommitted credit facility during the year ended December 31, 2022.
The Trust, along with certain other trusts for J.P. Morgan Funds (“Borrowers”), has entered into a joint syndicated senior unsecured revolving credit facility totaling $1.5 billion (“Credit Facility”) with various lenders and The Bank of New York Mellon, as administrative agent for the lenders. This Credit Facility provides a source of funds to the Borrowers for temporary and emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities. Under the terms of the Credit Facility, a borrowing portfolio must have a minimum of $25 million in adjusted net asset value and not exceed certain adjusted net asset coverage ratios prior to and during the time in which any borrowings are outstanding. If a portfolio does not comply with the aforementioned requirements, the portfolio must remediate within three business days with respect to the $25 million minimum adjusted net asset value or within one business day with respect to certain asset coverage ratios or the administrative agent at the request of, or with the consent of, the lenders may terminate the Credit Facility and declare any outstanding borrowings to be due and payable immediately.
Interest associated with any borrowing under the Credit Facility is charged to the borrowing portfolio at a rate of interest equal to 1.00% (the "Applicable Margin"), plus the greater of the federal funds effective rate or one month London Interbank Offered Rate ("LIBOR"). The annual
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
commitment fee to maintain the Credit Facility is 0.15% and is incurred on the unused portion of the Credit Facility and is allocated to all participating portfolios pro rata based on their respective net assets. Effective August 9, 2022, the Credit Facility has been amended and restated for a term of 364 days, unless extended, and to include a change in the interest associated with any borrowing to the higher, on the day of the borrowing, of (a) the federal funds effective rate, or (b) the one-month Adjusted SOFR Rate plus the Applicable Margin.
The Portfolio did not utilize the Credit Facility during the year ended December 31, 2022.
7. Risks, Concentrations and Indemnifications
In the normal course of business, the Portfolio enters into contracts that contain a variety of representations which provide general indemnifications. The Portfolio's maximum exposure under these arrangements is unknown. The amount of exposure would depend on future claims that may be brought against the Portfolio. However, based on experience, the Portfolio expects the risk of loss to be remote.
As of December 31, 2022, the Portfolio had four individual shareholders and/or non-affiliated omnibus accounts each owning more than 10% of the Portfolio's outstanding shares, and, collectively owning 77.9% of the Portfolio's outstanding shares.
Significant shareholder transactions by these shareholders may impact the Portfolio's performance and liquidity.
The Portfolio is subject to interest rate risk. Investments in bonds and other debt securities will change in value based on changes in interest rates. If rates increase, the value of these investments generally declines. Securities with greater interest rate sensitivity and longer maturities generally are subject to greater fluctuations in value. The Portfolio may face a heightened level of interest rate risk due to certain changes in monetary policy. It is difficult to predict the pace at which central banks or monetary authorities may increase interest rates or the timing, frequency, or magnitude of such increases. Any such changes could be sudden and could expose debt markets to significant volatility and reduced liquidity for Portfolio investments.
The Portfolio is subject to credit risk. The Portfolio's investments are subject to the risk that an issuer and/or a counterparty will fail to make payments when due or default completely. Prices of the Portfolio's investments may be adversely affected if any of the issuers or counterparties it is invested in are subject to an actual or perceived deterioration in their credit quality. Credit spreads may increase, which may reduce the market values of the Portfolio's securities. Credit spread risk is the risk that economic and market conditions or any actual or perceived credit deterioration may lead to an increase in the credit spreads (i.e. the difference in yield between two securities of similar maturity but different credit quality) and a decline in price of the issuer’s securities.
The Portfolio invests in high yield securities that are not rated or rated below investment grade (commonly known as “junk bonds”). These securities are considered to be high risk investments. Investments in lower-rated securities or unrated securities of comparable quality tend to be more sensitive to economic conditions than higher rated securities. Junk bonds involve a greater risk of default by the issuer because such securities are generally unsecured and are often subordinated to other creditors’ claims. The market price of these securities can change suddenly and unexpectedly. As a result, the Portfolio are intended for investors who are able and willing to assume a high degree of risk.
The Portfolio may have elements of risk not typically associated with investments in the United States of America due to concentrated investments in a limited number of foreign countries or regions, which may vary throughout the period. Such concentrations may subject the Portfolio to additional risks resulting from political or economic conditions in such countries or regions and the possible imposition of adverse governmental laws or currency exchange restrictions could cause the securities and their markets to be less liquid and their prices to be more volatile than those of comparable U.S. securities.
Investing in securities of foreign countries may include certain risks and considerations not typically associated with investing in U.S. securities. These risks include revaluation of currencies, high rates of inflation, repatriation restrictions on income and currencies, and future and adverse political, social and economic developments.
Derivatives may be riskier than other types of investments because they may be more sensitive to changes in economic and market conditions and could result in losses that significantly exceed the Portfolio's original investment. Many derivatives create leverage thereby causing the Portfolio to be more volatile than they would have been if they had not used derivatives. Derivatives also expose the Portfolio to counterparty risk (the risk that the derivative counterparty will not fulfill its contractual obligations), including credit risk of the derivative counterparty. The possible lack of a liquid secondary market for derivatives and the resulting inability of the Portfolio to sell or otherwise close a derivatives position could expose the Portfolio to losses and could make derivatives more difficult for the Portfolio to value accurately.
LIBOR is intended to represent the rate at which contributing banks may obtain short-term borrowings from each other in the London interbank market. On March 5, 2021, the U.K. Financial Conduct Authority ("FCA") publicly announced that (i) immediately after December 31, 2021, publication of the 1-week and 2-month U.S. Dollar LIBOR settings will permanently cease; (ii) immediately after June 30, 2023, publication of the overnight and 12-month U.S. Dollar LIBOR settings will permanently cease; and (iii) immediately after June 30, 2023, the 1-month, 3-month and 6-month U.S. Dollar LIBOR settings will cease to be provided or, subject to the FCA's consideration of the case, be provided on a synthetic basis and no longer be representative of the underlying market and economic reality they are intended to measure and that representativeness will not be restored. There is no assurance that the dates announced by the FCA will not change or that the administrator of LIBOR and/or regulators will not take further action that could impact the availability, composition or characteristics of LIBOR or the currencies and/or tenors for which LIBOR is published. In addition,
certain regulated entities ceased entering into most new LIBOR contracts in connection with regulatory guidance or prohibitions. Public and private sector industry initiatives are currently underway to implement new or alternative reference rates to be used in place of LIBOR. There is no assurance that any such alternative reference rate will be similar to or produce the same value or economic equivalence as LIBOR or that it will have the same volume or liquidity as did LIBOR prior to its discontinuance, unavailability or replacement, all of which may affect the value, volatility, liquidity or return on certain of the Portfolio's loans, notes, derivatives and other instruments or investments comprising some or all of the Portfolio's investments and result in costs incurred in connection with changing reference rates used for positions closing out positions and entering into new trades. Certain of the Portfolio's investments may transition from LIBOR prior to the dates announced by the FCA. The transition from LIBOR to alternative reference rates may result in operational issues for the Portfolio or its investments. No assurances can be given as to the impact of the LIBOR transition (and the timing of any such impact) on the Portfolio and its investments.
The Portfolio is subject to infectious disease epidemics/pandemics risk. The worldwide outbreak of COVID-19 has negatively affected economies, markets and individual companies throughout the world. The effects of this COVID-19 pandemic to public health, and business and market conditions, including among other things, reduced consumer demand and economic output, supply chain disruptions and increased government spending may continue to have a significant negative impact on the performance of the Portfolio's investments, increase the Portfolio's volatility, exacerbate other pre-existing political, social and economic risks to the Portfolio and negatively impact broad segments of businesses and populations. In addition, governments, their regulatory agencies, or self-regulatory organizations have taken or may take actions in response to the pandemic that affect the instruments in which the Portfolio invests, or the issuers of such instruments, in ways that could also have a significant negative impact on the Portfolio's investment performance. The duration and extent of COVID-19 and associated economic and market conditions and uncertainty over the long-term cannot be reasonably estimated at this time. The ultimate impact of COVID-19 and the extent to which the associated conditions impact the Portfolio will also depend on future developments, which are highly uncertain, difficult to accurately predict and subject to frequent changes.
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Trustees of JPMorgan Insurance Trust and Shareholders of JPMorgan Insurance Trust Income Builder Portfolio
Opinion on the Financial Statements
We have audited the accompanying statement of assets and liabilities, including the schedule of portfolio investments, of JPMorgan Insurance Trust Income Builder Portfolio (one of the portfolios constituting JPMorgan Insurance Trust, referred to hereafter as the “Portfolio”) as of December 31, 2022, the related statement of operations for the year ended December 31, 2022, the statements of changes in net assets for each of the two years in the period ended December 31, 2022, including the related notes, and the financial highlights for each of the five years in the period ended December 31, 2022 (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Portfolio as of December 31, 2022, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended December 31, 2022 and the financial highlights for each of the five years in the period ended December 31, 2022 in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Portfolio’s management. Our responsibility is to express an opinion on the Portfolio’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Portfolio in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of December 31, 2022 by correspondence with the custodian, transfer agent, agent banks and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
/s/ PricewaterhouseCoopers LLP
New York, New York
February 15, 2023
We have served as the auditor of one or more investment companies in the JPMorgan Funds complex since 1993.
The Portfolio's Statement of Additional Information includes additional information about the Portfolio's Trustees and is available, without charge, upon request by calling 1-800-480-4111 or on the Portfolio's website at www.jpmorgan.com/variableinsuranceportfolios.
Name (Year of Birth);
Positions With
the Portfolio (1) | Principal Occupation
During Past 5 Years | Number of
Funds in Fund
Complex Overseen
by Trustee (2) | Other Directorships Held
During the Past 5 Years |
| | | |
John F. Finn (1947); Chair
since 2020; Trustee since 1998. | Chairman, Gardner, Inc. (supply chain management company serving industrial and consumer markets) (serving in various roles 1974-present). | | Director, Greif, Inc. (GEF) (industrial package products and services) (2007-present); Trustee, Columbus Association for the Performing Arts (1988-present). |
Stephen P. Fisher (1959);
Trustee since 2018. | Retired; Chairman and Chief Executive Officer, NYLIFE Distributors LLC (registered broker-dealer) (serving in various roles 2008-2013); Chairman, NYLIM Service Company LLC (transfer agent) (2008-2017); New York Life Investment Management LLC (registered investment adviser) (serving in various roles 2005-2017); Chairman, IndexIQ Advisors LLC (registered investment adviser for ETFs) (2014-2017); President, MainStay VP Funds Trust (2007-2017), MainStay DefinedTerm Municipal Opportunities Fund (2011-2017) and MainStay Funds Trust (2007-2017) (registered investment companies). | | Honors Program Advisory Board Member, The Zicklin School of Business, Baruch College, The City University of New York (2017-present). |
Gary L. French (1951);
Trustee since 2014. | Real Estate Investor (2011-2020); Investment management industry Consultant and Expert Witness (2011-present); Senior Consultant for The Regulatory Fundamentals Group LLC (2011-2017). | | Independent Trustee, The China Fund, Inc. (2013-2019); Exchange Traded Concepts Trust II (2012-2014); Exchange Traded Concepts Trust I (2011-2014). |
Kathleen M. Gallagher (1958);
Trustee since 2018. | Retired; Chief Investment Officer — Benefit Plans, Ford Motor Company (serving in various roles 1985-2016). | | Non- Executive Director, Legal & General Investment Management (Holdings) (2018-present); Non-Executive Director, Legal & General Investment Management America (U.S. Holdings) (financial services and insurance) (2017-present); Advisory Board Member, State Street Global Advisors Total Portfolio Solutions (2017-present); Member, Client Advisory Council, Financial Engines, LLC (registered investment adviser) (2011-2016); Director, Ford Pension Funds Investment Management Ltd. (2007-2016). |
Robert J. Grassi (1957);
Trustee since 2014. | Sole Proprietor, Academy Hills Advisors LLC (2012-present); Pension Director, Corning Incorporated (2002-2012). | | |
TRUSTEES
(Unaudited) (continued)
Name (Year of Birth); Positions With the Portfolio (1) | Principal Occupation During Past 5 Years | Number of Funds in Fund Complex Overseen by Trustee (2) | Other Directorships Held During the Past 5 Years |
Frankie D. Hughes (1952);
Trustee since 2008. | President, Ashland Hughes Properties (property management) (2014-present); President and Chief Investment Officer, Hughes Capital Management, Inc. (fixed income asset management) (1993-2014). | | |
Raymond Kanner (1953);
Trustee since 2017. | Retired; Managing Director and Chief Investment Officer, IBM Retirement Funds (2007-2016). | | Advisory Board Member, Penso Advisors, LLC (2020-present); Advisory Board Member, Los Angeles Capital (2018-present); Advisory Board Member, State Street Global Advisors Total Portfolio Solutions (2017- present); Acting Executive Director, Committee on Investment of Employee Benefit Assets (CIEBA) (2016-2017); Advisory Board Member, Betterment for Business (robo advisor) (2016- 2017); Advisory Board Member, BlueStar Indexes (index creator) (2013-2017); Director, Emerging Markets Growth Fund (registered investment company) (1997-2016); Member, Russell Index Client Advisory Board (2001-2015). |
Thomas P. Lemke (1954);
Trustee since 2014. | | | (1) Independent Trustee of Advisors’ Inner Circle III fund platform, consisting of the following: (i) the Advisors’ Inner Circle Fund III, (ii) the Gallery Trust, (iii) the Schroder Series Trust, (iv) the Delaware Wilshire Private Markets Fund (since 2020), (v) Chiron Capital Allocation Fund Ltd., and (vi) formerly the Winton Diversified Opportunities Fund (2014-2018); and (2) Independent Trustee of the Symmetry Panoramic Trust (since 2018). |
Lawrence R. Maffia (1950);
Trustee since 2014 | Retired; Director and President, ICI Mutual Insurance Company (2006-2013). | | Director, ICI Mutual Insurance Company (1999-2013). |
Mary E. Martinez (1960); Vice
Chair since 2021; Trustee since 2013. | Associate, Special Properties, a Christie’s International Real Estate Affiliate (2010-present); Managing Director, Bank of America (asset management) (2007-2008); Chief Operating Officer, U.S. Trust Asset Management, U.S. Trust Company (asset management) (2003-2007); President, Excelsior Funds (registered investment companies) (2004-2005). | | |
Marilyn McCoy (1948);
Trustee since 2005. | Vice President of Administration and Planning, Northwestern University (1985-present). | | |
Name (Year of Birth); Positions With the Portfolio (1) | Principal Occupation During Past 5 Years | Number of Funds in Fund Complex Overseen by Trustee (2) | Other Directorships Held During the Past 5 Years |
Dr. Robert A. Oden, Jr. (1946); Trustee
since 2005. | Retired; President, Carleton College (2002-2010); President, Kenyon College (1995-2002). | | Trustee, The Coldwater Conservation Fund (2017-present); Trustee, American Museum of Fly Fishing (2013-present); Trustee and Vice Chair, Trout Unlimited (2017-2021);Trustee, Dartmouth- Hitchcock MedicalCenter (2011-2020). |
Marian U. Pardo* (1946);
Trustee since 2013. | Managing Director and Founder, Virtual Capital Management LLC (investment consulting) (2007-present); Managing Director, Credit Suisse Asset Management (portfolio manager) (2003-2006). | | Board Chair and Member, Board of Governors, Columbus Citizens Foundation (not-for-profit supporting philanthropic and cultural programs) (2006-present). |
Emily A. Youssouf (1951);
Trustee since 2022. | Adjunct Professor (2011-present) and Clinical Professor (2009-2011), NYU Schack Institute of Real Estate; Board Member and Member of the Audit Committee (2013–present), Chair of Finance Committee (2019-present), Member of Related Parties Committee (2013-2018) and Member of the Enterprise Risk Committee (2015-2018), PennyMac Financial Services, Inc.; Board Member (2005-2018), Chair of Capital Committee (2006-2016), Chair of Audit Committee (2005-2018), Member of Finance Committee (2005-2018) and Chair of IT Committee (2016-2018), NYC Health and Hospitals Corporation. | | Trustee, NYC School Construction Authority (2009-present); Board Member, NYS Job Development Authority (2008-present); Trustee and Chair of the Audit Committee of the Transit Center Foundation (2015-2019). |
| | | |
Robert F. Deutsch** (1957);
Trustee since 2014. | Retired; Head of ETF Business for JPMorgan Asset Management (2013-2017); Head of Global Liquidity Business for JPMorgan Asset Management (2003-2013). | | Treasurer and Director of the JUST Capital Foundation (2017-present). |
Nina O. Shenker** (1957);
Trustee since 2022. | Vice Chair (2017-2021), General Counsel and Managing Director (2008-2016), Associate General Counsel and Managing Director (2004-2008), J.P. Morgan Asset & Wealth Management. | | Director and Member of Legal and Human Resources Subcommittees, American Jewish Joint Distribution Committee (2018-present). |
|
| The year shown is the first year in which a Trustee became a member of any of the following: the JPMorgan Mutual Fund Board, the JPMorgan ETF Board, the heritage J.P. Morgan Funds or the heritage One Group Mutual Funds. Trustees serve an indefinite term, until resignation, retirement, removal or death. The Board’s current retirement policy sets retirement at the end of the calendar year in which the Trustee attains the age of 75, provided that any Board member who was a member of the JPMorgan Mutual Fund Board prior to January 1, 2022 and was born prior to January 1, 1950 shall retire from the Board at the end of the calendar year in which the Trustee attains the age of 78. |
| A Fund Complex means two or more registered investment companies that hold themselves out to investors as related companies for purposes of investment and investor services or have a common investment adviser or have an investment adviser that is an affiliated person of the investment adviser of any of the other registered investment companies. The J.P. Morgan Funds Complex for which the Board of Trustees serves currently includes nine registered investment companies (179 J.P. Morgan Funds). |
| In connection with prior employment with JPMorgan Chase, Ms. Pardo was the recipient of non-qualified pension plan payments from JPMorgan Chase in the amount of approximately $2,055 per month, which she irrevocably waived effective January 1, 2013, and deferred compensation payments from JPMorgan Chase in the amount of approximately $7,294 per year, which ended in January 2013. In addition, Ms. Pardo receives payments from a fully-funded qualified plan, which is not an obligation of JPMorgan Chase. |
| Designation as an “Interested Trustee” is based on prior employment by the Adviser or an affiliate of the Adviser or interests in a control person of the Adviser. |
TRUSTEES
(Unaudited) (continued)
| The contact address for each of the Trustees is 277 Park Avenue, New York, NY 10172. |
Name (Year of Birth),
Positions Held with
the Trust (Since) | Principal Occupations During Past 5 Years |
Brian S. Shlissel (1964),
President and Principal Executive
Officer (2016)* | Managing Director and Chief Administrative Officer for J.P. Morgan pooled vehicles, J.P. Morgan Investment Management Inc. since 2014. |
Timothy J. Clemens (1975),
Treasurer and Principal Financial
Officer (2018) | Executive Director, J.P. Morgan Investment Management Inc. since February 2016. Mr. Clemens has been with J.P. Morgan Investment Management Inc. since 2013. |
Gregory S. Samuels (1980),
Secretary (2019) (formerly Assistant
Secretary 2010-2019) | Managing Director and Assistant General Counsel, JPMorgan Chase & Co. Mr. Samuels has been with JPMorgan Chase & Co. since 2010. |
Stephen M. Ungerman (1953),
Chief Compliance Officer (2005) | Managing Director, JPMorgan Chase & Co. Mr. Ungerman has been with JPMorgan Chase & Co. since 2000. |
Kiesha Astwood-Smith (1973),
Assistant Secretary (2021) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since June 2021; Senior Director and Counsel, Equitable Financial Life Insurance Company (formerly, AXA Equitable Life Insurance Company) from September 2015 through June 2021. |
Matthew Beck (1988),
Assistant Secretary (2021)** | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since May 2021; Senior Legal Counsel, Ultimus Fund Solutions from May 2018 through May 2021; General Counsel, The Nottingham Company from April 2014 through May 2018. |
Elizabeth A. Davin (1964),
Assistant Secretary (2005)** | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Ms. Davin has been with JPMorgan Chase & Co. (formerly Bank One Corporation) since 2004. |
Jessica K. Ditullio (1962)
Assistant Secretary (2005)** | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Ms. Ditullio has been with JPMorgan Chase & Co. (formerly Bank One Corporation) since 1990. |
Anthony Geron (1971),
Assistant Secretary (2018) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since September 2018; Lead Director and Counsel, AXA Equitable Life Insurance Company from 2015 to 2018 and Senior Director and Counsel, AXA Equitable Life Insurance Company from 2014 to 2015. |
Carmine Lekstutis (1980),
Assistant Secretary (2011) | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Mr. Lekstutis has been with JPMorgan Chase & Co. since 2011. |
Max Vogel (1990),
Assistant Secretary (2021) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since June 2021; Associate, Proskauer Rose LLP (law firm) from March 2017 to June 2021. |
Zachary E. Vonnegut-Gabovitch
(1986),
Assistant Secretary (2017) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since September 2016. |
Michael M. D’Ambrosio (1969),
Assistant Treasurer (2012) | Managing Director, J.P. Morgan Investment Management Inc. Mr. D’Ambrosio has been with J.P. Morgan Investment Management Inc. since 2012. |
Aleksandr Fleytekh (1972),
Assistant Treasurer (2019) | Vice President, J.P. Morgan Investment Management Inc. since February 2012. |
Shannon Gaines (1977),
Assistant Treasurer (2018)** | Vice President, J.P. Morgan Investment Management Inc. since January 2014. |
Jeffrey D. House (1972),
Assistant Treasurer (2017)** | Vice President, J.P. Morgan Investment Management Inc. since July 2006. |
Michael Mannarino (1985),
Assistant Treasurer (2020) | Vice President, J.P. Morgan Investment Management Inc. since 2014. |
Joseph Parascondola (1963),
Assistant Treasurer (2011)* | Executive Director, J.P. Morgan Investment Management, Inc. Mr. Parascondola has been with J.P. Morgan Investment Management Inc. since 2006. |
Gillian I. Sands (1969),
Assistant Treasurer (2012) | Executive Director, J.P. Morgan Investment Management Inc. Ms. Sands has been with J.P. Morgan Investment Management Inc. since 2012. |
|
The contact address for each of the officers, unless otherwise noted, is 277 Park Avenue, New York, NY 10172. |
OFFICERS
(Unaudited) (continued)
| The contact address for the officer is 575 Washington Boulevard, Jersey City, NJ 07310. |
| The contact address for the officer is 1111 Polaris Parkway, Columbus, OH 43240. |
SCHEDULE OF SHAREHOLDER EXPENSES
(Unaudited)
Hypothetical $1,000 Investment
As a shareholder of the Portfolio, you incur ongoing costs, including investment advisory fees, administration fees, distribution fees (for Class 2 Shares) and other Portfolio expenses. Because the Portfolio is a funding vehicle for Policies and Eligible Plans you may also incur sales charges and other fees relating to the Policies or Eligible Plans. The examples below are intended to help you understand your ongoing costs (in dollars) of investing in the Portfolio, but not the costs of the Policies or Eligible Plans, and to compare these ongoing costs with the ongoing costs of investing in other mutual funds. The examples assume that you had a $1,000 investment in each Class at the beginning of the reporting period, July 1, 2022, and continued to hold your shares at the end of the reporting period, December 31, 2022.
Actual Expenses
For each Class of the Portfolio in the table below, the first line provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line of each Class under the heading titled “Expenses Paid During the Period” to estimate the expenses you paid on your account during this period.
Hypothetical Example for Comparison Purposes
The second line of each Class in the table below provides information about hypothetical account values and hypothetical expenses based on the Class’ actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Class’ actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in each Class of the Portfolio and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds. Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs, such as sales charges (loads), or redemption fees , or the costs associated with the Policies and Eligible Plans through which the Portfolio is held, and expenses of the Underlying Funds and ETFs. Therefore, the second line for each Class in the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transaction costs were included, your costs would have been higher. The examples also assume all dividends and distributions have been reinvested.
| Beginning
Account Value
July 1, 2022 | Ending
Account Value
December 31, 2022 | Expenses
Paid During
the Period* | |
JPMorgan Insurance Trust Income Builder Portfolio | | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
|
| Expenses are equal to each Class’ respective annualized expense ratio, multiplied by the average account value over the period, multiplied by 184/365 (to reflect the one-half year period). |
BOARD APPROVAL OF INVESTMENT ADVISORY AGREEMENT
(Unaudited)
The Board of Trustees (the “Board” or the “Trustees”) has established various standing committees composed of Trustees with diverse backgrounds, to which the Board has assigned specific subject matter responsibilities to further enhance the effectiveness of the Board’s oversight and decision making. Effective January 2022, the Board consolidated with the J.P. Morgan Exchange-Traded Fund Trust Board and now consists of Trustees from both Boards. The Board and its investment committees (Money Market and Alternative Products Committee, Equity Committee, and Fixed Income Committee) met regularly throughout the year and, at each meeting, considered factors that are relevant to their annual consideration of the continuation of the investment advisory agreements. The Board also met for the specific purpose of considering investment advisory agreement annual renewals. The Board held meetings on June 21-22, 2022 and August 9-11, 2022, at which the Trustees considered the continuation of the investment advisory agreement for the Portfolio whose annual report is contained herein (the “Advisory Agreement”). At the June meeting, the Board’s investment committees met to review and consider performance, expense and related information for the Portfolio and the other J.P. Morgan Funds overseen by the Board in which the Portfolio may invest (“Underlying Funds”). Each investment committee reported to the full Board, which then considered each investment committee’s preliminary findings. At the August meeting, the Trustees continued their review and consideration. The Trustees, including a majority of the Trustees who are not parties to the Advisory Agreement or “interested persons” (as defined in the Investment Company Act of 1940) of any party to the Advisory Agreement or any of their affiliates, approved the continuation of the Advisory Agreement on August 11, 2022.
As part of their review of the Advisory Agreement, the Trustees considered and reviewed performance and other information about the Portfolio and Underlying Funds received from the Adviser. This information includes the Portfolio’s and Underlying Funds’ performance as compared to the performance of the Portfolio’s and Underlying Funds’ peers and benchmarks, and analyses by the Adviser of the Portfolio’s and Underlying Funds’ performance. In addition, at each of their regular meetings throughout the year, the Trustees considered reports on the performance of certain J.P. Morgan Funds (including certain ETFs, beginning in February 2022) provided by an independent investment consulting firm (“independent consultant”). In addition, in preparation for the June and August meetings, the Trustees requested, received and evaluated extensive materials from the Adviser, including, with respect to the Portfolio and/or Underlying Funds, performance and expense information compiled by Broadridge, using data from Lipper Inc. and/or Morningstar Inc., independent providers of investment company data (together, “Broadridge”). The independent consultant also provided additional analysis of the performance of certain Underlying Funds in connection
with the Trustees’ review of the Advisory Agreement. Before voting on the Advisory Agreement, the Trustees reviewed the Advisory Agreement with representatives of the Adviser, counsel to the Trust, and independent legal counsel and received a memorandum from independent legal counsel to the Trustees discussing the legal standards for their consideration of the Advisory Agreement. The Trustees also discussed the Advisory Agreement with independent legal counsel in executive sessions at which no representatives of the Adviser were present.
A summary of the material factors evaluated by the Trustees in determining whether to approve the Advisory Agreement is provided below. Each Trustee attributed different weights to the various factors and no factor alone was considered determinative. The Trustees considered information provided with respect to the Portfolio and Underlying Funds throughout the year, including additional reporting and information provided in connection with the COVID-19 pandemic, as well as materials furnished specifically in connection with the annual review process. From year to year, the Trustees consider and place emphasis on relevant information in light of changing circumstances in market and economic conditions.
After considering and weighing the factors and information they had received, the Trustees found that the compensation to be received by the Adviser from the Portfolio under the Advisory Agreement was fair and reasonable under the circumstances, and determined that the continuance of the Advisory Agreement was in the best interests of the Portfolio and its shareholders.
Nature, Extent and Quality of Services Provided by the Adviser
The Trustees received and considered information regarding the nature, extent and quality of services provided to the Portfolio under the Advisory Agreement. The Trustees took into account information furnished throughout the year at Trustee meetings, as well as the materials furnished specifically in connection with this annual review process. Among other things, the Trustees considered:
(i) The background and experience of the Adviser’s senior management and investment personnel, including personnel changes, if any;
(ii) The qualifications, backgrounds and responsibilities of the portfolio management team primarily responsible for the day-to-day management of the Portfolio and Underlying Funds, including personnel changes, if any;
(iii) The investment strategy for the Portfolio, and the infrastructure supporting the portfolio management team;
(iv) Information about the structure and distribution strategy for the Portfolio and how it fits with the Trust’s other fund offerings;
(v) The administration services provided by the Adviser in its role as Administrator;
(vi) Their knowledge of the nature and quality of the services provided by the Adviser and its affiliates gained from their experience as Trustees of the Trust and in the financial industry generally;
(vii) The overall reputation and capabilities of the Adviser and its affiliates;
(viii) The commitment of the Adviser to provide high quality service to the Portfolio and Underlying Funds, as applicable;
(ix) Their overall confidence in the Adviser’s integrity;
(x) The Adviser’s responsiveness to requests for additional information, questions or concerns raised by them, including the Adviser’s willingness to consider and implement organizational and operational changes designed to improve investment results and the services provided to the Portfolio and Underlying Funds; and
(xi) The Adviser’s business continuity plan and steps the Adviser and its affiliates have taken to provide ongoing services to the Portfolio and Underlying Funds, as applicable, during the COVID-19 pandemic, and the Adviser’s and its affiliates’ success in continuing to provide services to the Portfolio and its shareholders throughout this period.
Based upon these considerations and other factors, the Trustees concluded that they were satisfied with the nature, extent and quality of the services provided to the Portfolio by the Adviser.
Costs of Services Provided and Profitability to the Adviser and its Affiliates
The Trustees received and considered information regarding the profitability to the Adviser and its affiliates from providing services to the Portfolio and Underlying Funds. The Trustees reviewed and discussed this information. The Trustees recognized that this information is not audited and represents the Adviser’s determination of its and its affiliates’ revenues from the contractual services provided to the Portfolio, less expenses of providing such services. Expenses include direct and indirect costs and are calculated using an allocation methodology developed by the Adviser and reviewed with the Board. The Trustees also recognized that it is difficult to make comparisons of profitability from fund investment advisory contracts because comparative information is not generally publicly available and is affected by numerous factors, including the structure of the particular adviser, the types of funds it manages, its business mix, numerous assumptions regarding allocations and the fact that publicly-traded fund managers’ operating profits and net income are net of distribution and marketing expenses. Based upon their review, and taking into consideration the factors noted above, the Trustees concluded that the profitability to the Adviser under the Advisory Agreement was not unreasonable in light of the services and benefits provided to the Portfolio.
The Trustees also considered that JPMDS, an affiliate of the Adviser, and the Adviser earn fees from the Portfolio and Underlying Funds for providing administration services. These fees were shown separately in the profitability analysis presented to the Trustees. The Trustees also considered the payments of Rule 12b-1 fees to JPMDS, which also acts as the Portfolio’s distributor, and that these fees are in turn generally paid to insurance companies that use the Portfolio in connection with insurance products they issue, including financial intermediaries that are affiliates of the Adviser (although they are retained by JPMDS in certain instances). The Trustees also considered the fees earned by JPMorgan Chase Bank, N.A. (“JPMCB”), an affiliate of the Adviser, for custody, fund accounting and other related services for the Portfolio and/or Underlying Funds and the profitability of the arrangements to JPMCB.
Fall-Out Benefits
The Trustees reviewed information regarding potential “fall-out” or ancillary benefits received by the Adviser and its affiliates as a result of their relationship with the Portfolio. The Trustees considered that the J.P. Morgan Funds’ operating accounts are held at JPMCB, which, as a result, will receive float benefits for certain J.P. Morgan Funds, as applicable. The Trustees also noted that the Adviser supports a diverse set of products and services, which benefits the Adviser by allowing it to leverage its infrastructure to serve additional clients, including the benefits received by the Adviser and its affiliates in connection with the Portfolio’s investments in the Underlying Funds. The Trustees also reviewed the Adviser’s allocation of fund brokerage for the J.P. Morgan Funds complex, including allocations to brokers who provide research to the Adviser, as well as the Adviser’s use of affiliates to provide other services and the benefits to such affiliates of doing so.
Economies of Scale
The Trustees considered the extent to which the Portfolio may benefit from potential economies of scale. The Trustees considered that there may not be a direct relationship between economies of scale realized by the Portfolio and those realized by the Adviser as assets increase. The Trustees considered the extent to which the Portfolio was priced to scale and whether it would be appropriate to add advisory fee breakpoints, but noted that the Portfolio has implemented fee waivers and contractual expense limitations (“Fee Caps”) which allow the Portfolio’s shareholders to share potential economies of scale from its inception and that the fees remain satisfactory relative to peer funds. The Trustees considered the benefits to the Portfolio of the use of an affiliated distributor and custodian, including the ability to rely on existing infrastructure supporting distribution, custodial and transfer agent services, and the ability to negotiate competitive fees for the Portfolio. The Trustees further considered the Adviser’s and JPMDS’s
BOARD APPROVAL OF INVESTMENT ADVISORY AGREEMENT
(Unaudited) (continued)
ongoing investments in their business in support of the Portfolio, including the Adviser’s and/or JPMDS’s investments in trading systems, technology (including improvements to the J.P. Morgan Funds’ website, and cybersecurity improvements), retention of key talent, and regulatory support enhancements. The Trustees concluded that the current fee structure for the Portfolio, including Fee Caps that the Adviser has in place that serve to limit the overall net expense ratios of the Portfolio at competitive levels, was reasonable. The Trustees concluded that the Portfolio’s shareholders received the benefits of potential economies of scale through the Fee Caps and the Adviser’s reinvestment in its operations to serve the Portfolio and its shareholders. The Trustees noted that the Adviser’s reinvestment ensures sufficient resources in terms of personnel and infrastructure to support the Portfolio.
Fees Relative to Adviser’s Other Clients
The Trustees received and considered information about the nature and extent of investment advisory services and fee rates offered to other clients of the Adviser, including, to the extent applicable, institutional separate accounts, collective investment trusts, other registered investment companies and/or private funds sub-advised by the Adviser, for investment management styles substantially similar to that of the Portfolio. The Trustees considered the complexity of investment management for registered investment companies relative to the Adviser’s other clients and noted differences, as applicable, in the fee structure and the regulatory, legal and other risks and responsibilities of providing services to the different clients. The Trustees considered that serving as an adviser to a registered investment company involves greater responsibilities and risks than acting as a sub-adviser and observed that sub-advisory fees may be lower than those charged by the Adviser to the Portfolio. The Trustees also noted that the adviser, not the applicable investment company, typically bears the sub-advisory fee and that many responsibilities related to the advisory function are typically retained by the primary adviser. The Trustees concluded that the fee rates charged to the Portfolio in comparison to those charged to the Adviser’s other clients were reasonable.
Investment Performance
The Trustees receive and consider information about the Portfolio’s performance throughout the year. In addition, the Trustees received and considered absolute and/or relative performance information for the Portfolio in a report prepared by Broadridge. The Trustees considered the total return performance information, which included the ranking of the Portfolio within a performance universe comprised of funds with the same Broadridge investment classification and objective (the “Universe”), as well as a subset of funds within the Universe (the “Peer Group”), by total return for the applicable one-, three-and five-year periods. The Trustees
reviewed a description of Broadridge’s methodology for selecting mutual funds in the Portfolio’s Universe and Peer Group and noted that Universe and Peer Group quintile rankings were not calculated if the number of funds in the Universe and/or Peer Group did not meet a predetermined minimum. The Broadridge materials provided to the Trustees highlighted information with respect to a representative class to assist the Trustees in their review. As part of this review, the Trustees also reviewed the Portfolio’s performance against its benchmark and considered the performance information provided for the Portfolio at regular Board meetings by the Adviser. The Trustees also engaged with the Adviser to consider what steps might be taken to improve performance, as applicable. The Broadridge performance data noted by the Trustees as part of their review and the determinations made by the Trustees with respect to the Portfolio’s performance are summarized below:
The Trustees noted that the Portfolio’s performance for Class 1 shares was in the fifth quintile of the Peer Group for each of the one-, three- and five-year periods ended December 31, 2021, and in the third, fifth and fourth quintiles of the Universe for the one-, three- and five-year periods ended December 31, 2021, respectively. The Trustees noted that the Portfolio’s performance for Class 2 shares was in the fourth, fifth and fifth quintiles of the Peer Group, and in the third, fifth and fifth quintiles of the Universe for the one-, three- and five-year periods ended December 31, 2021, respectively. The Trustees discussed the performance and investment strategy of the Portfolio with the Adviser and based upon this discussion and various other factors, concluded that the Portfolio’s performance was satisfactory under the circumstances.
Advisory Fees and Expense Ratios
The Trustees considered the contractual advisory fee rate and administration fee rate paid by the Portfolio to the Adviser and compared the combined rate to the information prepared by Broadridge concerning management fee rates paid by other funds in the same Broadridge category as the Portfolio. The Trustees recognized that Broadridge reported the Portfolio’s management fee rate as the combined contractual advisory fee and administration fee rates. The Trustees also reviewed information about other expenses and the expense ratios for the Portfolio and noted that Universe and Peer Group quintile rankings were not calculated if the number of funds in the Universe and/or Peer Groups did not meet a predetermined minimum. The Trustees considered the Fee Caps currently in place for the Portfolio, the net advisory fee rate after taking into account any waivers and/or reimbursements, and, where deemed appropriate by the Trustees, additional waivers and/or reimbursements. The Trustees recognized that it can be difficult to make comparisons of advisory fees because there are variations in the services that are included in the fees paid
by other funds. The Trustees’ determinations as a result of the review of the Portfolio’s advisory fees and expense ratios are summarized below:
The Trustees noted that the Portfolio’s net advisory fee for Class 1 and Class 2 shares was in the first quintile of both the Peer Group and Universe, and that the actual total expenses for Class 1 and Class 2 shares were in the second quintile of both
the Peer Group and Universe. After considering the factors identified above, in light of this information, the Trustees concluded that the advisory fee was satisfactory in light of the services provided to the Portfolio and that such fee would be for services provided in addition to, rather than duplicative of, services provided under the advisory agreements of the Underlying Funds in which the Portfolio invests.
TAX LETTER
(Unaudited)
(Dollar values in thousands)
Dividends Received Deduction (DRD)
The Portfolio had 8.47%, or maximum allowable percentage, of ordinary income distributions eligible for the dividends received deduction for corporate shareholders for the fiscal year ended December 31, 2022.
Long Term Capital Gain
The Portfolio distributed $1,842, or maximum allowable amount, of long-term capital gain dividends for the fiscal year ended December 31, 2022.
J.P. Morgan Funds are distributed by JPMorgan Distribution Services, Inc., which is an affiliate of JPMorgan Chase & Co. Affiliates of JPMorgan Chase & Co. receive fees for providing various services to the funds.
Contact JPMorgan Distribution Services, Inc. at 1-800-480-4111 for a portfolio prospectus. You can also visit us at www.jpmorgan.com/variableinsuranceportfolios. Investors should carefully consider the investment objectives and risk as well as charges and expenses of the mutual fund before investing. The prospectus contains this and other information about the mutual fund. Read the prospectus carefully before investing.
Investors may obtain information about the Securities Investor Protection Corporation (SIPC), including the SIPC brochure, by visiting www.sipc.org or by calling SIPC at 202-371-8300.
The Portfolio files a complete schedule of its portfolio holdings for the first and third quarters of its fiscal year with the SEC as an exhibit to its report on Form N-PORT. The Portfolio’s Form N-PORT reports are available on the SEC’s website at http://www.sec.gov. The Portfolio's quarterly holdings can be found by visiting the Portfolio's website at www.jpmorgan.com/variableinsuranceportfolios.
A description of the Portfolio’s policies and procedures with respect to the disclosure of the Portfolio’s holdings is available in the prospectuses and Statement of Additional Information.
A copy of proxy policies and procedures is available without charge upon request by calling 1-800-480-4111 and on the Portfolio’s website at www.jpmorgan.com/variableinsuranceportfolios. A description of such policies and procedures is on the SEC’s website at www.sec.gov. The Trustees have delegated the authority to vote proxies for securities owned by the Portfolio to the Adviser. A copy of the Portfolio’s voting record for the most recent 12-month period ended June 30 is available on the SEC’s website at www.sec.gov or at the Portfolio’s website at www.jpmorgan.com/variableinsuranceportfolios no later than August 31 of each year. The Portfolio’s proxy voting record will include, among other things, a brief description of the matter voted on for each portfolio security, and will state how each vote was cast, for example, for or against the proposal.
J.P. Morgan Asset Management is the brand name for the asset management business of JPMorgan Chase & Co. and its affiliates worldwide.
© JPMorgan Chase & Co., 2022. All rights reserved. December 2022.
AN-JPMITIBP-1222
Annual Report
JPMorgan Insurance Trust
December 31, 2022
JPMorgan Insurance Trust Global Allocation Portfolio |
CONTENTS
Investments in the Portfolio are not deposits or obligations of, or guaranteed or endorsed by, any bank and are not insured or guaranteed by the FDIC, the Federal Reserve Board or any other government agency. You could lose money if you sell when the Portfolio’s share price is lower than when you invested.
Past performance is no guarantee of future performance. The general market views expressed in this report are opinions based on market and other conditions through the end of the reporting period and are subject to change without notice. These views are not intended to predict the future performance of the Portfolio or the securities markets.
This Portfolio is intended to be a funding vehicle for variable annuity contracts and variable life insurance policies (collectively “Policies”) offered by the separate accounts of various insurance companies. Portfolio shares may also be offered to qualified pension and retirement plans and accounts permitting accumulation of assets on a tax-deferred basis (“Eligible Plans”). Individuals may not purchase shares directly from the Portfolio.
Prospective investors should refer to the Portfolio’s prospectuses for a discussion of the Portfolio’s investment objective, strategies and risks. Call J.P. Morgan Funds Service Center at 1-800-480-4111 for a prospectus containing more complete information about the Portfolio, including management fees and other expenses. Please read it carefully before investing.
Letter to Shareholders
February 13, 2023 (Unaudited)
Dear Shareholder,
Financial markets have rebounded somewhat as the U.S. and other developed market economies have shown notable resilience in the face of higher inflation, rising interest rates and the ongoing war in Ukraine. While the factors that weighed on equity and bond markets in 2022 largely remain, there are signals that inflationary pressures may have peaked and the long-term economic outlook appears positive.
|
“Investors may face continued economic and geopolitical challenges in the year ahead. However, some of the acute risks encountered in 2022 appear to have receded and last year’s reset in asset prices may provide attractive investment opportunities.” — Brian S. Shlissel
|
While U.S. economic growth was surprisingly strong in the closing months of 2022, with broad gains in employment and consumer spending in the final months of the year, the U.S. Federal Reserve’s efforts to counter inflationary pressure through sharply higher interest rates could slow economic momentum in the months ahead.
Corporate earnings have been squeezed by higher costs for materials and labor, while the strong U.S. dollar has hindered export revenues. However, the impact of higher prices and interest rates has not landed on all sectors of the economy evenly. Energy sector profits have soared over the past year, while earnings in housing and construction sectors have declined.
Across Europe, the war in Ukraine has driven up prices for energy, food and a range of other goods and has fueled negative consumer sentiment. The prolonged nature of the conflict and its potential to spread remain key concerns among policymakers, diplomats, military planners, economists and investors. It is worth noting that Europe’s largest industrialized nations in concert with the European Union have moved swiftly to secure alternatives to Russian sources of natural gas and petroleum, which has eased an energy crisis that began last year.
Investors may face continued economic and geopolitical challenges in the year ahead. However, some of the acute risks encountered in 2022 appear to have receded and last year’s reset in asset prices may provide attractive investment opportunities. A long-term view and a properly diversified portfolio, in our opinion, remain key elements to a successful investment approach.
Our broad array of investment solutions seeks to provide investors with ability to build durable portfolios that can help them meet their financial goals.
Sincerely,
Brian S. Shlissel
President - J.P. Morgan Funds
J.P. Morgan Asset Management
1-800-480-4111 or www.jpmorganfunds.com for more information
JPMorgan Insurance Trust Global Allocation Portfolio
PORTFOLIO COMMENTARY
TWELVE MONTHS ENDED December 31, 2022 (Unaudited)
| |
Portfolio (Class 2 Shares)* | |
MSCI All Country World Index (net total return) | |
60% MSCI All Country World Index (net total return) / 40% Bloomberg Global Aggregate Index - Unhedged USD (formerly known as the Global Allocation Composite) | |
Net Assets as of 12/31/2022 (In Thousands) | |
INVESTMENT OBJECTIVE**
The JPMorgan Insurance Trust Global Allocation Portfolio (the “Portfolio”) seeks to maximize long-term total return.
HOW DID THE MARKET PERFORM?
Overall, financial markets tumbled in the first three quarters of 2022, but rebounded moderately in the final months of the year. Equity markets turned in their worst first-half performance since 1970, amid accelerating inflation, pandemic lockdowns across China and Russia’s invasion of Ukraine. While bond markets also slumped, investor demand for U.S. Treasury bonds and core U.S. corporate debt provided some support for the Bloomberg U.S. Aggregate Index, which broadly tracks the performance of the U.S. investment-grade bond market.
The S&P 500 Index, which gauges the performance of U.S. large-cap equities, reached a new closing high on January 3, 2022, bolstered by record high corporate earnings, sales, cash flows, share repurchases and dividends. However, investor sentiment began to sour as accelerating inflation started to erode consumer confidence and raise expectations for an increase in benchmark interest rates by the U.S. Federal Reserve (the “Fed”).
Russia’s invasion of Ukraine at the end of February 2022 initiated a sell-off in global financial markets that was further fueled by the highest U.S. inflation rate in more than 40 years. Equity prices recovered somewhat in March 2022 amid better-than-expected corporate earnings. However, the general trend in global financial markets was downward throughout the year.
In response to accelerating inflationary pressure, the Fed raised its benchmark interest rate mid-March, the first increase since December 2018. The central bank followed with six more rate increases over the course of 2022. The Bank of England, which began raising interest rates in late 2021, also continued to raise interest rates throughout the year, while the European Central Bank waited until June before sharply raising interest rates for the first time in 11 years.
In the U.S., equity prices experienced a sharp sell-off in August and September 2022 that coincided with U.S. Federal Reserve policy guidance on further interest rate increases. However,
corporate earnings for both the second and third quarters of 2022 generally were better than expected given a cooling economy and slower consumer spending. Meanwhile, the U.S. unemployment rate remained historically low - hovering between 3.5% and 3.7% for the six-month period - and by the end of 2022 data indicated some inflationary pressures had eased.
Across Europe, the energy crisis that followed Russia’s invasion of Ukraine in late February 2022 eased somewhat in the second half of the year as both the U.K. and the EU obtained alternatives to Russian energy imports and global energy prices receded. A political crisis in the U.K. roiled financial markets in London but the ascension of Rishi Sunak to prime minister appeared to remove some investor uncertainty.
Emerging markets broadly declined during the period but there was wide variance among individual nations. Chinese equities continued to underperform amid investor concerns about the economic impact of the country’s strict anti-pandemic policies, as well as weakness within China’s real estate sector and changes in the global trade for information. While energy prices retreated from historically high levels in the second half of 2022, overall commodities prices remained elevated, which benefitted markets in exporting nations but hurt markets in net importing nations.
For the twelve-month period, leading equity and bond market indexes were mostly negative, with non-U.S. developed markets equities outperforming both U.S. and emerging markets generally equities. Bonds in both developed and emerging markets also generally declined for the year.
WHAT WERE THE MAIN DRIVERS OF THE PORTFOLIO'S PERFORMANCE?
The Portfolio’s Class 2 Shares outperformed the MSCI All Country World Index (net total return) (the “Benchmark”) and underperformed the combined 60% MSCI All Country World Index (net total return) / 40% Bloomberg Global Aggregate Index (the “Composite”) for the twelve months ended December 31, 2022.
The Portfolio’s overall allocation to fixed income was a leading contributor to performance given relative to the Benchmark,
given the general underperformance of equities during the reporting period.
Relative to the Composite, the Portfolio’s allocation to extended credit, including high yield bonds (also known as junk bonds) and crossover credit were leading detractors from performance. The Portfolio’s allocations to short-duration fixed income and investment grade corporate debt were leading contributors to relative performance. Generally, shorter duration bonds will experience a smaller decrease in price compared with longer duration bonds when interest rates rise.
HOW WAS THE PORTFOLIO POSITIONED?
During the reporting period, the Portfolio was positioned to maximize total return while managing risk. While the portfolio managers decreased the Portfolio’s overall equity allocation, they did purchase call options on international developed equities to manage for potential rallies in the market. In terms of fixed income, the portfolio managers also decreased the
Portfolio’s short-duration high yield exposure.
TOP TEN HOLDINGS OF THE
PORTFOLIO AS OF December 31, 2022 | PERCENT OF
TOTAL
INVESTMENTS |
| JPMorgan Corporate Bond Fund, Class R6 | |
| JPMorgan Income Fund, Class R6 | |
| JPMorgan Emerging Markets Equity Fund, Class R6 | |
| JPMorgan Large Cap Value Fund, Class R6 | |
| U.S. Treasury Notes 0.13%, 1/31/2023 | |
| | |
| | |
| LVMH Moet Hennessy Louis Vuitton SE (France) | |
| Mastercard, Inc., Class A | |
| | |
PORTFOLIO COMPOSITION BY ASSET CLASS
AS OF December 31, 2022 | PERCENT OF
TOTAL
INVESTMENTS |
| |
Foreign Government Securities | |
| |
U.S. Treasury Obligations | |
| |
Others (each less than 1.0%) | |
| |
*
The return shown is based on net asset values calculated for shareholder transactions and may differ from the return shown in the financial highlights, which reflects adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
**
The adviser seeks to achieve the Portfolio’s objective. There can be no guarantee it will be achieved.
JPMorgan Insurance Trust Global Allocation Portfolio
PORTFOLIO COMMENTARY
TWELVE MONTHS ENDED December 31, 2022 (Unaudited) (continued)
AVERAGE ANNUAL TOTAL RETURNS AS OF December 31, 2022
LIFE OF PORTFOLIO PERFORMANCE (12/9/14 TO 12/31/22)
The performance quoted is past performance and is not a guarantee of future results. Mutual funds are subject to certain market risks. Investment returns and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance data shown. For up-to-date month-end performance information please call 1-800-480-4111.
The Portfolio commenced operations on December 9, 2014.
The graph illustrates comparative performance for $10,000 invested in Class 2 Shares of the JPMorgan Insurance Trust Global Allocation Portfolio, the MSCI All Country World Index (net total return), the Bloomberg Global Aggregate Index — Unhedged USD and the 60% MSCI ACWI Index (net total return) / 40% Bloomberg Global Aggregate Index-Unhedged USD (formerly known as the Global Allocation Composite) from December 9, 2014 to December 31, 2022. The performance of the Portfolio assumes reinvestment of all dividends and capital gain distributions, if any. The performance of the MSCI All Country World Index (net total return), Bloomberg Global Aggregate Index — Unhedged USD and 60% MSCI ACWI Index (net total return) / 40% Bloomberg Global Aggregate Index-Unhedged USD do not reflect the deduction of expenses associated with a mutual fund and have been adjusted to reflect reinvestment of all dividends and capital gain distributions of the securities included in the benchmarks, if applicable. The MSCI All Country World Index (net total return) is a free float-adjusted market capitalization weighted index that is designed to measure the performance of large- and mid- cap stocks in developed and emerging markets. Net total return figures assume the reinvestment of dividends after deduction of withholding tax, applying the maximum rate to nonresident
individual investors who do not benefit from double taxation treaties. Since November 30, 2020, the 60% MSCI ACWI Index (net total return) / 40% Bloomberg Global Aggregate Index-Unhedged USD is a composite benchmark comprised of unmanaged indices that includes the MSCI All Country World Index (net total return) (60%) and the Bloomberg Global Aggregate Bond Index (40%). Prior to November 30, 2020, the Global Allocation Composite Benchmark was a composite benchmark comprised of unmanaged indices that included the MSCI World Index (net total return) (60%) and the Bloomberg Global Aggregate Bond Index (40%). Investors cannot invest directly in an index.
Portfolio performance does not reflect any charges imposed by the Policies or Eligible Plans. If these charges were included, the returns would be lower than shown. Portfolio performance may reflect the waiver of the Portfolio’s fees and reimbursement of expenses for certain periods since the inception date. Without these waivers and reimbursements, performance would have been lower.
International investing involves a greater degree of risk and increased volatility. Changes in currency exchange rates and differences in accounting and taxation policies outside the United States can raise or lower returns. Also, some overseas markets may not be as politically and economically stable as the United States and other nations.
The returns shown are based on net asset values calculated for shareholder transactions and may differ from the returns shown in the financial highlights, which reflect adjustments made to the net asset values in accordance with accounting principles generally accepted in the United States of America.
JPMorgan Insurance Trust Global Allocation Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022
| | |
|
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Commonwealth Bank of Australia | | |
| | |
Flutter Entertainment plc* | | |
Fortescue Metals Group Ltd. | | |
| | |
| | |
| | |
Insurance Australia Group Ltd. | | |
| | |
Lottery Corp. Ltd. (The)* | | |
| | |
| | |
| | |
National Australia Bank Ltd. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Woodside Energy Group Ltd. | | |
Woodside Energy Group Ltd. | | |
| | |
| | |
| | |
|
|
| | |
| | |
| | |
|
Alimentation Couche-Tard, Inc. | | |
Canadian National Railway Co. | | |
Fairfax Financial Holdings Ltd. | | |
Toronto-Dominion Bank (The) | | |
| | |
|
BOC Hong Kong Holdings Ltd. | | |
Budweiser Brewing Co. APAC Ltd.(a) | | |
| | |
| | |
| | |
Wilmar International Ltd. | | |
Xinyi Glass Holdings Ltd. | | |
| | |
|
AP Moller - Maersk A/S, Class B | | |
| | |
| | |
| | |
| | |
Novo Nordisk A/S, Class B | | |
| | |
| | |
| | |
|
| | |
| | |
| | |
| | |
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Global Allocation Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Common Stocks — continued |
|
Cie Generale des Etablissements Michelin SCA | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
LVMH Moet Hennessy Louis Vuitton SE | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
Deutsche Post AG (Registered) | | |
Deutsche Telekom AG (Registered) | | |
| | |
| | |
| | |
Muenchener Rueckversicherungs-Gesellschaft AG (Registered) | | |
| | |
| | |
| | |
| | |
Volkswagen AG (Preference) | | |
| | |
| | |
| | |
|
| | |
| | |
CK Infrastructure Holdings Ltd. | | |
| | |
|
|
| | |
Hang Lung Properties Ltd. | | |
| | |
| | |
Hong Kong & China Gas Co. Ltd. | | |
Hong Kong Exchanges & Clearing Ltd. | | |
Jardine Matheson Holdings Ltd. | | |
| | |
| | |
Power Assets Holdings Ltd. | | |
| | |
Sun Hung Kai Properties Ltd. | | |
Techtronic Industries Co. Ltd. | | |
| | |
| | |
|
| | |
|
Bank Central Asia Tbk. PT | | |
|
| | |
| | |
| | |
| | |
|
| | |
| | |
FinecoBank Banca Fineco SpA | | |
| | |
| | |
| | |
|
| | |
| | |
| | |
Asahi Group Holdings Ltd. | | |
| | |
| | |
| | |
| | |
Central Japan Railway Co. | | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Common Stocks — continued |
|
Chubu Electric Power Co., Inc. | | |
Chugai Pharmaceutical Co. Ltd. | | |
| | |
Dai Nippon Printing Co. Ltd. | | |
Dai-ichi Life Holdings, Inc. | | |
| | |
| | |
Daiwa House Industry Co. Ltd. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Japan Exchange Group, Inc. | | |
Japan Post Holdings Co. Ltd. | | |
Japan Real Estate Investment Corp., REIT | | |
| | |
Kansai Electric Power Co., Inc. (The) | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
|
| | |
Mitsubishi Chemical Group Corp. | | |
| | |
Mitsubishi Electric Corp. | | |
Mitsubishi Estate Co. Ltd. | | |
Mitsubishi Heavy Industries Ltd. | | |
Mitsubishi UFJ Financial Group, Inc. | | |
| | |
| | |
| | |
| | |
Mizuho Financial Group, Inc. | | |
| | |
Murata Manufacturing Co. Ltd. | | |
| | |
| | |
Nihon M&A Center Holdings, Inc. | | |
| | |
Nippon Building Fund, Inc., REIT | | |
NIPPON EXPRESS HOLDINGS, Inc. | | |
Nippon Paint Holdings Co. Ltd. | | |
Nippon Prologis REIT, Inc., REIT | | |
| | |
Nippon Telegraph & Telephone Corp. | | |
| | |
Nissin Foods Holdings Co. Ltd. | | |
| | |
| | |
| | |
Nomura Research Institute Ltd. | | |
| | |
| | |
Odakyu Electric Railway Co. Ltd. | | |
| | |
Ono Pharmaceutical Co. Ltd. | | |
| | |
| | |
| | |
| | |
| | |
| | |
Recruit Holdings Co. Ltd. | | |
Renesas Electronics Corp.* | | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Global Allocation Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Common Stocks — continued |
|
| | |
| | |
| | |
Seven & i Holdings Co. Ltd. | | |
| | |
Shin-Etsu Chemical Co. Ltd. | | |
| | |
| | |
| | |
| | |
| | |
| | |
Square Enix Holdings Co. Ltd. | | |
| | |
| | |
Sumitomo Electric Industries Ltd. | | |
Sumitomo Metal Mining Co. Ltd. | | |
Sumitomo Mitsui Financial Group, Inc. | | |
Sumitomo Mitsui Trust Holdings, Inc. | | |
Sumitomo Realty & Development Co. Ltd. | | |
Suntory Beverage & Food Ltd. | | |
| | |
| | |
| | |
Takeda Pharmaceutical Co. Ltd. | | |
| | |
| | |
Tokio Marine Holdings, Inc. | | |
Tokyo Electric Power Co. Holdings, Inc.* | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
|
| | |
|
Wal-Mart de Mexico SAB de CV | | |
|
| | |
| | |
| | |
| | |
| | |
| | |
Koninklijke Ahold Delhaize NV | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
| | |
|
CapitaLand Integrated Commercial Trust, REIT | | |
Capitaland Investment Ltd. | | |
| | |
Oversea-Chinese Banking Corp. Ltd. | | |
| | |
| | |
Singapore Technologies Engineering Ltd. | | |
Singapore Telecommunications Ltd. | | |
United Overseas Bank Ltd. | | |
| | |
|
| | |
|
| | |
Samsung Electronics Co. Ltd. | | |
| | |
|
Banco Bilbao Vizcaya Argentaria SA | | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Common Stocks — continued |
|
| | |
Industria de Diseno Textil SA | | |
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
| | |
Adecco Group AG (Registered) | | |
| | |
Cie Financiere Richemont SA (Registered) | | |
| | |
| | |
Lonza Group AG (Registered) | | |
| | |
Partners Group Holding AG | | |
| | |
| | |
Straumann Holding AG (Registered) | | |
UBS Group AG (Registered) | | |
Zurich Insurance Group AG | | |
| | |
|
Taiwan Semiconductor Manufacturing Co. Ltd., ADR | | |
|
| | |
| | |
| | |
| | |
| | |
Berkeley Group Holdings plc | | |
| | |
British American Tobacco plc | | |
CK Hutchison Holdings Ltd. | | |
| | |
|
United Kingdom — continued |
| | |
| | |
| | |
Direct Line Insurance Group plc | | |
| | |
| | |
InterContinental Hotels Group plc | | |
| | |
| | |
| | |
London Stock Exchange Group plc | | |
| | |
Reckitt Benckiser Group plc | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
| | |
Advanced Micro Devices, Inc.* | | |
Albertsons Cos., Inc., Class A | | |
Alnylam Pharmaceuticals, Inc.* | | |
| | |
| | |
American Electric Power Co., Inc. | | |
| | |
American Homes 4 Rent, Class A, REIT | | |
American International Group, Inc. | | |
| | |
| | |
| | |
| | |
Apple Hospitality REIT, Inc., REIT | | |
| | |
| | |
| | |
| | |
Axalta Coating Systems Ltd.* | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Global Allocation Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Common Stocks — continued |
United States — continued |
| | |
| | |
| | |
| | |
Berkshire Hathaway, Inc., Class B* | | |
| | |
| | |
| | |
| | |
| | |
Brixmor Property Group, Inc., REIT | | |
| | |
| | |
Capital One Financial Corp. | | |
| | |
CBRE Group, Inc., Class A* | | |
| | |
Charles Schwab Corp. (The) | | |
Charter Communications, Inc., Class A* | | |
| | |
| | |
| | |
| | |
| | |
| | |
Citizens Financial Group, Inc. | | |
| | |
| | |
| | |
| | |
CommScope Holding Co., Inc.* | | |
| | |
Confluent, Inc., Class A* | | |
| | |
Constellation Brands, Inc., Class A | | |
| | |
| | |
| | |
Crowdstrike Holdings, Inc., Class A* | | |
| | |
| | |
| | |
| | |
Dick's Sporting Goods, Inc. | | |
| | |
|
United States — continued |
| | |
| | |
EastGroup Properties, Inc., REIT | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Estee Lauder Cos., Inc. (The), Class A | | |
| | |
| | |
Federal Realty Investment Trust, REIT | | |
| | |
| | |
| | |
FleetCor Technologies, Inc.* | | |
Fortune Brands Innovations, Inc. | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Hartford Financial Services Group, Inc. (The) | | |
| | |
Hilton Worldwide Holdings, Inc. | | |
| | |
Honeywell International, Inc. | | |
Horizon Therapeutics plc* | | |
| | |
| | |
| | |
| | |
| | |
International Business Machines Corp. | | |
| | |
Intuitive Surgical, Inc.* | | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Common Stocks — continued |
United States — continued |
| | |
James Hardie Industries plc, CDI | | |
Jazz Pharmaceuticals plc* | | |
JBG SMITH Properties, REIT | | |
| | |
| | |
Keysight Technologies, Inc.* | | |
| | |
| | |
| | |
Laboratory Corp. of America Holdings | | |
| | |
Lamar Advertising Co., Class A, REIT | | |
| | |
Liberty Broadband Corp., Class C* | | |
Liberty Media Corp.-Liberty SiriusXM, Class C* | | |
| | |
| | |
| | |
Marriott International, Inc., Class A | | |
Marsh & McLennan Cos., Inc. | | |
Martin Marietta Materials, Inc. | | |
| | |
Mastercard, Inc., Class A(b) | | |
| | |
| | |
| | |
| | |
Meta Platforms, Inc., Class A* | | |
Mettler-Toledo International, Inc.* | | |
| | |
| | |
Mid-America Apartment Communities, Inc., REIT | | |
| | |
| | |
| | |
| | |
| | |
| | |
National Vision Holdings, Inc.* | | |
| | |
| | |
| | |
|
United States — continued |
Nexstar Media Group, Inc., Class A | | |
| | |
| | |
| | |
| | |
| | |
| | |
Old Dominion Freight Line, Inc. | | |
Packaging Corp. of America | | |
Palo Alto Networks, Inc.* | | |
| | |
Philip Morris International, Inc. | | |
| | |
PNC Financial Services Group, Inc. (The) | | |
| | |
Procter & Gamble Co. (The) | | |
| | |
| | |
Public Service Enterprise Group, Inc. | | |
| | |
| | |
| | |
| | |
| | |
Raytheon Technologies Corp. | | |
Regeneron Pharmaceuticals, Inc.* | | |
| | |
| | |
Royal Caribbean Cruises Ltd.* | | |
Royalty Pharma plc, Class A | | |
| | |
| | |
| | |
SolarEdge Technologies, Inc.* | | |
| | |
Sun Communities, Inc., REIT | | |
| | |
| | |
| | |
T. Rowe Price Group, Inc. | | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Global Allocation Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Common Stocks — continued |
United States — continued |
| | |
Thermo Fisher Scientific, Inc. | | |
| | |
| | |
| | |
| | |
Trade Desk, Inc. (The), Class A* | | |
| | |
Travelers Cos., Inc. (The) | | |
| | |
| | |
| | |
United Parcel Service, Inc., Class B | | |
| | |
| | |
Verizon Communications, Inc. | | |
Vertex Pharmaceuticals, Inc.* | | |
| | |
| | |
| | |
| | |
| | |
Williams Cos., Inc. (The) | | |
| | |
| | |
| | |
Zebra Technologies Corp., Class A* | | |
Zimmer Biomet Holdings, Inc. | | |
Zoom Video Communications, Inc., Class A* | | |
| | |
| | |
Total Common Stocks
(Cost $47,785) | | |
| | |
Foreign Government Securities — 18.2% |
|
Commonwealth of Australia | | |
| | |
| | |
| | |
| | |
| | |
|
|
| | |
| | |
| | |
| | |
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Canada Housing Trust 1.25%, 6/15/2026(c) | | |
| | |
| | |
| | |
Province of British Columbia | | |
| | |
| | |
| | |
| | |
| | |
| | |
|
Export-Import Bank of China (The) 0.75%, 5/28/2023(a) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Foreign Government Securities — continued |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
Bundesobligation 1.30%, 10/15/2027(a) | | |
Bundesrepublik Deutschland | | |
| | |
| | |
| | |
| | |
| | |
|
Buoni Poliennali del Tesoro | | |
| | |
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Global Allocation Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
Foreign Government Securities — continued |
|
| | |
| | |
| | |
| | |
|
State of Qatar 3.88%, 4/23/2023(c) | | |
|
Export-Import Bank of Korea | | |
| | |
| | |
| | |
|
Bonos and Obligaciones del Estado | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
United Kingdom of Great Britain and Northern Ireland | | |
| | |
| | |
| | |
| | |
| | |
| | |
|
United Kingdom — continued |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
Total Foreign Government Securities
(Cost $22,110) | | |
| | |
Investment Companies — 16.8% |
| | |
JPMorgan Large Cap Value Fund, Class R6 Shares(d) | | |
JPMorgan Income Fund, Class R6 Shares(d) | | |
JPMorgan Emerging Markets Equity Fund, Class R6 Shares(d) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
| | |
Investment Companies — continued |
United States — continued | | |
JPMorgan Corporate Bond Fund, Class R6 Shares(d) | | |
Total Investment Companies
(Cost $18,591) | | |
| | |
U.S. Treasury Obligations — 2.2% |
U.S. Treasury Notes 0.13%, 1/31/2023(e)(Cost $2,476) | | |
|
|
Westpac Banking Corp. 2.00%, 1/13/2023 | | |
|
Ontario Teachers' Finance Trust | | |
| | |
| | |
| | |
| | |
|
China Development Bank 0.88%, 1/24/2024(a) | | |
|
BNP Paribas SA 3.50%, 3/1/2023(c) | | |
| | |
| | |
| | |
| | |
|
| | |
| | |
| | |
Nederlandse Waterschapsbank NV | | |
| | |
| | |
| | |
|
Korea Development Bank (The) 0.63%, 7/17/2023(a) | | |
| | |
|
|
Walt Disney Co. (The) 8.88%, 4/26/2023 | | |
Total Corporate Bonds
(Cost $2,530) | | |
|
Asian Development Bank, 3.40%, 9/10/2027(a) | | |
European Investment Bank, 0.50%, 6/21/2023 | | |
European Union, 0.70%, 7/6/2051(a) | | |
Inter-American Development Bank | | |
| | |
| | |
Total Supranational
(Cost $263) | | |
Commercial Mortgage-Backed Securities — 0.2% |
|
Citigroup Commercial Mortgage Trust Series 2012-GC8, Class D, 4.91%, 9/10/2045(c) (f) | | |
FHLMC, Multi-Family Structured Pass-Through Certificates Series K083, Class X1, IO, 0.04%, 9/25/2028(f) | | |
FREMF Series 2018-KF46, Class B, 6.09%, 3/25/2028(c) (f) | | |
| | |
Series 2017-KF32, Class B, 6.69%, 5/25/2024(c) (f) | | |
Series 2017-KF38, Class B, 6.64%, 9/25/2024(c) (f) | | |
Series 2018-KF45, Class B, 6.09%, 3/25/2025(c) (f) | | |
Series 2018-KF49, Class B, 6.04%, 6/25/2025(c) (f) | | |
Series 2019-KF63, Class B, 6.49%, 5/25/2029(c) (f) | | |
LB-UBS Commercial Mortgage Trust Series 2006-C6, Class AJ, 5.45%, 9/15/2039(f) | | |
Total Commercial Mortgage-Backed Securities
(Cost $241) | | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Global Allocation Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| | |
|
Call Options Purchased — 0.1% |
|
| | |
6/16/2023 at USD 69.00, American Style | | |
Notional Amount: USD 4,408 | | |
Counterparty: Exchange traded*(Cost $251) | | |
| | |
Collateralized Mortgage Obligations — 0.0% ^ |
|
Banc of America Funding Trust Series 2006-A, Class 1A1, 3.96%, 2/20/2036(f) | | |
Deutsche Alt-A Securities Mortgage Loan Trust Series 2007-3, Class 2A1, 5.14%, 10/25/2047(f) | | |
Morgan Stanley Mortgage Loan Trust Series 2004-5AR, Class 4A, 3.84%, 7/25/2034(f) | | |
Total Collateralized Mortgage Obligations
(Cost $7) | | |
Short-Term Investments — 7.6% |
Certificates of Deposits — 0.3% |
Barclays Bank plc, 5.72%, 12/7/2023 (Cost $250) | | |
|
American Honda Finance Corp., 4.80%, 2/3/2023(g) | | |
Bank of Montreal, 5.55%, 11/6/2023(g) | | |
Caisse des Depots et Consignations, 3.72%, 1/6/2023(c) (g) | | |
DBS Bank Ltd., 4.34%, 3/20/2023(g) | | |
DNB Bank ASA, 5.38%, 12/19/2023(g) | | |
Enel Finance America LLC, 4.97%, 1/12/2023(g) | | |
GTA Funding LLC, 4.05%, 1/25/2023(g) | | |
Healthpeak Properties, Inc., 5.05%, 1/31/2023(g) | | |
ING US Funding LLC, 5.27%, 9/21/2023(g) | | |
Louisville Gas and Electric Co., 4.89%, 1/10/2023(g) | | |
National Securities Clearing Corp., 4.40%, 2/15/2023(g) | | |
Natixis SA, 5.39%, 9/1/2023(g) | | |
| | |
|
Commercial Paper — continued |
Procter & Gamble Co. (The), 4.62%, 3/3/2023(g) | | |
PSP Capital, Inc., 3.76%, 1/6/2023(c) (g) | | |
Royal Bank of Canada, 5.53%, 12/8/2023(g) | | |
Societe Generale SA, 5.32%, 9/15/2023(g) | | |
TELUS Corp., 4.35%, 1/10/2023(g) | | |
TransCanada PipeLines Ltd., 5.01%, 2/2/2023(g) | | |
Waste Management, Inc., 4.74%, 1/10/2023(g) | | |
Total Commercial Paper
(Cost $4,637) | | |
| | |
Investment Companies — 3.1% |
JPMorgan Prime Money Market Fund Class Institutional Shares, 4.42%(d) (h) (Cost $3,405) | | |
Total Short-Term Investments
(Cost $8,292) | | |
Total Investments — 99.7%
(Cost $102,546) | | |
Assets in Excess of Other Liabilities — 0.3% | | |
| | |
Percentages indicated are based on net assets. |
Amounts presented as a dash ("-") represent amounts that round to less than a thousand. |
| |
| American Depositary Receipt |
| |
| |
| |
| Certificate of interbank deposits |
| |
| Europe, Australasia and Far East |
| |
| |
| Federal Home Loan Mortgage Corp. |
| |
SEE NOTES TO FINANCIAL STATEMENTS.
| Interest Only represents the right to receive the monthly interest payments on an underlying pool of mortgage loans. The principal amount shown represents the par value on the underlying pool. The yields on these securities are subject to accelerated principal paydowns as a result of prepayment or refinancing of the underlying pool of mortgage instruments. As a result, interest income may be reduced considerably. |
| |
| Morgan Stanley Capital International |
| |
| A special type of equity investment that shares in the earnings of the company, has limited voting rights, and may have a dividend preference. Preference shares may also have liquidation preference. |
| Limited liability company |
| Real Estate Investment Trust |
| Limited partnership with share capital |
| |
| |
| Amount rounds to less than 0.1% of net assets. |
| Non-income producing security. | |
| Security exempt from registration pursuant to Regulation S under the Securities Act of 1933, as amended. Regulation S applies to securities offerings that are made outside of the United States and do not involve direct selling efforts in the United States and as such may have restrictions on resale. | |
| All or a portion of this security is segregated as collateral for short sales. The total value of securities segregated as collateral is $1,287. | |
| Securities exempt from registration under Rule 144A or section 4(a)(2), of the Securities Act of 1933, as amended. | |
| Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. | |
| All or a portion of this security is deposited with the broker as initial margin for futures contracts. | |
| Variable or floating rate security, the interest rate of which adjusts periodically based on changes in current interest rates and prepayments on the underlying pool of assets. The interest rate shown is the current rate as of December 31, 2022. | |
| The rate shown is the effective yield as of December 31, 2022. | |
| The rate shown is the current yield as of December 31, 2022. | |
Summary of Investments by Industry, December 31, 2022
The following table represents the portfolio investments of the Portfolio by industry classifications as a percentage of total investments:
PORTFOLIO COMPOSITION BY ASSET CLASS
AS OF December 31, 2022 | PERCENT OF
TOTAL
INVESTMENTS |
Foreign Government Securities | |
| |
| |
| |
Semiconductors & Semiconductor Equipment | |
| |
| |
| |
Oil, Gas & Consumable Fuels | |
| |
| |
| |
| |
Textiles, Apparel & Luxury Goods | |
| |
Hotels, Restaurants & Leisure | |
Internet & Direct Marketing Retail | |
Health Care Equipment & Supplies | |
| |
| |
Health Care Providers & Services | |
Equity Real Estate Investment Trusts (REITs) | |
| |
Interactive Media & Services | |
Others (each less than 1.0%) | |
| |
Detailed information about investment portfolios of the underlying funds and ETFs can be found in shareholder reports filed with the Securities and Exchange Commission (SEC) by each such underlying fund semi-annually on Form N-CSR and in portfolio holdings filed quarterly on Form N-PORT, and are available for download from both the SEC’s as well as each respective underlying fund’s website. Detailed information about underlying J.P. Morgan Funds can also be found at www.jpmorganfunds.com or by calling 1-800-480-4111.
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Global Allocation Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
Futures contracts outstanding as of December 31, 2022 (amounts in thousands, except number of contracts):
| | | | | VALUE AND
UNREALIZED
APPRECIATION
(DEPRECIATION) ($) |
| | | | | |
| | | | | |
| | | | | |
Foreign Exchange AUD / USD | | | | | |
Foreign Exchange EUR / USD | | | | | |
Foreign Exchange GBP / USD | | | | | |
Foreign Exchange JPY / USD | | | | | |
| | | | | |
Foreign Exchange CAD / USD | | | | | |
| | | | | |
| | | | | |
MSCI Emerging Markets E-Mini Index | | | | | |
| | | | | |
U.S. Treasury 10 Year Note | | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
U.S. Treasury 10 Year Note | | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| |
| |
| |
| Europe, Australasia and Far East |
| |
| |
| |
| Morgan Stanley Capital International |
| Secured Overnight Financing Rate |
| Sterling Overnight Index Average |
| Australian Securities Exchange |
| |
| |
| Amount rounds to less than one thousand. |
SEE NOTES TO FINANCIAL STATEMENTS.
Forward foreign currency exchange contracts outstanding as of December 31, 2022 (amounts in thousands):
| | | | UNREALIZED
APPRECIATION
(DEPRECIATION) ($) |
| | | | | | |
| | | | | | |
| | | | Merrill Lynch International | | |
| | | | | | |
| | | | Merrill Lynch International | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | Merrill Lynch International | | |
| | | | Merrill Lynch International | | |
| | | | | | |
| | | | | | |
| | | | | | |
Total unrealized appreciation | |
| | | | | | |
| | | | | | |
| | | | Merrill Lynch International | | |
| | | | | | |
| | | | Merrill Lynch International | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | Goldman Sachs International | | |
| | | | | | |
| | | | Merrill Lynch International | | |
| | | | | | |
| | | | | | |
| | | | Merrill Lynch International | | |
| | | | | | |
| | | | Merrill Lynch International | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
Total unrealized depreciation | |
Net unrealized depreciation | |
SEE NOTES TO FINANCIAL STATEMENTS.
JPMorgan Insurance Trust Global Allocation Portfolio
SCHEDULE OF PORTFOLIO INVESTMENTS
AS OF December 31, 2022 (continued)
| Amount rounds to less than one thousand. |
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF ASSETS AND LIABILITIES
AS OF December 31, 2022
(Amounts in thousands, except per share amounts)
| JPMorgan
Insurance Trust
Global Allocation
|
| |
Investments in non-affiliates, at value | |
Investments in affiliates, at value | |
Options purchased, at value | |
| |
Foreign currency, at value | |
Deposits at broker for futures contracts | |
| |
Investment securities sold | |
| |
Interest from non-affiliates | |
Dividends from non-affiliates | |
Dividends from affiliates | |
| |
Securities lending income (See Note 2.C.) | |
Variation margin on futures contracts | |
Unrealized appreciation on forward foreign currency exchange contracts | |
| |
| |
| |
Investment securities purchased | |
Portfolio shares redeemed | |
Unrealized depreciation on forward foreign currency exchange contracts | |
| |
| |
| |
| |
Custodian and accounting fees | |
| |
| |
| |
(a)
Amount rounds to less than one thousand.
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF ASSETS AND LIABILITIES
AS OF December 31, 2022 (continued)
(Amounts in thousands, except per share amounts)
| JPMorgan Insurance Trust Global Allocation |
| |
| |
Total distributable earnings (loss) | |
| |
| |
| |
| |
| |
Outstanding units of beneficial interest (shares)
(unlimited number of shares authorized, no par value): | |
| |
| |
| |
Class 1 — Offering and redemption price per share | |
Class 2 — Offering and redemption price per share | |
Cost of investments in non-affiliates | |
Cost of investments in affiliates | |
Cost of options purchased | |
| |
(a)
Per share amounts may not recalculate due to rounding of net assets and/or shares outstanding.
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF OPERATIONS
FOR THE YEAR ENDED December 31, 2022
(Amounts in thousands)
| JPMorgan
Insurance Trust
Global Allocation
|
| |
Interest income from non-affiliates | |
Interest income from affiliates | |
Dividend income from non-affiliates | |
Dividend income from affiliates | |
Income from securities lending (net) (See Note 2.C.) | |
Foreign taxes withheld (net) | |
| |
| |
| |
| |
| |
| |
Custodian and accounting fees | |
Interest expense to affiliates | |
| |
Trustees’ and Chief Compliance Officer’s fees | |
Printing and mailing costs | |
Transfer agency fees (See Note 2.I.) | |
Dividend expense to non-affiliates on securities sold short | |
| |
| |
| |
Less expense reimbursements | |
| |
Net investment income (loss) | |
(a)
Amount rounds to less than one thousand.
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENT OF OPERATIONS
FOR THE YEAR ENDED December 31, 2022 (continued)
(Amounts in thousands)
| JPMorgan Insurance Trust Global Allocation |
REALIZED/UNREALIZED GAINS (LOSSES): | |
Net realized gain (loss) on transactions from: | |
Investments in non-affiliates | |
Investments in affiliates | |
| |
| |
| |
Foreign currency transactions | |
Forward foreign currency exchange contracts | |
| |
Distribution of capital gains received from investment company affiliates | |
Change in net unrealized appreciation/depreciation on: | |
Investments in non-affiliates | |
Investments in affiliates | |
| |
| |
| |
Foreign currency translations | |
Forward foreign currency exchange contracts | |
Change in net unrealized appreciation/depreciation | |
Net realized/unrealized gains (losses) | |
Change in net assets resulting from operations | |
SEE NOTES TO FINANCIAL STATEMENTS.
STATEMENTS OF CHANGES IN NET ASSETS
FOR THE PERIODS INDICATED
(Amounts in thousands)
| JPMorgan Insurance Trust Global
Allocation Portfolio |
| Year Ended
December 31, 2022 | Year Ended
December 31, 2021 |
CHANGE IN NET ASSETS RESULTING FROM OPERATIONS: | | |
Net investment income (loss) | | |
| | |
Distributions of capital gains received from investment company affiliates | | |
Change in net unrealized appreciation/depreciation | | |
Change in net assets resulting from operations | | |
DISTRIBUTIONS TO SHAREHOLDERS: | | |
| | |
| | |
Total distributions to shareholders | | |
| | |
Change in net assets resulting from capital transactions | | |
| | |
| | |
| | |
| | |
| | |
| | |
Proceeds from shares issued | | |
| | |
| | |
Change in net assets resulting from Class 1 capital transactions | | |
| | |
Proceeds from shares issued | | |
| | |
| | |
Change in net assets resulting from Class 2 capital transactions | | |
Total change in net assets resulting from capital transactions | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
SEE NOTES TO FINANCIAL STATEMENTS.
FINANCIAL HIGHLIGHTS
FOR THE PERIODS INDICATED
| Per share operating performance |
| | | |
| Net asset
value,
beginning
of period | Net
investment
income
(loss)(a)(b) | Net realized
and unrealized
gains
(losses) on
investments | Total from
investment
operations | | | |
JPMorgan Insurance Trust Global Allocation Portfolio | | | | | | | |
| | | | | | | |
Year Ended December 31, 2022 | | | | | | | |
Year Ended December 31, 2021 | | | | | | | |
Year Ended December 31, 2020 | | | | | | | |
Year Ended December 31, 2019 | | | | | | | |
Year Ended December 31, 2018 | | | | | | | |
| | | | | | | |
Year Ended December 31, 2022 | | | | | | | |
Year Ended December 31, 2021 | | | | | | | |
Year Ended December 31, 2020 | | | | | | | |
Year Ended December 31, 2019 | | | | | | | |
Year Ended December 31, 2018 | | | | | | | |
|
| Net investment income (loss) is affected by the timing of distributions from Underlying Funds. |
| Calculated based upon average shares outstanding. |
| Includes adjustments in accordance with accounting principles generally accepted in the United States of America and as such, the net asset values for financial reporting purposes and the returns based upon those net asset values may differ from the net asset values and returns for shareholder transactions. |
| Total returns do not include charges that will be imposed by variable insurance contracts or by Eligible Plans. If these charges were reflected, returns would be lower than those shown. |
| Includes earnings credits and interest expense, if applicable, each of which is less than 0.005% unless otherwise noted. |
| |
| | | | | |
Net expenses (excluding dividend and interest expense for securities sold short) | | | | | |
| | | | | |
| | | | | |
Expenses without waivers and reimbursements (excluding dividend and interest expense for securities sold short) | | | | | |
| | | | | |
| | | | | |
|
| Does not include expenses of Underlying Funds. |
| The Portfolio presents portfolio turnover in two ways, one including securities sold short and the other excluding securities sold short. |
SEE NOTES TO FINANCIAL STATEMENTS.
| |
| | | Ratios to average net assets |
Net asset
value,
end of
period | | Net assets,
end of
period
(000's) | Net
expenses
(including dividend
and interest expense
for securities sold
short)(e)(f)(g) | Net
investment
income
(loss)(a) | Expenses without
waivers and reimbursements
(including dividend
and interest expense
for securities sold
short)(f)(g) | Portfolio
turnover rate
(excluding securities
sold short)(h) | Portfolio
turnover rate
(including securities
sold short)(h) |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
SEE NOTES TO FINANCIAL STATEMENTS.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022
(Dollar values in thousands)
1. Organization
JPMorgan Insurance Trust (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company and is a Massachusetts business trust.
The following is a separate portfolio of the Trust (the “Portfolio”) covered by this report:
| | Diversification Classification |
JPMorgan Insurance Trust Global Allocation Portfolio | | |
The investment objective of the Portfolio is to seek to maximize long-term total return.
On December 12, 2022, the Board of Trustees of the Trust (the “Board”) approved the liquidation of the Portfolio which is expected to occur on or about April 25, 2023.
Portfolio shares are offered only to separate accounts of participating insurance companies and Eligible Plans. Individuals may not purchase shares directly from the Portfolio. For existing separate accounts of participating insurance companies and Eligible Plans who were shareholders of the Portfolio as of December 21, 2022, additional purchase of Portfolio shares will be accepted up through and including April 21, 2023. For other investors, purchases of Portfolio shares were no longer accepted as of December 21, 2022.
All classes of shares have equal rights as to earnings, assets and voting privileges, except that each class may bear different transfer agency fees and distribution fees and each class has exclusive voting rights with respect to its distribution plan and administrative services plan.
J.P. Morgan Investment Management Inc. (“JPMIM”), an indirect, wholly-owned subsidiary of JPMorgan Chase & Co. (“JPMorgan”), acts as Adviser (the “Adviser”) and Administrator (the “Administrator”) to the Portfolio.
2. Significant Accounting Policies
The following is a summary of significant accounting policies followed by the Portfolio in the preparation of its financial statements. The Portfolio is an investment company and, accordingly, follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 946 — Investment Companies, which is part of U.S. generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) disclosure of contingent assets and liabilities at the date of the financial statements, and (iii) the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates.
A. Valuation of Investments — Investments are valued in accordance with GAAP and the Portfolio's valuation policies set forth by, and under the supervision and responsibility of, the Board, which established the following approach to valuation, as described more fully below: (i) investments for which market quotations are readily available shall be valued at their market value and (ii) all other investments for which market quotations are not readily available shall be valued at their fair value as determined in good faith by the Board.
Under Section 2(a)(41) of the 1940 Act, the Board is required to determine fair value for securities that do not have readily available market quotations. Under SEC Rule 2a-5 (Good Faith Determinations of Fair Value), the Board may designate the performance of these fair valuation determinations to a valuation designee. The Board has designated the Adviser as the “Valuation Designee” to perform fair valuation determinations for the Portfolio on behalf of the Board subject to appropriate oversight by the Board. The Adviser, as Valuation Designee, leverages the J.P. Morgan Asset Management Americas Valuation Committee (“AVC”) to help oversee and carry out the policies for the valuation of Investments held in the Portfolio. The Adviser, as Valuation Designee, remains responsible for the valuation determinations.
This oversight by the AVC includes monitoring the appropriateness of fair values based on results of ongoing valuation oversight including, but not limited to, consideration of macro or security specific events, market events, and pricing vendor and broker due diligence. The Administrator is responsible for discussing and assessing the potential impacts to the fair values on an ongoing basis, and, at least on a quarterly basis, with the AVC and the Board.
Fixed income instruments are valued based on prices received from Pricing Services. The Pricing Services use multiple valuation techniques to determine the valuation of fixed income instruments. In instances where sufficient market activity exists, the Pricing Services may utilize a market-based approach through which trades or quotes from market makers are used to determine the valuation of these instruments. In instances where sufficient market activity may not exist, the Pricing Services also utilize proprietary valuation models which may consider market transactions in comparable securities and the various relationships between securities in determining fair value and/or market characteristics in order to estimate the relevant cash flows, which are then discounted to calculate the fair values.
Equities and other exchange-traded instruments are valued at the last sale price or official market closing price on the primary exchange on which the instrument is traded before the net asset values ("NAV") of the Portfolio are calculated on a valuation date. Certain foreign equity instruments, as well as certain derivatives with foreign equity reference obligations, are valued by applying international fair value factors provided by approved Pricing Services. The factors seek to adjust the local closing price for movements of local markets post-closing, but prior to the time the NAV is calculated.
Investments in open-end investment companies (“Underlying Funds”) are valued at each Underlying Fund’s NAV per share as of the report date.
Futures contracts and options are generally valued on the basis of available market quotations. Forward foreign currency exchange contracts are valued utilizing market quotations from approved Pricing Services.
Valuations reflected in this report are as of the report date. As a result, changes in valuation due to market events and/or issuer-related events after the report date and prior to issuance of the report are not reflected herein.
The various inputs that are used in determining the valuation of the Portfolio's investments are summarized into the three broad levels listed below.
•
Level 1 — Unadjusted inputs using quoted prices in active markets for identical investments.
•
Level 2 — Other significant observable inputs including, but not limited to, quoted prices for similar investments, inputs other than quoted prices that are observable for investments (such as interest rates, prepayment speeds, credit risk, etc.) or other market corroborated inputs.
•
Level 3 — Significant inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Portfolio's assumptions in determining the fair value of investments).
A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input, both individually and in the aggregate, that is significant to the fair value measurement. The inputs or methodology used for valuing instruments are not necessarily an indication of the risk associated with investing in those instruments.
The following table represents each valuation input as presented on the Schedule of Portfolio Investments ("SOI"):
| | |
| | Level 2
Other significant
observable inputs | Level 3
Significant
unobservable inputs | |
Investments in Securities | | | | |
Collateralized Mortgage Obligations | | | | |
Commercial Mortgage-Backed Securities | | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
| | |
| | Level 2 Other significant observable inputs | Level 3 Significant unobservable inputs | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
Foreign Government Securities | | | | |
| | | | |
| | | | |
| | | | |
U.S. Treasury Obligations | | | | |
| | | | |
| | | | |
| | | | |
| | | | |
Total Short-Term Investments | | | | |
Total Investments in Securities | | | | |
Appreciation in Other Financial Instruments | | | | |
Forward Foreign Currency Exchange Contracts | | | | |
| | | | |
Depreciation in Other Financial Instruments | | | | |
Forward Foreign Currency Exchange Contracts | | | | |
| | | | |
Total Net Appreciation/ Depreciation in Other Financial Instruments | | | | |
There were no significant transfers into or out of level 3 for the for the year ended December 31, 2022.
B. Restricted Securities — Certain securities held by the Portfolio may be subject to legal or contractual restrictions on resale. Restricted securities generally are resold in transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). Disposal of these securities may involve time-consuming negotiations and expense. Prompt sale at the current valuation may be difficult and could adversely affect the NAVs of the Portfolio.
As of December 31, 2022, the Portfolio had no investments in restricted securities other than securities sold to the Portfolio under Rule 144A and/or Regulation S under the Securities Act.
C. Securities Lending — The Portfolio is authorized to engage in securities lending in order to generate additional income. The Portfolio is able to lend to approved borrowers. Citibank N.A. (“Citibank”) serves as lending agent for the Portfolio, pursuant to a Securities Lending Agency Agreement (the “Securities Lending Agency Agreement”). Securities loaned are collateralized by cash equal to at least 100% of the market value plus accrued interest on the securities lent, which is invested in the Class IM Shares of the JPMorgan U.S. Government Money Market Fund and the Agency SL Class Shares of the JPMorgan Securities Lending Money Market Fund. The Portfolio retains the interest earned on cash collateral investments but is required to pay the borrower a rebate for the use of the cash collateral. In cases where the lent security is of high value to borrowers, there may be a negative rebate (i.e., a net payment from the borrower to the Portfolio). Upon termination of a loan, the Portfolio is required to return to the borrower an amount equal to the cash collateral, plus any rebate owed to the borrowers. The remaining maturities of the securities lending transactions are considered overnight and continuous. Loans are subject to termination by the Portfolio or the borrower at any time.
The net income earned on the securities lending (after payment of rebates and Citibank’s fee) is included on the Statement of Operations as Income from securities lending (net). The Portfolio also receives payments from the borrower during the period of the loan, equivalent to dividends and interest earned on the securities loaned, which are recorded as Dividend or Interest income, respectively, on the Statement of Operations.
Under the Securities Lending Agency Agreement, Citibank marks to market the loaned securities on a daily basis. In the event the cash received from the borrower is less than 102% of the value of the loaned securities (105% for loans of non-U.S. securities), Citibank requests additional cash from the borrower so as to maintain a collateralization level of at least 102% of the value of the loaned securities plus accrued interest (105% for loans of non-U.S. securities), subject to certain de minimis amounts.
The value of securities out on loan is recorded as an asset on the Statement of Assets and Liabilities. The value of the cash collateral received is recorded as a liability on the Statement of Assets and Liabilities and details of collateral investments are disclosed on the SOI.
The Portfolio bears the risk of loss associated with the collateral investments and is not entitled to additional collateral from the borrower to cover any such losses. To the extent that the value of the collateral investments declines below the amount owed to a borrower, the Portfolio may incur losses that exceed the amount it earned on lending the security. Upon termination of a loan, the Portfolio may use leverage (borrow money) to repay the borrower for cash collateral posted if the Adviser does not believe that it is prudent to sell the collateral investments to fund the payment of this liability. Securities lending activity is subject to master netting arrangements.
Securities lending also involves counterparty risks, including the risk that the loaned securities may not be returned in a timely manner or at all. Subject to certain conditions, Citibank has agreed to indemnify the Portfolio from losses resulting from a borrower’s failure to return a loaned security.
JPMIM voluntarily waived investment advisory fees charged to the Portfolio to reduce the impact of the cash collateral investment in the JPMorgan U.S. Government Money Market Fund from 0.13% to 0.06%. For the year ended December 31, 2022, JPMIM waived fees associated with the Portfolio's investment in the JPMorgan U.S. Government Money Market Fund as follows:
|
| Amount rounds to less than one thousand. |
The above waiver is included in the determination of earnings on cash collateral investment and in the calculation of Citibank’s compensation and is included on the Statement of Operations as Income from securities lending (net).
The Portfolio did not have any securities on loan as of December 31, 2022.
D. Investment Transactions with Affiliates — The Portfolio invested in Underlying Funds and ETFs, which are advised by the Adviser. An issuer which is under common control with the Portfolio may be considered an affiliate. For the purposes of the financial statements, the Portfolio assumes the issuers listed in the table below to be affiliated issuers. The Underlying Funds’ and ETFs' distributions may be reinvested into such Underlying Funds and ETFs. Reinvestment amounts are included in the purchases at cost amounts in the table below.
|
For the year ended December 31, 2022 |
| | | | | Change in
Unrealized
Appreciation/
(Depreciation) | | Shares at
December 31,
2022 | | Capital Gain
Distributions |
JPMorgan Corporate Bond Fund Class R6 Shares (a) | | | | | | | | | |
JPMorgan Emerging Markets Equity Fund Class R6 Shares (a) | | | | | | | | | |
JPMorgan High Yield Fund Class R6 Shares (a) | | | | | | | | | |
JPMorgan Income Fund Class R6 Shares (a) | | | | | | | | | |
JPMorgan Large Cap Value Fund Class R6 Shares (a) | | | | | | | | | |
JPMorgan Prime Money Market Fund Class Institutional Shares, 4.42% (a) (b) | | | | | | | | | |
JPMorgan U.S. Government Money Market Fund Class IM Shares, 4.12% (a) (b) | | | | | | | | | |
JPMorgan U.S. Value Factor ETF (a) | | | | | | | | | |
| | | | | | | | | |
|
| Investment in an affiliated fund, which is registered under the Investment Company Act of 1940, as amended, and is advised by J.P. Morgan Investment Management Inc. |
| The rate shown is the current yield as of December 31, 2022. |
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
| Amount rounds to less than one thousand. |
| Amount is included on the Statement of Operations as Income from securities lending (net) (after payments of rebates and Citibank’s fee). |
E. Foreign Currency Translation — The books and records of the Portfolio are maintained in U.S. dollars. Foreign currency amounts are translated into U.S. dollars at the prevailing exchange rates of such currencies against the U.S. dollar. The market value of investment securities and other assets and liabilities are translated at the exchange rate as of the valuation date. Purchases and sales of investment securities, income and expenses are translated at the exchange rate prevailing on the respective dates of such transactions.
The Portfolio does not isolate the effect of changes in foreign exchange rates from changes in market prices on securities held. Accordingly, such changes are included within Change in net unrealized appreciation/depreciation on investments in non-affiliates on the Statement of Operations.
Reported realized foreign currency gains and losses arise from the disposition of foreign currency, currency gains or losses realized between the trade and settlement dates on securities transactions, and the difference between the amounts of dividends, interest and foreign withholding taxes recorded on the Portfolio's books on the transaction date and the U.S. dollar equivalent of the amounts actually received or paid. These reported realized foreign currency gains and losses are included in Net realized gain (loss) on foreign currency transactions on the Statement of Operations. Unrealized foreign currency gains and losses arise from changes (due to changes in exchange rates) in the value of foreign currency and other assets and liabilities denominated in foreign currencies, which are held at year end and are included in Change in net unrealized appreciation/depreciation on foreign currency translations on the Statement of Operations.
F. Derivatives — The Portfolio used derivative instruments including options, futures contracts, forward foreign currency exchange contracts and swaps, in connection with its investment strategy. Derivative instruments may be used as substitutes for securities in which the Portfolio can invest, to hedge portfolio investments or to generate income or gain to the Portfolio. Derivatives may also be used to manage duration, sector and yield curve exposures and credit and spread volatility.
The Portfolio may be subject to various risks from the use of derivatives, including the risk that changes in the value of a derivative may not correlate perfectly with the underlying asset, rate or index; counterparty credit risk related to derivatives counterparties’ failure to perform under contract terms; liquidity risk related to the potential lack of a liquid market for these contracts allowing the Portfolio to close out its position(s); and documentation risk relating to disagreement over contract terms. Investing in certain derivatives also results in a form of leverage and as such, the Portfolio's risk of loss associated with these instruments may exceed its value, as recorded on the Statement of Assets and Liabilities.
The Portfolio is party to various derivative contracts governed by International Swaps and Derivatives Association master agreements (“ISDA agreements”). The Portfolio's ISDA agreements, which are separately negotiated with each dealer counterparty, may contain provisions allowing, absent other considerations, a counterparty to exercise rights, to the extent not otherwise waived, against the Portfolio in the event the Portfolio's net assets decline over time by a pre-determined percentage or fall below a pre-determined floor. The ISDA agreements may also contain provisions allowing, absent other conditions, the Portfolio to exercise rights, to the extent not otherwise waived, against a counterparty (e.g., decline in a counterparty’s credit rating below a specified level). Such rights for both a counterparty and the Portfolio often include the ability to terminate (i.e., close out) open contracts at prices which may favor a counterparty, which could have an adverse effect on the Portfolio. The ISDA agreements give the Portfolio and a counterparty the right, upon an event of default, to close out all transactions traded under such agreements and to net amounts owed or due across all transactions and offset such net payable or receivable against collateral posted to a segregated account by one party for the benefit of the other.
Counterparty credit risk may be mitigated to the extent a counterparty posts additional collateral for mark-to-market gains to the Portfolio.
Notes F(1) — F(3) below describe the various derivatives used by the Portfolio.
(1) Options — The Portfolio purchased and/or sold ("wrote") put and call options on various instruments including securities and options on indices to manage and hedge interest rate risks within its portfolio and also to gain long or short exposure to the underlying instrument, index, currency or rate. A purchaser of a put option has the right, but not the obligation, to sell the underlying instrument at an agreed upon price (“strike price”) to the option seller. A purchaser of a call option has the right, but not the obligation, to purchase the underlying instrument at the strike price from the option seller.
Options Purchased — Premiums paid by the Portfolio for options purchased are included on the Statement of Assets and Liabilities as Options purchased. The option is adjusted daily to reflect the current market value of the option and the change is recorded as Change in net unrealized appreciation/depreciation on options purchased on the Statement of Operations. If the option is allowed to expire, the Portfolio will lose the entire
premium it paid and record a realized loss for the premium amount. Premiums paid for options purchased which are exercised or closed are added to the amounts paid or offset against the proceeds on the underlying investment transaction to determine the realized gain (loss) or cost basis of the underlying investment.
(2) Futures Contracts — The Portfolio used currency, index, interest rate and treasury futures contracts to manage and hedge interest rate risk associated with portfolio investments and to gain or reduce exposure to particular countries or regions. The Portfolio also used futures contracts to lengthen or shorten the duration of the overall investment portfolio.
Futures contracts provide for the delayed delivery of the underlying instrument at a fixed price or are settled for a cash amount based on the change in the value of the underlying instrument at a specific date in the future. Upon entering into a futures contract, the Portfolio is required to deposit with the broker, cash or securities in an amount equal to a certain percentage of the contract amount, which is referred to as the initial margin deposit. Subsequent payments, referred to as variation margin, are made or received by the Portfolio periodically and are based on changes in the market value of open futures contracts. Changes in the market value of open futures contracts are recorded as Change in net unrealized appreciation/depreciation on futures contracts on the Statement of Operations. Realized gains or losses, representing the difference between the value of the contract at the time it was opened and the value at the time it was closed, are reported on the Statement of Operations at the closing or expiration of the futures contract. Securities deposited as initial margin are designated on the SOI, while cash deposited, which is considered restricted, is recorded on the Statement of Assets and Liabilities. A receivable from and/or a payable to brokers for the daily variation margin is also recorded on the Statement of Assets and Liabilities.
The use of futures contracts exposes the Portfolio to equity price, foreign exchange and interest rate risks. The Portfolio may be subject to the risk that the change in the value of the futures contract may not correlate perfectly with the underlying instrument. Use of long futures contracts subjects the Portfolio to risk of loss in excess of the amounts shown on the Statement of Assets and Liabilities, up to the notional amount of the futures contracts. Use of short futures contracts subjects the Portfolio to unlimited risk of loss. The Portfolio may enter into futures contracts only on exchanges or boards of trade. The exchange or board of trade acts as the counterparty to each futures transaction; therefore, the Portfolio's credit risk is limited to failure of the exchange or board of trade. Under some circumstances, futures exchanges may establish daily limits on the amount that the price of a futures contract can vary from the previous day’s settlement price, which could effectively prevent liquidation of positions.
The Portfolio's futures contracts are not subject to master netting arrangements (the right to close out all transactions traded with a counterparty and net amounts owed or due across transactions).
(3) Forward Foreign Currency Exchange Contracts — The Portfolio is exposed to foreign currency risks associated with some or all of its portfolio investments and used forward foreign currency exchange contracts to hedge or manage certain of these exposures as part of an investment strategy. The Portfolio also bought forward foreign currency exchange contracts to gain exposure to currencies. Forward foreign currency exchange contracts represent obligations to purchase or sell foreign currency on a specified future date at a price fixed at the time the contracts are entered into. Non-deliverable forward foreign currency exchange contracts are settled with the counterparty in U.S. dollars without the delivery of foreign currency.
The values of the forward foreign currency contracts are adjusted daily based on the applicable exchange rates of the underlying currencies. Changes in the value of these contracts are recorded as Change in net unrealized appreciation or depreciation until the contract settlement date. When the forward foreign currency exchange contract is closed, the Portfolio records a realized gain or loss equal to the difference between the value at the time the contract was opened and the value at the time it was closed. The Portfolio also records a realized gain or loss, upon settlement, when a forward foreign currency exchange contract offsets another forward foreign currency exchange contract with the same counterparty.
The Portfolio's forward foreign currency exchange contracts are subject to master netting arrangements (the right to close out all transactions with a counterparty and net amounts owed or due across transactions).
The Portfolio may be required to post or receive collateral for non-deliverable forward foreign currency exchange contracts.
(4) Summary of Derivatives Information —The following table presents the value of derivatives held as of December 31, 2022, by its primary underlying risk exposure and respective location on the Statement of Assets and Liabilities:
| |
Unrealized Appreciation on Futures Contracts* | |
Purchased Options at Market Value | |
Unrealized Depreciation on Futures Contracts* | |
Foreign Exchange Rate Risk Exposure: | |
Unrealized Appreciation on Futures Contracts* | |
Unrealized Appreciation on Forward Foreign Currency Exchange Contracts | |
Unrealized Depreciation on Futures Contracts* | |
Unrealized Depreciation on Forward Foreign Currency Exchange Contracts | |
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
Interest Rate Risk Exposure: | |
Unrealized Appreciation on Futures Contracts* | |
Unrealized Depreciation on Futures Contracts* | |
Net Fair Value of Derivative Contracts: | |
Unrealized Appreciation (Depreciation) on Futures Contracts* | |
Unrealized Appreciation (Depreciation) on Forward Foreign Currency Exchange Contracts | |
Purchased Options at Market Value | |
|
| Includes cumulative appreciation/(depreciation) on futures contracts, if any, as reported on the SOI. Only current day’s variation margin is reported within the Statement of Assets and Liabilities. |
The following table presents the Portfolio's gross derivative assets and liabilities by counterparty net of amounts available for offset under netting arrangements and any related collateral received or posted by the Portfolio as of December 31, 2022:
| Gross Amount of Derivative Assets
Subject to Netting Arrangements
Presented on the Statement of Assets
and Liabilities (a) | Derivatives
Available
for Offset | | Net Amount Due
From Counterparty
(Not less than zero) |
| | | | |
| | | | |
| | | | |
Merrill Lynch International | | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| Gross Amount of Derivative Liabilities Subject to Netting Arrangements Presented on the Statement of Assets and Liabilities (a) | Derivative Available for Offset | | Net Amount Due to Counterparty (Not less than zero) |
| | | | |
| | | | |
| | | | |
Goldman Sachs International | | | | |
| | | | |
Merrill Lynch International | | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
|
| For financial reporting purposes the Portfolio does not offset derivative assets and derivative liabilities subject to master netting arrangements on the Statement of Assets and Liabilities. |
The following table presents the effect of derivatives on the Statement of Operations for the year ended December 31, 2022, by primary underlying risk exposure:
Realized Gain (Loss) on Derivatives Recognized as a Result From Operations: | |
| |
| |
| |
Foreign Exchange Rate Risk Exposure: | |
| |
Forward Foreign Currency Exchange Contracts | |
Interest Rate Risk Exposure: | |
| |
Net Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized as a Result of Operations: | |
| |
| |
| |
Foreign Exchange Rate Risk Exposure: | |
| |
Forward Foreign Currency Exchange Contracts | |
Interest Rate Risk Exposure: | |
| |
Derivatives Volume
The table below discloses the volume of the Portfolio's options, futures contracts and forward foreign currency exchange contracts activity during the year ended December 31, 2022. Please refer to the tables in the Summary of Derivatives Information for derivative-related gains and losses associated with volume activity:
| |
| |
Average Notional Balance Long | |
Average Notional Balance Short | |
Ending Notional Balance Long | |
Ending Notional Balance Short | |
Forward Foreign Currency Exchange Contracts: | |
Average Settlement Value Purchased | |
Average Settlement Value Sold | |
Ending Settlement Value Purchased | |
Ending Settlement Value Sold | |
| |
Average Number of Contracts Purchased | |
Ending Number of Contracts Purchased | |
The Portfolio's derivatives contracts held at December 31, 2022 are not accounted for as hedging instruments under GAAP.
G. Short Sales — The Portfolio engaged in short sales as part of its normal investment activities. In a short sale, the Portfolio sells securities it does not own in anticipation of a decline in the market value of those securities. In order to deliver securities to the purchaser, the Portfolio borrows securities from a broker. To close out a short position, the Portfolio delivers the same securities to the broker.
The Portfolio is required to pledge cash or securities to the broker as collateral for the securities sold short. Collateral requirements are calculated daily based on the current market value of the short positions. Cash collateral deposited with the broker is recorded as Deposits at broker for securities sold short, while cash collateral deposited at the Portfolio's custodian for the benefit of the broker is recorded as Restricted cash for securities sold short on the Statement of Assets and Liabilities. Securities segregated as collateral are denoted on the SOI. The Portfolio may receive or pay the net of the following amounts: (i) a portion of the income from the investment of cash collateral; (ii) the broker’s fee on the borrowed securities (calculated daily based upon the market value of each borrowed security and a variable rate that is dependent on availability of the security); and (iii) a financing charge for the difference between the market value of the short position and cash collateral deposited with the broker. The net amounts of income or fees are included as interest income or interest expense on securities sold short on the Statement of Operations.
The Portfolio is obligated to pay the broker dividends declared on short positions when a position is open on the record date. Dividends on short positions are reported on ex-dividend date on the Statement of Operations as Dividend expense on securities sold short. The Portfolio is obligated to pay the broker interest accrued on short positions while the position is outstanding. Interest expense on short positions is reported as Interest expense to non-affiliates on securities sold short on the Statement of Operations. Liabilities for securities sold short are reported at market value on the Statement of Assets and Liabilities and the change in market value is recorded as Change in net unrealized appreciation/depreciation on the
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
Statement of Operations. Short sale transactions may result in unlimited losses as the security’s price increases and the short position loses value. There is no upward limit on the price a borrowed security could attain. The Portfolio is also subject to risk of loss if the broker were to fail to perform its obligations under the contractual terms.
The Portfolio will record a realized loss if the price of the borrowed security increases between the date of the short sale and the date on which the Portfolio replaces the borrowed security. The Portfolio will record a realized gain if the price of the borrowed security declines between those dates.
As of December 31, 2022, the Portfolio had no outstanding short sales as listed on the SOI.
H. Security Transactions and Investment Income — Investment transactions are accounted for on the trade date (the date the order to buy or sell is executed). Securities gains and losses are calculated on a specifically identified cost basis.
Interest income and interest expense on securities sold short, if any, is determined on the basis of coupon interest accrued using the effective interest method, which adjusts for amortization of premiums and accretion of discounts.
Dividend income, net of foreign taxes withheld, if any, dividend expense on securities sold short and distributions of net investment income and realized capital gains from Underlying Funds, if any, is recorded on the ex-dividend date or when the Portfolio first learns of the dividend.
To the extent such information is publicly available, the Portfolio records distributions received in excess of income earned from underlying investments as a reduction of cost of investments and/or realized gain. Such amounts are based on estimates if actual amounts are not available and actual amounts of income, realized gain and return of capital may differ from the estimated amounts. The Portfolio adjusts the estimated amounts of the components of distributions (and consequently its net investment income) as necessary, once the issuers provide information about the actual composition of the distributions.
I. Allocation of Income and Expenses— Expenses directly attributable to the Portfolio are charged directly to the Portfolio, while the expenses attributable to more than one portfolio of the Trust are allocated among the applicable portfolios. Investment income, realized and unrealized gains and losses and expenses, other than class-specific expenses, are allocated daily to each class of shares based upon the proportion of net assets of each class at the beginning of each day.
Transfer agency fees are class-specific expenses. The amount of the transfer agency fees charged to each share class of the Portfolio for the year ended December 31, 2022 are as follows:
|
| Amount rounds to less than one thousand. |
The Portfolio invested in Underlying Funds and ETFs and, as a result bear a portion of the expenses incurred by these Underlying Funds and ETFs. These expenses are not reflected in the expenses shown on the Statement of Operations and are not included in the ratios to average net assets shown in the Financial Highlights. Certain expenses of affiliated Underlying Funds and ETFs are waived as described in Note 3.E.
J. Federal Income Taxes— The Portfolio is treated as a separate taxable entity for Federal income tax purposes. The Portfolio’s policy is to comply with the provisions of the Internal Revenue Code (the “Code”) applicable to regulated investment companies and to distribute to shareholders all of its distributable net investment income and net realized capital gains on investments. Accordingly, no provision for Federal income tax is necessary. The Portfolio is also a segregated portfolio of assets for insurance purposes and intends to comply with the diversification requirements of Subchapter L of the Code. Management has reviewed the Portfolio’s tax positions for all open tax years and has determined that as of December 31, 2022, no liability for Federal income tax is required in the Portfolio’s financial statements for net unrecognized tax benefits. However, management’s conclusions may be subject to future review based on changes in, or the interpretation of, the accounting standards or tax laws and regulations. The Portfolio’s Federal tax returns for the prior three fiscal years remain subject to examination by the Internal Revenue Service.
K. Foreign Taxes —The Portfolio may be subject to foreign taxes on income, gains on investments or currency purchases/repatriation, a portion of which may be recoverable. The Portfolio will accrue such taxes and recoveries as applicable, based upon its current interpretation of tax rules and regulations that exist in the markets in which it invests. When a capital gains tax is determined to apply, the Portfolio records an estimated deferred tax liability in an amount that would be payable if the securities were disposed of on the valuation date.
L. Distributions to Shareholders — Distributions from net investment income, if any, are generally declared and paid at least annually and are declared separately for each class. No class has preferential dividend rights; differences in per share rates are due to differences in separate class expenses. Net realized capital gains, if any, are distributed at least annually. The amount of distributions from net investment income and net realized capital gains is determined in accordance with Federal income tax regulations, which may differ from GAAP. To the extent these “book/tax” differences are permanent in nature (i.e., that they result from other than timing of recognition — “temporary differences”), such amounts are reclassified within the capital accounts based on their Federal tax basis treatment.
The following amounts were reclassified within the capital accounts:
| | Accumulated
undistributed
(distributions in
excess of)
net investment
income | Accumulated
net realized
gains (losses) |
| | | |
The reclassifications for the Portfolio relate primarily to foreign currency gains or losses.
3. Fees and Other Transactions with Affiliates
A. Investment Advisory Fee — Pursuant to an Investment Advisory Agreement, the Adviser manages the investments of the Portfolio and for such services is paid a fee. The investment advisory fee is accrued daily and paid monthly at an annual rate of 0.55% of the Portfolio's average daily net assets.
The Adviser waived investment advisory fees and/or reimbursed expenses as outlined in Note 3.E.
B. Administration Fee — Pursuant to an Administration Agreement, the Administrator provides certain administration services to the Portfolio. In consideration of these services, the Administrator receives a fee accrued daily and paid monthly at an annual rate of 0.075% of the first $10 billion of the Portfolio's average daily net assets, plus 0.050% of the Portfolio's average daily net assets between $10 billion and $20 billion, plus 0.025% of the Portfolio's average daily net assets between $20 billion and $25 billion, plus 0.010% of the Portfolio's average daily net assets in excess of $25 billion. For the year ended December 31, 2022, the effective rate was 0.075% of the Portfolio's average daily net assets, notwithstanding any fee waivers and/or expense reimbursements.
The Administrator waived administration fees as outlined in Note 3.E.
JPMorgan Chase Bank, N.A. ("JPMCB"), a wholly-owned subsidiary of JPMorgan, serves as the Portfolio's sub-administrator (the “Sub-administrator”). For its services as Sub-administrator, JPMCB receives a portion of the fees payable to the Administrator.
C. Distribution Fees — Pursuant to a Distribution Agreement, JPMorgan Distribution Services, Inc. (“JPMDS”), an indirect, wholly-owned subsidiary of JPMorgan, serves as the Portfolio's principal underwriter and promotes and arranges for the sale of the Portfolio's shares.
The Board has adopted a Distribution Plan (the “Distribution Plan”) for Class 2 Shares of the Portfolio pursuant to Rule 12b-1 under the 1940 Act. Class 1 Shares of the Portfolio do not charge a distribution fee. The Distribution Plan provides that the Portfolio shall pay, with respect to the applicable share classes, distribution fees, including payments to JPMDS, at an annual rate of 0.25% of the average daily net assets of Class 2 Shares.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
D. Custodian and Accounting Fees — JPMCB provides portfolio custody and accounting services to the Portfolio. For performing these services, the Portfolio pays JPMCB transaction and asset-based fees that vary according to the number of transactions and positions, plus out-of-pocket expenses. The amounts paid directly to JPMCB by the Portfolio for custody and accounting services are included in Custodian and accounting fees on the Statement of Operations.
Interest income earned on cash balances at the custodian, if any, is included in Interest income from affiliates on the Statement of Operations.
Interest expense paid to the custodian related to cash overdrafts, if any, is included in Interest expense to affiliates on the Statement of Operations.
E. Waivers and Reimbursements —The Adviser, Administrator and/or JPMDS have contractually agreed to waive fees and/or reimburse the Portfolio to the extent that total annual operating expenses (excluding acquired fund fees and expenses other than certain money market fund fees as described below, dividend and interest expenses related to short sales, interest, taxes, expenses related to litigation and potential litigation, expenses related to trustee elections and extraordinary expenses) exceed the percentages of the Portfolio's respective average daily net assets as shown in the table below:
The expense limitation agreement was in effect for the year ended December 31, 2022 and the contractual expense limitation percentages in the table above are in place until at least April 30, 2023.
The Underlying Funds may impose separate advisory fees. The Adviser has agreed to voluntarily waive the Portfolio’s investment advisory fees in the weighted average pro-rata amount of the advisory fees charged by the affiliated Underlying Funds. During the year ended December 31, 2022, the Adviser waived $0. These waivers may be in addition to any waivers required to meet the Portfolio’s contractual expense limitations, but will not exceed the Portfolio’s advisory fee.
For the year ended December 31, 2022, the Portfolio's service providers waived fees and/or reimbursed expenses for the Portfolio as follows. None of these parties expect the Portfolio to repay any such waived fees and/or reimbursed expenses in future years.
Additionally, the Portfolio may invest in one or more money market funds advised by the Adviser (affiliated money market funds). The Adviser, Administrator and/or JPMDS, have contractually agreed to waive fees and/or reimburse expenses in an amount sufficient to offset the respective net fees each collects from the affiliated money market fund on the Portfolio's investment in such affiliated money market fund, except for investments of securities lending cash collateral. None of these parties expect the Portfolio to repay any such waived fees and/or reimbursed expenses in future years.
The amount of these waivers resulting from investments in these money market funds for the year ended December 31, 2022 was $8.
JPMIM voluntarily agreed to reimburse the Portfolio for the Trustee Fees paid to one of the interested Trustees. For the year ended December 31, 2022 the amount of this reimbursement was $2.
F. Other — Certain officers of the Trust are affiliated with the Adviser, the Administrator and JPMDS. Such officers, with the exception of the Chief Compliance Officer, receive no compensation from the Portfolio for serving in their respective roles.
The Board designated and appointed a Chief Compliance Officer to the Portfolio pursuant to Rule 38a-1 under the 1940 Act. The Portfolio, along with affiliated funds, makes reimbursement payments, on a pro-rata basis, to the Administrator for a portion of the fees associated with the office of the Chief Compliance Officer. Such fees are included in Trustees’ and Chief Compliance Officer’s fees on the Statement of Operations.
The Trust adopted a Trustee Deferred Compensation Plan (the “Plan”) which allows the independent Trustees to defer the receipt of all or a portion of compensation related to performance of their duties as Trustees. The deferred fees are invested in various J.P. Morgan Funds until distribution in accordance with the Plan.
During the year ended December 31, 2022, purchased securities from an underwriting syndicate in which the principal underwriter or members of the syndicate were affiliated with the Adviser.
The Securities and Exchange Commission ("SEC") has granted an exemptive order permitting the Portfolio to engage in principal transactions with J.P. Morgan Securities LLC, an affiliated broker, involving taxable money market instruments, subject to certain conditions.
4. Investment Transactions
During the year ended December 31, 2022, purchases and sales of investments (excluding short-term investments) were as follows:
| Purchases
(excluding
U.S. Government) | Sales
(excluding
U.S. Government) | Purchases
of U.S.
Government | | | Covers on
Securities
Sold Short |
| | | | | | |
5. Federal Income Tax Matters
For Federal income tax purposes, the estimated cost and unrealized appreciation (depreciation) in value of investments held at December 31, 2022 were as follows:
| | Gross
Unrealized
Appreciation | Gross
Unrealized
Depreciation | Net Unrealized
Appreciation
(Depreciation) |
| | | | |
The difference between book and tax basis appreciation (depreciation) on investments is primarily attributed to certain derivatives, tax adjustments on certain investments, straddle loss deferrals and wash sale loss deferrals.
The tax character of distributions paid during the year ended December 31, 2022 was as follows:
| | Net
Long-Term
Capital Gains | |
| | | |
|
| Short-term gain distributions are treated as ordinary income for income tax purposes. |
The tax character of distributions paid during the year ended December 31, 2021 was as follows:
| | Net
Long-Term
Capital Gains | |
| | | |
|
| Short-term gain distributions are treated as ordinary income for income tax purposes. |
As of December 31, 2022, the estimated components of net assets (excluding paid-in-capital) on a tax basis were as follows:
| Current
Distributable
Ordinary
Income | Current
Distributable
Long-Term
Capital Gain
(Tax Basis Capital
Loss Carryover) | Unrealized
Appreciation
(Depreciation) |
| | | |
The cumulative timing differences primarily consist of certain derivatives, tax adjustments on certain investments, straddle loss deferrals and wash sale loss deferrals.
At December 31, 2022, the Portfolio had net capital loss carryforwards which are available to offset future realized gains:
| Capital Loss Carryforward Character |
| | |
| | |
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
6. Borrowings
The Portfolio relies upon an exemptive order granted by the SEC (the “Order”) permitting the establishment and operation of an Interfund Lending Facility (the “Facility”). The Facility allows the Portfolio to directly lend and borrow money to or from any other fund relying upon the Order at rates beneficial to both the borrowing and lending funds. Advances under the Facility are taken primarily for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities, and are subject to the Portfolio's borrowing restrictions. The interfund loan rate is determined, as specified in the Order, by averaging the current repurchase agreement rate and the current bank loan rate. The Order was granted to the Trust and may be relied upon by the Portfolio because the Portfolio and the series of the Trust are all investment companies in the same “group of investment companies” (as defined in Section 12(d)(1)(G) of the 1940 Act).
The Portfolio had no borrowings outstanding from another fund, or loans outstanding to another fund, during the year ended December 31, 2022.
The Trust and JPMCB have entered into a financing arrangement. Under this arrangement, JPMCB provides an unsecured, uncommitted credit facility in the aggregate amount of $100 million to certain of the J.P. Morgan Funds, including the Portfolio. Advances under the arrangement are taken primarily for temporary or emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities, and are subject to the Portfolio's borrowing restrictions. Interest on borrowings is payable at a rate determined by JPMCB at the time of borrowing. This agreement has been extended until October 30, 2023.
The Portfolio had no borrowings outstanding from the unsecured, uncommitted credit facility during the year ended December 31, 2022.
The Trust, along with certain other trusts for J.P. Morgan Funds (“Borrowers”), has entered into a joint syndicated senior unsecured revolving credit facility totaling $1.5 billion (“Credit Facility”) with various lenders and The Bank of New York Mellon, as administrative agent for the lenders. This Credit Facility provides a source of funds to the Borrowers for temporary and emergency purposes, including the meeting of redemption requests that otherwise might require the untimely disposition of securities. Under the terms of the Credit Facility, a borrowing portfolio must have a minimum of $25 million in adjusted net asset value and not exceed certain adjusted net asset coverage ratios prior to and during the time in which any borrowings are outstanding. If a portfolio does not comply with the aforementioned requirements, the portfolio must remediate within three business days with respect to the $25 million minimum adjusted net asset value or within one business day with respect to certain asset coverage ratios or the administrative agent at the request of, or with the consent of, the lenders may terminate the Credit Facility and declare any outstanding borrowings to be due and payable immediately.
Interest associated with any borrowing under the Credit Facility is charged to the borrowing portfolio at a rate of interest equal to 1.00% (the “Applicable Margin”), plus the greater of the federal funds effective rate or one month London Interbank Offered Rate ("LIBOR"). The annual commitment fee to maintain the Credit Facility is 0.15% and is incurred on the unused portion of the Credit Facility and is allocated to all participating portfolios pro rata based on their respective net assets. Effective August 9, 2022, the Credit Facility has been amended and restated for a term of 364 days, unless extended, and to include a change in the interest associated with any borrowing to the higher, on the day of the borrowing, of (a) the federal funds effective rate, or (b) the one-month Adjusted SOFR Rate plus the Applicable Margin.
The Portfolio did not utilize the Credit Facility during the year ended December 31, 2022.
7. Risks, Concentrations and Indemnifications
In the normal course of business, the Portfolio enters into contracts that contain a variety of representations which provide general indemnifications. The Portfolio's maximum exposure under these arrangements is unknown. The amount of exposure would depend on future claims that may be brought against the Portfolio. However, based on experience, the Portfolio expects the risk of loss to be remote.
As of December 31, 2022, the Portfolio had three individual shareholder and/or non-affiliated omnibus accounts each owning more than 10% of the Portfolio's outstanding shares, and, collectively owning 81.7% of the Portfolio's outstanding shares.
Significant shareholder transactions by these shareholders may impact the Portfolio's performance and liquidity.
The Portfolio is subject to risks associated with securities with contractual cash flows including asset-backed and mortgage-related securities such as collateralized mortgage obligations, mortgage pass-through securities and commercial mortgage-backed securities, including securities backed by sub-prime mortgage loans. The value, liquidity and related income of these securities are sensitive to changes in economic conditions, including real estate value, pre-payments, delinquencies and/or defaults, and may be adversely affected by shifts in the market’s perception of the issuers and changes in interest rates.
The Portfolio is subject to interest rate and credit risk. The value of debt securities may decline as interest rates increase. The Portfolio could lose money if the issuer of a fixed income security is unable to pay interest or repay principal when it is due. The Portfolio invests in floating rate loans and other floating rate debt securities. Although these investments are generally less sensitive to interest rate changes than other fixed rate instruments, the value of floating rate loans and other floating rate investments may decline if their interest rates do not rise as quickly, or as much, as general interest rates. Many factors can cause interest rates to rise. Some examples include central bank monetary policy, rising inflation rates and general economic conditions. The Portfolio may face a heightened level of interest rate risk due to certain changes in monetary policy. During periods when interest rates are low or there are negative interest rates, the Portfolio’s yield (and total return) also may be low or the Portfolio may be unable to maintain positive returns. The ability of the issuers of debt to meet their obligations may be affected by economic and political
developments in a specific industry or region. The value of a Portfolio’s investments may be adversely affected if any of the issuers or counterparties it is invested in are subject to an actual or perceived deterioration in their credit quality.
Investing in securities of foreign countries may include certain risks and considerations not typically associated with investing in U.S. securities. These risks include revaluation of currencies, high rates of inflation, repatriation restrictions on income and currencies, and future and adverse political, social and economic developments.
As of December 31, 2022, a significant portion of the investments of the Portfolio consisted of securities that were denominated in foreign currencies. Changes in currency exchange rates will affect the value of, and investment income from, such securities.
Derivatives may be riskier than other types of investments because they may be more sensitive to changes in economic and market conditions and could result in losses that significantly exceed the Portfolio's original investment. Many derivatives create leverage thereby causing the Portfolio to be more volatile than they would have been if they had not used derivatives. Derivatives also expose the Portfolio to counterparty risk (the risk that the derivative counterparty will not fulfill its contractual obligations), including credit risk of the derivative counterparty. The possible lack of a liquid secondary market for derivatives and the resulting inability of the Portfolio to sell or otherwise close a derivatives position could expose the Portfolio to losses and could make derivatives more difficult for the Portfolio to value accurately.
The Portfolio is also subject to counterparty credit risk, which is the risk that a counterparty fails to perform on agreements with the Portfolio.
Because of the Portfolio's investments in the Underlying Funds and ETFs , the Portfolio indirectly pays a portion of the expenses incurred by the Underlying Funds and ETFs. As a result, the cost of investing in the Portfolio may be higher than the cost of investing in a mutual fund that invests directly in individual securities and financial instruments. The Portfolio is also subject to certain risks related to the Underlying Funds’ and ETFs’ investments in securities and financial instruments such as fixed income securities including high yield, asset-backed and mortgage-related securities, equity securities, foreign and emerging markets securities, commodities and real estate securities. These securities are subject to risks specific to their structure, sector or market.
In addition, the Underlying Funds and ETFs may use derivative instruments in connection with their individual investment strategies including futures contracts, forward foreign currency exchange contracts, options, swaps and other derivatives, which are also subject to specific risks related to their structure, sector or market and may be riskier than investments in other types of securities. Specific risks and concentrations present in the Underlying Funds and ETFs are disclosed within their individual financial statements and registration statements, as appropriate.
LIBOR is intended to represent the rate at which contributing banks may obtain short-term borrowings from each other in the London interbank market. On March 5, 2021, the U.K. Financial Conduct Authority ("FCA") publicly announced that (i) immediately after December 31, 2021, publication of the 1-week and 2-month U.S. Dollar LIBOR settings will permanently cease; (ii) immediately after June 30, 2023, publication of the overnight and 12-month U.S. Dollar LIBOR settings will permanently cease; and (iii) immediately after June 30, 2023, the 1-month, 3-month and 6-month U.S. Dollar LIBOR settings will cease to be provided or, subject to the FCA's consideration of the case, be provided on a synthetic basis and no longer be representative of the underlying market and economic reality they are intended to measure and that representativeness will not be restored. There is no assurance that the dates announced by the FCA will not change or that the administrator of LIBOR and/or regulators will not take further action that could impact the availability, composition or characteristics of LIBOR or the currencies and/or tenors for which LIBOR is published. In addition, certain regulated entities ceased entering into most new LIBOR contracts in connection with regulatory guidance or prohibitions. Public and private sector industry initiatives are currently underway to implement new or alternative reference rates to be used in place of LIBOR. There is no assurance that any such alternative reference rate will be similar to or produce the same value or economic equivalence as LIBOR or that it will have the same volume or liquidity as did LIBOR prior to its discontinuance, unavailability or replacement, all of which may affect the value, volatility, liquidity or return on certain of the Portfolio's loans, notes, derivatives and other instruments or investments comprising some or all of the Portfolio's investments and result in costs incurred in connection with changing reference rates used for positions closing out positions and entering into new trades. Certain of the Portfolio's investments may transition from LIBOR prior to the dates announced by the FCA. The transition from LIBOR to alternative reference rates may result in operational issues for the Portfolio or its investments. No assurances can be given as to the impact of the LIBOR transition (and the timing of any such impact) on the Portfolio and its investments.
The Portfolio is subject to infectious disease epidemics/pandemics risk. The worldwide outbreak of COVID-19 has negatively affected economies, markets and individual companies throughout the world. The effects of this COVID-19 pandemic to public health, and business and market conditions, including among other things, reduced consumer demand and economic output, supply chain disruptions and increased government spending may continue to have a significant negative impact on the performance of the Portfolio's investments, increase the Portfolio's volatility, exacerbate other pre-existing political, social and economic risks to the Portfolio and negatively impact broad segments of businesses and populations. In addition, governments, their regulatory agencies, or self-regulatory organizations have taken or may take actions in response to the pandemic that affect the instruments in which the Portfolio invests, or the issuers of such instruments, in ways that could also have a significant negative impact on the Portfolio's investment performance. The duration and extent of COVID-19 and associated economic and market conditions and uncertainty over the long-term cannot be reasonably estimated at this time. The ultimate impact of COVID-19 and the extent to which the associated conditions impact the Portfolio will also depend on future developments, which are highly uncertain, difficult to accurately predict and subject to frequent changes.
NOTES TO FINANCIAL STATEMENTS
AS OF December 31, 2022 (continued)
(Dollar values in thousands)
As of December 31, 2022, the Portfolio had non-U.S. country allocations representing greater than 10% of total investments as follows:
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Trustees of JPMorgan Insurance Trust and Shareholders of JPMorgan Insurance Trust Global Allocation Portfolio
Opinion on the Financial Statements
We have audited the accompanying statement of assets and liabilities, including the schedule of portfolio investments, of JPMorgan Insurance Trust Global Allocation Portfolio (one of the portfolios constituting JPMorgan Insurance Trust, referred to hereafter as the “Portfolio”) as of December 31, 2022, the related statement of operations for the year ended December 31, 2022, the statements of changes in net assets for each of the two years in the period ended December 31, 2022, including the related notes, and the financial highlights for each of the five years in the period ended December 31, 2022 (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Portfolio as of December 31, 2022, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period ended December 31, 2022 and the financial highlights for each of the five years in the period ended December 31, 2022 in conformity with accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Portfolio’s management. Our responsibility is to express an opinion on the Portfolio’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Portfolio in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of December 31, 2022 by correspondence with the custodian, transfer agent and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.
/s/ PricewaterhouseCoopers LLP
New York, New York
February 15, 2023
We have served as the auditor of one or more investment companies in the JPMorgan Funds complex since 1993.
The Portfolio's Statement of Additional Information includes additional information about the Portfolio's Trustees and is available, without charge, upon request by calling 1-800-480-4111 or on the Portfolio's website at www.jpmorgan.com/variableinsuranceportfolios.
Name (Year of Birth);
Positions With
the Portfolio (1) | Principal Occupation
During Past 5 Years | Number of
Funds in Fund
Complex Overseen
by Trustee (2) | Other Directorships Held
During the Past 5 Years |
| | | |
John F. Finn (1947); Chair
since 2020; Trustee since 1998. | Chairman, Gardner, Inc. (supply chain management company serving industrial and consumer markets) (serving in various roles 1974-present). | | Director, Greif, Inc. (GEF) (industrial package products and services) (2007-present); Trustee, Columbus Association for the Performing Arts (1988-present). |
Stephen P. Fisher (1959);
Trustee since 2018. | Retired; Chairman and Chief Executive Officer, NYLIFE Distributors LLC (registered broker-dealer) (serving in various roles 2008-2013); Chairman, NYLIM Service Company LLC (transfer agent) (2008-2017); New York Life Investment Management LLC (registered investment adviser) (serving in various roles 2005-2017); Chairman, IndexIQ Advisors LLC (registered investment adviser for ETFs) (2014-2017); President, MainStay VP Funds Trust (2007-2017), MainStay DefinedTerm Municipal Opportunities Fund (2011-2017) and MainStay Funds Trust (2007-2017) (registered investment companies). | | Honors Program Advisory Board Member, The Zicklin School of Business, Baruch College, The City University of New York (2017-present). |
Gary L. French (1951);
Trustee since 2014. | Real Estate Investor (2011-2020); Investment management industry Consultant and Expert Witness (2011-present); Senior Consultant for The Regulatory Fundamentals Group LLC (2011-2017). | | Independent Trustee, The China Fund, Inc. (2013-2019); Exchange Traded Concepts Trust II (2012-2014); Exchange Traded Concepts Trust I (2011-2014). |
Kathleen M. Gallagher (1958);
Trustee since 2018. | Retired; Chief Investment Officer — Benefit Plans, Ford Motor Company (serving in various roles 1985-2016). | | Non- Executive Director, Legal & General Investment Management (Holdings) (2018-present); Non-Executive Director, Legal & General Investment Management America (U.S. Holdings) (financial services and insurance) (2017-present); Advisory Board Member, State Street Global Advisors Total Portfolio Solutions (2017-present); Member, Client Advisory Council, Financial Engines, LLC (registered investment adviser) (2011-2016); Director, Ford Pension Funds Investment Management Ltd. (2007-2016). |
Robert J. Grassi (1957);
Trustee since 2014. | Sole Proprietor, Academy Hills Advisors LLC (2012-present); Pension Director, Corning Incorporated (2002-2012). | | |
Name (Year of Birth); Positions With the Portfolio (1) | Principal Occupation During Past 5 Years | Number of Funds in Fund Complex Overseen by Trustee (2) | Other Directorships Held During the Past 5 Years |
Frankie D. Hughes (1952);
Trustee since 2008. | President, Ashland Hughes Properties (property management) (2014-present); President and Chief Investment Officer, Hughes Capital Management, Inc. (fixed income asset management) (1993-2014). | | |
Raymond Kanner (1953);
Trustee since 2017. | Retired; Managing Director and Chief Investment Officer, IBM Retirement Funds (2007-2016). | | Advisory Board Member, Penso Advisors, LLC (2020-present); Advisory Board Member, Los Angeles Capital (2018-present); Advisory Board Member, State Street Global Advisors Total Portfolio Solutions (2017- present); Acting Executive Director, Committee on Investment of Employee Benefit Assets (CIEBA) (2016-2017); Advisory Board Member, Betterment for Business (robo advisor) (2016- 2017); Advisory Board Member, BlueStar Indexes (index creator) (2013-2017); Director, Emerging Markets Growth Fund (registered investment company) (1997-2016); Member, Russell Index Client Advisory Board (2001-2015). |
Thomas P. Lemke (1954);
Trustee since 2014. | | | (1) Independent Trustee of Advisors’ Inner Circle III fund platform, consisting of the following: (i) the Advisors’ Inner Circle Fund III, (ii) the Gallery Trust, (iii) the Schroder Series Trust, (iv) the Delaware Wilshire Private Markets Fund (since 2020), (v) Chiron Capital Allocation Fund Ltd., and (vi) formerly the Winton Diversified Opportunities Fund (2014-2018); and (2) Independent Trustee of the Symmetry Panoramic Trust (since 2018). |
Lawrence R. Maffia (1950);
Trustee since 2014 | Retired; Director and President, ICI Mutual Insurance Company (2006-2013). | | Director, ICI Mutual Insurance Company (1999-2013). |
Mary E. Martinez (1960); Vice
Chair since 2021; Trustee since 2013. | Associate, Special Properties, a Christie’s International Real Estate Affiliate (2010-present); Managing Director, Bank of America (asset management) (2007-2008); Chief Operating Officer, U.S. Trust Asset Management, U.S. Trust Company (asset management) (2003-2007); President, Excelsior Funds (registered investment companies) (2004-2005). | | |
Marilyn McCoy (1948);
Trustee since 2005. | Vice President of Administration and Planning, Northwestern University (1985-present). | | |
TRUSTEES
(Unaudited) (continued)
Name (Year of Birth); Positions With the Portfolio (1) | Principal Occupation During Past 5 Years | Number of Funds in Fund Complex Overseen by Trustee (2) | Other Directorships Held During the Past 5 Years |
Dr. Robert A. Oden, Jr. (1946); Trustee
since 2005. | Retired; President, Carleton College (2002-2010); President, Kenyon College (1995-2002). | | Trustee, The Coldwater Conservation Fund (2017-present); Trustee, American Museum of Fly Fishing (2013-present); Trustee and Vice Chair, Trout Unlimited (2017-2021);Trustee, Dartmouth- Hitchcock MedicalCenter (2011-2020). |
Marian U. Pardo* (1946);
Trustee since 2013. | Managing Director and Founder, Virtual Capital Management LLC (investment consulting) (2007-present); Managing Director, Credit Suisse Asset Management (portfolio manager) (2003-2006). | | Board Chair and Member, Board of Governors, Columbus Citizens Foundation (not-for-profit supporting philanthropic and cultural programs) (2006-present). |
Emily A. Youssouf (1951);
Trustee since 2022. | Adjunct Professor (2011-present) and Clinical Professor (2009-2011), NYU Schack Institute of Real Estate; Board Member and Member of the Audit Committee (2013–present), Chair of Finance Committee (2019-present), Member of Related Parties Committee (2013-2018) and Member of the Enterprise Risk Committee (2015-2018), PennyMac Financial Services, Inc.; Board Member (2005-2018), Chair of Capital Committee (2006-2016), Chair of Audit Committee (2005-2018), Member of Finance Committee (2005-2018) and Chair of IT Committee (2016-2018), NYC Health and Hospitals Corporation. | | Trustee, NYC School Construction Authority (2009-present); Board Member, NYS Job Development Authority (2008-present); Trustee and Chair of the Audit Committee of the Transit Center Foundation (2015-2019). |
| | | |
Robert F. Deutsch** (1957);
Trustee since 2014. | Retired; Head of ETF Business for JPMorgan Asset Management (2013-2017); Head of Global Liquidity Business for JPMorgan Asset Management (2003-2013). | | Treasurer and Director of the JUST Capital Foundation (2017-present). |
Nina O. Shenker** (1957);
Trustee since 2022. | Vice Chair (2017-2021), General Counsel and Managing Director (2008-2016), Associate General Counsel and Managing Director (2004-2008), J.P. Morgan Asset & Wealth Management. | | Director and Member of Legal and Human Resources Subcommittees, American Jewish Joint Distribution Committee (2018-present). |
|
| The year shown is the first year in which a Trustee became a member of any of the following: the JPMorgan Mutual Fund Board, the JPMorgan ETF Board, the heritage J.P. Morgan Funds or the heritage One Group Mutual Funds. Trustees serve an indefinite term, until resignation, retirement, removal or death. The Board’s current retirement policy sets retirement at the end of the calendar year in which the Trustee attains the age of 75, provided that any Board member who was a member of the JPMorgan Mutual Fund Board prior to January 1, 2022 and was born prior to January 1, 1950 shall retire from the Board at the end of the calendar year in which the Trustee attains the age of 78. |
| A Fund Complex means two or more registered investment companies that hold themselves out to investors as related companies for purposes of investment and investor services or have a common investment adviser or have an investment adviser that is an affiliated person of the investment adviser of any of the other registered investment companies. The J.P. Morgan Funds Complex for which the Board of Trustees serves currently includes nine registered investment companies (179 J.P. Morgan Funds). |
| In connection with prior employment with JPMorgan Chase, Ms. Pardo was the recipient of non-qualified pension plan payments from JPMorgan Chase in the amount of approximately $2,055 per month, which she irrevocably waived effective January 1, 2013, and deferred compensation payments from JPMorgan Chase in the amount of approximately $7,294 per year, which ended in January 2013. In addition, Ms. Pardo receives payments from a fully-funded qualified plan, which is not an obligation of JPMorgan Chase. |
| Designation as an “Interested Trustee” is based on prior employment by the Adviser or an affiliate of the Adviser or interests in a control person of the Adviser. |
| The contact address for each of the Trustees is 277 Park Avenue, New York, NY 10172. |
Name (Year of Birth),
Positions Held with
the Trust (Since) | Principal Occupations During Past 5 Years |
Brian S. Shlissel (1964),
President and Principal Executive
Officer (2016)* | Managing Director and Chief Administrative Officer for J.P. Morgan pooled vehicles, J.P. Morgan Investment Management Inc. since 2014. |
Timothy J. Clemens (1975),
Treasurer and Principal Financial
Officer (2018) | Executive Director, J.P. Morgan Investment Management Inc. since February 2016. Mr. Clemens has been with J.P. Morgan Investment Management Inc. since 2013. |
Gregory S. Samuels (1980),
Secretary (2019) (formerly Assistant
Secretary 2010-2019) | Managing Director and Assistant General Counsel, JPMorgan Chase & Co. Mr. Samuels has been with JPMorgan Chase & Co. since 2010. |
Stephen M. Ungerman (1953),
Chief Compliance Officer (2005) | Managing Director, JPMorgan Chase & Co. Mr. Ungerman has been with JPMorgan Chase & Co. since 2000. |
Kiesha Astwood-Smith (1973),
Assistant Secretary (2021) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since June 2021; Senior Director and Counsel, Equitable Financial Life Insurance Company (formerly, AXA Equitable Life Insurance Company) from September 2015 through June 2021. |
Matthew Beck (1988),
Assistant Secretary (2021)** | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since May 2021; Senior Legal Counsel, Ultimus Fund Solutions from May 2018 through May 2021; General Counsel, The Nottingham Company from April 2014 through May 2018. |
Elizabeth A. Davin (1964),
Assistant Secretary (2005)** | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Ms. Davin has been with JPMorgan Chase & Co. (formerly Bank One Corporation) since 2004. |
Jessica K. Ditullio (1962)
Assistant Secretary (2005)** | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Ms. Ditullio has been with JPMorgan Chase & Co. (formerly Bank One Corporation) since 1990. |
Anthony Geron (1971),
Assistant Secretary (2018) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since September 2018; Lead Director and Counsel, AXA Equitable Life Insurance Company from 2015 to 2018 and Senior Director and Counsel, AXA Equitable Life Insurance Company from 2014 to 2015. |
Carmine Lekstutis (1980),
Assistant Secretary (2011) | Executive Director and Assistant General Counsel, JPMorgan Chase & Co. Mr. Lekstutis has been with JPMorgan Chase & Co. since 2011. |
Max Vogel (1990),
Assistant Secretary (2021) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since June 2021; Associate, Proskauer Rose LLP (law firm) from March 2017 to June 2021. |
Zachary E. Vonnegut-Gabovitch
(1986),
Assistant Secretary (2017) | Vice President and Assistant General Counsel, JPMorgan Chase & Co. since September 2016. |
Michael M. D’Ambrosio (1969),
Assistant Treasurer (2012) | Managing Director, J.P. Morgan Investment Management Inc. Mr. D’Ambrosio has been with J.P. Morgan Investment Management Inc. since 2012. |
Aleksandr Fleytekh (1972),
Assistant Treasurer (2019) | Vice President, J.P. Morgan Investment Management Inc. since February 2012. |
Shannon Gaines (1977),
Assistant Treasurer (2018)** | Vice President, J.P. Morgan Investment Management Inc. since January 2014. |
Jeffrey D. House (1972),
Assistant Treasurer (2017)** | Vice President, J.P. Morgan Investment Management Inc. since July 2006. |
Michael Mannarino (1985),
Assistant Treasurer (2020) | Vice President, J.P. Morgan Investment Management Inc. since 2014. |
Joseph Parascondola (1963),
Assistant Treasurer (2011)* | Executive Director, J.P. Morgan Investment Management, Inc. Mr. Parascondola has been with J.P. Morgan Investment Management Inc. since 2006. |
Gillian I. Sands (1969),
Assistant Treasurer (2012) | Executive Director, J.P. Morgan Investment Management Inc. Ms. Sands has been with J.P. Morgan Investment Management Inc. since 2012. |
|
The contact address for each of the officers, unless otherwise noted, is 277 Park Avenue, New York, NY 10172. |
| The contact address for the officer is 575 Washington Boulevard, Jersey City, NJ 07310. |
| The contact address for the officer is 1111 Polaris Parkway, Columbus, OH 43240. |
SCHEDULE OF SHAREHOLDER EXPENSES
(Unaudited)
Hypothetical $1,000 Investment
As a shareholder of the Portfolio, you incur ongoing costs, including investment advisory fees, administration fees, distribution fees (for Class 2 Shares) and other Portfolio expenses. Because the Portfolio is a funding vehicle for Policies and Eligible Plans you may also incur sales charges and other fees relating to the Policies or Eligible Plans. The examples below are intended to help you understand your ongoing costs (in dollars) of investing in the Portfolio, but not the costs of the Policies or Eligible Plans, and to compare these ongoing costs with the ongoing costs of investing in other mutual funds. The examples assume that you had a $1,000 investment in each Class at the beginning of the reporting period, July 1, 2022, and continued to hold your shares at the end of the reporting period, December 31, 2022.
Actual Expenses
For each Class of the Portfolio in the table below, the first line provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line of each Class under the heading titled “Expenses Paid During the Period” to estimate the expenses you paid on your account during this period.
Hypothetical Example for Comparison Purposes
The second line of each Class in the table below provides information about hypothetical account values and hypothetical expenses based on the Class’ actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Class’ actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in each Class of the Portfolio and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds. Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs, such as sales charges (loads), or redemption fees , or the costs associated with the Policies and Eligible Plans through which the Portfolio is held. Therefore, the second line for each Class in the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds. In addition, if these transaction costs were included, your costs would have been higher. The examples also assume all dividends and distributions have been reinvested.
| Beginning
Account Value
July 1, 2022 | Ending
Account Value
December 31, 2022 | Expenses
Paid During
the Period* | |
JPMorgan Insurance Trust Global Allocation Portfolio | | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
|
| Expenses are equal to each Class’ respective annualized expense ratio, multiplied by the average account value over the period, multiplied by 184/365 (to reflect the one-half year period). |
BOARD APPROVAL OF INVESTMENT ADVISORY AGREEMENT
(Unaudited)
The Board of Trustees (the “Board” or the “Trustees”) has established various standing committees composed of Trustees with diverse backgrounds, to which the Board has assigned specific subject matter responsibilities to further enhance the effectiveness of the Board’s oversight and decision making. Effective January 2022, the Board consolidated with the J.P. Morgan Exchange-Traded Fund Trust Board and now consists of Trustees from both Boards. The Board and its investment committees (Money Market and Alternative Products Committee, Equity Committee, and Fixed Income Committee) met regularly throughout the year and, at each meeting, considered factors that are relevant to their annual consideration of the continuation of the investment advisory agreements. The Board also met for the specific purpose of considering investment advisory agreement annual renewals. The Board held meetings on June 21-22, 2022 and August 9-11, 2022, at which the Trustees considered the continuation of the investment advisory agreement for the Portfolio whose annual report is contained herein (the “Advisory Agreement”). At the June meeting, the Board’s investment committees met to review and consider performance, expense and related information for the Portfolio and the other J.P. Morgan Funds overseen by the Board in which the Portfolio may invest (“Underlying Funds”). Each investment committee reported to the full Board, which then considered each investment committee’s preliminary findings. At the August meeting, the Trustees continued their review and consideration. The Trustees, including a majority of the Trustees who are not parties to the Advisory Agreement or “interested persons” (as defined in the Investment Company Act of 1940) of any party to the Advisory Agreement or any of their affiliates, approved the continuation of the Advisory Agreement on August 11, 2022.
As part of their review of the Advisory Agreement, the Trustees considered and reviewed performance and other information about the Portfolio and Underlying Funds received from the Adviser. This information includes the Portfolio’s and Underlying Funds’ performance as compared to the performance of the Portfolio’s and Underlying Funds’ peers and benchmarks, and analyses by the Adviser of the Portfolio’s and Underlying Funds’ performance. In addition, at each of their regular meetings throughout the year, the Trustees considered reports on the performance of certain J.P. Morgan Funds (including certain ETFs, beginning in February 2022) provided by an independent investment consulting firm (“independent consultant”). In addition, in preparation for the June and August meetings, the Trustees requested, received and evaluated extensive materials from the Adviser, including, with respect to the Portfolio and/or Underlying Funds, performance and expense information compiled by Broadridge, using data from Lipper Inc. and/or Morningstar Inc., independent providers of investment company data (together, “Broadridge”). The independent consultant also provided additional analysis of the performance of certain Underlying Funds in connection
with the Trustees’ review of the Advisory Agreement. Before voting on the Advisory Agreement, the Trustees reviewed the Advisory Agreement with representatives of the Adviser, counsel to the Trust, and independent legal counsel and received a memorandum from independent legal counsel to the Trustees discussing the legal standards for their consideration of the Advisory Agreement. The Trustees also discussed the Advisory Agreement with independent legal counsel in executive sessions at which no representatives of the Adviser were present.
A summary of the material factors evaluated by the Trustees in determining whether to approve the Advisory Agreement is provided below. Each Trustee attributed different weights to the various factors and no factor alone was considered determinative. The Trustees considered information provided with respect to the Portfolio and Underlying Funds throughout the year, including additional reporting and information provided in connection with the COVID-19 pandemic, as well as materials furnished specifically in connection with the annual review process. From year to year, the Trustees consider and place emphasis on relevant information in light of changing circumstances in market and economic conditions.
After considering and weighing the factors and information they had received, the Trustees found that the compensation to be received by the Adviser from the Portfolio under the Advisory Agreement was fair and reasonable under the circumstances, and determined that the continuance of the Advisory Agreement was in the best interests of the Portfolio and its shareholders.
Nature, Extent and Quality of Services Provided by the Adviser
The Trustees received and considered information regarding the nature, extent and quality of services provided to the Portfolio under the Advisory Agreement. The Trustees took into account information furnished throughout the year at Trustee meetings, as well as the materials furnished specifically in connection with this annual review process. Among other things, the Trustees considered:
(i)
The background and experience of the Adviser’s senior management and investment personnel, including personnel changes, if any;
(ii)
The qualifications, backgrounds and responsibilities of the portfolio management team primarily responsible for the day-to-day management of the Portfolio and Underlying Funds, including personnel changes, if any;
(iii)
The investment strategy for the Portfolio, and the infrastructure supporting the portfolio management team;
(iv)
Information about the structure and distribution strategy for the Portfolio and how it fits with the Trust’s other fund offerings;
BOARD APPROVAL OF INVESTMENT ADVISORY AGREEMENT
(Unaudited)
(v)
The administration services provided by the Adviser in its role as Administrator;
(vi)
Their knowledge of the nature and quality of the services provided by the Adviser and its affiliates gained from their experience as Trustees of the Trust and in the financial industry generally;
(vii)
The overall reputation and capabilities of the Adviser and its affiliates;
(viii)
The commitment of the Adviser to provide high quality service to the Portfolio and Underlying Funds, as applicable;
(ix)
Their overall confidence in the Adviser’s integrity;
(x)
The Adviser’s responsiveness to requests for additional information, questions or concerns raised by them, including the Adviser’s willingness to consider and implement organizational and operational changes designed to improve investment results and the services provided to the Portfolio and Underlying Funds; and
(xi)
The Adviser’s business continuity plan and steps the Adviser and its affiliates have taken to provide ongoing services to the Portfolio and Underlying Funds, as applicable, during the COVID-19 pandemic, and the Adviser’s and its affiliates’ success in continuing to provide services to the Portfolio and its shareholders throughout this period.
Based upon these considerations and other factors, the Trustees concluded that they were satisfied with the nature, extent and quality of the services provided to the Portfolio by the Adviser.
Costs of Services Provided and Profitability to the Adviser and its Affiliates
The Trustees received and considered information regarding the profitability to the Adviser and its affiliates from providing services to the Portfolio and Underlying Funds. The Trustees reviewed and discussed this information. The Trustees recognized that this information is not audited and represents the Adviser’s determination of its and its affiliates’ revenues from the contractual services provided to the Portfolio, less expenses of providing such services. Expenses include direct and indirect costs and are calculated using an allocation methodology developed by the Adviser and reviewed with the Board. The Trustees also recognized that it is difficult to make comparisons of profitability from fund investment advisory contracts because comparative information is not generally publicly available and is affected by numerous factors, including the structure of the particular adviser, the types of funds it manages, its business mix, numerous assumptions regarding allocations and the fact that publicly-traded fund managers’ operating profits and net income are net of
distribution and marketing expenses. Based upon their review, and taking into consideration the factors noted above, the Trustees concluded that the profitability to the Adviser under the Advisory Agreement was not unreasonable in light of the services and benefits provided to the Portfolio.
The Trustees also considered that JPMDS, an affiliate of the Adviser, and the Adviser earn fees from the Portfolio and Underlying Funds for providing administration services. These fees were shown separately in the profitability analysis presented to the Trustees. The Trustees also considered the payments of Rule 12b-1 fees to JPMDS, which also acts as the Portfolio’s distributor, and that these fees are in turn generally paid to insurance companies that use the Portfolio in connection with insurance products they issue, including financial intermediaries that are affiliates of the Adviser (although they are retained by JPMDS in certain instances). The Trustees also considered the fees earned by JPMorgan Chase Bank, N.A. (“JPMCB”), an affiliate of the Adviser, for custody, fund accounting and other related services for the Portfolio and/or Underlying Funds and the profitability of the arrangements to JPMCB.
Fall-Out Benefits
The Trustees reviewed information regarding potential “fall-out” or ancillary benefits received by the Adviser and its affiliates as a result of their relationship with the Portfolio. The Trustees considered that the J.P. Morgan Funds’ operating accounts are held at JPMCB, which, as a result, will receive float benefits for certain J.P. Morgan Funds, as applicable. The Trustees also noted that the Adviser supports a diverse set of products and services, which benefits the Adviser by allowing it to leverage its infrastructure to serve additional clients, including the benefits received by the Adviser and its affiliates in connection with the Portfolio’s investments in the Underlying Funds. The Trustees also reviewed the Adviser’s allocation of fund brokerage for the J.P. Morgan Funds complex, including allocations to brokers who provide research to the Adviser, as well as the Adviser’s use of affiliates to provide other services and the benefits to such affiliates of doing so.
Economies of Scale
The Trustees considered the extent to which the Portfolio may benefit from potential economies of scale. The Trustees considered that there may not be a direct relationship between economies of scale realized by the Portfolio and those realized by the Adviser as assets increase. The Trustees considered the extent to which the Portfolio was priced to scale and whether it would be appropriate to add advisory fee breakpoints, but noted that the Portfolio has implemented fee waivers and contractual expense limitations (“Fee Caps”) which allow the Portfolio’s shareholders to share potential economies of scale from its inception and that the fees remain satisfactory relative
to peer funds. The Trustees considered the benefits to the Portfolio of the use of an affiliated distributor and custodian, including the ability to rely on existing infrastructure supporting distribution, custodial and transfer agent services, and the ability to negotiate competitive fees for the Portfolio. The Trustees further considered the Adviser’s and JPMDS’s ongoing investments in their business in support of the Portfolio, including the Adviser’s and/or JPMDS’s investments in trading systems, technology (including improvements to the J.P. Morgan Funds’ website, and cybersecurity improvements), retention of key talent, and regulatory support enhancements. The Trustees concluded that the current fee structure for the Portfolio, including Fee Caps that the Adviser has in place that serve to limit the overall net expense ratios of the Portfolio at competitive levels, was reasonable. The Trustees concluded that the Portfolio’s shareholders received the benefits of potential economies of scale through the Fee Caps and the Adviser’s reinvestment in its operations to serve the Portfolio and its shareholders. The Trustees noted that the Adviser’s reinvestment ensures sufficient resources in terms of personnel and infrastructure to support the Portfolio.
Fees Relative to Adviser’s Other Clients
The Trustees received and considered information about the nature and extent of investment advisory services and fee rates offered to other clients of the Adviser, including, to the extent applicable, institutional separate accounts, collective investment trusts, other registered investment companies and/or private funds sub-advised by the Adviser, for investment management styles substantially similar to that of the Portfolio. The Trustees considered the complexity of investment management for registered investment companies relative to the Adviser’s other clients and noted differences, as applicable, in the fee structure and the regulatory, legal and other risks and responsibilities of providing services to the different clients. The Trustees considered that serving as an adviser to a registered investment company involves greater responsibilities and risks than acting as a sub-adviser and observed that sub-advisory fees may be lower than those charged by the Adviser to the Portfolio. The Trustees also noted that the adviser, not the applicable investment company, typically bears the sub-advisory fee and that many responsibilities related to the advisory function are typically retained by the primary adviser. The Trustees concluded that the fee rates charged to the Portfolio in comparison to those charged to the Adviser’s other clients were reasonable.
Investment Performance
The Trustees receive and consider information about the Portfolio’s performance throughout the year. In addition, the Trustees received and considered absolute and/or relative performance information for the Portfolio in a report prepared by Broadridge. The Trustees considered the total return
performance information, which included the ranking of the Portfolio within a performance universe comprised of funds with the same Broadridge investment classification and objective (the “Universe”), as well as a subset of funds within the Universe (the “Peer Group”), by total return for the applicable one-, three-and five-year periods. The Trustees reviewed a description of Broadridge’s methodology for selecting mutual funds in the Portfolio’s Universe and Peer Group and noted that Universe and Peer Group quintile rankings were not calculated if the number of funds in the Universe and/or Peer Group did not meet a predetermined minimum. The Broadridge materials provided to the Trustees highlighted information with respect to a representative class to assist the Trustees in their review. As part of this review, the Trustees also reviewed the Portfolio’s performance against its benchmark and considered the performance information provided for the Portfolio at regular Board meetings by the Adviser. The Trustees also engaged with the Adviser to consider what steps might be taken to improve performance, as applicable. The Broadridge performance data noted by the Trustees as part of their review and the determinations made by the Trustees with respect to the Portfolio’s performance are summarized below:
The Trustees noted that the Portfolio’s performance for Class 1 shares was in the fourth, second and first quintiles of the Peer Group, and in the third, second and first quintiles of the Universe, for the one-, three- and five-year periods ended December 31, 2021, respectively. The Trustees noted that the Portfolio’s performance for Class 2 shares was in the fourth, third and third quintiles of the Peer Group, and in the fourth, second and first quintiles of the Universe, for the one-, three- and five-year periods ended December 31, 2021, respectively. The Trustees discussed the performance and investment strategy of the Portfolio with the Adviser and based upon this discussion and various other factors, concluded that the Portfolio’s performance was satisfactory under the circumstances.
Advisory Fees and Expense Ratios
The Trustees considered the contractual advisory fee rate and administration fee rate paid by the Portfolio to the Adviser and compared the combined rate to the information prepared by Broadridge concerning management fee rates paid by other funds in the same Broadridge category as the Portfolio. The Trustees recognized that Broadridge reported the Portfolio’s management fee rate as the combined contractual advisory fee and administration fee rates. The Trustees also reviewed information about other expenses and the expense ratios for the Portfolio and noted that Universe and Peer Group quintile rankings were not calculated if the number of funds in the Universe and/or Peer Groups did not meet a predetermined minimum. The Trustees considered the Fee Caps currently in place, for the Portfolio, the net advisory fee rate after taking
BOARD APPROVAL OF INVESTMENT ADVISORY AGREEMENT
(Unaudited)
into account any waivers and/or reimbursements, and, where deemed appropriate by the Trustees, additional waivers and/or reimbursements. The Trustees recognized that it can be difficult to make comparisons of advisory fees because there are variations in the services that are included in the fees paid by other funds. The Trustees’ determinations as a result of the review of the Portfolio’s advisory fees and expense ratios are summarized below:
The Trustees noted that the Portfolio’s net advisory fee for Class 1 shares was in the third and second quintiles of the Peer Group and Universe, respectively, and that the actual total expenses for Class 1 shares were in the fourth quintile of both
the Peer Group and Universe. The Trustees noted that the Portfolio’s net advisory fee for Class 2 shares was in the second quintile of both the Peer Group and Universe, and that the actual total expenses for Class 2 shares were in the fourth quintile of both the Peer Group and Universe. After considering the factors identified above, in light of this information, the Trustees concluded that the advisory fee was satisfactory in light of the services provided to the Portfolio and that such fee would be for services provided in addition to, rather than duplicative of, services provided under the advisory agreements of the Underlying Funds in which the Portfolio invests.
TAX LETTER
(Unaudited)
(Dollar values in thousands)
Dividends Received Deduction (DRD)
The Portfolio had 8.98%, or maximum allowable percentage, of ordinary income distributions eligible for the dividends received deduction for corporate shareholders for the fiscal year ended December 31, 2022.
Long Term Capital Gain
The Portfolio distributed $4,360, or maximum allowable amount, of long-term capital gain dividends for the fiscal year ended December 31, 2022.
THIS PAGE IS INTENTIONALLY LEFT BLANK
J.P. Morgan Funds are distributed by JPMorgan Distribution Services, Inc., which is an affiliate of JPMorgan Chase & Co. Affiliates of JPMorgan Chase & Co. receive fees for providing various services to the funds.
Contact JPMorgan Distribution Services, Inc. at 1-800-480-4111 for a portfolio prospectus. You can also visit us at www.jpmorgan.com/variableinsuranceportfolios. Investors should carefully consider the investment objectives and risk as well as charges and expenses of the mutual fund before investing. The prospectus contains this and other information about the mutual fund. Read the prospectus carefully before investing.
Investors may obtain information about the Securities Investor Protection Corporation (SIPC), including the SIPC brochure, by visiting www.sipc.org or by calling SIPC at 202-371-8300.
The Portfolio files a complete schedule of its portfolio holdings for the first and third quarters of its fiscal year with the SEC as an exhibit to its report on Form N-PORT. The Portfolio’s Form N-PORT reports are available on the SEC’s website at http://www.sec.gov. The Portfolio's quarterly holdings can be found by visiting the Portfolio's website at www.jpmorgan.com/variableinsuranceportfolios.
A description of the Portfolio’s policies and procedures with respect to the disclosure of the Portfolio’s holdings is available in the prospectuses and Statement of Additional Information.
A copy of proxy policies and procedures is available without charge upon request by calling 1-800-480-4111 and on the Portfolio’s website at www.jpmorgan.com/variableinsuranceportfolios. A description of such policies and procedures is on the SEC’s website at www.sec.gov. The Trustees have delegated the authority to vote proxies for securities owned by the Portfolio to the Adviser. A copy of the Portfolio’s voting record for the most recent 12-month period ended June 30 is available on the SEC’s website at www.sec.gov or at the Portfolio’s website at www.jpmorgan.com/variableinsuranceportfolios no later than August 31 of each year. The Portfolio’s proxy voting record will include, among other things, a brief description of the matter voted on for each portfolio security, and will state how each vote was cast, for example, for or against the proposal.
J.P. Morgan Asset Management is the brand name for the asset management business of JPMorgan Chase & Co. and its affiliates worldwide.
© JPMorgan Chase & Co., 2022. All rights reserved. December 2022.
AN-JPMITGAP-1222
ITEM 2. CODE OF ETHICS.
Disclose whether, as of the end of the period covered by the report, the registrant has adopted a code of ethics that applies to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the registrant or a third party. If the registrant has not adopted such a code of ethics, explain why it has not done so.
The registrant must briefly describe the nature of any amendment, during the period covered by the report, to a provision of its code of ethics that applies to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the registrant or a third party, and that relates to any element of the code of ethics definition enumerated in paragraph (b) of this Item. The registrant must file a copy of any such amendment as an exhibit pursuant to Item 13(a)(1), unless the registrant has elected to satisfy paragraph (f) of this Item by positing its code of ethics on its website pursuant to paragraph (f)(2) of this Item, or by undertaking to provide its code of ethics to any person without charge, upon request, pursuant to paragraph (f)(3) of this Item.
If the registrant has, during the period covered by the report, granted a waiver, including an implicit waiver, from a provision of the code of ethics that applies to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the registrant or third party, that relates to one or more items set forth in paragraph (b) of this Item, the registrant must briefly describe the nature of the waiver, the name of the person to whom the waiver was granted, and the date of the waiver.
The Registrant has adopted a code of ethics that applies to the Registrant’s principal executive officer and principal financial officer. There were no amendments to the code of ethics or waivers granted with respect to the code of ethics in the period covered by the report.
ITEM 3. AUDIT COMMITTEE FINANCIAL EXPERT.
(a) (1) Disclose that the registrant’s board of directors has determined that the registrant either:
(i) Has at least one audit committee financial expert serving on its audit committee; or
(ii) Does not have an audit committee financial expert serving on its audit committee.
The Registrant’s Board of Trustees has determined that the Registrant has at least one audit committee financial expert serving on its audit committee. The Securities and Exchange Commission has stated that the designation or identification of a person as an audit committee financial expert pursuant to this Item 3 of Form N-CSR does not impose on such person any duties, obligations or liabilities that are greater than the duties, obligations and liabilities imposed on such person as a member of the Audit Committee and the Board of Trustees in the absence of such designation or identification.
(2) If the registrant provides the disclosure required by paragraph (a)(1)(i) of this Item, it must disclose the name of the audit committee financial expert and whether that person is “independent.” In order to be considered “independent” for purposes of this Item, a member of an audit committee may not, other than in his or her capacity as a member of the audit committee, the board of directors, or any other board committee:
(i) Accept directly or indirectly any consulting, advisory, or other compensatory fee from the issuer; or
(ii) Be an “interested person” of the investment company as defined in Section 2(a)(19) of the Act (15 U.S.C. 80a-2(a)(19)).
The Audit committee financial expert is Kathleen M. Gallagher. Ms. Gallagher is not an “interested person” of the Registrant and is also “independent” as defined by the U.S. Securities and Exchange Commission for the purposes of the audit committee financial expert determination. Effective February 9, 2023, Gary L. French, Raymond Kanner and Lawrence R. Maffia have also been designated as Audit Committee financial experts by the Registrant’s Board of Trustees, each of whom is not an “interested person” of the Registrant and is also “independent” as defined by the U.S. Securities and Exchange Commission for the purposes of the audit committee financial expert determination.
(3) If the registrant provides the disclosure required by paragraph (a)(1)(ii) of this Item, it must explain why it does not have an audit committee financial expert.
Not applicable.
ITEM 4. PRINCIPAL ACCOUNTANT FEES AND SERVICES.
(a) Disclose, under the caption Audit Fees, the aggregate fees billed for each of the last two fiscal years for professional services rendered by the principal accountant for the audit of the registrant’s annual financial statements or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years.
AUDIT FEES
2022 – $336,182
2021 – $330,430
(b) Disclose, under the caption Audit-Related Fees, the aggregate fees billed in each of the last two fiscal years for assurance and related services by the principal accountant that are reasonably related to the performance of the audit of the registrant’s financial statements and are not reported under paragraph (a) of this Item. Registrants shall describe the nature of the services comprising the fees disclosed under this category.
AUDIT-RELATED FEES
2022 – $47,960
2021 – $47,960
Audit-related fees consists of semi-annual financial statement reviews and security count procedures performed as required under Rule 17f-2 of the Investment Company Act of 1940 during the Registrant’s fiscal year.
(c) Disclose, under the caption Tax Fees, the aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning. Registrants shall describe the nature of the services comprising the fees disclosed under this category.
TAX FEES
2022 – $58,286
2021 – $58,788
The tax fees consist of fees billed in connection with preparing the federal regulated investment company income tax returns for the Registrant for the tax years ended December 31, 2022 and 2021, respectively.
For the last fiscal year, no tax fees were required to be approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X.
(d) Disclose, under the caption All Other Fees, the aggregate fees billed in each of the last two fiscal years for products and services provided by the principal accountant, other than the services reported in paragraphs (a) through (c) of this Item. Registrants shall describe the nature of the services comprising the fees disclosed under this category.
ALL OTHER FEES
2022 – Not applicable
2021 – Not applicable
(e) (1) Disclose the audit committee’s pre-approval policies and procedures described in paragraph (c)(7) of Rule 2-01 of Regulation S-X.
Pursuant to the Registrant’s Audit Committee Charter and written policies and procedures for the pre-approval of audit and non-audit services (the “Pre-approval Policy”), the Audit Committee pre-approves all audit and non-audit services performed by the Registrant’s independent public registered accounting firm for the Registrant. In addition, the Audit Committee pre-approves the auditor’s engagement for non-audit services with the Registrant’s investment adviser (not including a sub-adviser whose role is primarily portfolio management and is sub-contracted or overseen by another investment adviser) and any Service Affiliate in accordance with paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X, if the engagement relates directly to the operations and financial reporting of the Registrant. Proposed services may be pre-approved either 1) without consideration of specific case-by-case services or 2) require the specific pre-approval of the Audit Committee. Therefore, initially the Pre-approval Policy listed a number of audit and non-audit services that have been approved by the Audit Committee, or which were not subject to pre-approval under the transition provisions of Sarbanes-Oxley Act of 2002 (the
“Pre-approval List”). The Audit Committee annually reviews and pre-approves the services included on the Pre-approval List that may be provided by the independent public registered accounting firm without obtaining additional specific pre-approval of individual services from the Audit Committee. The Audit Committee adds to, or subtracts from, the list of general pre-approved services from time to time, based on subsequent determinations. All other audit and non-audit services not on the Pre-approval List must be specifically pre-approved by the Audit Committee.
One or more members of the Audit Committee may be appointed as the Committee’s delegate for the purposes of considering whether to approve such services. Any pre-approvals granted by the delegate will be reported, for informational purposes only, to the Audit Committee at its next scheduled meeting. The Audit Committee’s responsibilities to pre-approve services performed by the independent public registered accounting firm are not delegated to management.
(2) Disclose the percentage of services described in each of paragraphs (b) through (d) of this Item that were approved by the audit committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.
2022 – 0.0%
2021 – 0.0%
(f) If greater than 50 percent, disclose the percentage of hours expended on the principal accountant’s engagement to audit the registrant’s financial statements for the most recent fiscal year that were attributed to work performed by persons other than the principal accountant’s full-time, permanent employees.
Not applicable—Less than 50%.
(g) Disclose the aggregate non-audit fees billed by the registrant’s accountant for services rendered to the registrant, and rendered to the registrant’s investment adviser (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control with the adviser that provides ongoing services to the registrant for each of the last two fiscal years of the registrant.
The aggregate non-audit fees billed by the independent registered public accounting firm for services rendered to the Registrant, and rendered to Service Affiliates, for the last two calendar year ends were:
2022 – $30.6 million
2021 – $30.1 million
(h) Disclose whether the registrant’s audit committee of the board of directors has considered whether the provision of non-audit services that were rendered to the registrant’s investment adviser (not including any subadviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant that were not pre-approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X is compatible with maintaining the principal accountant’s independence.
The Registrant’s Audit Committee has considered whether the provision of the non-audit services that were rendered to Service Affiliates that were not pre-approved (not requiring pre-approval) is compatible with maintaining the independent public registered accounting firm’s independence. All services provided by the independent public registered accounting firm to the Registrant or to Service Affiliates that were required to be pre-approved were pre-approved as required.
(i) A registrant identified by the Commission pursuant to Section 104(i)(2)(A) of the Sarbanes-Oxley Act of 2002 (15 U.S.C. 7214(i)(2)(A)), as having retained, for the preparation of the audit report on its financial statements included in the Form NCSR, a registered public accounting firm that has a branch or office that is located in a foreign jurisdiction and that the Public Company Accounting Oversight Board has determined it is unable to inspect or investigate completely because of a position taken by an authority in the foreign jurisdiction must electronically submit to the Commission on a supplemental basis documentation that establishes that the registrant is not owned or controlled by a governmental entity in the foreign jurisdiction. The registrant must submit this documentation on or before the due date for this form. A registrant that is owned or controlled by a foreign governmental entity is not required to submit such documentation.
Not applicable.
(j) A registrant that is a foreign issuer, as defined in 17 CFR 240.3b-4, identified by the Commission pursuant to Section 104(i)(2)(A) of the Sarbanes-Oxley Act of 2002 (15 U.S.C. 7214(i)(2)(A)), as having retained, for the preparation of the audit report on its financial statements included in the Form N-CSR, a registered public accounting firm that has a branch or office that is located in a foreign jurisdiction and that the Public Company Accounting Oversight Board has determined it is unable to inspect or investigate completely because of a position taken by an authority in the foreign jurisdiction, for each year in which the registrant is so identified, must provide the below disclosures. Also, any such identified foreign issuer that uses a variable-interest entity or any similar structure that results in additional foreign entities being consolidated in the financial statements of the registrant is required to provide the below disclosures for itself and its consolidated foreign operating entity or entities. A registrant must disclose:
| | (1) | That, for the immediately preceding annual financial statement period, a registered public accounting firm that the PCAOB was unable to inspect or investigate completely, because of a position taken by an authority in the foreign jurisdiction, issued an audit report for the registrant; |
| | (2) | The percentage of shares of the registrant owned by governmental entities in the foreign jurisdiction in which the registrant is incorporated or otherwise organized; |
| | (3) | Whether governmental entities in the applicable foreign jurisdiction with respect to that registered public accounting firm have a controlling financial interest with respect to the registrant; |
| | (4) | The name of each official of the Chinese Communist Party who is a member of the board of directors of the registrant or the operating entity with respect to the registrant; and |
| | (5) | Whether the articles of incorporation of the registrant (or equivalent organizing document) contains any charter of the Chinese Communist Party, including the text of any such charter. |
Not applicable.
ITEM 5. AUDIT COMMITTEE OF LISTED REGISTRANTS.
(a) If the registrant is a listed issuer as defined in Rule 10A-3 under the Exchange Act (17CFR 240.10A-3), state whether or not the registrant has a separately-designated standing audit committee established in accordance with Section 3(a)(58)(A) of the Exchange Act (15 U.S.C. 78c(a)(58)(A)). If the registrant has such a committee, however designated, identify each committee member. If the entire board of directors is acting as the registrant’s audit committee as specified in Section 3(a)(58)(B) of the Exchange Act (15 U.S.C. 78c(a)(58)(B)), so state.
(b) If applicable, provide the disclosure required by Rule 10A-3(d) under the Exchange Act (17CFR 240.10A-3(d)) regarding an exemption from the listing standards for all audit committees.
Not applicable.
ITEM 6. INVESTMENTS.
File Schedule I – Investments in securities of unaffiliated issuers as of the close of the reporting period as set forth in Section 210.12-12 of Regulation S-X, unless the schedule is included as part of the report to shareholders filed under Item 1 of this Form.
Included in Item 1.
ITEM 7. DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.
Not applicable.
ITEM 8. PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES.
Not applicable.
ITEM 9. PURCHASE OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS.
Not applicable.
ITEM 10. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
Describe any material changes to the procedures by which shareholders may recommend nominees to the registrant’s board of directors, where those changes were implemented after the registrant last provided disclosure in response to the requirements of Item 7(d)(2)(ii)(G) of Schedule 14A (17 CFR 240.14a-101), or this Item.
No material changes to report.
ITEM 11. CONTROLS AND PROCEDURES.
(a) Disclose the conclusions of the registrant’s principal executive and principal financial officers, or persons performing similar functions, regarding the effectiveness of the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Act (17 CFR 270.30a-3(c))) as of a date within 90 days of the filing date of the report that includes the disclosure required by this paragraph, based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the Act (17 CFR 270.30a-3(b)) and Rules 13a-15(b) or 15d-15(b) under the Exchange Act (17 CFR 240.13a-15(b) or 240.15d-15(b)).
The Registrant’s principal executive and principal financial officers have concluded, based on their evaluation of the Registrant’s disclosure controls and procedures as of a date within 90 days of the filing date of this report, that the Registrant’s disclosure controls and procedures are reasonably designed to ensure that information required to be disclosed by the Registrant on Form N-CSR is recorded, processed, summarized and reported within the required time periods and that information required to be disclosed by the Registrant in the reports that it files or submits on Form N-CSR is accumulated and communicated to the Registrant’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.
(b) Disclose any change in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Act (17 CFR 270.30a-3(d)) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
There were no changes in the Registrant’s internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Registrant’s internal control over financial reporting.
ITEM 12. DISCLOSURE OF SECURITIES LENDING ACTIVITIES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.
Not applicable.
ITEM 13. EXHIBITS.
| | (a) | File the exhibits listed below as part of this Form. Letter or number the exhibits in the sequence indicated. |
(1) Any code of ethics, or amendment thereto, that is the subject of the disclosure required by Item 2, to the extent that the registrant intends to satisfy the Item 2 requirements through filing of an exhibit.
Code of Ethics applicable to its Principal Executive and Principal Financial Officers pursuant to Section 406 of the Sarbanes-Oxley Act of 2002 attached hereto.
(2) A separate certification for each principal executive officer and principal financial officer of the registrant as required by Rule 30a-2(a) under the Act (17 CFR 270.30a-2), exactly as set forth below:
Certifications pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 are attached hereto.
(1) Any written solicitation to purchase securities under Rule 23c-1 under the Act (17 CFR 270.23c-1) sent or given during the period covered by the report by or on behalf of the registrant to 10 or more persons.
Not applicable.
(2) Change in the registrant’s independent public accountant. Provide the information called for by Item 4 of Form 8-K under the Exchange Act (17 CFR 249.308). Unless otherwise specified by Item 4, or related to and necessary for a complete understanding of information not previously disclosed, the information should relate to events occurring during the reporting period.
Not applicable.
| | (b) | A separate or combined certification for each principal executive officer and principal officer of the registrant as required by Rule 30a-2(b) under the Act of 1940. |
Certifications pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 are attached hereto.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
JPMorgan Insurance Trust
| | |
| By: | | /s/ Brian S. Shlissel |
| | Brian S. Shlissel |
| | President and Principal Executive Officer |
| | February 23, 2023 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| | |
| By: | | /s/ Brian S. Shlissel |
| | Brian S. Shlissel |
| | President and Principal Executive Officer |
| | February 23, 2023 |
| |
| By: | | /s/ Timothy J. Clemens |
| | Timothy J. Clemens |
| | Treasurer and Principal Financial Officer |
| | February 23, 2023 |
